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Chronic lower back pain (CLBP) remains a physiotherapy treatment challenge with evidence lacking 
in which treatments best improve outcomes. Furthermore, the presence of CLBP phenotypes, 
including nociceptive and neuropathic phenotypes, is rarely mentioned in physiotherapy literature. 
 
The primary objective of this randomised controlled trial was to assess changes in pain intensity 
between baseline and 12-week follow-up, between and within the following three treatment groups: 
usual care physiotherapy (P), a partly supervised pedometer-based walking intervention (W), and a 
combination of both (PW) in patients with nociceptive or neuropathic CLBP. Secondary objectives 
assessed changes in disability, kinesiophobia and pain catastrophizing between baseline and 12-week 
follow-up between and within the three groups.  
 
The review of literature demonstrates the complex neurophysiology involved in CLBP pain 
phenotypes. Physiotherapists currently lack a comprehensive knowledge of pain. Associated 
psychosocial pain outcomes in literature exploring usual care physiotherapy and walking has been 
sparse. The limited randomized controlled trials involved up until now have not fully explored 
walking as exercise independently nor combined with usual care physiotherapy to treat CLBP.  
 
A sample of 147 participants, 62.6% (92/147) female and 37.4% (55/147) males; mean age (SD) 46.2 
(10.9) years with nociceptive (52.4%, 77/147) or neuropathic (47.6%, 70/147) CLBP were recruited 
from three private practice physiotherapy clinics in Johannesburg, South Africa. Consenting 
participants completed self-reported measures of pain intensity, disability, kinesiophobia, pain 
catastrophizing. Physical activity was measured using pedometers to record weekly steps. 
Participants were randomly allocated to P (n=46), W (n=52), or PW (n=49) groups, and followed up 
at 12-weeks (completion 72.8%, 107/147). 
 
An intention-to-treat analysis using a linear mixed model showed significant improvement in pain 
intensity (p<0.01), disability (p<0.01), kinesiophobia (p<0.01) and pain catastrophizing (p<0.01) in 
all groups but there was no statistically significant difference between groups at 12-week follow-up. 
However, a minimally clinically important difference in pain intensity was only observed in the PW 
group at the 12-week follow-up. Moreover, greater than two physiotherapy visits showed a 
significant improvement in pain intensity (p=0.01), kinesiophobia (p=0.01) and on pain 
catastrophizing (p=0.01). Further exploration of the ideal number of physiotherapy visits may be 
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Chapter 1: Introduction 
 
1.1 Research overview 
 
Internationally, Lower Back Pain (LBP) is estimated to affect up to 85% of individuals during their 
lifetime (van Tulder et al., 2006a; Rubin, 2007). In developed countries, it is estimated to affect 84% 
of working adults (Thiese et al., 2014). Up to 15% of individuals experiencing LBP progress to 
experiencing chronic lower back pain, (CLBP) (Cilliers and Maart 2013). CLBP diagnosis is based 
on anatomical location and a timeframe of LBP lasting for more than three-months, unlike acute LBP 
which normally resolves in six-weeks (Liddle, Baxter and Gracey, 2004). 
 
Using World Health Organization data, it has been predicted that from 2010-2020, developing 
countries are likely to experience the greatest prevalence of CLBP (at least one episode in a lifetime) 
(Woolf and Pfleger, 2003). A recent systematic review concurs with this in emphasizing that 
contributing factors are likely to be biopsychosocial in nature (Meucci, Fassa and Faria, 2015). These 
include low income and lower levels of education both associated with poorer living and working 
conditions. (Woolf and Pfleger, 2003; Meucci, Fassa and Faria, 2015). Two systematic reviews 
reporting on prevalence in CLBP and LBP in Africa concur that these factors may consequently 
cause these populations to experience the greatest impact on their economic, societal, and public 
health when compared with developed nations (Louw, Morris and Grimmer-Somers, 2007; Morris 
et al., 2018).  
 
The diagnosis of LBP is mainly characterised by the presence of pain (Goldby et al., 2006). 
Difficulties with comparing pain prognoses in patients with LBP include different aetiologies, 
treatments, and outcome parameters (Rubin, 2007). Methods used to determine a favourable 
prognosis are variable, it may be defined by complete amelioration of pain, return to work or 
discontinued treatment. As a source of treatment, sign and symptom, pain itself has not received 
enough attention in physiotherapy studies. Unlike the 2009 UK NICE guidelines, the 2016 UK NICE 
guidelines do encourage patient stratification using the STarT back tool highlighting the involvement 
of pain phenotypes and biopsychosocial risk factors (National Collaborating Centre for Primary Care 
[UK], 2009; National Institute for Health and Care Excellence, 2016). Pain is often considered a 
symptom of pathology, but it has been described as a disease, with emotional, sensory, and cognitive 
consequences (Meyer, 2007). Often the origin of pain in CLBP is unknown and some researchers 
argue that effective management requires more research into defining pain phenotypes within cohorts 
(Chetty et al., 2012; Baron et al., 2016; Courtney, Fernández-de-Las-Peñas and Bond, 2017). Pain 
phenotypes classify pain according to the dominant neurophysiological mechanism responsible for 
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its origin and/ or maintenance (Smart, O’Connell and Doody 2008; Courtney, Fernández-de-Las-
Peñas and Bond, 2017). Where pain once was considered as a homogenous entity, CLBP has been 
described as heterogonous, occurring in distinct phenotypes, largely accepted as having a major 
neuropathic or nociceptive component (Smart et al., 2012a; Smart et al., 2012b; Baron et al., 2016; 
Spahr et al., 2017). Nociceptive pain (NP) can arise from noxious stimulation of the lumbar spine or 
associated soft tissues (Costigan, Scholz and Woolf, 2009; Hoheisal et al., 2013). Neuropathic 
(peripheral) pain (PNP) has been explained as a lesion/ dysfunction of the somatosensory system 
(Woolf, 2004). Up until now, the literature reveals pain phenotypes have not been explored in a 
modelling process when examining patients with CLBP in physiotherapy studies.  
 
Physiotherapy treatment is common practice in conservative therapy for CLBP (Qaseem et al., 2017). 
Over the last three decades, physiotherapy treatments have evolved from a biomedical to a 
biopsychosocial approach, with the former concentrating on mechanical treatments and the latter 
integrating biological, psychological, and social components (Gatchel et al., 2007). Conservative 
therapy or non-surgical CLBP management includes traditional medical management e.g., cupping, 
pharmacotherapy, self-management programs e.g., strength and stretching exercises and 
interventional pain management e.g., rhizotomies (Airaksinen, et al 2006; Chou et al, 2007; Krein et 
al., 2013).  The UK National Institute for Health and Care Excellence’s (NICE) recommendations 
for CLBP management, parallel those used by physiotherapists in South Africa (National 
Collaborating Centre for Primary Care [UK], 2009; Naidoo et al., 2012). Both recommend the 
combined use of massage, manipulation, exercise, and advice on self-management e.g., remaining 
physically active.  
 
Exercise is a sub-set of physical activity and is advocated in the treatment of CLBP (Chou, 2010). 
There is still debate regarding the optimal type, frequency, and duration of exercise (Lawford, 
Walters and Ferrar, 2015). As yet, with isometric lumbar stabilizing exercises and walking programs 
advised with varied methodologies, an ideal exercise program that is superior to others is yet to be 
found. Physical activity (PA) and exercise in the form of walking have been recently explored as a 
conservative treatment for CLBP (Lawford, Walters and Ferrar., 2015; Sitthipornvorakul et al., 
2018). However, its usefulness as an optimal treatment for CLBP is equivocal when compared to 
standard treatments utilised by physiotherapists such as varied amounts of spinal manipulation, 
massage, electrotherapy, and isometric lumbar stabilizing exercises (Hendrick et al., 2010; Lawford, 
Walters and Ferrar., 2015; Sitthipornvorakul et al., 2018).  
 
Treatments using usual care physiotherapy, walking exercise and a combination of the two have not 
yet been compared. The current trial proposed to use a randomised controlled study design to 
investigate the effect of usual care physiotherapy modalities, a walking intervention, and a 
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combination of both on the biopsychosocial outcomes of CLBP, including pain intensity, disability, 
kinesiophobia, and catastrophic thinking. It will examine these in the context of nociceptive and 
neuropathic pain phenotypes in the modelling process.  
 
1.2 Research question and aim  
 
Research question: Does a usual care physiotherapy intervention or a combination of usual 
care physiotherapy and a partly supervised pedometer-based walking intervention show 
greater improvements in pain intensity and associated CLBP outcomes than a partly 
supervised pedometer-based walking intervention alone in participants with chronic low back 
pain? Walking programs used in previous studies have not been compared to usual care 
physiotherapy intervention or a combination of usual care physiotherapy and a partly supervised 
pedometer-based walking intervention whilst objectively measuring steps taken in all treatment 
arms. The treatments in this trial have never all been compared to each other in a single trial.  
 
Aim: To determine whether a 12-week pedometer-based walking intervention versus usual care 
(comprising of manipulation, massage, and isometric lumbar stabilization exercises) or a 
combination of the two interventions, improves participants’ perception of pain intensity, disability, 
kinesiophobia and pain catastrophizing, in relation to CLBP.  
 
1.3 Statement of purpose 
 
Conservative treatments for CLBP are poorly understood including usual care physiotherapy and 
walking exercise which have been used previously as treatments. The two have not yet been 
combined and trialled against its constituent parts in a study. This trial sets out to investigate the 
difference between treatments including a partly supervised walking program, usual care 
physiotherapy, and a combination of both on participants with CLBP using appropriate 
biopsychosocial outcome measures. In addition, pain has been considered as a homogenous entity 
previously, pain phenotyping categorizing nociceptive and neuropathic pain phenotypes was 
included in the current modelling process. In order to accomplish the trial, it was necessary to achieve 






a. To determine whether a pedometer-based walking intervention, usual care, or a 
combination of the two best decreases pain intensity at 12-week follow-up. 
b. To determine whether a pedometer-based walking intervention, usual care, or a 
combination of the two best decreases disability, kinesiophobia and pain catastrophizing at 
12-week follow-up.  
 
1.4 Organisation of thesis  
 
A search strategy was conducted prior to the literature review. Listed sources included were PubMed, 
Web of science, Scopus, Embase and Google. The search was structured using studies with keywords 
of chronic lower back pain, treatment, massage, manipulation, physiotherapy, walking, pedometer, 
exercise, physical activity, neurophysiology, pain phenotype, nociceptive pain, neuropathic pain, 
lumbar spine. Each search used a combination of free text and subject headings. The search combined 
these keywords so that studies were identified that included chronic lower back pain and treatment, 
and in addition had terms relating to either walking or physiotherapy treatment. Only randomized 
controlled trials using walking and physiotherapy relevant to lower back pain lasting for longer than 
three months were included in the review. Treatment was furthermore searched relating to 
nociceptive or neuropathic pain phenotypes. The listed journals were searched from first issue 1960 
to March-April 2020. 
 
Following an introduction in chapter one, an in-depth review of the relevant literature was undertaken 
in chapter two. This was followed by a methodology including a feasibility study described in chapter 
three. The methodology was set out to justify the explicit design of three treatment groups due to the 
heterogenous nature of treatments used in previous studies using walking and physiotherapy to treat 
CLBP. Screening tools are discussed to familiarize readers with pain phenotyping using the 
painDETECT questionnaire. All the outcome measures are described in this section. To improve 
objective step measurement between treatment groups, pain and activity diaries are well described 
which were used by all participants and not only those using the pedometer-based walking 
intervention. A feasibility study was conducted prior to the main RCT to streamline trial processes 
used if necessary. The methodology describes the main RCT which compared a 12-week pedometer-
based walking intervention versus usual care (comprising of manipulation, massage and isometric 
lumbar stabilization exercises) versus a combination of the two interventions. The reference group 
used in this RCT was the pedometer-based walking intervention. The term usual care physiotherapy 
was used since usual care is a term used to describe “the full spectrum of patient care practices in 
which clinicians have the opportunity (which is not necessarily seized) to individualize care” 
(Thompson and Schoenfeld, 2007). The participants (n=147) were Johannesburg citizens with CLBP 
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randomised to the three treatment groups having equal numbers of nociceptive and neuropathic 
CLBP participants in each treatment group. Comparisons were conducted on participants’ perception 
of pain intensity, disability, kinesiophobia and pain catastrophizing, in relation to nociceptive and 
neuropathic CLBP. Results in chapter four from the main RCT include linear mixed models and 
descriptive analysis of the data. Chapter five is a discussion of the interpretation of the results from 
the main RCT. The relevance of the findings is discussed in the context of the aim and objectives 
posed at the start of this thesis and in relation to the previous literature. Limitations of the current 
RCT are discussed with recommendations made for future study for clinical use. Chapter six is the 
conclusion of the thesis with insights into potential relevance of the study findings to the clinical 
environment. The references are followed by supplementary information provided in the appendices. 
 
1.5 Conflict of interest statement 
 
Fifty OMRON Walking Style One 2.1 HJ 321 E Pedometers were purchased and 30 were supplied 
as a sponsorship from Omron Europe. The sponsored pedometers were obtained six-weeks after the 
RCT began therefore there was no conflict of interest. The author declares that he has neither 
competing interests nor conflict of interest.   
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Chapter 2: Review of the Literature:  
 
2.1 Epidemiology of chronic lower back pain 
 
Internationally, LBP is one of the most common and frequent medical conditions among adults 
(Schwellnus et al., 2011). LBP is defined as pain between the inferior ribcage and above the inferior 
gluteal fold. It may present with or without leg pain (Duffy 2010). In 10-15% of patients’ acute LBP 
develops into CLBP (Cilliers and Maart, 2013). This is characterized as pain lasting for more than 
three months (Liddle, Baxter and Gracey, 2004).  
 
A recent systematic review of 13 international articles states that there is almost no agreement among 
researchers regarding the definition of LBP, where studies included various kinds of LBP (Fatoye. 
F., Gebrye, T., & Odeyemi, I., 2019). The various kinds included were acute, subacute, chronic, with 
radiating pain and without radiating pain (Fatoye. F., Gebrye, T., & Odeyemi, I., 2019). Annually, 
15-20% of adults will report an incident of LBP, with 50% -80% reporting at least one episode of 
LBP throughout their lifespan (Deyo, Rainville and Kent, 1992; Dagenais, Caro and Haldeman, 
2008). International epidemiological studies indicate lifetime prevalence rates of 70 -85% (Rubin, 
2007; Hoy et al., 2010). A systematic review evaluating the prevalence of LBP internationally from 
1966-1998 found that, prevalence varied widely (Walker, 2000). This was attributed to disparate 
methods of data collection, inadequate sample size, and cohort variability. Cohort variability 
included the non-standardisation of age and psychosocial function among different cohorts, varied 
levels of PA and inconsistent measurement and reporting of physical features (e.g., body mass index 
[BMI], gender, lumbar mobility, trunk strength and radiographic abnormalities) and general health 
status.  
 
From the 56 studies included in a systematic review of international prevalence of LBP, although 11 
of the studies were conducted in developing countries, none were conducted on African populations 
(Walker, 2000). This highlights a paucity of data on the prevalence of CLBP, in Africa. A systematic 
review and meta-analysis of 65 epidemiological studies on the prevalence of LBP in Africa describes 
a pooled lifetime, annual and point prevalence of LBP in Africa to be 47%, 57% and 39% 
respectively (Morris et al., 2018). Following Nigeria, the majority (25%, n=16) of these studies were 
conducted in South Africa (Morris et al., 2018). In 2016, data was obtained from a face-to-face survey 
of 10,336 adults in the 2016 South Africa Demographic and Household Survey (Kamerman et al., 
2020). The prevalence of chronic pain was 18.3% (95% confidence interval [CI]: 17.0-19.7). 
Following limb pain, the second most frequent complaint of chronic pain was CLBP (30.5% [95% 
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CI: 27.7-33.6]). In summary, although there are not many studies, the prevalence of LBP in Africa 
appears to be higher or comparable to global LBP prevalence (Morris et al., 2018). 
 
CLBP negatively affects patient’s function and quality of life and can increase disability (Chou, 
2010; Meucci, Fassa and Faria, 2015). Evaluations of the disability caused by CLBP are 
heterogeneous, with at least 26 different methods of evaluations being available in clinical practice 
(Longo et al., 2010). Several contributing categories to disability are affected by CLBP, and include 
pain intensity, personal care, lifting, walking, sitting, standing, sleep, sexual function, social activity 
and travelling (Fairbank and Pynsent, 2000). As LBP persists to CLBP, increased reports of disability 
and work absenteeism are noted (Woolf and Pfelger, 2003). This is however controversial due to the 
greater awareness of minor symptoms and increased willingness to report them thereby increasing 
the association with disability (Woolf and Pfelger, 2003). Such disability has economic implications 
for governments, businesses, communities, families, and individuals (Schwellnus et al., 2011). These 
economic implications and costs have been described as direct (medical expenses), and indirect 
(absenteeism, decreased productivity) (Dagenais, Caro and Haldeman, 2008). 
 
2.2 Risk Factors 
 
Risk factors implicated in CLBP in the aetiology of LBP internationally, have been broadly defined 
as demographic, health, occupational, psychological, and spinal anatomical factors (Table 1) (Rubin, 
2007). This work concurs with work conducted in South Africa (Schwellnus et al., 2011), where 
sixteen risk factors were identified. However, as many as 55 different risk factors related to LBP 





Table 1: Risk factors associated with CLBP 
Risk factors according to Rubin, 2007. Risk factors according to Schwellnus et al., 2011. 
Socioeconomic status and education level Low socioeconomic status and level of education 
Age Increased age 
Gender Female gender 
Demographic factors Drug abuse 
Health factors Psychosocial factors: stress, depression, work-related factors such 
as dissatisfaction and monotonous work 
Monotonous tasks 
Job dissatisfaction 
Psychological factors including depression 
Body mass index (BMI) Obesity (BMI>30/kg/m²) 
Tobacco use Smoking 
Perceived general health status Low self-rated health status 
Occupational factors Increased high risk physical activities (occupational& leisure time) 
Physical activity, such as bending, lifting, or 
twisting 
Heavy physical work, prolonged static work postures, heavy 
lifting, twisting, vibration 
Physical inactivity 
Spinal anatomy factors including anatomical 
variations 




Imaging abnormalities Pregnancy 
History of headache 
 
The paradigm of assessing risk factors has moved from a biomedical towards a biopsychosocial 
assessment (O’Sullivan, 2005). This more recent paradigm attempts to explain the pain experience 
through cognitive, emotional, and sensory realms; expressing the dynamic interplay between 
biological, psychological and social factors rather than through biological and physical factors alone 
(Gatchel et al., 2007; Meyer, 2007). A biomedical model supports risk factors for CLBP that have 
been associated with anatomical variations and abnormalities linked to anatomical lumbar spine 
structures (Table 2) (Jackson and Simpson, 2006; Rubin, 2007). However, the predictive value of 
imaging to define anatomical abnormalities causing the pain is poor (Borenstein et al., 2001; van 





Table 2: Lumbar spine pain sources (Jackson and Simpson, 2006). 







Somatosensory system/ nerve 
 
Furthermore, psychosocial risk factors are mentioned as a category for CLBP risk factors 
(Schwellnus et al., 2011). The South African study does not describe the multiple psychosocial 
factors contributing to CLBP. Psychological risk factors associated with CLBP that are independent 
of other variables and include stress, distress, anxiety, and depression (Linton, 2000). However, 
psychosocial variables such as pessimistic attitude, passive coping, and fear-avoidance beliefs have 
more impact than biomedical factors on CLBP disability (Linton, 2000; Woolf and Pfelger, 2003). 
These findings concur with those found in a systematic review (Raymond et al., 2011) reporting 23 
papers and examining 16 psychosocial risk factors. Of these, catastrophizing and kinesiophobia were 
independently linked with poor outcomes in CLBP (Vlaeyen et al., 1995; Picavet, Vlaeyen and 
Schouten, 2002; Barke et al., 2016). Catastrophizing is defined as an exaggerated negative mental 
set brought to bear during actual or anticipated painful experience (Picavet, Vlaeyen and Schouten, 
2002; Sullivan et al., 2009). Kinesiophobia is defined as an irrational and debilitating fear of physical 
movement and activity resulting from a feeling of vulnerability to painful injury or re-injury (Kori, 
Miller and Todd, 1990). In recognizing the biopsychosocial model, the significant predictive values 
of the risk factors, kinesiophobia and catastrophizing, are acknowledged (Barke et al., 2016, National 
Institute for Health and Care Excellence, 2016).  
 
Over-reliance on risk factors for determining predisposition to CLBP can be problematic since risk 
factors vary with LBP definitions. Reliance on mostly self-reported or mechanical factors may 
explain inconsistencies between reviews. Related to different risk factors, in studies related to CLBP 
epidemiology, small sample size often limits their usefulness and reliability (Rubin, 2007). Further 
challenges in reliability include self-perceived health status often reported in epidemiological studies 





2.3 Lumbar spine anatomy implicated in chronic lower back pain 
 
Structural abnormalities have been a historical focus in the literature (Figure 1 and 2; Table 2) 
(Jackson and Simpson, 2006; Vela, Haladay and Denegar, 2011). Figure 2 demonstrates the 
proximity of the nervous system to the articulations of the lumbar vertebrae. Implicated in biomedical 
models for classifying CLBP, anatomical structures of the lower back can lead to the development 
of CLBP (Langevin and Sherman, 2007; Allegri et al., 2016). 
 
Figure 1: Lumbar vertebrae and disc including a lateral nucleus pulposus herniation 
 







Figure 2: Lumbo-sacral spine 
 
 
(Reproduced with Permission from OrthoInfo © American Academy of Orthopaedic 
Surgeons.http://orthoinfo.aaos.org) 
 
Objectively verifying pathology in the lumbosacral structures has relied on diagnostic imaging by 
MRIs, CT scans and X-Rays. In contrast to the findings by Yang et al., (2015), where there was a 
positive correlation in symptoms of lumber disc degeneration and increased inflammatory factors 
with MRI findings (n=57), other studies have found that relying on imaging is not predictive of pain, 
with anatomical abnormalities also seen in healthy controls (Deyo and Weinstein, 2001; van Tulder, 
2006b; Steffens et al., 2014; Allegri et al., 2016). In 85% of people pain is not attributable to visible 
pathology or intrusion into neural structures (van Tulder, 2006b). A systematic review of 12 LBP 
MRI studies, concluded poor LBP prognostic value associated to MRI patho-anatomical evidence 
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(Steffens et al., 2014). However, study limitations included a small sample sizes, heterogeneity of 
MRI findings and limited clinical outcomes between participants. Authors concur, symptoms, 
pathology, and radiological evidence remain poorly correlated to give specific diagnoses (Borenstein 
et al., 2001; van Tulder et al., 2006c; Chou, 2010; Steffens et al., 2014). 
  
Additionally, concurring views acknowledged that leg pain can be associated with CLBP (Jackson 
and Simpson, 2006; Brukner and Kahn, 2012). Referred lower limb pain which originates in the 
lower back is said to be somatic or radicular in origin and can occur with or without LBP (Brukner 
and Kahn, 2012). Clinical history and physical examination can provide clues to which anatomical 
structure may have led to the origin of the pain but are not specific enough in describing which micro 
anatomical features and processes may be responsible for the pain (Dankaerts et al., 2006; Jackson 
and Simpson, 2006). Explanations of CLBP, focussing only on the lumbar spine, appear limited. 
Consideration of somatosensory system and neurophysiological processes which influence the pain 
experience may be necessary (Woolf, 2004; Davis et al., 2017). 
 
2.4 Basic neurobiology of nociception and pain 
 
Due to the clinical complaint of pain, it is salient that pain itself be examined prior to treatment.  
 
Nociception 
The sensory system responsible for the conscious perception of pain as well as pressure, touch, 
position, movement and vibration from the joints, muscles, fascia, and skin is called the 
somatosensory system. Nociception is not pain (Moseley, 2007). Nociception is sensation provoked 
by noxious mechanical, chemical, or thermal stimuli and is elicited as an early-warning physiological 
protection mechanism (Woolf, 2010). Nociceptive receptors of the somatosensory system are located 
in almost all body tissues (Dubin and Patapoutian, 2010). The framework supported in this trial 
outlines that pain is an indication of the complex experience and conviction of one’s brain to protect 
body tissues and not as a marker of tissue damage (Moseley, 2007; Sullivan and Adams, 2010). A 
fundamental function of the somatosensory system is to signal actual or potential tissue damage, 
promoting withdrawal from the stimulus (Woolf, 2010).  
 
Reference has traditionally been made to specific ‘pain receptors’ (Osterweis, Kleinman and 
Mechanic, 1987). However, more recently a distinction has been drawn between pain and 
nociception (Dubin and Patapoutian, 2010). Nociceptors are high threshold mechano and 
chemoreceptors. Acute injury sets off a complex cascade of chemical and electrical changes which 
sensitizes nociceptors depending on the magnitude and rate of activation (Purves et al., 2001). 
Damaged structures result in release of pro-inflammatory chemical irritants which activate peripheral 
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nociceptors causing depolarization of cell membranes.  Nociceptive impulses are transmitted in A-
delta and C fibres (Woolf, 2000; Koltzenburg, 1999). Nociceptor axons may be lightly myelinated 
A-delta fibres or unmyelinated C fibres. A-delta fibres have faster conduction velocities than C 
fibres. Both types of fibre transmit localized sensations which may be perceived as painful (Table 3) 
(Meyer et al., 2006; Dubin and Patapoutian, 2010). Nociceptive sensitization mechanisms may 
further explain the experience of pain. It is widely debated the interactive role of peripheral 
sensitization and central sensitization in chronic pain and CLBP. 
 
Table 3: Nociceptive fibre myelination and impulse velocity. (Siegel and Sapru, 2011)  
Nociceptive fibres Conduction velocity Impulse conduction 
velocity 
Axon diameter Myelination 
A Delta 3-30 m/s Fast 1-5 μm Myelinated 
C 0.5-2 m/s Slow 0.2-1.5 μm Unmyelinated 
 
Nociception is relayed in phases through the somatosensory system, via 1st, 2nd, and 3rd order neurons. 
This is known as transduction, conduction, transmission, modulation, and perception (Figure 3) 
(Woolf and Ma, 2007). Saliently, impulse facilitation or inhibition is referred to as modulation (Staud 
2013). The principal distinction between pain and nociception remains: pain emerges from the 
brain’s evaluation of potential danger to the body (Moseley, 2007; Legrain et al., 2011; Sullivan, 
2013).  
 
Figure 3: Phases of nociception relayed through the somatosensory system. 
 





Pain pathways: 1st; 2nd and 3rd order neurons 
Sensations from the lower back and leg delivered to the sensory cortex in the parietal lobe, arise via 
a three-neuron system beginning at the periphery, and ascend through spinal cord, brainstem, and 
thalamic relay nuclei pathways (Figure 3). Early research showed this system comprises of first 
order, second order and third order neurons (Brodal, 1981), enabling the hypothesis that pain is not 
a binary switch highlighting all nociception to the conscious awareness of sensations in the cortex 
(Woolf, 2010). This somatosensory system can be described as modulatory circuits facilitating and 
inhibiting pain (Ossipov, Dussor and Porreca, 2010).   
 
The peripheral nervous system includes first order neurons. The central nervous system encompasses 
second and third order neurons. Various sensory receptors are the first point where nociception is 
relayed to the somatosensory system (Table 4). Sensory receptors corresponding with specific 
somatosensory axons, function by determining changes in their surrounding environment, varying in 
size, myelination, anatomical structure, and function (Bhatnagar, 2002; Dubin and Patapoutian, 
2010). Dorsal root ganglia in the spinal cord housing the first order neurons, receive impulses from 
sensory afferents (Dubin and Patapoutian, 2010). 
 
Table 4: Sensory receptor microanatomy (Parent, 1996; Bhatnagar, 2002)    
Receptor Microanatomy 
Expanded tip endings 
Encapsulated nerve endings 
Free nerve endings 
 
Second order neurons relay nociceptive signals within the spinal cord. These neurons relay to the 
medulla oblongata, pons and midbrain, and end at the thalamus (Parent, 1996; Diaz and Morales, 
2016). Excitation and inhibition mechanisms can alter transmission and function of second order 
neurons. Under ‘normal’ conditions, descending modulation to decrease painful sensations occurs at 
the midbrain (Periaqueductal gray matter); Pons (Locus coruleus); and Medulla (nucleus raphe 
magnus) (Dubin and Patapoutian, 2010). A review by D’Mello and Dickenson (2008) states that in 
neuropathic or inflammatory conditions, shifts can occur, heightening dorsal neurons response to 
afferent signals and increased signalling to the brain. 
 
From the thalamus, third order neurons transmit information to cortical sensory areas forming a 
complicated functional network (Parent, 1996). The function of the primary somatosensory cortex is 
sensory information integration and determination of pain. Nociception is therefore the detection and 
transmission of information about potentially painful stimuli by nociceptors. Pain is a product of 
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higher brain centres. This network of synergistic connections in the higher centres allows for 
detection, attention, orientation, and reaction to actual or potential threats (Legrain et al., 2011).  
 
The ‘relay’ stations of nociceptive pathways highlight that the experience of pain can be upregulated 
or downregulated at various levels affecting the pain state (Ossipov, Dussor and Porreca, 2010). Both 
‘bottom–up’ and ‘top–down’ modulatory circuits within the spinal cord and brain are known to 
regulate the pain experience. Pain experiences among individuals are highly variable, corroborated 
by multiple studies (Dubin and Patapoutian, 2010; Staud 2013). This is attributed to both variable 
central nervous system processing and variation of sensitivities in peripheral pain receptors. Pain can 
be facilitated or inhibited by peripheral impulse modification in the dorsal horn. Additionally, central 
modulatory mechanisms have a regulatory effect. (Dubin and Patapoutian, 2010; Staud 2013). 
However, in an IASP consensus statement, the brain (through brain imaging) and its complex 
network, is now widely considered as the area where diagnosis, prognosis and treatment should be 
examined (Davis et al., 2017).  
 
Pain  
Eccleston and Crombez (1999) stated the qualities of the pain experience include pain being an 
unpleasant emotional experience, having unique perceptual and sensory characteristics, and no 
definitive correspondence between tissue damage and pain.  
 
A review which defined and classified pain, maintains that pain is subjective (Kumar and Elavarasi, 
2016). A prerequisite for effective pain management is accurate assessment of pain intensity 
(Charette and Ferrell, 2007). Pain intensity is typically measured by specific questionnaires such as 
the Numerical rating scale (NRS) and Visual Analogue Scale (VAS), which are used in 
physiotherapy and CLBP studies (Heymans et al., 2006; Kääpä et al., 2006). Concurring evidence 
states that ≥2 points on the 0–10 NRS or a change on the NRS of 20% between two time-points 
isrecognized as a minimal clinically important difference (MCID) (Haefeli and Elfering, 2006; 
Suzuki et al., 2020). A MCID on a VAS in CLBP is around 20mm, or 20% (Hägg, Fritzell and 
Nordwall, 2003; Ostelo and de Vet, 2005). Recognizing this, either can be used to in pain studies. 
Most tools to measure pain intensity have been developed in developed countries in Europe and 
America (Bagwath Perstad, Kamerman and Wadley, 2017). Recently, recognition of the NRS was 
established in African studies. The NRS worked well as a pain intensity outcome measure in an 
English speaking, educated cohort of SA university students in a model of experimental pain 
(Bagwath Persad, Kamerman and Wadley 2017). The NRS is recommended as a measure of change 
in pain intensity by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials 
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(IMMPACT) recommendations (Dworkin et al., 2008). However, it is also possible to detect pain 
objectively using fMRI imaging technology (Kucyi and Davis, 2015).  
 
Acute pain is defined as pain that subsides within three months (Taxonomy, I.A.S.P., 2017). Pain 
involves a sophisticated interaction of immune, endocrine, and nervous systems (Chapman, Tuckett 
and Song, 2008). Physiological changes occur in the peripheral somatosensory system, spinal cord 
and brain in pain (Voscopoulos and Lema, 2010; Feizerfan and Sheh, 2014). Physiological studies 
show these changes differ in acute versus chronic pain (Voscopoulos and Lema, 2010; Feizerfan and 
Sheh, 2014).  
 
Pain mechanisms 
The function of the somatosensory system, and its contribution to the sensation of pain, is dynamic.  
 
Peripheral sensitization: When peripheral sensory nerve fibres establish a reduced sensory threshold 
and when their response is magnified, this constitutes peripheral sensitization (Dubin and 
Patapoutian, 2010; Courtney, Fernández-de-Las-Peñas and Bond, 2017). In the dorsal root ganglia, 
nociceptive and non-nociceptive sensory afferents can become sensitized in chronic pain states 
(Gangadharan and Kuner, 2013). This sensitization can be due to an accentuated inflammatory 
response stimulating C fibres, inciting retrograde neurogenic inflammation (Meyer et al., 2006). 
Authors concur that the heightened sensitivity may result in more than expected pain from a painful 
stimulus (hyperalgesia) and pain perception from innocuous non-painful stimuli and normal body 
sensations (allodynia) (Julius and Basbaum, 2001; Costigan, Scholz and Woolf, 2009; Schweizerhof 
et al., 2009; Gangadharan and Kuner, 2013). 
 
Central sensitization: Chronic pain also involves a mechanism of central sensitization whereby 
nociceptive neurons in the central nervous system have an increased responsiveness to noxious 
stimuli mediated at spinal and supraspinal levels (Woolf, 2011; Courtney, Fernández-de-Las-Peñas 
and Bond, 2017). A review describes central sensitization as a prolonged, however reversible 
phenomenon (Fleming and Volcheck, 2015). Central sensitization has been described as a CLBP 
phenotype existing alongside neuropathic and nociceptive pain (Smart et al., 2012a; Roussel et al., 
2013). However, the co-morbidity of central sensitization with pain conditions including nociceptive 
pain (NP) and peripheral neuropathic pain (PNP) can be expected (Campbell and Meyer, 2006; 
Costigan, Scholz and Woolf, 2009; Woolf, 2011). 
 
Understanding the involvement of somatosensory system and the brain in particular, with regards to 
pain, is now better understood. Modulation can occur at this first order neuron from regulation of 
inflammatory processes and conduction to the second order neurons, as well as interneuron activity 
17 
 
at the synaptic junction and descending pathways from the brainstem and cortex along the second 
order neuron (Figure 4) (Dubin and Patapoutian, 2010). With studies attempting to examine these 
signals further, heterogeneity is noted between the periphery and the brain. Nerve impulses in PNP 
phenotypes travel a more complicated path in the somatosensory system than with NP phenotypes 
(D’Mello and Dickenson, 2008; Garcia-Larrea and Peyron, 2013). This can be corroborated 
clinically, with delayed outcomes in PNP phenotypes (Chetty et al, 2012). A number of reviews 
highlight ascending and descending somatosensory system pathways, and multiple brain areas, that 
assist modulation of the experience of pain (Ossipov, Dussor and Porreca, 2010; Garcia-Larrea and 
Peyron, 2013; Courtney, Fernández-de-Las-Peñas and Bond, 2017).  
 
Figure 4: Pain modulatory areas within the second order neuron.  
 
Adapted from Dubin and Patapoutian 2010 
 
The role of the brain in pain 
Reviews have concluded that CLBP can affect brain morphology, chemistry, and neuronal activity 
(Ossipov, Dussor and Porreca, 2010; Garcia-Larrea and Peyron, 2013). Gray matter density is 
decreased in those with CLBP (Apkarian et al., 2004; Kregel et al., 2015). Compared to healthy 
controls, brain chemistry is altered in the thalamus, anterior cingulate cortex, and prefrontal cortex 
in chronic pain patients (Grachev, Fredrickson and Apkarian, 2000; Apkarian et al., 2004; Siddall et 
al., 2006). Unsuccessful pain modulation may be the result of a reorganized somatosensory cortex (a 
brain area associated with pain processing) and neuronal activity which is altered in people with 
CLBP (Flor et al., 1997; Giesecke et al., 2004; Diers et al., 2007; Lloyd et al., 2008; Kregel et al., 
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2015). Recent fMRI objective evidence shows cortical changes take place in human chronic pain 
(Davis et al., 2017). Imaging techniques have shown that pain is associated with brain modulatory 
pathways, network, and region abnormalities. Spinal cord ‘bottom-up’ pathways activated by 
noxious stimuli, together with ‘top-down’ pathways which modulate ascending nociceptive signals 
operate in dysfunctional regulation. In people with chronic pain, the Salience network (encompassing 
mid-cingulate cotex, temporoparietal junction and anterior insula), sensorimotor network 
(encompassing the thalamus, primary somatosensory cortex, periaqueductal grey and posterior 
insula) and the default mode network (encompassing the posterior cingulate cortex and medial 
prefrontal cortex) activities are found to be abnormal (Davis et al., 2017). 
 
More recently, further brain complexity has been seen where brain networks communicate 
intrinsically and dynamically and attentional states are persistently fluctuating (Kucyi and Davis, 
2015; Davis et al., 2017). These brain regions involved in pain have been referred to as the pain 
matrix (Ossipov, Dussor and Porreca, 2010; Garcia-Larrea and Peyron, 2013). However, the term 
pain matrix has been superseded, since it refers to brain regions not necessarily specific to pain (Davis 
et al., 2017). The complexity of the somatosensory system interactions is recognized. The most recent 
model is termed the dynamic pain connectome (Kucyi and Davis, 2015; Davis et al., 2017). No single 
definition of boundaries of these interconnected networks exists, however there is some overlap in 
intrinsic salience, somatosensory and default mode networks from the previous pain matrix (Davis 
et al., 2017).  
 
Abnormalities are noticed in brains of patients with CLBP (Davis, 2006). Conclusions were made 
highlighting abnormal forebrain responses to somatic stimuli implicating increased sensitivity in 
cortical somatosensory processing, abnormal attentional processes, poor endogenous pain 
modulation and atypical connectivity in normally connected cortical and subcortical networks 
(Davis, 2006). Authors concur that amplified somatosensory abnormalities exist in neuropathic pain 
(Davis, 2006; Gustin et al., 2011; Garcia-Larrea and Peyron 2013). This highlights the salience of 
pain phenotypes. Neuropathic pain has been defined as pain attributable to a lesion /dysfunction of 
the peripheral nerve, dorsal root ganglion or dorsal root (Woolf, 2004; Devor, 2006). This is unlike 
nociceptive pain that arises from actual or threatened damage to non-neural structures and is due to 
activation of nociceptors (Taxonomy, I. A. S. P., 2019). Acknowledging pain phenotype existence 
in CLBP, highlights the importance of the brain as a source of future investigation. 
 
These multidimensional and not exclusively somatosensory operations highlight the clinical context, 
where pain has been described with sensory-discriminative and affective-motivational dimensions 
(Davis, 2006; Senkowski, Hofle and Andreas, 2014). Anatomically the former is associated with the 
primary and secondary somatosensory cortices, and the latter, the anterior cingulate cortex, insular 
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and prefrontal cortex (Senkowski and Heinz, 2016). The affective-motivational dimension is related 
to psychological, motivational, and higher cognition (empathy and relative demands to pain) and 
reflects perceived unpleasantness of the pain experience. The sensory discriminative dimension 
fulfils the perceived intensity, quality, and location of pain. This according to Davis et al., (2017) 
corroborates the limitations of the dynamic pain connectome in chronic pain due to brain activity 
varying across time, people, and context.  
 
Limitations of neuroimaging techniques include limitations in associated statistical modelling, the 
impact of testing conditions, understanding of normal ranges within individual noxious stimuli and 
population’s variance in pain evocation (Davis, 2006).  In context, an IASP presidential task force in 
2015 examined the capabilities of brain imaging to diagnose chronic pain as having ethical, 
economic, and legal implications (Davis et al., 2017). A final statement was made stating imaging 
cannot exclusively define an individual’s chronic pain (Davis et al., 2017). However, neuroimaging 
evidence brings to light the need to consider the neurophysiological alongside biopsychosocial 
models when examining CLBP (Davis, 2006; Ossipov, Dussor and Porreca, 2010; Senkowski and 
Heinz, 2016). The limitations of objective measures and lack of clinical utility elucidates the need 
for more information when classifying and diagnosing CLBP. 
 
2.5 Clinical decision making 
 
Classification of chronic lower back pain 
Anatomical or pathological aetiology cannot be used to classify CLBP in 90% of cases (Koes, van 
Tulder and Thomas, 2006; Spahr et al., 2017). Since imaging is not a reliable indicator of pathology, 
the underlying pain mechanism cannot be assumed (O’Sullivan, 2005). Patients often present with 
symptoms with no clear, specific cause, and are classified as having non-specific lower back pain 
(NSLBP) (O’Sullivan, 2005; Dankaerts et al., 2006; Schwellnus et al., 2011). Specific lower back 
pain involves an inclusion of a specific pathology, e.g.: Cauda equina syndrome, fracture (Koes, van 
Tulder and Thomas, 2006). The classification of specific and non-specific CLBP has limitations, due 
to multiple factors contributing to the classification (O’ Sullivan, 2005). Clinically useful 
classifications should be based on mechanisms driving the disorder; this in turn may predict the 
outcome (O’Sullivan, 2005). Several models including the pathoanatomical, neurophysiological, 
psychosocial, peripheral pain generator, mechanical loading, signs and symptoms, motor control and 
biopsychosocial models, have been used for classification and diagnosis of CLBP (O’Sullivan, 
2005). 
 
Pathoanatomical, mechanical loading and signs and symptoms models are similar. They are based 
on assumptions that CLBP interventions should be aimed at structural abnormalities like 
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intervertebral disc degeneration (including annulus prolapse and tears), facet-joint degeneration, 
spondylolisthesis, spinal stenosis, with or without nerve pain (Borenstein and Calin, 2012). 
Limitations of the pathoanatomical model include evidence that these abnormalities are found in pain 
free individuals and little attention is paid to neurophysiological and psychosocial variables 
(Nachemson, 1999; Humphreys and Irgens, 2002; Dankaerts et al., 2009). 
 
The mechanical loading model has several causative factors associated with CLBP symptoms. These 
include very high and low levels of lumbar spine loading, repeated or heavy lifting in flexion, 
sustained positions at awkward angles, frequent or intense loads in sport or at work, increased BMI, 
joint hypermobility, limited trunk strength, limited lower limb flexibility and overloaded spinal 
segments out of their normal ranges of movement (Balague, Troussier and Salimen, 1999; Heneweer 
et al., 2011; Trompeter, Fett and Platen, 2017). Similarly, neurophysiological, and psychosocial 
contributors are sparsely accounted for. 
 
Based on pathoanatomical and biomechanical assessment, the signs and symptoms model is usually 
supported by physiotherapists internationally and in South Africa, to classify CLBP (Maitland, 1986; 
Delitto, Erhard and Bowling, 1995; McKenzie, 2000; Naidoo et al., 2012). This model relies on area 
and nature of pain symptoms, functional and motor control changes, vertebrae mobility and 
sensitivity to mechanical provocation, and centralization or peripheralization of the pain (Maitland, 
1986; McKenzie, 2000). However, consideration of biopsychosocial factors is limited.  
 
Similarly, the peripheral pain generator model relies on identifying the painful structure, through 
clinical examination, patient history, and diagnostic blocks using intramuscular and intra-articular 
zygapophysial joint anaesthetic injections (Bogduck, 1995). Treatment incorporates identification of 
the painful structure and blocking or denervating the nociceptive source (Carette et al., 1991; 
O’Sullivan, 2005). This model also does not account for psychosocial components (Carette et al., 
1991; Nachemson, 1999). 
 
The motor control model claims mal-adaptive movement and motor control occur with CLBP 
(O’Sullivan, 2005). It was reliant on mal-adaptive movement driving peripheral nociception 
(O’Sullivan, Twomey and Allison, 1997). Problems with this model included model-derived 
treatment aimed at muscular control when additional variables from a psychological or 
neurobiological driver may have caused the motor control problem (Hodges and Moseley, 2003). To 
mitigate these limitations, the model has evolved to include three subgroups: adaptive altered motor 
responses to underlying disorders, altered motor responses secondary to psychological factors and 




In the neurophysiological model, the focus is on neuromodulation and biochemical changes in the 
somatosensory system (Freynhagen et al., 2006; Smart et al., 2012a; Spahr et al., 2017). A 
mechanism-based classification is used for CLBP where pain is classified by the dominant 
neurophysiological mechanism responsible for its origin and/or maintenance in order to treat pain 
phenotypes effectively (Smart et al., 2012a). Differentiation of nociceptive, neuropathic, and central 
sensitization CLBP phenotypes are used within this model but remain controversial. This controversy 
is due to differences between definitions and diagnostic outcomes (Smart et al., 2012b; Spahr et al., 
2017). For example, the definition of neuropathic pain involves a demonstrable lesion of the 
somatosensory system (Taxonomy, I.A.S.P., 2017). However, contradictory clinical evidence shows 
many patients without demonstrable lesions present with symptoms indicating neuropathic pain 
(spread of pain, allodynia, dysesthesia) (Spahr et al., 2017).  
 
The psychosocial model implicates social and psychological factors in driving the somatosensory 
system to modulate pain (Zusman, 2002; Waddell, 2004). The broad spectrum of social factors 
includes financial compensation, home and work tensions, and cultural beliefs; all of which can affect 
pain. Both disability and pain can be affected by psychological variables for example catastrophizing, 
pathological fear and anxiety, avoidant behaviour, hyper-vigilance, and negative thinking, which are 
mal-adaptive (Nachemson, 1999). Despite the debate as to which of these factors predispose the pain, 
authors concur maladaptive coping can be reduced through descending inhibition via distraction, 
appropriate pacing, and adaptive coping measures (O’Sullivan, 2005; Peters, Vlaeyen and Weber, 
2005). The argument exists that there is an over reliance by physiotherapists to implicate 
psychosocial factors in Non-Specific Chronic Lower Back Pain (NSCLBP) with only a small group 
having this as the primary driver for the disorder (O’Sullivan, 2005).  
 
Due to its multidimensional approach, the biopsychosocial model is widely accepted and used by 
physiotherapists treating CLBP (Turk and Gatchell, 2002; O’Sullivan, 2005). Due to the 
multifactorial nature of this model, the driver for pain is determined using clinical expertise, and the 
relevant information gained through interviews, clinical neuromuscular assessment, and perhaps 
radiological screening (O’Sullivan 2005; Waddell, 2004). Previously biomedical models were 
emphasized, however, a systematic review of 49 papers highlighted that social factors are often 
overlooked in their contribution to CLBP (Froud et al., 2014). The biopsychosocial model, however, 
has been criticised for its epistemological underpinnings and misuse, because it contains no 
safeguards against over/ under representation of biological, psychological, or social domains 
(Benning, 2015).  
 
To improve treatment outcomes, subgroups of CLBP have been identified (Delitto, 2005; Stanton 
and Kawchuk, 2008; Huijnen, 2015). A review examining physiotherapy interventions based on 
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subgroup classification (Alrwaily et al., 2016) concurs with the potential to enhance effect sizes in 
studies with identical CLBP interventions if participants are classified by type of CLBP (O’ Sullivan, 
2005; Delitto, 2005; Dankaerts et al., 2006; Stanton and Kawchuk, 2008; Huijnen, 2015).  
 
In two recent reviews, physiotherapy treatments were matched according to subgroup classification 
(Karayannis, Jull and Hodges, 2012; Alrwaily et al., 2016). For example, mechanical diagnosis was 
designed to identify non-musculoskeletal pain and emphasize self-treatment such as the McKenzie 
Method of exercise (McKenzie, 2000). In movement system impairment classification, treatment is 
based on correcting the impaired alignment and movement patterns as well as correcting the tissue 
adaptations associated with the impaired alignment and movement patterns using manipulation, 
massage and stretching as part of therapy (Sahrmann et al., 2017). The majority of studies reviewed 
relied on biomechanical assessment (Karayannis, Jull and Hodges, 2012). However, one 
classification developed by O’Sullivan (2005), considered neurophysiological and psychosocial 
aspects. In Alrwaily et al., (2016), four classification subgroups sparsely explored psychosocial 
factors. Both Ford and Hahne (2013) and Alrwaily et al., (2016) concur that no classification is 
completely comprehensive, since different CLBP clinical pictures account for variation during the 
treatment period, and some systems require specialist knowledge about treatments matching 
diagnostic classification. In absence of this knowledge, success of treatment by subgroup 
classification may be limited. Incorporation of valid psychosocial outcomes within treatment 
interventions should be encouraged with clinicians recognizing that variables such as kinesiophobia 
and pain catastrophizing may require management in CLBP cohorts. Elucidating subgroup 
classification according to neurophysiological phenotype may enhance statistical modelling when 
examining CLBP reducing the paucity of knowledge in pain nuerophysiology. 
 
Neurophysiological classifications of CLBP have only recently been explored in physiotherapy 
assessment (Courtney, Fernández-de-Las-Peñas and Bond, 2017). This classification is not yet 
explicitly used in treatment guidelines. A study of 55/100 English respondents in chronic pain 
sufferers were treated as a homogenous group with standardized treatments (Brown, 2004). Albeit 
not only CLBP, pain phenotyping was not used for subgroup classification. A review by Woolf 
(2010) classifies pain as nociceptive pain, inflammatory pain, or pathological pain. Pathological pain 
can be argued as having two subtypes: neuropathic pain, and dysfunctional pain (Woolf, 2004; 
Costigan, Scholz and Woolf, 2009). Dysfunctional pain occurs with no identifiable noxious stimulus 
or apparent inflammation or damage to the somatosensory system. It is widespread or isolated, 
typically with hyperalgesic presentation (Costigan, Scholz and Woolf, 2009). Neuropathic pain 
typically presents with dysesthesia (abnormal unpleasant symptoms) and responses to noxious and 
innocuous stimuli are enhanced (Costigan, Scholz and Woolf, 2009). Each pain phenotype is driven 
by a different neurobiological process (Woolf, 2010). Early warning physiological protection and 
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guarding against noxious stimuli defines nociceptive pain (Costigan, Scholz and Woolf, 2009; 
Woolf, 2010). Inflammatory pain is a result of inflammation activating nociceptors, increasing 
peripheral sensory sensitivity (Costigan, Scholz and Woolf, 2009; Woolf, 2010). Acute inflammation 
is therefore functional, and chronic inflammation is not. Pathological pain is not a symptom of a 
disorder but is due to a diseased state of the somatosensory system (Woolf, 2010). The difference 
lies in pathological pain resulting from abnormal neural processing, whereas inflammatory pain 
occurs due to a demarcated peripheral pathology causing a hypersensitive reaction (Woolf, 2010). 
 
Neurophysiological classification exhibits challenges. Experts concur that PNP is defined by 
spontaneous pain and hypersensitivity to pain with a lesion or damage of the somatosensory system 
(Woolf, 2004; Costigan, Scholz and Woolf 2009; Woolf, 2010). However, this statement is 
challenging. Even though abnormal neural plasticity may occur, and nociceptive signals may be 
enhanced in response to noxious and innocuous, not normally painful stimuli, a lesion is necessary 
but not always sufficient to generate neuropathic pain (Costigan, Scholz and Woolf, 2009). 
Concurring with this, Spahr et al., (2017), advocates that a significant neuropathic component to 
CLBP may be present, irrespective of any demonstrable lesion or pathological status. Now, in 
addition to nociceptive and neuropathic pain, a third mechanistic descriptor of pain has been created: 
nociplastic pain. Nociplastic pain arises from altered nociception, despite no clear evidence of actual 
or potential tissue damage resulting in peripheral nociceptor activation, or evidence for a lesion or 
disease of the somatosensory system (Kosek et al., 2018). What is agreed currently is that pain occurs 
in select phenotypes (Taxonomy, I. A. S. P., 2019). In summary, combining neurophysiological 
classifications and the biopsychosocial model may be warranted for physiotherapy diagnosis 
(Waddell, 2004; Elvey and O’Sullivan, 2004). 
 
Diagnosis 
There are multiple interacting factors that influence the development of CLBP (O’Sullivan, 2005). 
Previously described classification systems, which aid diagnosis are of finite clinical value unless 
the underlying mechanism(s) driving the pain disorder are identified (Wand and O’Connell, 2008). 
The biopsychosocial model is widely accepted as the most holistic approach to diagnosing and 
treating chronic pain (Gatchel et al., 2007). A recent paper encourages physiotherapists to identify 
pain according to neurophysiological drivers (Courtney, Fernández-de-Las-Peñas and Bond, 2017). 
However, CLBP diagnosis continues to lack evidence linking neurophysiological drivers within this 
model when applied to patient diagnosis. 
 
It is possible to assign a pain phenotype to CLBP according to neurobiological mechanisms 
(Freynhagen and Baron, 2009; Spahr et al., 2017). For example, nociceptive and neuropathic 
subgroupings have been used for some time to base individual pain diagnosis (Smart et al., 2012b; 
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von Hehn et al., 2013, Spahr et al., 2017). Using pain phenotype subgroupings for diagnostic 
purposes however has not been explored in physiotherapy and walking studies of CLBP patients. 
 
Guidelines from the current International Association for the Study of Pain (IASP) distinguishing 
neuropathic CLBP from nociceptive CLBP rely on a demonstrable lesion or disease within the 
somatosensory system in neuropathic pain (Taxonomy, I.A.S.P., 2017) Many patients are 
misdiagnosed as not having a neuropathic component to their pain when it may be present 
(Freynhagen et al., 2006; Attal et al., 2010; Campbell et al., 2013; Spahr et al., 2017). In IMMPACT 
(Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials) recommendations for 
diagnostic purposes, self-report screening instruments should not replace clinical examination 
(Edwards et al., 2016). However, phenotyping CLBP can be aided using validated reliable diagnostic 
questionnaires such as the painDETECT (Bennet et al., 2007; Edwards et al., 2016; Spahr et al., 
2017). The painDETECT questionnaire is endorsed diagnostically, demonstrating that patients may 
present with a significant neuropathic component to their pain irrespective of any demonstrable 
lesion or pathological status (Spahr et al., 2017). The paucity of physiotherapy knowledge regarding 
neurobiological processes of CLBP is documented (Naidoo et al., 2012; Smart et al., 2012b; 
Ouedraogo et al., 2012; Chetty et al., 2012). It may be relevant to encourage physiotherapists to use 
the painDETECT questionnaire to aid diagnosis.  
 
Pain phenotypes involved in chronic lower back pain 
CLBP is a heterogeneous disorder due to underlying pathophysiological mechanisms, including 
patients with dominant nociceptive and neuropathic pain phenotypes (Scholz et al., 2009; Walker 
and Williamson, 2009; Smart et al., 2012c; Förster et al, 2013; Nijs et al., 2015). Despite no unified 
hypothesis explaining pathophysiology of all pain states (Bridges, Thompson and Rice, 2001), the 
mechanism-based classification of pain is categorized according to the main neurophysiological 
mechanism involved through inception to maintenance of the pain state (Woolf et al., 1998). 
According to Cruccu et al., (2004), chronic pain can occur as five phenotypes of pain (Table 5). A 
recent advance by the IASP added a further mechanistic descriptor of pain, namely nociplastic pain, 
to cover cases not adequately covered by “nociceptive pain” or “neuropathic pain” (Kosek et al., 





Table 5: Chronic pain phenotypes (Cruccu et al., 2004). 







There are several pain phenotyping questionnaires in existence (Kaki, El-Yuski and Youseif, 2005; 
Bennet et al., 2007; Jay and Barkin, 2014; van Hecke et al., 2015). To differentiate nociceptive from 
neuropathic pain, two most frequently used are the painDETECT and the Leeds assessment of 
neuropathic symptoms and signs (LANSS) questionnaires (Kaki, El-Yuski and Youseif, 2005; 
Freynhagen et al., 2006; Bennet et al., 2007; Jay and Barkin, 2014; van Hecke et al., 2015). Two 
studies phenotyped CLBP patients into nociceptive and neuropathic pain subgroups using valid and 
reliable questionnaires (Hassan, Saleh and Baroudy, 2005; Spahr et al., 2017). One study with 100 
patients in the Middle East used the LANSS questionnaire (Hassan, Saleh and Baroudy, 2005). 
Another study in London with 50 CLBP patients used the painDETECT questionnaire (Spahr et al., 
2017). The painDETECT has a sensitivity of 84%, and a specificity of 84%, where the LANSS has 
sensitivity and specificity ranging from 82% to 91% and 80% to 94% respectively (Potter et al., 
2003; Kaki, El-Yuski and Youseif,  2005). However, they are not a substitute for clinical examination 
(Baron et al., 2016; van Hecke et al., 2015).  
 
A recent review demonstrated differences in the nature and consequences of pain, by phenotype; 
PNP was associated with greater pain intensity, disability and was more costly to treat (Baron et al., 
2016). This neurophysiological viewpoint concurs with a paper reviewing pain phenotype 
mechanisms giving depth to patient presentations within chronic pain cohorts (Courtney, Fernández-
de-Las-Peñas and Bond, 2017). 
 
Nociceptive lower back pain  
Nociceptive pain (NP) can arise from noxious stimulation of the lumbar spine or associated soft 
tissues (Costigan, Scholz and Woolf, 2009; Hoheisal et al., 2013). The IASP defines NP as “pain that 
arises from actual or threatened damage to non-neural structures and is due to activation of 
nociceptors” (Taxonomy, I. A. S. P., 2019). Referred somatic pain can occur in parallel with CLBP 
of nociceptive origin (Arendt-Nielson and Svenson, 2001). It is suggested that symptomatic features 




NP is brought about by a noxious stimulus which stimulates peripheral receptive terminals of Aδ and 
C fibres (Ekman and Koman, 2004; Julius and McCleskey, 2006). Authors concur LBP may arise 
due to chemical alterations (Butler and Matherson, 2000; McMahon, Bennet and Bevan, 2006). Soft 
tissue ischemia allowing a decrease in pH of surrounding tissues or following the inflammatory 
cascade inducing chemically mediated nociception (Butler and Matherson, 2000; McMahon, Bennet 
and Bevan, 2006). Both localized and referred pain is possible in NP. Localised CLBP of nociceptive 
origin symptoms arise from non-neural structures (injured vertebrae, ligaments and discs) provoking 
nociception, in turn stimulating the sensory discriminative function of the somatosensory cortex 
(Arendt-Nielson and Svenson, 2001; Bushnell and Akparin, 2006).  
 
Helliwell et al., (2003) supported pain classification using an absence together with presence of 
symptoms and signs. To differentiate pain phenotypes, screening instruments phenotyping pain as 
nociceptive or largely neuropathic (having a neuropathic component) are listed in Table 6 (Bennet et 
al., 2007).  
 
Table 6: Neuropathic screening instruments (Bennet et al., 2007) 
Neuropathic screening instruments References 
painDETECT Freynhagen et al., 2006 
Standardised Evaluation of Pain Scholz et al., 2009 
Douleur Neuropathique 4 Bouhassira et al., 2005 
Neuropathic Pain questionnaire Krause and Backonja, 2003  
Leeds Assessment of Neuropathic Symptoms and Signs Bennet et al., 2007 
 
Diagnosis involves varying intensities of unpleasant abnormal sensations known as dysesthetic 
symptoms (Table 7). Using a regression analysis to identify a cluster of predictive criteria, presence 
of dysesthesias decreased the odds of being classified with NP by 85% (Smart et al., 2012a). In a 
diagnosis by exclusion, the absence of nerve damage associated with NP may be predicted by the 





Table 7: Dysesthesia symptoms typical of neuropathic pain: qualities used for discrimination 
between nociceptive and neuropathic pain phenotypes (Bennet et al., 2007; Smart, O’Connell and 
Doody, 2008; Freynhagen and Baron, 2009; Smart et al., 2012b). 
Dysesthesia symptoms of PNP in neuropathic questionnaires 
Burning/hot sensations 
Electrical shock quality/ shooting pain 
Crawling/ pricking/tingling/ paroxysmal pain 
Cold/ numbness 
Heavy feeling 
Dysesthesias and pain in a dermatomal distribution 
Pain evoked by innocuous stimuli like light touch/ spontaneous pain 
 
Qualities of pain may predict NP (Smart et al., 2012a; Smart et al., 2012b). When resting, pain may 
present as dull, aching or throbbing due to nociceptor stimulation by constant inflammation or initial 
nociception (Gifford and Butler, 1997). Mechanical stimulation of primary nociceptors and signal 
transmission by Aδ fibres can explain sharp and intermittent pain nature (Butler and Matherson, 
2000; Smart et al., 2012a). Concurring evidence states movement away from the painful nociceptive 
stimulus may be for protection of structures due to increased fear, stress, and attention together with 
CNS motor planning changes associated with the anterior cingulate cortex (Hodges and Moseley, 
2003; Hall and Elvey, 2004; Smart et al., 2012a). 
 
Neuropathic lower back pain (peripheral) 
Authors concur that when compared to NP, patients with CLBP of neuropathic origin have increased 
pain intensity and disability, greater psychological co-morbidities, lower health related quality of 
life, and increased medical expenses (Bouhassira et al., 2008; Freynhagen and Baron, 2009; Smith 
et al., 2012; Spahr et al., 2017). Four hundred chronic pain patients were assessed using the 
painDETECT questionnaire confirming the negative impact of PNP (Shaygan, Böger and Kröner‐
Herwig, 2013). Compared to NP, the patients with PNP symptoms had significantly higher levels of 
pain intensity, disability, higher levels of depression and pain chronicity together with longer hospital 
stays (Shaygan, Böger and Kröner‐Herwig, 2013). 
 
Peripheral Neuropathic Pain (PNP) based on a mechanisms-based classification of pain is 
distinguishable from NP and central sensitization (Bennet et al., 2007; Smart, O’Connell and Doody, 
2008; Costigan, Scholz and Woolf, 2009). The definition of PNP is pain attributable to a lesion 
/dysfunction of the peripheral nerve, dorsal root ganglion or dorsal root (Woolf, 2004; Devor, 2006). 
CLBP with a neuropathic component may have no history or confirmatory evidence despite a 
contrary clinical picture (Spahr et al., 2017). Clinical evidence of patient’s signs and symptoms allow 
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CLBP patients classification with a neuropathic component irrespective of any lesion or pathological 
status (Spahr et al., 2017). This contributes to the definition of maladaptive plasticity caused by a 
lesion and not solely a consequence of a disease process or lesion (Spahr et al., 2017). 
Characteristically responses to noxious and innocuous stimuli are enhanced (Costigan, Scholz and 
Woolf, 2009).  
 
A narrative review suggested 16% to 55% of people with CLBP have a neuropathic component 
(Baron et al., 2016). CLBP contributes greatly to global PNP (Chetty et al., 2012). Fifty percent of 
black Africans (Ouedraogo et al., 2012), and 55% of adults seeking outpatient care for CLBP in the 
Arabian Gulf (El Sissi et al., 2010) may exhibit a neuropathic component. No estimates of South 
African neuropathic CLBP have been reported (Chetty et al., 2012).  
 
Despite varied aetiologies of neuropathies, authors concur that in CLBP, these aetiologies occur 
through inflammation, ischemia, compression, or trauma (Bridges, Thompson and Rice, 2001; 
Woolf, 2004; Devor, 2006). Neuropathic CLBP can arise from mechanical compression of a nerve 
root, damaged nociceptive sprouts inside a degenerating disc and/or degenerative disc inflammatory 
mediators causing nerve root inflammation and damage (Baron et al., 2016).  
 
Animal models have been developed to explain neuropathic pain physiology (Li et al., 2000; Bridges, 
Thompson and Rice, 2001; Hoheisel et al., 2013; Strong et al., 2013; Baron et al., 2016). However, 
they do not typify the human response to somatosensory system injury. Animals under experimental 
conditions cannot verbalize their experience unlike humans, which is the hallmark of human PNP 
physiotherapy diagnosis, by using phenotyping questionnaires. Several authors concur that notable 
changes are associated with PNP in the peripheral somatosensory system (Bridges, Thompson and 
Rice, 2001; Costigan, Scholz and Woolf, 2009; Smart et al., 2012b). Notable changes are mostly 
clinically observed as signs and symptoms including ectopic discharges and ephaptic conduction of 
nerve impulses. The former occurs when the firing threshold is reached in a primary afferent neuron 
without the input of a stimulus (Wall and Gutnick, 1974; Yoon, 1996; Li et al., 2000). The latter 
occurring when A-fibres and C-fibres seen to demonstrate sub-threshold membrane oscillations 
causing thresholds reached sooner, and neuronal cross excitation through their membranes (Amir, 
Michaelis, and Devor, 1999; Bridges, Thompson and Rice, 2001; Vascopoulus and Lema, 2010). 
Cross excitation can occur between A and C fibres (Amir and Devor, 2000).  
 
CLBP of neuropathic origin can be localised or referred, including radicular pain and radiculopathy 
which are distinct from somatic referred pain seen in NP (Baron et al., 2016). Radiculopathy is an 
objective sensory and/ or motor functional loss due to nerve root damage. It can occur with or without 
pain (Baron et al., 2016). Alternate evidence shows CLBP of neuropathic origin is not restricted to 
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typical radicular presentations (Attal et al., 2011; Campbell et al., 2013). This explains why 
clinically, atypical presentations may lead to poor treatment execution (Spahr et al., 2017).  
 
Diagnostically, imaging measurements are not used as a gold standard for PNP. However, inference 
is made on clinical symptoms and signs corresponding to PNP mechanisms (Finnerup and Jensen, 
2006; Baron et al., 2016). Imaging demonstrates spinal nerve root compression in 4%-17% of 
patients without pain (Boos and Lander, 1996; Weishaupt et al., 1998). CNS modulation though 
descending inhibitory and facilitatory mechanisms may explain why injuries which could cause PNP 
do not in all people (Finnerup et al., 2007a; Finnerup et al., 2007b; Costigan, Scholz and Woolf, 
2009).  
 
Therefore, use is made of screening tools identify PNP qualitative symptoms which present in 
combinations or alone (Bennet et al., 2007). Symptoms typical of PNP are noted in Table 7. 
Differentiating neuropathic from nociceptive CLBP phenotypes is made possible by screening tools 
such as the painDETECT (Freynhagen et al., 2006; Bennet et al., 2007; Spahr et al., 2017). A timeous 
musculoskeletal examination, spinal palpation and assessment of the patients’ motor, sensory and 
autonomic nervous systems would help identify the neurological dysfunction and structures 
responsible (Haanpää et al., 2011; Nijs et al., 2015). PNP symptoms are neither universally present 
nor constitute an absolute diagnosis. Their presence, however, increases the percentage of a PNP 
component (Freynhagen et al., 2006; Rehm, Koroschetz and Baron, 2008).  
 
Typical positive signs are seen in both rat animal models and humans (Bridges, Thompson and Rice, 
2001; Baron et al., 2016). These signs are largely due to ectopic activity, include spontaneous pain, 
pain-like behaviour (not stimulus induced), and hypersensitivities: allodynia and hyperalgesia 
(Bridges, Thompson and Rice, 2001; Baron et al., 2016). Painful positive signs can also be evoked 
(stimulus induced hypersensitivity) e.g., worsening of pain by benign slow repetitive noxious stimuli 
(Rehm, Koroschetz and Baron, 2008).  Spontaneous pain can be burning, shooting and electric shock-
like in nature (Rehm, Koroschetz and Baron, 2008). Abnormal sensations are frequently reported 
with maximal pain often extending over this area with some patients reporting hypersensitivity with 
no sensation impairment (Rehm, Koroschetz and Baron, 2008). Typical positive signs reported 
include non-painful paraesthesia’s (tingling, crawling). Signs of PNP may be resultant from nerve 
root inflammation, compression, and nerve sprouts that pathologically innervate a spinal disc (Baron 
et al., 2016). 
 
Available treatment guidelines advocate a multimodal approach with pharmacotherapy for symptom 
relief together with PA and behavioural interventions (Baron et al., 2016). Authors concur, 
improvements in therapies are still required (Finnerup et al., 2007; Courtney, Fernández-de-Las-
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Peñas and Bond, 2017). Non-pharmacological treatments for CLBP of neuropathic origin include 
transcutaneous electrical nerve stimulation (TENS), spinal cord stimulation, epidural steroid 
injections (Kumar, Abbas and Rizvi, 2012; Morlion, 2013). Specialist physiotherapy including 
cognitive behavioural therapy is mentioned as treatment of CLBP with neuropathic origins (Baron 
et al., 2016). No explicit descriptions of specialist physiotherapy are available.  
 
Mixed pain 
Many clinical presentations appear to be a mix of nociceptive, central and peripheral neuropathic 
mechanisms although a dominance of one neurobiological mechanism may be apparent clinically 
(Bennet et al., 2007; Schäfer et al., 2009; Fishbain et al., 2014). According to Picelli et al., (2016), 
CLBP should be considered a mixed pain syndrome. The conference paper states that 50%-70% of 
LBP is identified as NP, where PNP is present in 5%-15% of cases (Picelli et al., 2016). The pain 
DETECT demonstrates dominance of a phenotype in CLBP with the screening result final score 
comprising of three scenarios: a PNP component being unlikely (15%), an ambiguous result however 
a PNP component may be present; or a likely PNP component present (90%) (Freynhagen et al., 
2006).  
 
Despite diagnosis of mixed pain, studies and clinical pictures continue to demonstrate a dominance 
of a pain phenotype. In Shaygan et al., (2013), 37% (148/400) of patients had a dominance of PNP. 
Using the painDETECT, 48% (24/50) of CLBP patients showed a dominance of PNP (Spahr et al., 
2017). By understanding pain phenotypes, physiotherapists and patients alike may be educated into 
rationale why not all CLBP pain complaints follow homogenous trajectories. This may add value in 
education and psychological support of patients. 
 
Psychological factors involved in the pain experience in physiotherapy 
Gate control theory describes how pain can be reduced at the spinal cord level by another sensory 
input (Melzack and Wall 1965). However, pain can be affected at other interfaces outside of the 
spinal cord. Holistic assessment and treatment is required due the complex nature of CLBP. Pain is 
considered as a combination of factors namely sensory, emotional, cognitive-evaluative, 
interpersonal, and cultural. In a review of 18 articles of psychosocial factors and pain chronicity and 
83% (15/18) reported an association of psychosocial factors and pain chronicity (Hruschak and 
Cochran, 2018). Psychosocial variables such as kinesiophobia and pain catastrophizing are 
implicated in CLBP (Picavet, Vlaeyen and Schouten, 2002; Turk and Okifuji, 2002; Peters, Vlaeyen 
and Weber, 2005; Quartana, Campbell and Edwards, 2009). The NeuPSIG (Special Interest Group 
on Neuropathic Pain) guidelines on CLBP and PNP assessment in daily practice and clinical trials 
recommend measuring kinesiophobia and pain catastrophizing (Haanpää et al., 2011). Psychosocial 
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factors are recognized as important moderators of the pain experience and may lead to different 
treatment responses in various patient phenotypes (Turk and Okifuji, 2002). 
 
Kinesiophobia 
Kinesiophobia is defined as an irrational and debilitating fear of physical movement and activity 
resulting from a feeling of vulnerability to painful injury or re-injury (Kori, Miller and Todd, 1990; 
Celletti et al., 2013). Patients with kinesiophobia tend to avoid movements that they believe may 
increase pain (Schwellnus et al., 2011). Activity avoidance can result in impaired strength and 
flexibility, increased pain and depression, helplessness, and disability (Moore, 2010; Schwellnus et 
al., 2011). Vlaeyen et al., (1995) identified patients with CLBP whose disability was driven by 
kinesiophobia and not nociception. This important finding demonstrated that diagnosis and treatment 
should include examining kinesiophobia associated with CLBP and not only the report of pain. 
 
The scale most used, internationally, to measure kinesiophobia is the Tampa Kinesiophobia Scale 
(TSK). The scale measures fear of movement/ (re)injury and is often used in studies, supporting the 
fear avoidance model (FAM) (Figure 5) (Vlaeyen et al., 1995; Nicholas et al., 2012). This model 
describes patients who acquire a fear of movement and chronic disability after an initial acute phase 
of pain (Crombez et al., 2012). In a review of related measures to pain-related fear, constructs of fear 
avoidance, fear of movement and kinesiophobia are identified albeit having unsupported construct 
validity (Lundberg et al., 2011). Self-reflection should be noted when choosing the TSK as an 
outcome measure since therapist’s own fear-avoidance beliefs may impact on their patient’s LBP 
outcomes (Coudeyre et al., 2006). Authors concur, rationale for treatment of kinesiophobia could 
target risk factors to facilitate rehabilitation (Vlaeyen et al., 2002; Pincus et al., 2010). 
 
Figure 5: The fear avoidance model (Vlaeyen et al., 1995). 
 
 
Therapeutically, graded activity interventions have shown a reduction in kinesiophobia (Van Den 
Hout et al., 2003; Sullivan and Stanish, 2003). A study of 33 patients with CLBP and a systematic 
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review of 37 articles on pain related fear, 13 of which were specific to kinesiophobia, concur that 
strategies can be developed to reduce kinesiophobia in CLBP (Vlaeyen et al., 1995; Lundberg, 2011).  
 
Pain catastrophizing 
Pain catastrophizing is defined as an exaggerated, negative mental state that can occur in patients in 
response to an actual or anticipated painful experience (Sullivan et al., 2001a). Pain catastrophizers 
are known to report higher pain intensities and disability (Sullivan and Stanish, 2003). A reduction 
in catastrophizing from baseline measures may demonstrate a minimising of pain and disability 
(Sullivan et al., 2006a; Adams et al., 2007). 
 
Since catastrophizing can exaggerate pain, it is thought to be a coping mechanism related to acute 
pain. Thus, catastrophizing could be considered helpful unless the patient develops a chronic pain 
condition (Sullivan, Adams, and Sullivan, 2004). To mitigate pain when applying a given treatment, 
understanding theoretical models underpinning catastrophizing may assist the therapeutic 
application. These models include the Beckian model of cognitive errors (Beck, 1995), an appraisal 
process resulting in heightened attention to pain (Eccleston and Crombez, 1999), and a social coping 
mechanism (Sullivan, Adams, and Sullivan, 2004). The Beckian model suggesting catastrophizing 
as a cognitive error proposes treatment using cognitive restructuring, replacing identifiable automatic 
maladaptive cognitions with realistic and rational thinking (Beck, 1995). If catastrophizing involves 
an appraisal process causing greater attention to pain, expectation of increased pain and threat 
perception, then a therapeutic proposal is to modify attentional focus towards distraction and positive 
coping strategies (Eccleston and Crombez, 1999). Catastrophizing was proposed as a coping 
mechanism to gain social support (Sullivan, Adams, and Sullivan, 2004). Ideally this may solicit 
empathy socially but may unfortunately trigger, maintain, or reinforce exaggerated pain expression 
(Sullivan et al., 2001a). It was suggested that the relation between central nociceptive mechanisms 
is bi-directional (Sullivan et al., 2001a, 2001b). Interventions to mitigate catastrophizing require 
incorporating treatments to assist catastrophizers to disengage their attention from painful symptoms 
(Sullivan et al., 2001a). 
 
Patients who catastrophize about their pain, often have difficulties in using cognitive attention 
diversions strategies such as distraction using positive coping strategies, to help decrease their 
sensation of pain (Heyneman et al., 1990; Crombez et al., 1998). Excessive focus on nociception or 
pain sensations may allow facilitation of pain access into consciousness and pain magnification 
(Eccleston et al., 1997; Eccleston and Crombez, 1999). Catastrophizers’ central neural mechanisms 
might become more sensitized by engaging in cognitive activities which amplify pain signals 
(Sullivan, 2001b). Catastrophizers are shown in neuro-imaging studies to have significantly more 
activated areas responsible for attentional modulation in painful experiences (Gracely et al., 2004; 
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Seminowicz and Davis, 2006). Concurring evidence shows attentional focus appears to be the 
common conduit for cognitive and affective variables influencing the chronic pain experience 
(Gracely et al., 2004; Seminowicz and Davis, 2006; Sullivan et al., 2009). 
 
Clinical research shows pain catastrophizing is a modifiable variable and fundamental in 
interventions facilitating recovery or chronic pain adaptations (Jensen, Turner and Romano, 2001; 
Keefe, Abernethy and Campbell, 2005; Sullivan et al., 2005a; Smeets et al., 2006a; Smeets et al., 
2006b; Smeets et al., 2006c). Ten weeks (50 hours) treatment involving exercise and psychosocial 
treatment led to reduced pain catastrophizing in 75 patients with whiplash (Adams et al., 2007). A 
multidisciplinary pain treatment program used in a RCT with 214 patients with non-specific spinal 
pain, showed up to 40% reduction in Pain Catastrophizing Scale (PCS) scores in 3 weeks (82 hours) 
(Jensen, Turner and Romano, 2001). Similarly, decreases in catastrophic thinking range between 
24% and 27% in two physical therapy intervention studies done over ten and four weeks respectively 
(Sullivan et al., 2006c; Sullivan et al., 2008). However, Smeets et al., (2006a) found no significant 
decrease in catastrophizing between physiotherapy, cognitive and combined treatments. A recent 
systematic review of 79 studies of musculoskeletal pain showed the best evidence (moderate-high 
quality) was found for cognitive-behavioural therapy, multimodal treatment, and acceptance and 
commitment therapy (Schűtze et al., 2017). 
 
Clinically, rehabilitating pain catastrophizers may have limitations too. Concurring evidence shows 
catastrophizers reported poor analgesic effects with an opiate pharmacological intervention, and 
topical analgesics in pain catastrophizers, resulting in increased pain responses with PNP sufferers 
(Haythornthwaite et al., 2003a; Haythornthwaite et al., 2003b; Fillingham et al., 2005; Mankovsky 
et al., 2012). Suggested mechanisms involved in these negative responses are an endogenous nocebo 
effect due to negative cognitions (Fillingim et al., 2005). Further negative responses are attributable 
to compromised descending pain inhibition (Edwards et al., 2006; Weissman-Fogel, Sprecher and 
Pud, 2008; Goodin et al., 2009).  
 
The PCS is criticized as being underdeveloped (Quartana, Campbell and Edwards, 2009). However, 
on balance it is a broad assessment of catastrophic thinking in individuals in homogenous pain, as 
well as in neuropathic pain (Picavet, Vlaeyen and Schouten, 2002; Sullivan et al., 2009; Haanpää et 
al., 2011). Treatment rationale for catastrophizing proposes implementation of risk factor targeted 
interventions to facilitate CLBP rehabilitation (Sullivan et al., 2009).  
 
Despite catastrophizing being recognized as a useful modifiable outcome for CLBP, it was not 
utilized in the reviews using walking to treat CLBP (Hendrick et al., 2010; Lawford, Walters and 
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Ferrar 2015; Sitthipornvorakul et al 2018). By and large, a systematic review recommended further 




Aside from numerous physiotherapy modalities reviewed by the American Pain Society (Table 8) 
used worldwide, a variety of treatments are available for CLBP (Chou et al., 2007). These include 
traditional medical management (mainly via general practitioners and pharmacotherapy), self-
management programs, and interventional pain management programs (Airaksinen et al 2006; Chou 
et al, 2007; Vargas-Schaffer, G., 2010; Krein et al, 2013). In an article reviewing systematic reviews 
and randomised controlled trials of physical treatments for CLBP, exercise, massage and spinal 
manipulations were shown to be effective, with exercise having the most durable effect (Maher, 
2004). CLBP treatment guidelines from 13 countries were similar and recommend medication, 
manipulation, supervised exercise therapy, cognitive behavioural therapy (CBT), and 
multidisciplinary treatment (Koes et al., 2010). These guidelines exclude South Africa which 
currently has no guidelines for CLBP. A South African physiotherapy study showed reasons for the 
selection of the treatment modalities were undergraduate education received, individual clinical 
experience and postgraduate course attendance (Naidoo et al, 2012). Data on CLBP treatment in low-
income countries are scarce (Omokhodion and Sanya, 2003).  
 
Table 8: Non-pharmacological therapies for CLBP were reviewed by the American Pain Society and 
American College of Physicians (Chou et al., 2007). 
Non-pharmacological 
therapies for CLBP 
Acupuncture 







Short wave diathermy 
Superficial heat/ cold therapy 
Lumbar supports 








Between 2010 and 2018 three systematic reviews were conducted comparing an array of combined 
physiotherapy modalities (manipulation, massage, education, supervised exercise, self-treatment, 
electrotherapy) to a variety of walking programs (Hendrick et al., 2010; Lawford, Walters and Ferrar, 
2015; Sitthipornvorakul et al 2018). A systematic review on CLBP treatment concludes that exercise 
therapy had the most durable effect on CLBP (Maher 2004). However, two reviews comparing 
walking exercise therapy to usual care physiotherapy concurred that there was low quality evidence 
that walking as exercise therapy was as effective as various combinations of physiotherapy 
modalities in improving pain and disability in CLBP (Hendrick et al., 2010; Lawford, Walters and 
Ferrar, 2015). RCT’s incorporated effective modalities of walking as exercise, massage, and spinal 
manipulations (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al 
2018). No study had yet compared walking on its own to stabilization exercise, massage and 
manipulation; and to a combination of these. Furthermore, descriptions of usual care physiotherapy 
in three reviews did not allow for comparison between studies (Hendrick et al., 2010; Lawford, 
Walters and Ferrar, 2015; Sitthipornvorakul et al 2018). Modalities used in usual care physiotherapy 
differed between the primary studies in the reviews. Similarly, there was a wide variety of walking 
exercise interventions used in the three reviews (Hendrick et al., 2010; Lawford, Walters and Ferrar, 
2015; Sitthipornvorakul et al 2018). Various forms of therapeutic walking exercise (treadmill, over 
ground, using stairs) and different protocols of administration (pedometer-based, heart rate based, 
time based without objective measure, un/supervised) may have resulted in differing conclusions 
regarding the use of walking as exercise. However, no study using walking as a treatment for CLBP 
has yet described pain phenotypes in the participants.  
 
Authors concur, with PNP resistant to analgesia, PNP patients exhibit heightened pain intensities, 
impacting negatively on their physical, psychological, and social functioning (Turk and Okifuji, 
2002; Chetty et al., 2012). Most treatment recommendations for neuropathic CLBP are 
pharmacological, with minimal physiotherapy modality advice (Chetty et al., 2012; Baron et al., 
2016). ‘Specialized physiotherapy’ is recommended as a treatment for neuropathic CLBP (Chetty et 
al., 2012; Baron et al., 2016). However, albeit numerous modalities are available, there is no 
definition of ‘specialized physiotherapy’ (Chou et al., 2007). Conflicting evidence is seen where the 
UK NICE 2016 guidelines do not recommend transcutaneous electrical nerve stimulation (TENS) 
for CLBP treatment. However, the modality is recommended in other neuropathic guidelines (Chetty 
et al., 2012; Baron et al., 2016). This further demonstrates the gap in knowledge CLBP pain 
phenotypes in physiotherapy. 
 
Unlike physiotherapy modalities, pharmacological guidelines acknowledge that nociceptive and 
neuropathic CLBP are separate entities (Pergolizzi et al., 2008; Romanò, Romanò and Lacerenza, 
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2012; Chetty et al., 2012; Baron et al., 2016; National Institute for Health and Care Excellence, 
2019). Despite the development of guidelines, pharmacological treatment has limitations for PNP 
and NP phenotypes, including, inefficiency, inadequacy or adverse effects (Chou, Clark and Helfand, 
2003; Kalso et al., 2004; Moore and McQuay, 2005). Including pain phenotypes in modelling of 
physiotherapy studies has yet to be explored. A cross-sectional study conducted in South-Africa 
examined the role of spinal manipulation, massage, and isometric lumber stabilisation exercises on 
patients with CLBP commented on a dearth of knowledge regarding pain phenotypes in South 
African physiotherapists (Naidoo et al., 2012).  
 
Physiotherapy treatment / usual care 
A number of different therapies (Table 8) can be used by physiotherapists for the treatment of CLBP 
(Chou et al., 2007; van Middelkoop et al., 2011). CLBP responds favourably to spinal manipulation, 
massage and isometric lumbar stabilization exercise and advice (Maher, 2004; Liddle, Baxter and 
Gracey, 2009; Clenzos, Naidoo and Parker, 2013; Naidoo et al., 2012).  
 
Physiotherapy modalities chosen by South African physiotherapists included general exercises 
(30%); spinal manipulation (28%); massage (18%); education (12%) and exercising core stabilizing 
muscles (12%) (Naidoo et al., 2012). A national survey of 419 Irish physiotherapists demonstrated 
whilst also using manipulation and massage, that advice and specifically exercising core stabilizing 
muscles were most frequently used to treat CLBP (Liddle, Baxter and Gracey, 2009). A review which 
advocated exercise more than manipulation and massage to treat CLBP, expressed that the limitation 
in exercise was generic prescription (Maher 2004). For example, Liddle, Baxter and Gracey (2009) 
showed that Irish physiotherapists preferred prescribing core stabilization to flexibility exercise and 
aerobic exercise (such as walking). Pain intensity but not pain phenotype was considered when 
prescribing these types of exercise. Furthermore, 207 specialist physiotherapists in South Africa 
completed questionnaires acknowledging that assessment of pain prior to treatment was inadequate 
(Clenzos, Naidoo and Parker, 2013). This possibly highlights that CLBP management may require 
exploration of pain phenotypes. 
 
A study of 489 CLBP patients living in South Africa was completed and concluded that CLBP 
management in South Africa appears ineffective due to 90% of patients receiving medication only, 
minimal physiotherapy referral and no guideline base to treat CLBP (Major-Helsloot et al., 2014). 
NHS NICE 2016 guidelines and 2007 Austrian guidelines recommend the use of mobilization, 
massage and exercise for CLBP (Liddle, Baxter and Gracey, 2009; Koes et al., 2010; National 
Institute for Health and Care Excellence, 2016). Despite widespread use of these modalities in CLBP, 
sub-grouping through patient screening and pain phenotyping is not explicit in the review of national 
guidelines in Koes et al., (2010). Neurological screening was based largely on a straight leg raise test 
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in Koes et al., (2010) and use of the STarT Back risk assessment tool (National Institute for Health 
and Care Excellence, 2016). This may not be sufficient in phenotyping CLBP.  
 
Due to the paucity of evidence with physiotherapists using pain phenotyping, exploration of CLBP 
phenotyping may provide insight into these patients’ presentations. 
 
Spinal manipulation  
Spinal mobilization comprises of low-velocity passive movements within or at the limit of joint range 
(Koes et al., 1996; Ruddock et al., 2016). Spinal manipulation though is defined as a high velocity 
thrust to a joint past its restricted range of movement (Koes et al., 1996; Ruddock et al., 2016). 
Harvey et al., (2003) shows most systematic reviews do not distinguish between manipulation and 
mobilization, as is seen in Lawford, Walters and Ferrar (2015) and Hendrick et al., (2010). This is 
commonly referred to as spinal manipulation/ manual therapy. Manipulation of neural structures may 
have analgesic effects in neuropathic pain (Vigotsky and Bruhns, 2015). However, care should be 
taken when using manipulation for neuropathic pain as the mechanical stimulus may increase 
sensitization (Gosling, 2013; Courtney, Fernández-de-Las-Peñas and Bond, 2017). 
 
Manipulation improves spinal mobility and potentially has immediate effects of relieving LBP 
(Chiradenant et al., 2003; Goosens et al., 2005; Bokarius and Bokarius, 2010; Ruddock et al., 2016). 
A review of any joint manipulation in the body concurred with a narrative review which included six 
studies on spinal manipulation (Savva et al., 2014; Vigotsky and Bruhns, 2015). Joint manipulation 
has an important role in post treatment hypoalgesia. Both reviews argue the analgesic mechanism 
involved increases pain tolerance and decreases sensitization which is neurophysiological in nature 
through descending modulation circuits (Savva et al., 2014; Vigotsky and Bruhns, 2015). Clinically, 
different operator velocities and spinal-level locations during manipulation elicit varied descending 
pain modulation mechanisms (Vigotsky and Bruhns, 2015). The varied methodologies, use of rat 
models and human models, and small sample sizes highlighted in this review leads to the conclusion 
that exact analgesic circuitry in human populations remains unknown (Vigotsky and Bruhns, 2015). 
The authors acknowledge this uncertainty regarding the circuitry involved and the confounding effect 
of touch (when using manipulation) and placebo, which are known to share endogenous opioid and 
endocannabinoid analgesic mechanisms (Vigotsky and Bruhns, 2015). The Pain Gate theory 
(Melzack and Wall 1965) is still applied currently where another review of physiotherapy treatment 
maintains skin touch stimulates Aβ mechanoreceptors following a proprioceptive stimulus. This 
assists with inhibition of painful stimuli in the CNS (Gosling, 2013). Manipulation results in opioid 
activation and endorphin release, as well as non-opioid (serotonin, norepinephrine, dopamine, 
GABA, and growth hormone) neurotransmitter and hormone release (Gosling, 2013). In this review 
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of 38 articles from 1997 to 2011, sources of data and methods of use in contributing studies were not 
identified, but summaries of the mechanisms by which physiotherapy techniques reduced pain were.  
 
Two reviews concurred manipulation did not significantly reduce pain (Avery and O’Driscoll, 2004; 
Rubinstein et al., 2011). The review not supporting manipulation included three RCTs but did not 
mention how the studies were selected (Avery and O’Driscoll, 2004). Another review included 26 
RCTs, with a comprehensive search methodology (Rubinstein., et al; 2011). Although Rubinstein., 
et al (2011) found high quality evidence that manipulation has a small and significant effect on short 
term CLBP pain relief, the authors concluded that this was not clinically relevant due to inefficiency 
of short term relief on the chronic nature of CLBP. However, the UK evidence report supported 
manipulation for effectively treating CLBP (Bronfort et al., 2010). The UK evidence report supported 
the use of manipulation through five systematic reviews, including 70 RCTs (Bronfort et al., 2010). 
The reviews found manipulation superior to sham interventions. Since auditory, touch and movement 
cues are similar between real and sham manipulation, there is little agreement among experts as to 
what constitutes an effective sham manipulation. However, there is some evidence as to what may 
be acceptable as an effective sham manipulation of the lumbar spine. Described in Hancock et al., 
(2006), “the trunk and pelvis are then rolled together so no lumbar inter-vertebral motion occurs”. 
Additionally, three internationally used guidelines recommend the use of manipulation. These 
include: NICE, the American College of Physicians, American Pain Society, and the European 
guidelines for CLBP (National Collaborating Centre for Primary Care [UK], 2009; Chou et al., 2007; 
Airaksinen et al., 2006).  
 
Massage  
Massage is defined as soft tissue manipulation using one’s hands or a mechanical device (Furlan et 
al., 2002). Massage is applied as a sole treatment or in combination with other treatments, with 
techniques varying between effleurage, petrissage, friction, hacking and kneading (Maher, 2004; 
Airaksinen et al., 2006).  
 
Several mechanisms of action implied in massage include decreasing muscle tone and fatigue, diffuse 
noxious inhibitory controls (DNIC), and pain gate theory (Ernst and Fialka, 1994; Vigotsky and 
Bruhns, 2015; Melzack and Wall 1965; Gosling, 2013; Field, 2014). Reviews on physiotherapy 
techniques concur gentle massages may activate Aβ fibres inhibiting nociceptive input via Aδ and C 
fibres (Gosling, 2013; Vigotsky and Bruhns, 2015). Massage may activate non-opioid substances 
namely serotonin, norepinephrine, dopamine, GABA, and growth hormone which inhibit nociception 
(Gosling, 2013). The reviews which supported the use of massage failed to define explicit methods 
used to determine how articles were included (Gosling, 2013; Vigotsky and Bruhns, 2015). A five-
week comparison study of skin contact versus Swedish massage (n=45) and four papers reporting on 
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pleasure and analgesia related to human touch and interaction, concur on the therapeutic nature of 
human touch (Rapaport, Schettler and Bresee, 2012; Ellingsen, 2014). Skin contact elevates oxytocin 
levels, functioning as a somatosensory system analgesic (Rapaport, Schettler and Bresee, 2012; 
Ellingsen, 2014). Albeit not studying CLBP patients, participants in both studies were treated with 
non-noxious touch. Clinically relevant, a dose dependant relationship was highlighted with bi-
weekly massage being more potent than once a week (Rapaport, Schettler and Bresee, 2012). 
Findings in four papers acknowledge dose dependant relationships again, between increased 
frequency of gentle massage and increasing pleasure or pain reduction, enhancing the positive effects 
of oxytocin (Ellingsen, 2014). However, no large effect-size differences for neuroendocrine 
measures on pain were observed between once-weekly and twice-weekly massage sessions 
(Rapaport, Schettler and Bresee, 2012). The frequency of massage and effect size in pain reduction 
for CLBP may warrant further investigation. 
 
Despite evidence supporting massage as a CLBP treatment, a systematic review of systematic 
reviews concludes massage has limitations (Kumar, Beaton and Hughes, 2013). Massage was not 
recommended in the 2004 European guidelines for NSCLBP (Airaksinen et al., 2006). However, 
massage was reported as an effective therapy for CLBP in the UK evidence report and is included in 
the 2016 UK NICE guidelines treatment package for LBP (Bronfort et al., 2010; National Institute 
for Health and Care Excellence, 2016). Depending on the context of the organizational infrastructure 
which supports or refutes the use of massage, it is arguable as to its appropriateness as a treatment 
choice. 
 
Two systematic reviews of high quality (Ernst, 1999; Furlan et al., 2002) were used in the 2004 
European guidelines for NSCLBP (Airaksinen et al., 2006). Eight RCTs formed the basis of the 
evidence in one review Furlan (2002).  Massage therapy was compared to a variety of treatments and 
limited evidence showed massage was more effective in improving pain outcomes than sham 
procedures (Preyde, 2000), remedial exercise and posture education (Preyde, 2000), acupuncture 
(Cherkin et al., 2003), and general physical therapies (Hsieh et al., 1992, Pope et al., 1994). A 
systematic review including 25 RCTs specifically assessed the effects of massage for CLBP and 
acute LBP (Farber and Wieland, 2016). The review compared massage to sham therapy, waiting list/ 
no treatment, manipulation, mobilization, TENS, acupuncture, traction, relaxation, physical therapy, 
and exercises or self-care education (Farber and Wieland, 2016). The authors concluded reduced 
disability benefits for CLBP patients using massage when compared to sham therapy or waiting list. 
 
A systematic review concurred with an updated Cochrane review, that benefits of massage include 
decreased pain and improved functional status, especially if combined with exercise and CLBP 
education (Ernst, 1999; Furlan et al., 2008). The review of 13 randomised and quasi-randomised 
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trials associated benefits depending on massage technique (Furlan et al., 2008). Acupuncture 
massage, defined as tonic stimulation of entire meridians, was more beneficial than classical, 
Swedish or Thai massage (Furlan et al., 2008). Since only two studies in the review compared 
different techniques of massage, this may warrant further exploration. Despite examining the 
evidence for massage as a treatment for a variety of musculoskeletal (CLBP, LBP, cervicogenic 
headache) and non-musculoskeletal conditions (fibromyalgia, asthma), conclusions were made that 
massage is an effective treatment for CLBP (Bronfort et al., 2010). The report included 49 recent 
relevant systematic reviews, 46 RCTs not included in other systematic reviews and 16 evidence-
based clinical guidelines. Due to the robust nature of the systematic review described in the previous 
paragraph (Farber and Wieland, 2016), evidence report (Bronfort et al., 2010), and Cochrane review 
(Furlan et al., 2008), massage is likely to be clinically supported. 
 
Core stabilization intervention exercise program  
The most common form of exercise treatment for CLBP by SA and UK physiotherapists is to use 
spinal stabilization exercises (Liddle, Baxter and Gracey, 2009; Naidoo et al., 2012). The core or 
spinal pelvic complex is a multi-segmental structure consisting of a thoracic cage, pelvic rim, five 
lumbar vertebrae, and hip joints and associated soft tissues. Typical of the motor control model of 
CLBP classification, the wide-spread use of stabilization exercises is based largely on a hypothesis 
that there is a link between activation and timing of local spinal stabilizing muscles and retardation 
of LBP (Richardson, Hodges, and Hides, 2004). Authors concur that working synergistically, lower 
back muscles, abdominal muscles, connective tissue between trunk muscles and lumbar spine 
neuromuscular control are thought to generate and control motion (Richardson, Hodges and Hides, 
2004; Behm et al., 2010). A meta-analysis of 16 CLBP studies published before 2011 showed motor 
control exercise or stabilization given for an average of eight weeks was superior to other forms of 
exercise with intermediate term pain relief and improved functional outcomes (Byström, Rasmussen-
Barr and Grooten, 2013).  
 
A review demonstrates the success of core strengthening on CLBP pain and disability reduction 
(deducing core stabilization and conventional exercise independently both lower CLBP) (Gordon 
and Bloxham, 2016). The review based on biomechanical theory, identified distinct muscles involved 





Table 9: Core lumbar spine abdominal bracing muscles (Gordon and Bloxham, 2016).  
Core lumbar spine abdominal bracing muscles 
Abdominal muscles Lower back muscles 
Rectus abdominus Psoas Major 
Obliquus externus abdominus Interspinales and Intertransverarii  
Obliquus internus abdominus Quadratus Lumborum 
Transversus abdominus Lumbar multifidus 
Longissimus thoracis pars lumborum 
Longissimus thoracis pars thoracis 
Iliocostalis lumborum pars lumborum 
Iliocostalis lumborum pars lumborum 
 
This biomedical approach supports the hypothesis that muscular hypertrophy and spinal stiffness are 




Table 10: Muscular strength and stabilization programs for NSCLBP patients (Gordon and Bloxham, 2016). 
Core exercise used Length of 
intervention 
Study type Outcome measures Findings of the study Population group Author 
Using an unstable standing surface and 
performing unexpected upper limb 
movements. 
8-week Pilot study Pain Visual Analogue Scale 39.5% significant reduction in pain post 
intervention 
10 NSCLBP patients 
(3 male, 7 female) 
(Ŝarabon, 
2011)  
Core exercises using slow curl ups, bird 
dog, plank, sit ups compared with 
conventional exercise using stretching of 
tight muscles 
12-week RCT Pain Visual Analogue Scale Post intervention, reductions in Pain Visual 
Analogue Scale were 76.8% in the Experimental 
group and 62.8% in the Control group  
30 NSCLBP patients 
(20 male, 10 female) 
(Inani and 
Selkar, 2013) 
Strengthening of transversus abdominus 
and internal oblique muscles alone and 
compared to strengthening together with 
ankle dorsiflexion against resistance of a 
rubber band (experimental group) to 
enhance core strengthening. 10 sets of 20 
seconds. 
8-week RCT Pain Visual Analogue Scale   
Pain Disability Index 
Visual Analogue Scale Pain 
Rating Scale 
Post intervention significant reductions in 
Experimental groups Pain Visual Analogue Scale 
of 32.5%, 23.2% Pain Disability Index, and 21.5% 
in pain rating scale. The Control group post 
intervention had significant reductions in Pain 
Visual Analogue Scale of 16.8%, 12.4% in Pain 
Disability Index and 8% in Pain Rating Scale. 
40 NSCLBP patients 
(19 male, 21 female) 
(You et al., 
2014) 
Core muscular strength programme was 






Oswestry Disability Index 
Short-Form 36 
Post intervention, significant reduction of 53% in 
the experimental group and 14% reduction in the 
control group. 
160 NSCLBP patients 
(63 male, 97 female) 
(Stankovic et 
al., 2012) 
Exercises to improve lumbar stability. 
Abdominal curl ups with a slight rotation 
and a squat. This program involved 
education and correction of lifting 
techniques 
12-month RCT Visual Analogue Scale Significant reduction of 39% in pain 106 middle aged 
working men 
reporting an episode 
of NSLBP within the 




(Suni et al., 
2006) 
Muscular strength program used with 
varied inversion traction angles. 
8-week Clinical trial Visual Analogue Scale Significant reductions in Pain Visual Analogue 
Scales of 61.6% in both inversion groups of -30° 
and -60°. Significant reduction of 34.9% in the 
supine group.  
47 women with 
NSCLBP 





The biomedical approach to using abdominal muscles to support the lumbar spine in potentially 
treating CLBP is inconclusive into how it can specifically be applied as exact lumbar stabilization 
exercise protocol is seldom described. Furthermore, mechanical models may be limited in clinical 
application. Three studies including asymptomatic participants concur that abdominal bracing and 
strengthening have generic spinal stiffening effects (Stanton and Kawchuk, 2008; Stokes, Gardner-
Morse & Henry, 2011; Katsura et al., 2011). If muscular hypertrophy and spinal stiffness are 
clinically meaningful, then these studies support this as treatment. In 28 asymptomatic participants, 
strengthening was said to significantly increase posterior-anterior spinal tissue stiffness (p<0.05) 
thereby improving core stability through dampening lumbar stresses (Stanton and Kawchuk, 2008). 
Using a biomechanical model of the spine and its musculature, spinal stability is not significantly 
influenced by selective abdominal muscle activation (Stokes, Gardner-Morse & Henry, 2011). 
Forcing either transversus, obliques, or rectus to be preferentially active did not systematically 
increase stability, however generic intra-abdominal pressure increased stability (Stokes, Gardner-
Morse & Henry, 2011). No patterns associating forced activations with either an increase or a 
decrease in stability were identified. Hydrotherapy programs in women exercising the core compared 
resistance versus no resistance, and demonstrated significant improvements in abdominal strength 
and function, together with abdominal muscular hypertrophy, in the resistance group (Katsura et al., 
2011). However, the studies using human participants described above exclude psychosocial 
measures, which if measured may have highlighted the psychosocial effects of lumbar stabilization. 
 which may provide more information of the mechanism by which the stabilization exercises worked. 
 
Following this, varied exercises appear to have generic mechanical benefit for symptomatic persons 
with CLBP. A systematic review and meta-analysis which included 22 studies of patients with LBP 
and CLBP examining disability and pain outcomes compared stabilization exercise to other forms of 
exercise such as stationary cycling and using slings (Smith, Littlewood and May, 2014). Stabilization 
exercises were the sole intervention for the majority of studies, five studies examined patients treated 
individually, nine studies involved exercises done as group sessions, and three studies combined with 
general exercises or electrotherapy (Smith, Littlewood and May, 2014). The review concluded that 
stabilization is no more effective than any other form of active exercise in the long term. Furthermore, 
when using psychosocial outcomes, no benefits were seen in terms of fear avoidance when 
stabilisation exercises were compared to stationary bike exercise, sling, or general exercises 
(Unsgaard-Tøndel et al., 2010). There has been some suggestion that stabilization exercise promotes 
unhealthy beliefs and kinesiophobia (Nijs et al., 2013). 
 
Despite exercise recommendations for the treatment of CLBP, the specific ideal exercise type 
remains inconclusive (Koes et al., 2001; American College of Sports Medicine, 2013). Studies have 
often used different methodology for stabilization exercises (Table 10). Several studies on CLBP 
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pain outcomes, show variability in core stabilization exercise methodology (Chon, Chang and You, 
2010; Katsura et al., 2011; You et al., 2014). This could impact on the effectiveness of this type of 
exercise in patients with CLBP and associated psychosocial outcomes. 
 
However, Table 11 demonstrates that several studies estimate core stabilization success is dependent 
on patient selection based and objective mechanical tests, and not on stabilization exercise 
methodology (Hicks et al., 2005; Gazzi et al., 2014). The concentration on patient selection also 
appears to be based on mechanical classification.  
  
Table 11: Four variables influence CLBP stabilization exercise program success (Hicks et al., 2005).  
If three or more are present, then it predicts stabilization exercises being successful in decreasing CLBP. 
Age (under the age of 40 increases the treatment success) 
An Active straight leg raise test higher than 91 degrees 
Presence of aberrant movement during lumbar range of movement 
Presence of a positive prone instability test 
 
Despite the use of stabilization exercise as an exercise-based treatment for CLBP in the UK and SA, 
there seems insufficient evidence in reviews to recommend its use in preference to other exercise 
forms (Smith, Littlewood and May, 2014; Wang et al., 2012). Examination of biopsychosocial 
outcomes is highlighted when exploring exercise to treat CLBP. Other forms of exercise such as 
walking merit exploration for the treatment of CLBP. 
 
Walking used as physical activity, and exercise  
Recognizing that walking has application in health research as discriminant PA and exercise is 
salient. Physical activity (PA) is a broad term used to describe any bodily movements that results in 
energy expenditure (Caspersen, Powell and Christenson, 1985). Exercise is defined as structured and 
planned physical activity (Caspersen, Powell and Christenson, 1985; Winter and Fowler, 2009; 
Tremblay et al., 2017). However, often the terms exercise and PA are used interchangeably. They 
are discretely different (Table 12). Furthermore, people can be both physically active and sedentary 
(Thivel et al., 2018). According to this recent classification, a previous study using a walking 





Table 12: Definitions of Physical activity and Sedentary behaviours (Thivel et al., 2018) 
Terms Definitions 
Physical activity Body movements generated by the contraction of skeletal 
muscle that raises energy expenditure above resting 
metabolic rate.  It is characterized by its modality, 
frequency, duration, and context of practice.  
Physical inactivity Represents the non-achievement of physical activity 
guidelines 
Exercise Subcategory of physical activity that is planned, 
structured, and repetitive, and favours physical fitness 
maintenance or development. 
Sport Sport is part of the physical activity spectrum and 
corresponds to any institutionalized and organized 
practice, reined over specific rules. 
Sedentary behaviours Any waking behaviours characterized by an energy 
expenditure ≤ 1.5 METs, while in sitting, reclining, or 
lying posture. 
 
Walking can be defined as either. It can be purposeful and structured or encompass activities of daily 
living, such as housework, and yard work. Walking as an activity of daily living PA or exercise has 
a myriad of general health benefits (Table 13). It has low risk of injury, is considered affordable, 
requires no training, supervision, or specialized equipment, and has high accessibility (Hendrick et 





Table 13: Health benefits of walking.  
Medical condition Health benefit of walking References 
Chronic Lower Back 
Pain 
Walking according to American College of Medicine 
guidelines is shown to improve pain, disability and fear 
of movement outcome measures 
Eadie et al., 2013; Hurley et al 
2015; American College of 
Sports Medicine, 2011 
Dementia Deceased depression and decline in dementia associated 
with walking. 
Kvæl, Bergland and Telenius, 
2017 
Diabetes Walking ≥7,500 steps/day, of which ≥3,000 steps 
(representing at least 30 min) should be taken at a 
cadence ≥100 steps/min can reduce the risk of type II 
diabetes. 
Tudor-Locke and Schuna, 2012 
Heart disease Prevalence of any walking decreased with increasing 
CVD risk Cardiovascular disease risk decreased with any 
walking done including leisure time walking, 12-week 
walking programs may assist with decreasing total 
cholesterol mitigating heart disease. 
Omura et al., 2019; Coghill and 
Cooper, 2008; American College 
of Sports Medicine, 2011; 
Rodriguez-Sanchez et al., 2014 
Arthritis Walking can reduce pain and improve function, mobility, 
mood, quality of life, without worsening symptoms 
Bruno et al., 2006; Katz et al., 
2018 
Depression and anxiety Walking facilitates endorphin release, promoting 
relaxation, preventing anxiety and depression 
Bruno et al., 2006 
Alzheimer’s disease Walking facilitated exercise adaptations improving sleep 
and quality of life in Alzheimer’s patients 
McCurry et al., 2011 
Weight loss Walking 20 minutes per day will metabolize 7 pounds of 
body fat per annum. Women walking 1 hour per day, 5 
times per week with a regulated diet can lose 25 pounds 
and maintain the weight loss 
Richardson et al., 2008, 
American College of Sports 
Medicine, 2011 
Prostate cancer Lower mortality risk, decreased side effects, improved 
function quality of life and weight loss. 
Champ et al., 2016; Gerriten and 
Vincent, 2016 
Colon cancer Walking regularly following the ACSM guidelines 
reduces cancer related fatigue, improves quality of life 
and function in colorectal cancer patients.  
Oruç and Kaplan, 2019 
Longevity Walking for more than one hour per day extended life 
expectancy. 
Nagai et al., 2011 
Immune function Short acting boost in immune function Nieman et al., 2005; Kimura et 
al., 2006 
*1 mile= 1.6 kilometres 
 
Concurring authors show that walking has been categorized as an aerobic exercise by a survey by 
Irish physiotherapists on the exercise advised and provided to their patients for CLBP, a systematic 
review of aerobic exercise for reducing CLBP, and a review on walking to treat CLBP and (Liddle, 
Baxter and Gracey., 2009; Privett, 2012; Lawford, Walters and Ferrar., 2015). A review on walking 
as a treatment for CLBP, also defines exercise as structured and deliberate PA to improve health and 
specifically CLBP (Lawford, Walters and Ferrar, 2015). This highlights the context of application of 
walking. It can be advised for mobility and activities of daily living however physiotherapists can 





As a consequence of the health benefits from PA, evidence predicts a reduction of at least 50% 
mortality in highly fit people than people with low fitness (Warburton, Nicol and Bredin, 2006). 
However, physical inactivity is associated with the development of several different long-terms 
conditions and diseases, such as those described in Table 14 (Warburton et al., 2007; Pedersen and 
Saltin, 2015). Insufficient walking in populations can be detrimental to health (Tudor-Locke, Hart 
and Washington 2009; Hirvensalo et al., 2011; Pillay et al., 2015; Parker et al., 2017; Althoff et al., 
2017). With exercise being a subset of PA, converging evidence support both as prevention and 
treatment for conditions described in Table 14 (Warburton et al., 2007; Moore et al., 2012; Warburton 
and Bredin, 2017). Authors concur, the dose-response relationship for PA is curvilinear with 
relatively small increases in levels of PA, resulting in increased health benefits (Warburton et al., 





Table 14: Chronic diseases affected by physical activity. 
Chronic diseases mitigated by elements of physical activity and exercise 
Chronic Disease Mitigating Effect Studies involving PA 
Studies involving 
exercise 
Physical disability Improving aerobic metabolic 
status, increased strength and joint 
range of movement, improved 
mood 
Moore et al., 2012  Parker et al., 2017 
Arthritis Improving joint functioning and 
neurophysiological pain control 
Booth, Roberts and Laye, 
2012 
Goh et al., 2019 
Obesity Improving aerobic metabolic 
status 
Kumanyika et al. 2008; 
Weinstein and Sesso, 2006 
Lee et al., 2010; Slenz et 
al., 2004  




guidelines committee 2008 
Rothon et al., 2010; 
Hillman, Erickson and 
Kramer, 2008   
Cognitive function Organise thoughts, manage time, 
improved decision making 
Etnier et al., 2006; Bidzan-
Bluma and Lipowska, 
2018 
Kramer et al., 1999; 
Colcombe and Kramer, 
2003; Colcombe et al., 
2006 
Coronary artery disease Increased energy expenditure 
lowering artery plaques in heart 
disease 
Warburton, Nicol and 
Bredin 2006; Mora et al., 
2007 
Deveza, Elkins and 
Saragiotto, 2017 
Diabetes Improving glycaemic control Crandall et al., 2008; 
Warbuton et al., 2006 
Kump and Booth, 2005 
Osteoporosis Increasing new bone production 
with weight bearing 
Warburton, Nicol and 
Bredin, 2006 
Engelke et al., 2006 
Certain cancers (e.g.: 
breast, colon) 
Lowering inflammation and 
improved immune function 
Monninkhof et al., 2007; 
Colditz, Cannuscio and 
Frazier, 1997; Rezende et 
al., 2018 




Increasing breathing rates 
improving cardiorespiratory 
health 
Warburton, Nicol and 
Bredin 2006; Booth, 
Roberts and Laye 2012 
Kujala et al., 1996; 
Martinez et al., 2014 
Chronic lower back pain Reduces pain, disability, 
kinesiophobia and improves 
function through improved 
muscular strength, increased 
cardiorespiratory health and 
improves psychological 
wellbeing. 
Maher, 2004; Slade, 
Molloy and Keating, 2009; 
Lin et al., 2011 
Hayden et al., 2005a; 
Mayer, Mooney and 
Dagenais, 2008; Slade, 
Molloy and Keating, 
2009; Freburger et al., 
2009;  Privett, 2012; 
Kruger and Billson, 
2012; Smith, 
Littlewood and May, 
2014; Gordon and 
Bloxham, 2016 
 
If walking is observed as a PA, it may be necessary to have objective evaluations of peoples PA 
suffering with CLBP. Increasing PA to reduce pain related disability outcomes from CLBP remains 
controversial. Systematic reviews aiming to examine the association with PA and CLBP outcomes 
of pain related disability have opposing conclusions (Lin et al., 2011; Hendrick et al., 2011). A 
systematic review of 18 studies investigated the role of PA on disability from CLBP and LBP, 14 of 
which included only participants with CLBP (Lin et al., 2011). Pooled results indicated that those 
who reported lower levels of activity were most likely to have higher levels of disability (Lin et al., 
49 
 
2011). Opposing this evidence, a systematic review of 12-studies, with only two studies including 
participants with CLBP, investigated whether increasing levels of PA above baseline decreased 
disability (Hendrick et al., 2011).  In conclusion, increased PA was not associated with reduced levels 
of disability in participants with CLBP (Hendrick et al., 2011). Only one cross sectional study (n=13) 
in the latter review objectively measured PA using accelerometers (Verbunt et al 2001). The former 
review included five studies using objective measures of PA detailing more evidence supporting 
associations of low PA and disability in people with CLBP (Verbunt et al., 2001; Bousema et al., 
2007; Ryan et al., 2009; van Weering et al., 2009; Huijnen et al., 2009). As seen in the two reviews, 
objectively measuring PA and increased PA may both account for reporting reduced self perceived 
disability. It has been observed when pedometers are used, and improved health outcomes are noted 
(Krein et al., 2013; Harris et al., 2015). 
 
Measuring devices should be valid for specific PA outcomes. Measuring steps is valid if steps are 
being compared within or between treatments. Equal comparison of PA between studies may not be 
fully observed due to interventions including varied methodologies of structured repetitive exercise 
in both reviews (Hendrick et al., 2011; Lin et al., 2011). Exercises included in the reviews on PA 
included lumbar stabilization or strength programs (Hendrick et al., 2011; Lin et al., 2011). Step 
measurements may not be ideal measurements of PA for these interventions. Exercises may have 
heterogenous mechanisms related to outcomes of improvement. For example, steps taken are not 
identical to strength outcomes. Furthermore, studies making use of accelerometers over seven to 14 
days may not represent participant behaviour over longer periods of time. If pedometer or 
accelerometer measurements are to be observed when examining the effect of PA on CLBP, PA type 
using walking as a treatment may be worth further exploration. 
 
Prior or additional PA may affect CLBP participant outcomes. As made clear in a review of 
examining how many steps are enough for health benefits, dissociating additional PA done as 
exercise from daily overall PA should be considered in its effect on health-related outcomes (Tudor-
Locke and Bassett, 2004). Objectively measuring PA may be fundamental in treating CLBP. Both 
reviews did not specify including either insufficiently active or active participants only (Lin et al., 
2011; Hendrick et al., 2011). Cohort and cross-sectional studies in the two reviews with participants 
having high or low levels of PA may display different responses to additional PA. Objectively 
monitoring of PA at both baseline and done when exercising outside of overall daily PA, may further 
demonstrate if additional PA executed as walking exercise is affecting outcomes. For example, when 
using walking to treat CLBP, objective monitoring of steps throughout a study and steps done during 
a walking exercise intervention, may provide objective evidence for effects on outcome measures. 
Studies in both reviews when not employing objective measures used recall questionnaires (Lin et 
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al., 2011; Hendrick et al., 2011). Recall measures used by researchers are subjective to participant 
recall bias as to changing levels of PA over time. 
 
Exercise as a subset of PA has therapeutic benefits. It is unknown if an optimal objective amount of 
PA exists for populations suffering with CLBP. This can be examined if structured, repetitive, and 
objectively monitored PA is delivered as exercise for people with CLBP. 
  
Walking shares challenges with other exercise types. Varied exercise types aside from walking can 
be used in treating CLBP (Van Tulder et al., 2000; Pedersen and Saltin, 2015). Multiple factors 
associated with exercise may affect associated outcomes. Exercise duration, frequency and intensity 
are often used to measure progress in exercise programmes. The mode of supervision can vary from 
unsupervised, to varied levels of supervision, either in person, on the telephone or via the internet. 
Further research is required into what mechanisms, patient characteristics, and outcomes when 
considering exercise types and amounts to beneficially treat CLBP. 
 
Despite the ease to which walking can be delivered as an exercise to treat CLBP, there remain a wide 
array of exercises supported as a treatment for CLBP as seen in Table 15 (Hayden 2005b; Mayer, 
Mooney and Dagenais, 2008; Henchoz and Kai-Lik So, 2008; Liddle, Baxter and Gracey, 2009; 
Naidoo et al., 2012; Smith, Littlewood and May, 2014; Pederson and Saltin, 2015). The role of 
exercise in treating CLBP has been incorporated into clinical guidelines for example the 2004 
European guidelines for NSCLBP and the 2016 UK NHS NICE guidelines (Airaksinen et al., 2006; 
National Institute for Health and Care Excellence, 2016). The reviews on exercise for CLBP 
conclude that supervised exercise compared with unsupervised exercise is more effective in reducing 
CLBP associated pain and disability (Mayer, Mooney and Dagenais, 2008; Henchoz and Kai-Lik So, 
2008). Reviews on exercise for CLBP detail numerous factors remain inconclusive in application of 
exercise (Mayer, Mooney and Dagenais, 2008; Henchoz and Kai-Lik So, 2008). A limitation of 
systematic reviews and guidelines relating to the use of exercise in treating CLPB includes the lack 
of homogeneity between the studies. This makes it difficult to determine a definitive delivery for the 
type, duration, frequency and intensity of exercise required. Table 15 shows multiple subcategories 





Table 15: Exercise categories used to treat CLBP (Mayer, Mooney and Dagenais, 2008) 
CLBP exercise subcategories 
Activity as usual (recommendations against physical restrictions) 
Aerobic (walking/cycling) 
Hydrotherapy 
Directional preference (McKenzie) 
Proprioceptive/ co-ordination (wobble board, stability ball) 
Flexibility (yoga, stretching) 
Stabilization (low load exercises specific to spinal and abdominal musculature) 
Strengthening (resistance exercises) 
 
Furthermore, exercises are often combined with more than one exercise type. Strengthening/ 
flexibility, aerobic/ strengthening, aerobic (included postural advice), multimodal (included 
behavioural, positive coping, ergonomic advice), hydrotherapy, McKenzie exercises, and 
callisthenics are described as specific exercise to treat CLBP (Liddle, Baxter and Gracey 2004). 
However, two exercise subcategories are often done together (e.g., strengthening/ flexibility) and the 
exercise advised for the majority of the time is recognized as the specific exercise (Liddle, Baxter 
and Gracey 2004). This may contribute uncertainty to whish exercise used was responsible for a 
change in outcomes. A systematic review of 45 randomised trials showed strength/ resistance and 
stabilization/ co-ordination interventions demonstrated improved pain outcomes in CLBP patients 
compared to cardiorespiratory and combined exercise programs (Searle et al., 2015). However, the 
2016 NICE guidelines are not explicit in recommending specific exercise to treat CLBP, only that 
patient subjective preferences should be considered including one’s needs, capabilities, and 
preferences (National Institute for Health and Care Excellence, 2016). These guidelines concur with 
both a review of 14 studies of exercise intervention programmes for CLBP summarized that aerobic 
fitness, muscular strength and flexibility are all beneficial, and with Exercise is Medicine advice 
(Gordon and Bloxham, 2016; Exercise is Medicine, 2019). The systematic review of the effects of 
exercise on NSCLBP highlights the complexity of advocating specifics since CLBP is recognized as 
multifactorial and not a homogenous condition (Gordon and Bloxham, 2016). Due to the ease of 
application of walking as an exercise due to its nature as typical PA, further investigation into its 
effects may be warranted. 
 
Numerous benefits are ascribed to varied exercise types for people with CLBP. Mechanisms related 
to aerobic function, strength or motor control, and psychological adaptations, may be responsible for 
outcome measure changes (Gosling, 2013; Gordon and Bloxham 2016; Sluka et al., 2018). Walking 
has elements of all these factors (Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al 2018; 
Yoshiko et al., 2018). Concurring reviews propose aerobic exercise modulates CLBP biomedically 
in the peripheral tissues by increasing blood flow and nutrients to lower back soft tissues, improving 
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the healing process, and decreasing stiffness (Gosling, 2013; Gordon and Bloxham 2016). 
Recognizing the psychological benefits of aerobic exercise, pain perception is decreased if one takes 
part in 30-40 minutes of aerobic exercise (Mayo and Weissman, 2011; Gordon and Bloxham 2016).  
Two reviews concurred stating exercises based on muscle strength have benefits on strength, and 
psychologically decrease kinesiophobia in people with CLBP by increasing the patient’s locus of 
control (Mayer, Mooney and Dagenais, 2008; Dreisinger, 2014). Flexibility, endurance, and balance 
gains were also seen (Dreisinger, 2014). In summary, a review of physiotherapy treatments explains 
that the modulation of pain via the somatosensory system is salient (Gosling 2013). It occurs through 
descending inhibition via opioid activation from aerobic/ regular exercise together with effects on 
the cerebral cortex in cortical reorganization, psychophysiological, behavioural and placebo effects 
(Gosling 2013). Since evidence highlights biomedical and psychological mechanisms response to 
exercise for CLBP, it is not clear if one mechanism in isolation is responsible for CLBP relief. Several 
mechanisms may be involved with walking used to treat CLBP. Authors agree, mechanisms and 
therapeutic techniques may range from distraction, mastery over the problem, therapeutic alliance, 
patient education, and expectations of therapeutic success or failure (Tavel, 2014; Stilwell et al., 
2017). The effects of both PA and exercise on CLBP modulation are seen in the central nervous 
system and in the body’s tissues. 
 
Due to the mechanisms involved in exercise having possible effects on aerobic function, strength, 
and psychological adaptation, consideration of appropriate outcomes is necessary using walking as 
an exercise. In exercise studies historical focus was on biomedical outcomes including pain, general 
health, and function. An early review of 43 trials using exercise to treat CLBP, pain, function, work 
absenteeism rates and overall health improvement outcomes were used (Hayden et al., 2005a). A 
review of 17 RCT’s that used exercise as treatment for CLBP, outcomes used were back specific 
function, generic health status, pain, work disability and treatment satisfaction (Liddle, Baxter and 
Gracey, 2004). The results showed an improvement in patient’s muscular strength outcomes (Liddle, 
Baxter and Gracey, 2004). Both reviews show a paucity of psychosocial outcomes such as 
behavioural support and positive coping strategies (Liddle, Baxter and Gracey, 2004). 
Recommendations from the reviews were for more high-quality trials using fewer yet essential 
outcome measures. Latter reviews on the effects of exercise on CLBP concurred that further research 
is required on the psychosocial effects (Mayer, Mooney and Dagenais, 2008; Henchoz and Kai-Lik 
So, 2008). A review of exercise induced analgesia incorporates improving psychosocial outcomes 
namely kinesiophobia and catastrophic thinking, although the review suggests the combination of 
exercise and other treatments may be more efficient in reducing pain (Sluka et al., 2018).  
 
The dosage of physiotherapy and associated CLBP exercise currently remains a combination of 
evidence, experience, and common sense.  There is also limited evidence of how treatment frequency 
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correlates with biopsychosocial outcomes. Amounts of exercise are primarily intended on improving 
pain and disability outcomes. To accrue health benefits, convergent information is found in Exercise 
is Medicine advice and a review explaining exercise induced analgesia (Exercise is Medicine, 2019; 
Sluka et al., 2018). Adults are advised at least 150 minutes per week of moderate-intensity aerobic 
activity, 75 minutes of vigorous aerobic activity, or a combination of both together with flexibility 
exercise (Exercise is Medicine, 2019; Sluka et al., 2018). Due to the wide variety of exercise 
protocols used to treat CLBP, the exercise amount recommended is a minimum of 3-4 times per 
week, with a guideline base of 10-15 minutes per bout, aiming for 30-60 minutes per day (Fielding 
et al., 2017; Exercise is Medicine, 2019; Sluka et al., 2018). Advised frequency varies between 3-7 
days a week for aerobic exercise (Exercise is Medicine, 2019).  For strengthening, a minimum of 
two to five days a week is recommended (Freburger et al., 2009; Exercise is Medicine, 2019; Sluka 
et al., 2018). Intensity is not finite and can be based on pain symptoms when progressing in exercise. 
Duration of exercise in a systematic review of 43 RCT’s of 72 exercise treatments stated exercise 
exceeding 20 hours over a six-week period assists in decreasing CLBP (Hayden et al., 2005a). There 
was no significant difference between four exercise sessions over two weeks, versus eight sessions 
over four weeks, in terms of pain reduction (Callaghan, 1994).  
 
According to the above guidelines, approximately 39% of UK adults and approximately 26% of US 
adults are not active enough to benefit their health (British Heart Foundation, 2017b; American 
Health Rankings, 2018). In South Africa, approximately 46% of adults between the ages of 25-64 
would be classified as classified as insufficiently active (Guthold et al., 2011; Micklesfield et al., 
2013).   
 
Exercise for CLBP is often led by physiotherapist supervision in scheduled physiotherapy visits. In 
a national survey of physiotherapists in Ireland seeking mainly to reduce pain associated with CLBP, 
the majority (64% of respondents, n= 179) provided between six and 10 physiotherapy visits (Liddle, 
Baxter and Gracey 2009). This frequency lies in the upper range of physiotherapy visits with the 
nine-week non-specific exercise regimen advised in previous NICE guidelines (National 
Collaborating Centre for Primary Care [UK], 2009). Current NICE guidance acknowledges the 
persistence of CLBP requires longer term management (National Institute for Health and Care 
Excellence, 2019). The optimal number of treatments involving exercise or supervision necessary to 
achieve optimal outcomes for CLBP, has yet to be described.  
 
Further research is required into whether walking as exercise, how much, and the amount of 
supervision required, is beneficial for treating CLBP over and above levels of ambient PA. Whilst 
exercise has been shown as one of the most effective strategies for managing CLBP (Liddle, Baxter 
and Gracey 2004; Maher, 2004; Rainville et al., 2004; Hayden et al., 2005b; van Tulder et al., 2006a; 
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Chou et al., 2007), the evidence for walking as an exercise for CLBP is controversial. A recent review 
examining whether walking was an effective treatment for CLBP, found it no more effective than 
other non-pharmacological treatment (Lawford, Walters and Ferrar, 2015). If the following were also 
measured: psychosocial components of kinesiophobia and catastrophizing, and objective measures 
of PA and walking delivered separately as an exercise, this would potentially improve practitioner 
delivery of evidence-based specific CLBP walking exercise and assist patient centred care. 
 
Objectively measuring physical activity, exercise, and walking  
Objective measures of PA can include step counts (Ainsworth et al., 2000; Tudor-Locke et al., 2011; 
Parker et al., 2017; Althoff et al., 2017). Step counts may vary by instrument used, placement of the 
pedometer, calibration, axis of measurement (i.e., bi, tri axial). A recommended target for healthy 
individuals is 10,000 steps per day (American College of Sports Medicine, 2011; Tudor-Locke et al., 
2011).  
 
Pedometers can be used to enable researchers, clinicians, and patients to better monitor walking 
activities. Pedometers and structured walking programs have been shown to help patients increase 
levels of PA (Merom et al., 2007; Baker et al., 2008; Kang et al, 2009; Harris et al., 2015). A 
systematic review of using pedometers to increase PA, included 26 studies with 2767 participants in 
total (Bravata et al., 2007). The systematic review included 8 RCTs where pedometer users 
significantly increased their PA by 2491 steps per day more than control participants (95% 
confidence interval [CI], 1098-3885 steps per day, P < .001). Pedometer users increased their PA by 
26.9% over baseline, indicating that pedometer use is associated with significant increases in PA. 
There is some research that supports their use for motivating participants to be physically active 
though daily step count goals (Krein et al., 2013; McDonough et al., 2013; Harris et al., 2015). Two 
systematic reviews of dietary studies concurred that motivation to increase PA is significantly 
associated with pedometer use (Greaves et al., 2011; Dombrowski et al., 2012).   
 
Pedometers often provide the user with visual feedback on the number of steps taken, can be 
inexpensive, unsophisticated, and usually measure in one axis only (vertical displacement). The UK 
National Institute for Clinical Excellence (NICE) supports pedometer use for research and PA 
encouragement (Harris et al., 2015). In a systematic review examining walking as a treatment for 
CLBP, pedometers were used in two of seven RCT’s measuring walking to treat CLBP (Lawford, 
Walters and Ferrar 2015; Krein et al., 2013; McDonough et al., 2013). Pedometers are produced by 
several manufacturers. In a review of 837 articles analysing step counts in various populations, 
Omron pedometers were reviewed and assessed as suitable tools with which to measure walking in 
research (Tudor-Locke et al., 2011). In a randomised clinical trial by Rodriguez-Sanchez et al., 
(2014), the validated Omron Walking Style One 2.1, Hj-321 digital pedometer was used to assess a 
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three-month PA program amongst patients with dementia and their caregivers. The fundamental 
benefits of this pedometer were that it was simple and easy to use, had a digital clock, only monitoring 
steps taken and distance walked (Rodriguez-Sanchez et al., 2014). 
 
As with pedometers, accelerometers are also available to objectively measure step counts. 
Accelerometers, on the other hand, tend to be more sophisticated, often working in more than one 
axis (vertical, sagittal, and horizontal). They tend to consist of a ‘closed box’, requiring connection 
to a computer and use specific software, to translate activity ‘counts’ into steps. The participant tends 
not to have the same visual display interaction found in a pedometer (Corder et al., 2007). 
 
Pedometer-based step count ranges that classify the level of PA were developed and are described in 
Table 16 (Tudor-Locke and Bassett (2004)). People not achieving PA guidelines are recently referred 
to as insufficiently active, since people can be both sedentary and active (Thivel et al., 2018). 
 
Table 16: Activity level defined by number of pedometer-based steps (Tudor-Locke and Bassett, 
2004) 
Number of daily steps taken Activity level 
0-5000 Sedentary 
5000-7499 Low active 
7500-9999 Somewhat active 
10000-12500 Active 
12500 or more Highly active 
 
According to Tudor-Locke (2011), few adults achieve the 10,000-step target (Table 17). This has 
also been confirmed by other studies (Tudor-Locke, Hart and Washington 2009; Hirvensalo et al., 
2011; Pillay et al., 2015; Parker et al., 2017; Althoff et al., 2017). The main reasons and predictors 
for not achieving these step counts include chronic pain (Parker et al., 2017), increased body fat 
(Pillay et al., 2015), increased age (>50 years) (Tudor-Locke, Hart and Washington 2009; Tudor-
Locke et al., 2011), and cultural factors (Tudor-Locke et al., 2011; Hirvensalo et al., 2011). Mean 
daily step counts from both UK and South African populations, classify populations in Table 17 as 





Table 17: Values of average daily step counts seen in different populations living without a disability 
or chronic illness. 
Country Average steps taken per day Age range in years Reference 
United States of America 5100 (pedometer) 6500 (accelerometer) 18< Tudor-Locke et 
al., 2011 
Japan 7200 (pedometer) 15< 
Western Australia 9600 (pedometer) 18< 
Belgium 9600 (pedometer) 27-75 
United Kingdom 5500 (smartphone) 0< Althoff et al., 2017 
South Africa 4100 (smartphone) 0< 
 
Further data were collected demonstrating daily step counts below 10,000 in South Africa. These are 
observed in a cross-sectional study that used pedometers in a healthy population (Pillay et al., 2015). 
Using a valid and reliable Omron HJ 720 ITC pedometer, the study was completed by 312 
participants (mean age 37±9 years). The mean steps/day in adult men and women was 7476 steps/day 
and 5769 steps/day respectively (Pillay et al., 2015). These step counts categorize this South African 
population of healthy individuals between individuals living with disability or chronic illness and 
healthy older adults over 50 years as determined by a systematic review of 32 studies examining step 









Ten thousand steps are suggested as a reasonable daily step count for healthy adults (Yamanouchi et 
al., 1995; Hatano 1993; Tudor-Locke and Myers 2001b). However, empirical evidence supports the 
relation to cardiovascular and diabetes health-related outcomes (Tudor-Locke et al., 2002b; Bassett 
et al., 2003). Suggested values of steps per day can serve as benchmarks for comparison purposes 
but should not be misinterpreted as recommendations for appropriate activity levels among all 
illnesses. There is a paucity of evidence on how many steps are useful in treating appropriate 
outcomes related to CLBP. Recommendations can only be made once accumulated evidence supports 
specific health-related cut points (Tudor-Locke et al., 2002a). Researchers and practitioners require 
practice guidelines including step counts associated with health-related outcomes (Tudor-Locke & 
Myers, 2001b). No cut points in step count for achieving reduced pain, disability, kinesiophobia and 




















Mean steps/day  
Category: Population groups 
1=8-10 year old children 
2=14-16 year old adolescents 
3=Healthy younger adults (approx. 20-50 years) 
4=Healthy older adults (>50 years) 




Subsets of the population may have different daily step counts, which may be affected by their 
physical or social status. In a study of 1,921 adults’ aged 18 years and older an Accusplit AE120 
pedometers was used to measure step counts (Bassett et al., 2010). Data were weighted to reflect the 
general U.S. population according to age, gender, race, education, and income. The results described 
that being male, of ages between 19-29 years old, having greater educational attainment, BMI 
classified as not overweight, and being single, were all positively associated with a higher number 
of daily step counts (Bassett et al., 2010) [Table 18]. Diversity within classifications of pain 
phenotypes, levels of disability, kinesiophobia and pain catastrophizing may also be seen if step 
counts are explored in populations with CLBP.  
  
Table 18: Descriptive characteristics of pedometer-measured physical activity in the United States 
(Bassett et al., 2010). 
Variable Mean steps per day p value 
Gender 
Male 5340 0.034 
Female 4912  
Age 
19-29 5843 <0.001 
30-39 5127  
40-49 5915  
50-59 4742  
60+ 4027  
Education level 
Less than high school 3920 0.059 
High school graduate 4947  
Some college 5274  
College graduate 5241  
Some postgraduate study 5385  
Marital status 
Single 6076 <0.001 
Married/ partner 4793  
Divorced  5463  
Widowed  3394  
BMI (calculated from self-
reported height and 
weight) 
Non-overweight/obese 5864 <0.001 
Overweight 5200  
Obese 4330  
 
Experts from University College Hospital in London and the United Sates argue the earlier guidelines 
regarding 10,000 steps per day are ‘hard to meet and are discouraging’, supporting additional 
strategies to increase PA (British Heart Foundation, 2017a; Tuso, 2015). Insufficiently active 
individuals – i.e., those defined as people taking less than 10, 000 steps per day and people living 
with a chronic disease are estimated to take 3500-5500 steps/day (Thivel et al., 2018; Tudor-Locke 
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and Basset, 2004). This may suggest the 10,000 steps/day goal is unsustainable for particular 
populations. Setting these targets for CLBP treatment may risk attrition or failure. 
 
In summary, a recent systematic review demonstrates that increases in PA are important in achieving 
health outcomes, however benefits are observed with smaller amounts than the 150 minutes 
minimum or 10,000 steps frequently recommended (Warburton and Bredin, 2017). This concurs with 
the statement that there is no universal goal existing for all populations (Tudor-Locke et al, 2002a). 
This seems reasonable in a CLBP context as unexplored step count recommendation may increase 
patients’ pain and disability due to neurophysiological processes of increasing sensitization. Indeed, 
it is not yet known how many daily steps are ideal to treat CLBP. However, currently one study 
protocol is in the process of attempting to accumulate data for recommendations of step counts for a 
CLBP walking program over 12-weeks in the Saskatchewan province in Canada (Milosavljevic et 
al., 2015). Its methods reported using <7500 steps (inclusion criteria) per day as a cut off for 
interventions relative to health improvements, based on previous work (Tudor-Locke et al, 2008). It 
will be of interest what percentage of increased steps above the 7500 steps per day cut-off will 
demonstrate a significant change in Modified Oswestry Low Back Pain Disability Questionnaire 
(ODQ), International Physical Activity Questionnaire short form (IPAQ), Fear-Avoidance Beliefs 
Questionnaire (FABQ), and EuroQol health survey instrument (EQ-5D-5 L) outcomes used in the 
CLBP Canadian study. Furthermore, step counts associated with improved outcomes may add 
useable data to future CLBP exercise and walking interventions. 
 
Two recent reviews state that walking is no more effective than usual care, strength specific exercise, 
medical exercise therapy and supervised exercise classes to improve pain and disability in adults 
with CLBP (Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al 2018). Gaps are noted in the 
reviews calling for more objective data on participant’s PA at baseline, during and post intervention 
(Lawford, Walters and Ferrar 2015). Other gaps are to include insufficiently active participants to 
see what effects walking may have on their step count behaviour and outcome measures. It may be 
necessary to examine step counts of all treatment groups within a single study and not only those 
participating in walking interventions as noted in previous reviews on walking to treat CLBP 
(Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015, Sitthipornvorakul et al 2018). 
 
Walking as treatment for chronic lower back pain  
Three reviews have been done on the effect of walking on CLBP and shown it to be a useful adjunct 
treatment of pain and disability associated with CLBP despite acknowledging future research is 
required (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015, Sitthipornvorakul et al 2018). 
The main outcomes used were to examine pain intensity reduction, improved disability, return to 
work, and improved quality of life. Psychosocial outcomes have not been widely explored in these 
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reviews with only two latter reviews including them, focussing on kinesiophobia. In reviewing seven 
RCTs, Lawford, Walters and Ferrar (2015) found no evidence that walking is more effective than 
usual care, specific strength exercise, supervised exercise class or medical exercise therapy in 
improving quality of life and reducing disability in adults with CLBP. This was corroborated by a 
later review of nine studies highlighting though that walking should be advocated as a treatment for 
CLBP pain and disability (Sitthipornvorakul et al 2018).  
 
Over time objective step measurements have become more detailed in the reviews however more 
step data within and between treatment groups may be necessary for future recommendations. 
Objective measurement of steps, using pedometers or accelerometery, was not done in the 
comparator groups to the walking interventions in any of the studies used in the three reviews 
(Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015, Sitthipornvorakul et al 2018). Walking 
exercise duration, intensity and frequency is not consistent throughout the literature. One way of 
managing these factors is to base a walking program on evidence-based guidelines (American 
College of Sports Medicine, 2011). In the three reviews, when providing exercise established on 
evidence-based guidelines, or measuring PA changes objectively within the cohort, it appears to have 
significant benefit to pain and disability outcomes. In objectively supplying duration, intensity and/ 
or frequency changes in PA through steps taken, there may be an effect on CLBP outcomes 
notwithstanding pain, disability, and kinesiophobia. A recent paper which summarizes effects of PA 
in modulating chronic pain, concluded rather that insufficient activity be reduced rather than PA 
increased (Law and Sluka et al., 2017). Furthermore, the use of walking as exercise may have greater 
effect when used with insufficiently active populations, and this could be demonstrated if objective 
measurements were used from baseline until completion. Without further objective measurement of 
PA, or an example of an ideal amount of walking, the questions of suitability of walking as treatment 
for CLBP remain. 
 
Table 19 includes only RCTs done with LBP that were defined as chronic, or pain lasting for more 
than three months (Hendrick et al., 2010; Lawford, Walters and Ferrar 2015; Sitthipornvorakul et al 
2018). Methodological differences between the CLBP studies are described in Table 19. Case 
studies, cross-sectional studies, and studies with acute and subacute LBP with physiotherapy and 
walking were not included in the review since findings may not be comparable to RCT’s on CLBP. 
With the paucity of studies done on walking to treat CLBP, and the variety in methodologies of 
walking exercise protocols used, implies best practice or definitive objective amounts of walking for 
optimal effects on outcome measures have yet to be discovered. However, there were key limitations 
in some of these studies that may have affected the outcomes. A fundamental limitation in a key RCT 
comparing walking to both exercise and usual care physiotherapy was the lack of a pragmatic control 
group, which implied improvements were attributed to the mean (Hurley et al., 2015). A limitation 
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for some studies included small sample size which reduced the power to detect differences between 
baseline and follow-up (Eadie et al., 2013; Karadeniz et al., 2014; McDonough et al., 2013). Sample 
sizes ranged from n=60, n=18, n=56 respectively. Being insufficiently active were not inclusion 
criteria in several studies hence different levels of PA in participants may affect their response to 
advised walking interventions (Torstensen et al., 1998; Koldaş Doğan et al 2008; Eadie et al., 2013; 
Karadinez et al., 2014; Magalhães et al 2015; Cho et al., 2015). Baseline PA levels were not 
monitored using the same measure between studies, nor objective changes in PA throughout the 
walking interventions. This limited the objective measurement of the effect of walking on 
populations with the same level of baseline PA or observing changes in step count from baseline 
throughout the studies (Torstensen et al., 1998; Eadie et al., 2013; Shnayderman and Katz 2013; 
Karadinez et al., 2014; Magalhães et al 2015; Cho et al., 2015). Between and within treatment group 
step count has not yet been done, so comparison of steps between treatment types requires further 
examination (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015, Sitthipornvorakul et al 2018). 
A cohort of 229 veterans was recruited from one medical centre (Krein et al., 2013). Even though 
the primary outcome of sub-group analysis of moderate disability showed significant improvement 
(p=0.01) of the intervention group using a pedometer driven walking program and educational tools 
compared to control group, the trial produced results with low generalizability due to participants 
only recruited from one centre. Reduced treatment fidelity due to high number of treating therapists, 
and a lack of blinding in patients and therapists was observed in Hurley et al., (2015). A randomised 
clinical trial for CLBP compared supervised Nordic walking to unsupervised Nordic walking and 
advice to stay active (Hartvigsen et al 2010). However, inclusion criteria stated LBP for more than 
eight weeks which does not meet criteria for classifying CLBP which is defined by symptoms for 
more than three months.  
 
Despite varied treatment methodologies used in combination with walking, the role of expectation 
of pain outcome changes may be an important and unexplored factor. A systematic review of studies 
from the United Kingdom, included studies that measured satisfaction post treatment; however, 
expectation of change in pain intensity was not measured (Lawford, Walters and Ferrar 2015). An 
article discussing neurological underpinnings of pain, the role of placebo, clinical applications, and 
the context of society, concludes that patients experience pain at a level influenced by their 
expectation (Tracey 2016). This article highlighted the importance of measuring expectations of pain 
outcomes in clinical contexts. This was further corroborated by the need to evaluate health services 
from patient perspectives (Liddle et al., 2007; Sanderson et al., 2010; Blank and Burau, 2010; Froud 
et al., 2014). Some South African studies have acknowledged the use of patient’s expectation in 
treatment (Westway et al., 2003; Narasimooloo, 2011). However, none of the reviews involving 
walking to treat CLBP had measured what expectation of improvement participants had before 
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beginning treatment (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015, Sitthipornvorakul et 
al 2018).  
 
Outcome measures used when treating CLBP with walking. 
Outcome measures that have frequently been used were pain and disability; however psychosocial 
outcomes have not been measured extensively in studies using walking to treat CLBP. Outcome 
measures that have and have not been used will be discussed below. Table 19 shows study details 
included in three reviews using walking to treat CLBP (Hendrick et al., 2010; Lawford, Walters and 
Ferrar, 2015, Sitthipornvorakul et al 2018). Table 19 displays the key findings of pain intensity as 




Table 19: Walking study comparison used in three reviews on walking to treat CLBP 




Outcome measures Findings of the study Population group 
Study design & 
author 
2 groups- Both received vertical 
ambulatory traction for 12 days/ 20-
minutes per session. Followed by 8 
more sessions of 30 minutes on alt. 
days 
Control: Sit/stand no walking 
intervention 
Intervention: Walked an additional 
15 minutes / session on a treadmill. 











Pain Visual Analogue Scale 0-10 
demonstrated on a bar graph 
Range of movement: ROM 
Patient satisfaction 
Intervention group had significant pain 
reduction (p<0.0001), increased ROM, 
increased satisfaction compared to the 
control group. Pain intensity at baseline 
for both groups <7/10, >6/10. Pain 
intensity at one-month: control = 4/10 
intervention group >2/10 <3/10. Pain 
intensity at six months: control = <5/10 
>4/10 intervention group 3/10. Pain 
intensity at 12 months: control <5/10 
>4/10 intervention group <4/10 >3/10 
Mechanical CLBP confirmed by X-
Ray, CT or MRI scan (42 male, 34 
female) 





(Mirovsky et al., 
2006) 
Interventions lasted 1 hour 3 times a 
week for 12 weeks. 
Conventional physiotherapy (CP): 
heat, cryotherapy, massage, 
electrotherapy, traction, unspecified 
exercise 
 Medical exercise therapy (MET): 
Medical exercises in classes advised 
in sets, repetitions, ROM. 7-9 
exercises with 1000 repetitions 
between them in total. 
Walking group/ self exercise (SE): 
Walk unsupervised 1 hour 3 times a 








Pain Visual Analogue Scale 
Oswestry Disability Index: ODI 
Sick Leave 
Patient satisfaction 
CP & MET had statistically significant 
decreased LBP (p=0.01) and leg pain 
(p=0.003) versus the walking group. 
Baseline, Mean (S.D.); CP= 50.9 (19.2); 
MET=53.1 (21.3); SE= 55.0 (21.0). 
After 12 weeks of treatment, Mean 
(S.D.); CP= 39.0 (28.0); MET=37.2 
(25.3); SE= 50.4 (27.2). CP & MET had 
statistical significant decreased ODI 
(p=0.01) versus the walking group. 
Satisfaction scores were Conventional 
physiotherapy (32.2%), medical 
exercise therapy (34.2%), walking group 
(9.5%). 
208 CLBP patients (103 male, 105 
female) Mean age 42.1 (medical 
exercise therapy), 43.0 (conventional 










Interventions / experimental conditions 
Length of 
intervention 
Outcome measures Findings of the study Population group 
Type of study 
& author 
Group 1: Supervised aerobic treadmill 
walking three times/ week for six-weeks. 
Walk for 40-50 minutes at 65%-75% max 
HR plus daily defined home exercise 
program (flexion, extension, mobilization 
and stretching). 
Group 2: Physiotherapy (hot packs, 
electrotherapy) plus defined home 
exercise program (flexion, extension, 
mobilization and stretching). 
Group 3: Daily defined home exercise 








three times a 
week for six-
weeks 





Pain Visual Analogue Scale 
(0-100).   
Roland Morris Disability 
questionnaire: RMDQ 
Becks depression Inventory 
General Health questionnaire 
Exercise test duration  
Met scores  
Spinal mobility/ Schober test 
 
No significant difference between groups in 
pain, disability and depression scores. VAS 
(mean, SD): Group 1 baseline 57.0±24.5, 
follow-up 34.1±27.6 p=0.002. Group2 baseline 
61.2.3±20.5, follow-up 28.8±28.1 p=0.0001. 
Group 3 baseline 56.0±19.9, follow-up 
33.6±24.3 p=0.001. 
Physiotherapy and home exercise showed 
largest improvements in disability and 
depression scores. 
General Health Questionnaire improved in 
groups 1&2. 
Exercise test duration and MET scores similar 
improvements in all three groups 
No significant difference was found between 
and within groups spinal mobility 
CLBP patients started (15 
male, 45 female). Mean 





et al., 2008) 
Group 1: Supervised treadmill walking (3-
3.5 km/h) for 30 minutes three times a 
week plus lower back exercises and 
ergonomic advice for 30 minutes three 
times a week of 14 exercises 
Group 2/ Control: Lower back exercises 
and ergonomic advice for 30 minutes three 
times a week of 14 exercises 
8- weeks  
Follow-up 
completed at 
baseline and at 8 
weeks 
Pain Visual Analogue Scale 
(0-100)   
Oswestry Disability Index 
Lower Back Extensor strength 
VAS and ODI trend improved in both groups. 
VAS (mean, SD): Group 1 baseline 31.3±17.9, 
post treatment 16.9±9.3. Group2 baseline 
36.3±17.4, post treatment 20.5±13.1. 
Increased strength at 12°, 24, 36° of lumbar 
flexion in treadmill walking group. 
CLBP (20 male patients, 
ten in each group).  
IVG: 27.7±4.2 years 










Interventions / experimental conditions 
Length of 
intervention 
Outcome measures Findings of the study Population group 
Type of study 
& author 
Group 1 Walking program up to 30 
minutes 5 times/ week 
Group 2 Supervised exercises 1 times a 
week for 8 weeks 
Group 3 Usual care physiotherapy 
(exercise, manipulation and education at 




completed at 12 
weeks and 6 
months 
Numerical rating scale 
(back and leg pain) 
Oswestry Disability 
Index: ODI 
Quality of life: SF-36 
Mental component 
score: MCS 
Pittsburgh Sleep Quality 
Index 








All 3 groups improved with large CI’s with the 
smallest seen in the walking group. 
Results presented as change in NRS and ODI scores 
presented as means ±95% confidence interval. At 12 
weeks- Average LBP Group 1: -0.68(-2.10 to 0.75); 
Average leg pain: 0.50 (-0.73 to 1.73); Group 2: -
0.68(-1.58 to 0.22); Average leg pain: 0.43 (-1.33 to 
2.19); Group 3: -1.96 (-3.53 to 0.39); Average leg pain: 
-0.31 (-2.65 to 2.04). 
 
At 12 weeks- ODI: Group 1: -3.35 (-8.97 to 2.26); 




(23 male, 37 female) 




(Eadie et al., 
2013) 
2 groups: walking three days/ week 
Group 1: Treadmill walking: 20-60 
minutes supervised 









VAS Pain scores 
Oswestry Disability 
Index: ODI 
Quality of life: SF-36 
Spinal Mobility 
VO₂ Max, Max HR, 
MET, Anaerobic 
threshold. 
G1: ODI&VAS improvement p=0.025 
G2: ODI&VAS improvement p<0.025 
G2: significantly greater decrease in ODI vs. G1 
(p=0.025). VAS decrease similar between group 
(p>0.05). 
G2: showed a significant decrease in time to reach 
target HR (p=0.008). degree of change between G1&2 
similar between group (p>0.05). 
10 women 8 men CLBP 
without radicular pain. 









Interventions / experimental conditions 
Length of 
intervention 
Outcome measures Findings of the study Population group 
Type of study 
& author 
Group 1: Group exercise classes: once a 
week for 1 hour for 8 weeks (up to 10 
exercises with 3 levels of difficulty, 
including: warm up, stretching, aerobic, 
trunk and upper and lower limb 
strengthening, cool down and relaxation) 
Group 2: Individualized walking program 
(variable 10-30 minutes 4-5 times a week) 
Group 3: Usual care physiotherapy: 
multimodal, education, advice, 
manipulation, exercise based on 
physiotherapists discretion) Expected 






outcomes at 3, 6, 
and 12 months 











Weighted Health Index 
Readiness to change 
questionnaire 
Patient satisfaction  
Significant improvements in NRS-average pain, ODI, 
fear avoidance for physical activity, exercise-self 
efficacy questionnaire between baseline and at 12 
months follow-up. 
NRS (mean ±95% confidence interval): Group 1 
baseline 5.65(5.23-6.06), 12 weeks 5.17 (4.71-5.62). 
Group 2 baseline 5.59(5.18-6.01), 12 weeks 4.78 
(4.32-5.24). Group 3 baseline 5.77(5.36-6.19), 12 
weeks 4.55 (4.10-5.01). 
Results presented as change in NRS presented as 
means ±95% confidence interval. At 12 weeks- Group 
1: -0.43(0.07 to -0.94); Group 2: -0.97(-0.45 to -1.48); 
Group 3: -1.16(-0.66 to -1.66).  No significant change 
between group in satisfaction with care or outcomes at 
three months (p.0.05). Satisfaction with care not 
reported at 12 months. 
EuroQOL Weighted Health Index improved but no 
significant changes over time. No significant change 
in Back Belief questionnaire at 12 months follow-up. 
 
CLBP 
79 men 167 women were 
randomised 
219 received treatment  









Interventions / experimental conditions 
Length of 
intervention 
Outcome measures Findings of the study Population group 
Type of study 
& author 
Group 1/ intervention: Pedometer-based 
internet mediated walking program with 
goals and feedback 
Group 2/ Enhanced usual care: 




Follow-ups at 6 













Internet mediated group (Group 1) reported less back 
pain disability (at 6 months but not at 12 months), 
increased physical activity and less pain (at 6 months). 
Group 1 NRS mean (SD): baseline 6.0 (SD not given), 
six months 4.7 (2.1). Group 2 NRS mean (SD): 
baseline 6.1 (SD not given), six months 5.2 (2.1). 
Adjusted between-group difference 
(95% CI) 0.5 
(-0.01 to 0.98) was not significant p=0.06 
Mean age 51 years 200 










Interventions / experimental conditions 
Length of 
intervention 
Outcome measures Findings of the study Population group 
Type of study 
& author 
Group 1/ Intervention: treadmill walking 
graded moderate using heart rate monitor, 
CLBP education using Back Book, 
strength exercises 
Group 2/ Physiotherapy group: Stretching, 
strengthening and motion control exercise 
Each treatment 
was done for one 




baseline and at 
six-weeks 






Health related quality of 
life 
Global perceived effect 
Return to work 
Tampa Scale of 
Kinesiophobia: TSK  
Baecke Questionnaire: 
Daily habitual PA 
Physical Capacity 
NRS (mean, SD): Group 1 baseline 7.2±2.1, post 
treatment 2.4±1.8 p<0.001. Group2 baseline 7.6±1.7, 
post treatment 2.6±1.6 p<0.001.  
All outcome measures improved for both treatment 
groups showed significant improvement (p<0.05) 
There were no statistically significant differences 
between groups 
Therefore, no form of exercise is superior to another 
for CLBP treatment. 
IVG: 9 males 24 females 
mean age 47.2 (±10.5) 
Physiotherapy group: 8 










Interventions / experimental conditions 
Length of 
intervention 
Outcome measures Findings of the study Population group 
Type of study 
& author 
Group1/ SEG strength exercise group with 
stretching 
Group2/ CEG combined exercise group 
(strength exercise and walking exercise 
using a step box) with stretching 





exercise for 50 
minutes twice 







VAS Pain score (0-100) 
Back flexibility  
 Back strength Roland 
Morris Disability 
Questionnaire:  RMDQ 
Muscle mass change  
Fat mass change 
 
VAS (mean, SD): Group 1 baseline 32.3±14.9, post 
treatment 22.0±1.3. Group2 baseline 45.3±14.8, post 
treatment 33.1±20.0. VAS showed significant group 
differences (p=0.04) 
Flexibility showed no significant changes 
Back strength significant difference over time but 
group differences were not significant 
Post hoc analysis showed significant differences 
between SEG and CG, and CEG and CG with no 
difference between exercise groups. 
RMDQ showed significant time interaction with group 
(p<0.04). 12 weeks of combined exercise can 
demonstrate decreased disability 
Muscle mass showed no significant difference 
Fat mass showed significant group difference 
(p=0.04). Time interaction with group was significant 
(p<0.04) between SEG and CG demonstrating fat mass 
reduction using strength exercise programs. 
 CLBP (all overweight 
(BMI>23/kgm²) 
SEG n=15 mean age 
42.7±13.4 
CEG n=15 mean age 
46.7±8.1 
 












Interventions / experimental conditions 
Length of 
intervention 
Outcome measures Findings of the study Population group 
Type of study 
& author 
Group 1: Pedometer driven walking 
program and advice to stay active with 
education n=39 




follow-ups at 9 
weeks and 6 
months 







Quality of life: EQ5D 
Self-Efficacy 
Back Beliefs Outcome 
State of change 
Patient Satisfaction 
Larger mean improvement in pain (d=0.4) and 
physical activity (d=0.59) in the walking program 
group.  
Results presented as mean unadjusted change in NRS 
(±95% confidence interval) and between group effect 
sizes. At 9 weeks- Group 1: -0.9(-1.6 to -0.1); Group 
2: -0.7(1.6 to 0.2) between group effect sizes -0.1; At 
6 months- Group 1: -1.6(-2.6 to -0.6); Group 2: -0.5(-
1.8 to 0.8) between group effect sizes -0.4.  
The walking group also demonstrated on Oswestry 
Disability Questionnaire 8.2%-point improvement 
(95% CI, -13 to-3.4) compared to 1.6% (95% CI, -9.3 
to 6.1) on the advice/ exercise only group. Fear 
avoidance and self-efficacy had small improvements 
over time with small differences between groups. 
CLBP 
Mean age 49.5 years 







Both interventions twice a week for six-
weeks 
Group 1: Moderate intense treadmill 
walking  






6-minute walk test 
Back and abdomen 
muscle endurance tests 
Oswestry Disability 
Index: ODI 
Lower back Function: 
LBPFS 
Significant improvements in all outcomes in both 
groups, non-significant differences between groups. 
Pain intensity was not used therefore analysed. 
CLBP 
Mean age 45.3 years 












Pain was measured as an outcome in the three reviews (Table 19). When walking and additional 
treatment modalities were combined in studies in the three systematic reviews, it is unknown which 
factors were responsible for pain reduction. Many factors involved in modalities added to walking 
were manual therapy and/or education, and/or additional strength/stretching/stabilization exercises. 
Results show this may have positively influenced the pain outcomes. The trials included in Table 19 
have varied results and differences between studies worth noting in statistical significance and 
clinical significance when examining pain intensity. When comparing two trials with similar 
treatment groups these differences are noticeable. In a fully powered RCT where all interventions 
were combined with education, walking was compared to usual care physiotherapy and exercise 
classes, there was no statistically significant differences between the three groups at follow-up 
(p=0.476) (Hurley et al., 2015). Although in the same trial no MCID in mean pain intensity scores 
(≥2/10) were noted between treatment groups, the largest percentage of MCIDs was observed in the 
walking intervention. Divergent information was observed in an earlier RCT with similar treatment 
groups. Walking was used as a treatment with no addition of manual therapy, education, or strength/ 
stretching stabilization exercises and demonstrated no statistically significant change in pain 
outcomes in the walking group (Torstensen et al., 1998). Pain after 12 weeks of treatment when 
compared with pre-treatment showed a highly significant difference (p=0.00006) in favour of the 
medical exercise therapy and conservative physiotherapy groups versus the walking treatment group 
(Torstensen et al., 1998). However, none of the groups reported a minimally clinically important 
difference (MCID) in pain intensity (≥20%) on a VAS after 12 weeks of treatment, although the 
difference in pain intensity reduction was the smallest in the walking group (Torstensen et al., 1998). 
The remaining studies which used walking in combination with another modality all showed a 
significant improvement in pain intensity which is noted in Table 19 (Mirovsky et al., 2006; Koldaş 
Doğan et al 2008; Eadie et al., 2013; McDonough et al., 2013; Karadeniz et al., 2014; Hurley et al., 
2015 Magalhães et al 2015; Cho et al., 2015; Lee and Kang 2016).  
 
A MCID is indicated by greater than 20 percent improvement pain intensity score (Farrar et al., 2001; 
Hägg, Fritzell and Nordwall, 2003; Ostelo and de Wet, 2005; Haefeli and Elfering, 2006, Suzuki et 
al., 2020). Only three studies in Table 19 demonstrate this difference in mean pain intensity scores. 
Only one of these studies showed a statistically significant difference between pain scores at all 
follow-up points in favour of the walking and traction (p<0.0001) (Mirovsky et al., 2006). The 
remaining two studies showed no statistically significant difference between treatment groups 
(Koldaş Doğan et al 2008; Magalhães et al., 2015). A six-week RCT comparing walking and home 
exercises to physiotherapy modalities and also to home exercises showed a MCID greater than 20% 
in all treatment groups (Koldaş Doğan et al 2008). The greatest MCID (greater than 30%) was seen 
in the physiotherapy group. A six-week RCT comparing a walking program, education on CLBP and 
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strength exercises to a treatment group using physiotherapy exercises displayed MCIDs over 40% in 
both groups (Magalhães et al., 2015). Only the intervention group using walking and ambulatory 
traction in the third study showed a MCID of more than 20% (Mirovsky et al., 2006). Between the 
three studies, the intervention length was six weeks or less and positive MCID may have been due 
to recording pain intensity in this period. RCTs in Table 19 with follow-ups eight weeks or longer 
reported smaller improvements in mean pain intensity score. The ambulatory traction trial however 
is the only trial of its kind comparing manual traction alone to walking combined with manual 
traction. The suggestion of walking exercise added to a manual therapy may have clinical and 
statistically significant changes regarding pain intensity. 
 
Manual therapy was combined with walking in two studies, both showing reductions in pain intensity 
(Mirovsky et al., 2006; Karadeniz et al., 2014). A RCT investigating the effects of walking combined 
with vertical ambulatory traction compared with vertical ambulatory traction alone, found that pain 
had reduced significantly (p<0.001) more in the group with walking exercise addition (Mirovsky et 
al., 2006). Both treatment groups displayed reduced pain on a VAS bar graph, however only the 
group with walking exercise added displayed a MCID of >2/10 at all follow-up time points. This 
early study suggests adding manual therapy using a traction device to walking may enhance clinical 
improvements in pain intensity. A RCT using heart rate monitors to track pacing comparing treadmill 
walking to over ground walking found pain reductions in both groups (Karadeniz et al., 2014), 
however manual therapy factors were added to walking treatments. Both groups had physiotherapy 
five times per week and hydrotherapy twice a week for four weeks. Interactions of factors involved 
in physiotherapy and hydrotherapy may have positively influenced the pain outcomes. Walking may 
not solely have been responsible for reduced pain outcomes. Mean pain scores were not discussed in 
the results (Karadeniz et al., 2014). It is unknown if a MCID was achieved in this four-week 
intervention using walking and physiotherapy combined.   
 
Delivery of education about CLBP when combined with walking treatments may influence pain 
outcomes. Walking exercise was compared to both usual care physiotherapy and medical exercise 
therapy for CLBP in Torstensen et al., (1998); Eadie et al., (2013) and Hurley et al., (2015). 
Standardized education via the ‘Back Book’ on LBP was not included in the methodology of one of 
these trials, and significant reductions in pain intensity were not observed in the treatment group 
using walking (Torstensen et al., 1998). Accordingly, one study used walking combined with CLBP 
education compared to education alone (McDonough et al., 2013). The education was based on the 
Back Book, and both treatment groups showed reductions in pain intensity (McDonough et al., 2013). 
However, in a RCT a treatment using walking, strength training, and education from the Back Book 
was compared to physiotherapy with no education and pain improved in both groups significantly 
(Magalhães et al 2015). The significant improvement in pain in the physiotherapy group may be in 
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response to factors other than education, for example the process of caring for the patient through 
physiotherapy attention. The requirement of education on CLBP delivery requires more attention as 
results show varied methods of CLBP education application, if any. Pain reduction was seen in both 
treatment groups where education combined with both treatment groups was not based on pain 
management as seen in the Back Book but on mechanical ergonomic principles (Cho et al., 2015). 
Two studies seen in Table 19 had no education on CLBP in any intervention, and all interventions 
demonstrated a significant reduction in pain intensity (Koldaş Doğan et al 2008; Lee and Kang 2016). 
The earlier review on using walking to treat CLBP may indicate that CLBP education and advice in 
addition to treatment or used independently influence pain reduction (Lawford, Walters and Ferrar, 
2015). However, studies involved in the latter review indicate that even treatments which do not 
involve education have a pain-relieving effect (Sitthipornvorakul et al., 2018). These differences in 
treatment delivery may be worth exploration if education on CLBP is to be used to facilitate greater 
pain reduction than without education. 
 
Evidence-based walking programs may have led to reduction in pain intensity. Three studies showing 
pain reduction in groups using walking as treatment used evidence-based walking programs. Two 
were based on ACSM guidelines (Eadie et al., 2013; Hurley et al., 2015). Another was based on the 
5 A’s framework (McDonough et al., 2013). Comparatively, walking used in Torstensen et al., (1998) 
was not based on an evidence-based guideline and was the only walking treatment not to show 
significant reductions in pain intensity when compared to usual care physiotherapy and medical 
exercise therapy for CLBP. However, in the latter review, trials which used walking not based on 
any evidence-based walking programs had reductions in pain when compared to various other CLBP 
exercise programs (Koldaş Doğan et al 2008; Magalhães et al 2015; Cho et al., 2015; Lee and Kang 
2016). These studies recognize that walking was potentially beneficial to pain outcomes as PA is 
considered beneficial, however, walking structured on evidence-based guidelines, typically has 
frequency, intensity and/ or duration that can be progressively manipulated was not used. This 
highlights that potentially an ideal walking program to treat CLBP pain outcomes has not yet been 
formulated. 
 
Objective monitoring of step counts via pedometer or accelerometer may be beneficial understanding 
reductions in pain intensity. Differences in step counts between treatment groups may affect 
understanding pain outcomes. No single study using active treatments has thus far objectively 
measured steps in all treatment groups (Table 19). Furthermore, only two studies showed increased 
objectively measured step counts from baseline to completion in the walking group (Krein et al., 
2013; McDonough et al., 2013). The benefit of only providing intervention groups doing walking is 
that measuring steps using a pedometer is known to motivate increased PA (Merom et al., 2007; 
Baker et al., 2008; Kang et al, 2009; Greaves et al., 2011; Dombrowski et al., 2012; Harris et al., 
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2015). If treatment groups not randomized to walking measured their steps, participants may have 
extrinsically been motivated to increase PA. The disadvantage however is not being able to compare 
PA through steps between and within these groups in the same study. Four studies seen in Table 19 
employed objective measures in groups using walking as a treatment (Krein et al., 2013; Eadie et al., 
2013; McDonough et al., 2013; and Hurley et al., 2015). However, lack of PA data and low 
compliance of accelerometer wear time was noted as a limitation (Eadie et al., 2013; Hurley et al., 
2015). In the latter review walking was not measured using objective pedometery or accelerometery 
programs (Koldaş Doğan et al 2008; Magalhães et al 2015; Cho et al., 2015; Lee and Kang, 2016). 
Therein, the objective effect of number of steps taken on pain outcomes is unknown in these studies. 
 
Insufficiently active and active populations may respond differently to treatments used in CLBP 
studies using walking as a treatment. The impact of PA on improving fitness, strength and feelings 
of wellbeing associated to increased PA in insufficiently active populations is documented (Law and 
Sluka et al., 2017; Warburton and Bredin, 2017). The benefit of added PA to insufficiently active or 
active populations is equivocal in pain outcomes in studies using walking as a treatment. 
Furthermore, in an earlier review on walking to treat CLBP, one study population did not specify the 
inclusion of only insufficiently active individuals (Lawford, Walters and Ferrar, 2015; Torstensen et 
al., 1998). Later studies using walking as a comparative treatment included only insufficiently active 
participants (Eadie et al., 2013; McDonough et al., 2013; Hurley et al., 2015). Inclusion of 
insufficiently active individuals in three RCT’s may have been the reason walking as a treatment 
showed reduced pain outcomes, since participants which may have been physically active may not 
have responded exponentially to an exercise intervention. Only some of the studies employed 
objective measures via accelerometery prior to baseline to include insufficiently active populations 
(Eadie et al., 2013; McDonough et al., 2013; Hurley et al., 2015). However, significant pain 
reductions were seen in all interventions in the recent review (Sitthipornvorakul et al., 2018). Only 
one study in the review described a subjective measure of insufficiently active at inclusion (Lee and 
Kang, 2016). The other CLBP studies in the recent review did not specify inclusion of insufficiently 
active participants (Koldaş Doğan et al 2008; Magalhães et al 2015; Cho et al., 2015). When 
examining the effects of walking as a treatment on pain intensity, comparing the effects on 
insufficiently active to active populations may be worth exploring in order to understand what effects 
walking has on CLBP populations with varied levels of PA.  
 
Supervised exercise programs are most likely to reduce pain outcomes in CLBP (Hayden et al., 
2015a). Varied levels of supervision were apparent in treatment groups in three reviews (Table 19). 
Supervision was provided in each treatment provided by a clinician present during the treatment, in 
a group exercise, via the telephone or the internet. It is unclear if mode of supervision was associated 
with pain reduction. It is a key limitation that the supervision or number of visits was not examined 
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as an independent variable associated with pain intensity in any of the studies in table 19. The effect 
of participant supervision may require further exploration in CLBP studies outcomes including pain 
intensity. Recording participant’s pain during treatment may modify clinical supervision depending 
on whether pain symptoms change with allocated treatment. Internet log ins were used to maintain 
supervision in one walking study (Krein et al., 2013). Paper diaries were used in another walking 
study to record adverse events and walking program (McDonough et al., 2013). No physiotherapy 
studies using walking incorporated diaries to monitor pain. Decreasing the need for interviews, 
patient diaries used on participants with pain of the age range 18-65 years were an alternative to 
capturing patient perceptions of their pain (Miller, Pinnington and Stanley, 1999). Participants need 
not rely on recall and can demonstrate an up-to-date daily experience of their pain typified by diary 
use in complementary scenarios in pain clinics (Follick, Ahern and Laser-Wolston, 1984). Diaries 
can have limitations. In one pain study, diaries were qualitative and excluded participants with a lack 
of basic literacy skill and included participants of the age range 18-65 years. Furthermore, the crude 
response rate using diaries was 40% (Miller, Pinnington and Stanley (1999). Advantageously 
however, evening pain score entries were more frequent and reportedly more convenient compared 
to morning entries (Miller, Pinnington and Stanley, 1999). Pain diaries may provide supervisory 
information to researchers and clinicians alike. 
 
Disability  
Measuring disability experienced by patients with CLBP is critical to function and quality of life. 
Disability was measured using either the Oswestry Disability Index (ODI) or Roland Morris 
Disability Questionnaire (RMDQ) in several studies (Table 19).  
 
Reduced disability is seen at follow-up in varied comparators in studies using walking to treat CLBP. 
Varied belief in a treatment for CLBP between population groups may affect disability outcomes, 
including other factors such as whether the walking is performed on a treadmill or outdoors. 
 
Differences in population’s belief in treatment may affect disability outcomes. A Turkish population 
showed statistically significant improvement in disability when exposed to physiotherapy and home 
exercise (p=0.01) unlike exposure to walking and home exercise (Koldaş Doğan et al 2008). The 
authors stated that this positive outcome may be related to stronger population belief in physiotherapy 
treatment using hot packs and electrotherapy rather than walking (Koldaş Doğan et al 2008). Two 
trials conducted in Ireland showed no statistically significant difference between groups in the change 
in disability scores (Eadie et al., 2013; Hurley et al., 2015). The two RCT’s compared the 
effectiveness of physiotherapy using three groups: a walking program, supervised exercise, and usual 
care physiotherapy on CLBP (Eadie et al., 2013; Hurley et al., 2015). When observing these different 
results, two geographically similar Irish populations may have been historically exposed to a 
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different context and content of CLBP treatment to Turkish patients. These differences suggest the 
study of participant expectation of treatment outcome is worthwhile. 
 
When over ground walking was compared to walking done a treadmill to treat CLBP, there were 
significant reductions in the former treatment group (p=0.02) (Karadeniz et al., 2014). The authors 
propose the influence of well-being associated to the outdoors reduced disability; however, this 
association was not investigated further in the trial. 
 
Observing step count affecting disability related to walking interventions was well documented in 
one trial. A feasibility trial comparing pedometer driven walking and CLBP advice to CLBP advice 
alone, summarized that patients who increased their PA through increased steps demonstrated 
reduced CLBP associated disability (McDonough et al., 2013). At six months the group with a 
walking intervention demonstrated a mean improvement in the Oswestry Disability Questionnaire of 
8.2% points (95% CI, -13 to -3.4) compared to 1.6% (95% CI, -9.3 to 6.1). At baseline, all 57 Irish 
participants were issued with ActivPAL accelerometers which confirmed that both groups included 
had an objective measure of insufficiently active baseline PA. This demonstrated the validity of the 
results using interventions on participants with CLBP that are insufficiently active. The group using 
walking and education as a treatment wore pedometers and results showed an increase in mean steps 
per day taken from baseline to follow-up (2776 steps). Unlike previous RCT’s this was an 
improvement in understanding whether increased steps on an insufficiently active CLBP population 
positively influences disability outcomes. The baseline accelerometer data ensured objective 
inclusion of insufficiently active participants unlike comparative studies using walking to treat 
CLBP. Although only the group using walking used pedometers to further measure steps throughout 
the trial. Objectively measured steps between the two groups could not be compared nor could it be 
determined if steps correlated with disability outcomes in both groups.  
 
A RCT investigated the effect of an aerobic treadmill walking program versus a lower back muscle 
strengthening program on disability and fear avoidance in CLBP participants and showed significant 
improvements in disability in both groups (Shnayderman and Katz-Leurer, 2013). Both groups were 
treated twice a week for 6 weeks, with no significant difference between groups (Shnayderman and 
Katz-Leurer, 2013). Neither group used objective measurement comparing walking, PA or exercise 
done during the trial. Only a six-minute walk test was compared between groups from baseline to 
follow-up as an objective measure. The authors also concluded that findings may have been more 
illustrative if subgroups based on CLBP classification according to signs and symptoms were first 
identified. This subgrouping for modelling purposes using pain phenotypes may hold for any study 




The review by Lawford, Walters and Ferrar (2015) states that walking studies with heterogeneous 
methodologies demonstrate that walking is no more effective in improving disability than 
strengthening, progressively graded medical exercise, and supervised exercise classes; with the 
limitation that walking had not been compared to a true control (no intervention).   
 
Psychosocial Outcome Measures 
When comparing three reviews (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; 
Sitthipornvorakul et al 2018), only the latter two reviews highlighted the use of biopsychosocial 
outcomes as secondary outcomes. The biopsychosocial outcome included frequently was fear 
avoidance, but pain catastrophizing was not included at all. Six studies in the latter reviews supported 
the use of measuring fear avoidance as a contributing variable to CLBP (Shnayderman and Katz-
Leurer, 2013; Eadie et al., 2013; McDonough et al., 2013; Karadeniz et al., 2014; Hurley et al., 2015; 
Magalhães et al 2015). When comparing a walking program, supervised exercise, and usual care 
physiotherapy, two RCTs using the same interventions demonstrated a small mean reduction of fear 
avoidance behaviour in all groups (Eadie et al., 2013; Hurley et al., 2015). A significantly greater 
reduction was noted, in the walking program, with those who achieved clinically significantly 
improvements in pain (NRS) and disability (ODI) suggesting the mediating effect for fear avoidance 
on pain and disability (Hurley et al., 2015). The study population included was insufficiently active. 
The exposure to increased PA in the walking group may indicate greater reductions in fear avoidance 
when using walking in CLBP patients. Similarly, when comparing walking and CLBP advice to 
advice alone, small improvements in fear avoidance at follow-up were found in both insufficiently 
active groups in favour of the group using walking (McDonough et al., 2013). Changes were similar 
between groups and regarded as unlikely to be clinically important due to the small change. The 
improvements in three trials were likely to be result of re-assurance through advice, mitigating fear 
avoidant behaviour, which was common to all (McDonough et al., 2013; Eadie et al., 2013; Hurley 
et al., 2015). A limitation noted in one RCT was that the mean baseline score for fear avoidance was 
low suggesting a selection bias of participants agreeing to participate due to low fear of movement 
(Shnayderman and Katz-Leurer, 2013). Other studies using walking for chronic pain, not specifically 
CLBP, did use catastrophizing as an outcome to successfully rehabilitate patients (Sullivan et al., 
2006c). Using walking as a treatment may utilize the Beckian model (Beck, 1995). Identifiable 
automatic maladaptive cognitions could be replaced by rational thinking though demonstrating new 
behaviour by adding PA or exercise in a walking intervention. This type of positive coping strategy 
to decrease pain has been described in previous exercise interventions (Eccleston and Crombez, 
1999). However, it was not explored in the reviews using walking to treat CLBP (Hendrick et al., 





Combination treatment  
In two reviews that examine walking as a treatment for CLBP, minimal research has been done on 
walking exercise combined with manual physiotherapy as a treatment (Hendrick et al., 2010; 
Lawford, Walters and Ferrar, 2015). In the reviews, walking has also been combined with education 
on CLBP or additional exercises (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; 
Sitthipornvorakul et al 2018). Two studies showed pain reductions when walking was combined with 
manual therapy (Mirovsky et al., 2006; Karadeniz et al., 2014). A RCT investigating the effects of 
walking combined with vertical ambulatory traction compared with vertical ambulatory traction 
alone, found that pain had reduced significantly (p<0.001) more in the group with walking exercise 
addition (Mirovsky et al., 2006). A RCT using heart rate monitors to track pacing comparing 
treadmill walking to over ground walking found pain reductions in both groups (Karadeniz et al., 
2014). However, manual therapy factors appear in these walking treatments, where both groups had 
physiotherapy five times per week and hydrotherapy twice a week for four weeks (Karadeniz et al., 
2014). Interactions of factors involved in physiotherapy and hydrotherapy may have positively 
influenced the pain outcomes. Combination treatment was not trialled against walking or 
physiotherapy alone. It has not yet been deduced if walking combined with physiotherapy shows 
statistically or clinically significant differences compared to both physiotherapy and walking 
independently. A later review which included four studies with CLBP participants used walking 
combined with other exercises (Sitthipornvorakul et al 2018). This combination of treatments was 
not studied in the current RCT. 
 
2.7 Summary  
 
Physiotherapy modalities used in UK NICE guidelines and by the majority of South African 
physiotherapists involve manipulation, massage, and exercise. There is a paucity of evidence 
supporting walking as an exercise, either used alone or combined with physiotherapy, and for this 
reason, together with available physiotherapy treatments, it merits further investigation. 
Consideration of baseline PA and guidance of the time spent walking as an exercise, and the number 
of steps taken should be reviewed when choosing walking as a CLBP treatment when comparing 
physiotherapy treatments to it. CLBP may be considered as a heterogeneous entity with pain 
phenotypes including nociceptive and neuropathic CLBP (Smart et al., 2012a; Baron et al., 2016). 
For this reason, including pain phenotypes in the modelling process may be a point of departure for 
future investigation of CLBP cohorts. Following this review of the literature, requirements for studies 





• Improved objective documentation of activity in all treatment groups 
• Improved documentation of walking intervention amount and duration. 
• Examining patients’ pain expectations relative to outcome 
• Examining walking as a sole intervention and as an intervention coupled with usual care 
physiotherapy 
• Explicit definitions of allocated usual care physiotherapy 
• Examining physiotherapy treatment content when compared to walking 
• Examining the role of supervision as number of visits 
• Sample size representing a fully powered RCT 
• Specifying subgroups within CLBP (pain phenotypes) as a covariate for modelling purposes 
 
Following this review of the literature, requirements for studies using walking as a CLBP treatment 
include the use of three treatments defined as: 1) Usual care/ Physiotherapy (P); 2) Pedometer driven 
Walking intervention (W); and 3) Usual care/ Physiotherapy and Pedometer driven Walking 
intervention (PW), to explore their effects on pain, disability, kinesiophobia and pain catastrophizing 
outcomes. The cohort will be examined in the context of nociceptive and neuropathic pain 





Chapter 3: Methods 
 




Ethical approval for this randomised controlled trial (RCT) was granted from the University of Bath 
Ethics Committee on the 10th August 2015, (REACH reference number EP 15/16 18) (Appendix 1). 
This ensured that ‘good clinical practice’ was maintained throughout, with refusal or participation in 
the RCT not compromising clinical care for any of the participants. The RCT was retrospectively 
registered on the Pan African Clinical Trials Registry (PACTR) on the 5th June 2016 
(PACTR201606001660285) (Appendix 2). Patient sensitive information was stored in locked 
cupboards. Participants were anonymised using numerical reference numbers. 
 
3.2 Intervention planning: Evidence supporting design of treatment groups  
 
Methodological differences in walking interventions to treat CLBP and usual care physiotherapy are 
noted in previous studies (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; 
Sitthipornvorakul et al., 2018). This has made it difficult to assess the efficacy and or effectiveness 
of such a treatment. To address these disparities, the current RCT has used a randomised controlled 
design, comparing a pedometer-based walking intervention partly supervised by physiotherapists 
against usual care (physiotherapy treatment) and a combination of the two. The treatment proposed 
in this RCT was extracted from (inter)national clinical guidelines, clinical expert opinion, and 
systematic reviews for treatment of CLBP (National Collaborating Centre for Primary Care [UK], 
2009; Liddle, Baxter and Gracey, 2009; Hendrick et al., 2010; Koes et al., 2010; American College 
of Sports Medicine, 2011; Naidoo et al., 2012; American College of Sports Medicine, 2013). An 
overview of the proposed three treatment groups is described in Table 20.  The treatments in the 
study were: Usual care (physiotherapy) (P); Pedometer-based walking intervention (W); and Usual 






Table 20: Overview of three treatment groups planned for the main RCT. 
 Treatment groups 
Components 
of treatment 
Usual care /Physiotherapy 
treatment (P) 
The pedometer-based 
walking intervention (W) 
Combination treatment (PW) 
Usual care/ 
Physiotherapy 
treatment     
10-15 minutes of lumbar and 
gluteal massage. 
5-10 minutes of Maitland spinal 
vertebrae mobilisation  
10 minutes of Lumbar 
stabilisation exercise consisting 
of sub-maximal isometric 
transversus abdominus 
contractions.  These would be 
encouraged to be done at home 
unsupervised daily for 10 
minutes daily. 
CLBP advice/ discussion. 
No hands-on treatment 10-15 minutes of lumbar and 
gluteal massage. 
5-10 minutes of Maitland spinal 
vertebrae mobilisation  
10 minutes of Lumbar 
stabilisation exercise consisting 
of sub-maximal isometric 
transversus abdominus 
contractions.  These would be 
encouraged to be done at home 
unsupervised daily for 10 
minutes daily. 






No hands-on treatment Standardized daily walking 
intervention per week. 
Intervention only supervised 
when attending a physiotherapy 
visit, with remaining walks 
unsupervised. 
Minimum weekly walking 
required = 0 days. This was to 
ensure no increase in 
sensitization if participants 
were subjectively too sore. 
Maximum weekly walking 
required = 7 days 
One walk per day 
(recommended) 
Weekly Incremental time 
addition by 10% every week 




CLBP advice/ discussion. 
Adherence and Incremental 
walking intervention advised 
for 12-weeks (unless pain 
increases) 
Standardized daily walking 
intervention per week. 
Intervention only supervised 
when attending a physiotherapy 
visit, with remaining walks 
unsupervised. 
Minimum weekly walking 
required = 0 days. This was to 
ensure no increase in 
sensitization if participants 
were subjectively too sore. 
Maximum weekly walking 
required = 7 days 
One walk per day 
(recommended) 
Weekly Incremental time 
addition by 10% every week 




CLBP advice/ discussion. 
Adherence and Incremental 
walking intervention advised 





3 – 9 Treatments with a 
physiotherapist. A tenth 
physiotherapy visit was added 
to obtain incomplete outcome 
measures or pain and activity 
diaries not submitted. 
3 – 9 Treatments with a 
physiotherapist. A tenth 
physiotherapy visit was added 
to obtain incomplete outcome 
measures or pain and activity 
diaries not submitted. 
3 – 9 Treatments with a 
physiotherapist. A tenth 
physiotherapy visit was added 
to obtain incomplete outcome 
measures or pain and activity 
diaries not submitted. 
Treatment 
duration 





NICE guidelines support up to nine physiotherapy treatments of usual care and exercise over a 12-
week period for non-specific chronic lower back pain NSCLBP (National Collaborating Centre for 
Primary Care [UK], 2009). As no guidelines existed in the South African physiotherapy context at 
the beginning of this RCT, UK NICE guidelines were chosen as the framework to base treatment 
type and frequency on in this RCT.  
 
All participants were encouraged to visit the physiotherapist during the 12-week RCT, thereby every 
group was designed to have an opportunity to have a therapeutic relationship between participant 
and physiotherapist. All three treatment groups had face to face physiotherapist interaction with each 
participant. All three treatment groups received advice and education. A form of exercise for CLBP 
treatment was done in all three treatment groups (isometric lumbar stabilization exercise, a 
pedometer-based walking exercise, or a combination of both exercises). Exercises were also partly 
supervised. During physiotherapy visits in all three treatment groups, the included exercises were 
supervised, however participants were advised to continue with the supervised exercise at home daily 
on advice of the physiotherapist, therefore unsupervised at home.   
 
Advice and education to participants given by physiotherapists in all three treatment groups was 
based on current knowledge and attitudes towards CLBP, used by the physiotherapists prior to the 
RCT. During physiotherapy visits, all participants were verbally educated about chronic pain, 
benefits of the treatment they were receiving for their CLBP, addressing specific participant 
questions regarding their treatment, and encouraging participants to continue with the three-month 
course of the RCT. While encouraging participation for 12-weeks, all participants were encouraged 
to maintain their participation in exercises advised and continue making regular appointments 
depending on the participant’s choice on appointment frequency providing it was between three and 
nine appointments.  
 
The two interventions of P, and PW were tested against the W intervention. A protocol was 
developed to explicitly define the three treatment groups used in this RCT (Table 20). If participants 
received the usual care intervention modalities (P or PW), they would receive spinal manipulation, 
massage, and isometric lumbar stabilization during every treatment visit (Table 20). These modalities 
were defined a priori which contrasts with other similar studies (Torstensen et al., 1998; Hurley et 
al., 2015). The justification for treatment protocol was based on CLBP treatments used, in previous 
studies (Torstensen et al., 1998; Maher, 2004; Koes et al., 2010; American College of Sports 
Medicine, 2011; American College of Sports Medicine, 2013). Standardized treatment is 
demonstrated in Table 20. If participants received a pedometer-based walking intervention, only the 




Table 21: Summary of proposed pedometer-based walking intervention 













* If pain intensity increased, participants were to attempt doing the amount of walking daily in the previous week. 
 
One exercise intervention in this RCT was a pedometer-based walking exercise intervention. It was 
performed in isolation (W), and in combination with usual care (PW). It was a planned duration 
intervention, however measuring step counts and distance for all three treatment groups would 
provide an objective measure between and within groups for this. All participants were instructed in 
and requested to complete a daily pain and activity diary (Appendix 3 and 4). Table 22 describes the 
content of these diaries, by treatment group. 
 
Table 22: Pain and activity diaries (A and B) used in the 3 RCT treatments 
Pain and activity 
diary used 
Treatment group Information from diary 
Diary A Usual care/ Physiotherapy (P) Pain Intensity VAS 
Total daily steps 
Total daily kilometres  
Diary B Pedometer-based walking intervention 
(W) 
Pain Intensity VAS 
Total daily steps 
Total daily kilometres 
Walking intervention steps for the day 
Walking intervention kilometres for the day 
Minutes spent doing walking intervention for the day 
Diary B Usual care/ Physiotherapy treatment and 
pedometer-based walking intervention 
(PW) 
Pain Intensity VAS 
Total daily steps 
Total daily kilometres 
Walking intervention kilometres for the day 




Three physiotherapy visits were allocated to collect outcome measures at baseline, 6-week and 12-
week follow-up. Aside from the three mandatory physiotherapy visits to complete outcome 
measures, the number of physiotherapy visits in this RCT was discretionary. In the context of South 
African physiotherapy private practice, participants could choose the number of physiotherapy visits 
they would like. Two primary studies using walking to treat CLBP used the approach allowing the 
discretion of the treating physiotherapist for when and how often to treat participants/ schedule the 
number of physiotherapy visits (Eadie et al., 2013; Hurley et al., 2015). The number of physiotherapy 
visits was not included as an independent variable in the analysis of previous reviews that used a 
walking intervention for the treatment of CLBP (Hendrick et al., 2010; Lawford, Walters and Ferrar, 
2015; Sitthipornvorakul et al 2018). However, in the current RCT, it was included as an independent 
variable. The primary researcher felt the frequency of physiotherapy, which was not previously 
investigated in studies using walking to treat CLBP, may affect outcomes for pain, disability, 
kinesiophobia and pain catastrophizing. 
 
Participants in this RCT as in other CLBP walking RCTs using a walking and usual care, were 
advised to continue normal medication intervention (Eadie et al., 2013; McDonough et al., 2013; 
Hurley et al., 2015).  
 
Justification to define usual care/ physiotherapy treatment group 
Previous systematic reviews of walking to treat CLBP refer to heterogeneous applications of 
individual physiotherapy modalities as usual care (Hendrick et al., 2010). In this RCT, P treatment 
group is described in Table 20.  
 
An evidence-based decision was taken to use spinal manipulation, massage, exercise (isometric 
lumbar stabilization) and advice to treat CLBP in this RCT (National Collaborating Centre for 
Primary Care [UK], 2009; Liddle, Baxter and Gracey, 2009; Naidoo et al., 2012). These modalities 
for the treatment of CLBP are used in parallel by physiotherapists implementing UK NICE guidelines 
and typical South African physiotherapists (National Collaborating Centre for Primary Care [UK], 
2009; Liddle, Baxter and Gracey, 2009; Naidoo et al., 2012).  
 
Justification to design a pedometer-based walking intervention treatment group  
A Literature search of eleven different countries guidelines for the treatment of CLBP showed them 
to be generally similar, supporting staying mobile and increased physical activity (Koes et al., 2010). 
Staying mobile can be measured by step count therefore having walking compared with usual care 
physiotherapy and to a combination all while measuring the step count between and within all three 
treatment groups, may explain the levels of PA that occurred when using the treatments in this RCT. 
Systematic reviews concluded it would be prudent to encourage people to use walking to treat CLBP 
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Hendrick et al., 2010; Sitthipornvorakul et al 2018). The recommendations in the former review were 
assessing participant specific characteristics, objectively measuring walking and the review had no 
evidence-based walking programs used in their methodology. In the current RCT, daily steps counts 
were monitored and recorded by each participant using a pedometer and recorded in a pain and 
activity diary (Table 22). Step counts were presented as weekly steps taken. The current RCT also 
measured patient specific characteristics, phenotyping participants CLBP into nociceptive and 
neuropathic pain phenotypes, and utilized biopsychosocial outcome measures (kinesiophobia and 
pain catastrophizing). This would aid understanding into objectively measured step counts and these 
patient specific characteristics. 
 
The ACSM provides evidenced based guidelines for walking for health, which are internationally 
recognised. Guidelines for starting a walking programme, published by The American College of 
Sports Medicine (American College of Sports Medicine, 2011) were used to develop the pedometer-
based walking intervention methodology for this RCT (Table 21). Incremental increases in walking 
time duration were utilized. The methodology devised in this RCT was to increase PA levels in two 
of the treatment groups (P and PW) using walking as an exercise.  
 
ACSM recommendations state the duration of a walking programme is between 10-30 minutes 
(American College of Sports Medicine, 2013). At baseline participants in this RCT were classified 
as insufficiently active. That is, performing less than 150 minutes of exercise per week (Warburton 
and Bredin, 2017; Fielding et al., 2017; Exercise is Medicine, 2019). By asking participants in the 
pedometer-based walking interventions to walk for 20 minutes, seven days a week for the first week 
in the RCT, the total walking exercise time required after one week’s participation would still be 
classified as insufficiently active (totalling 140 minutes per week). As for step counts achieved, 
according to the literature recommended daily step counts for populations with disabilities or chronic 
illness are 4000-6000 steps per day (Tudor-Locke and Myers, 2001b).  
 
Participants were advised to walk daily at a moderate intensity providing the intensity did not 
increase their pain intensity. In line with ACSM recommendations, participants were requested to 
increase their advised daily walk by two minutes each week (10%), over the 12-week intervention 
period (Table 21). This walking advise would classify participants as no longer insufficiently active 
by week two of the pedometer-based walking interventions. They were not excluded from the RCT 
if pain prevented walking. The intervention was designed to encourage exercise through walking but 
to not increase peripheral and central sensitization, resulting in pain. Objective measures of number 
of steps taken per week from baseline to 12-week follow-up would be compared between treatment 




Participants were requested to try and maintain compliance with time and frequency of the 
pedometer-based walking intervention but not to continue with the walking intervention for the day 
if pain levels increased. An additional instruction to this was to continue with the pedometer-based 
walking interventions when pain intensity decreased or reached ambient/ previous levels. If, or once 
decreased pain levels were reached, the participants were advised to begin walking at the daily time 
duration prior to the increase in pain, unless this was reached in week-one. If so, participants were to 
start walking again at the 20-minute duration. Regardless of the exercise prescription, participants 
were not excluded if they walked less than the recommended amount (Table 21). This may have been 
due to other pragmatic reasons (e.g.: sickness, work or family duties, unforeseen obstructive 
circumstances such as motor vehicle accidents). To standardize the pedometer-based walking 
interventions, participants were encouraged not to exceed the amount of walking advised. Adherence 
to the pedometer-based walking interventions would be recorded over the 12-week RCT. Participants 
in the W and PW groups would complete diaries with total daily step counts, distance covered, and 
time taken to complete the daily pedometer-based walking intervention. 
 
All participants in the W treatment group attended physiotherapy visits (Table 20). In previous 
studies comparing a walking intervention and usual care, participants used telephone contact as 
physiotherapy visits (Hurley et al., 2015; Eadie et al., 2013; Torsensen et al., 1998). Participants in 
the W treatment group would not receive telephone calls by the physiotherapist every one to two 
weeks but attend a face to face physiotherapy visit. Furthermore, every participant in the W and PW 
treatment groups went for a minimum of one mandatory supervised walk with the physiotherapist 
during the 12-week RCT to ensure walking was done at a moderate pace. The remainder of the 
physiotherapy visits could be a supervised walk together with the physiotherapist with advice on 
their pain, or advice on CLBP, without including a supervised walk. This decision was based on 
whether the participant had already completed their daily walk or if they felt pain intensity prevented 
walking on the day. Thus, the pedometer-based walking intervention (W and PW) was only partly 
supervised. Physiotherapy visits included discussing their progress or problems around any pain and 
disability, or a face to face meeting and discussion about their progress or problems encountered in 
the walking intervention. The decision by the patient to not increasing the walking time as per Table 
21 was based on increased participant pain and disability since the last treatment preventing desired 
increased walking time. During physiotherapy visits participants were encouraged to make further 
physiotherapy appointments based on their perceived need for support.  
 
Justification to design combined usual care and pedometer-based walking intervention 
group.  
This treatment design was an additive treatment combining both the stand-alone pedometer-based 
walking intervention (W) and stand-alone usual care treatment (P). The participants randomised to 
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this treatment were asked to complete the pedometer-based walking intervention and attend up to 
nine physiotherapy visits for massage, manipulation, and isometric transversus abdominus exercise, 
over the RCT period. The same education and advice on CLBP as used in the former treatment groups 
was incorporated in the PW treatment. Any problems the participants encountered as in the 
pedometer-based walking interventions would be addressed within the physiotherapy treatment. 
 
Strategy to ensure participant safety  
For ethical reasons and to prevent increased sensitization, instructions were given to physiotherapists 
not to persevere with any treatment that was causing increased pain.  
 
All the physiotherapists involved in this RCT were trained to instruct the participants to stop their 
pedometer-based walking interventions if pain increased. The participants were instructed to start the 
pedometer-based walking interventions again only if pain ceased or returned to pre-treatment levels. 
Once pain had reached these levels, the pedometer-based walking interventions would continue at 
the time duration used one week prior to the pain increasing. The incremental 20% time increase for 
every second week would be applied for the remainder of the intervention.  
 
Physiotherapists were instructed not to cause participants increased pain when using massage, 
manipulation, and isometric transversus abdominus exercises. Adverse events which were 
experienced by participants were recorded in the pain and activity diary. Participants were free to 
withdraw from the RCT at any time if they were unable to cope with exercise for any physical reason, 




Initial measures taken were only completed at baseline. Outcome measures for the trial were 
completed at baseline, at six-weeks and at 12-weeks. Visual Analogue Scale Pain and Activity 
diaries were completed daily by participants. 
 
Baseline questionnaires, screening tools and lumbar assessments 
Measures recorded at baseline only are described in Table 23. 
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Reference Method of measurement: 
Health history & 
demographic 
questionnaire 
Health History demographic questionnaire used to 
gather demographic data 
Baseline Designed by the 
primary 
researcher 
Questionnaire: Self-measurement by participant  
Anthropometric data height, body mass and stride 
length were recorded by the physiotherapist. 
Pain phenotype 
screening tool 
painDETECT questionnaire   
0-12 unlikely to have a neuropathic component 
13-19 Ambiguous but a neuropathic component is 
likely 
>19 a neuropathic component is likely 
Baseline Freynhagen et 
al., 2006 





Questionnaire measuring participant expectation of 
pain intensity at follow-up measured on a NRS (0-
100)    0=no pain; 100=worst imaginable pain 
Baseline Sanderson et 
al., 2012 




To record professional examination of participant 
and exclude any red flags (infection, fracture, 
cancer). Postural and movement observation; 
history of participant symptoms; basic 
physiotherapist neurological tests; joint and muscle 
palpation; and special tests to confirm CLBP 
Baseline Maitland, 2001 Observational assessment by attending 




Health history and demographic questionnaire  
This questionnaire was designed to assess participant eligibility for the RCT (Appendix 5). In 
addition, demographic data were recorded by participants at baseline in this questionnaire. 
Furthermore, participant anthropometric height, body mass and stride length were recorded by the 
physiotherapist. Stride length, measured with a standard tape measure in centimetres, was assessed 
as a mean of ten strides. Digital home bathroom scales were deemed fit to provide accurate and 
consistent body mass measurement (Yorkin et al., 2013). Body mass was measured in kilograms 
using new digital Beurer scales with participants fully clothed but without shoes on. Height was 
recorded in centimetres using a fixed vertical tape measure mounted on the wall. 
 
PainDETECT questionnaire  
Prior to a lumbar evaluation and outcome measure assessments, categorizing participants by their 
dominant pain phenotype was conducted using the painDETECT questionnaire. Pain phenotyping 
would be included in the modelling process. This is a validated instrument which enables a 
physiotherapist to identify nociceptive and neuropathic pain phenotypes in patients with CLBP 
(Freynhagen et al., 2006), it is further described in appendix 6. The painDETECT was developed and 
validated in German and is available in English (Freynhagen et al., 2006). The tool has a sensitivity 
of 85% and specificity of 80% for correctly classifying CLBP. It has good internal consistency for 
the detection of dominance of neuropathic pain phenotype; with a Cronbach’s alpha > 0.83 and 
excellent test-retest reliability, showing an ICC = 0.93 (Mathieson and Lin, 2013). 
 
The painDETECT consists of a nine item self-report questionnaire. Pain patterns are described in the 
questionnaire by seven weighted sensory descriptor items (0 = ‘never’ to 5 = ‘very strongly’) and 
two items relating to the spatial (radiating) and temporal characteristics. The score ranges from 0-38. 
The principal researcher used the score interpretation to phenotype participants according to their 
pain. Participants LBP scoring 0-12 were classified as having nociceptive CLBP. Participants having 
scores of 13-38 were classed as having a neuropathic pain component, or neuropathic CLBP 
(Freynhagen et al., 2006). The questionnaire indicates that scores ≤12 are unlikely to have a 
neuropathic component (<15%), whereas a score of ≥19 suggests that pain is likely to comprise of a 
neuropathic component (>90%). The score from 13 - 18 is categorized as ambiguous in the 
questionnaire and that a neuropathic component may be present (Freynhagen et al., 2006). A cut-off 
point at 13 was decided upon by the principal researcher in the current RCT. To summarise, scores 





Participant expectation of pain reduction at follow-up  
At baseline, each patient’s expectation of their pain at 12-week follow-up, was assessed using the 
Patient Centred Outcome Questionnaire seen in appendix 7 (PCOQ). The PCOQ has five sections 
where initially participants indicate their usual levels (during the past week) of pain, fatigue, 
emotional distress, and interference with daily activities on 101-point NRS (0 = none, 100 = worst 
imaginable) (Sanderson et al., 2012). Only the expectation of pain intensity scores gathered at 
baseline were analysed in this RCT. In pilot data of 21 spinal pain patients, there was acceptable test-
retest reliability with reliability values ranging from 0.84 to 0.90 (p<0.001) (Brown, 2004). The 
PCOQ has good concurrent validity with standardized measures of pain, mood, and disability 
(Brown, 2004). 
 
3.4 Lumbar assessment  
 
There is no current gold standard in lumbar assessment. The lumbar assessment used followed a 
Maitland style approach (Maitland, 2001). The lumbar assessment at baseline included postural and 
movement observation; taking a detailed history of patient symptoms; basic physiotherapist 
neurological tests; joint and muscle palpation; and special tests to confirm that the diagnosis of CLBP 
was correct. The assessment is further described in Appendix 8. 
 
Outcome Measures 
Table 24 describes the outcome measures selected for this RCT. Outcome measures were selected to 
evaluate biopsychosocial aspects and functioning of participants. The outcome measures were 





Table 24: Outcome measures taken at baseline, six-weeks and 12-weeks follow-up in the RCT. 
 Definition 
Description of outcome 
measure 
Reference 











Numerical rating scale of pain 
intensity (NRS) (0-100) 0=no 
pain; 100=worst imaginable 
Ostelo and de 
Vet, 2005; van 













Oswestry disability index 
(ODI). A greater score 







Tampa Scale of 
Kinesiophobia (TSK). A 
greater score indicates a 
greater level of kinesiophobia. 
Vlaeyen et al., 
1995 
Pain Catastrophizing scale 
(PCS). A greater score 






Numerical rating Scale of Pain intensity  
Pain intensity is typically measured by specific questionnaires, which are used in physiotherapy and 
CLBP studies (Heymans et al., 2006; Kääpä et al., 2006). Reliability and validity of the Numerical 
rating scale (NRS) and Visual Analogue Scale (VAS) are well established to assess pain intensity 
(Haefeli and Elfering, 2006; Mannion et al., 2007; Boonstra et al, 2016; Suzuki et al., 2020). The 
minimum clinically important difference (MCID) is an indicator of clinical effectiveness. A 20% 
change is recognized as a MCID on the NRS (Farrar et al., 2001; Haefeli and Elfering, 2006).   
 
A review by Mannion et al., (2007) summarizes a NRS to be the most practical index when measuring 
pain intensity in LBP due to responsiveness to change, ease of administration and sensitivity (defined 
by the number of available response categories). Thus a NRS was used to measure the primary 
outcome of pain intensity (Appendices 9, 10, and 11).  Some studies have a minimum level of pain 
as inclusion criteria. However, the RCT using walking to treat CLBP advocated no minimum due to 
the recurrent nature of CLBP having episodes of little, or no noticeable LBP (Hurley et al., 2015). 
Anchoring statements for the outcome for pain intensity and time frame measuring pain must be well 
defined (Ogon et al., 1996). The NRS used in this RCT was anchored with the statement of your 






The Oswestry Disability Index  
The Oswestry Disability Index (ODI) is used to measure a person’s disability, relating from spinal 
disorders (Fairbank and Pynsent, 2000). It is considered the best index for measuring how lower back 
or leg pain affects an individual’s ability to manage in everyday life (Fairbank and Pynsent, 2000; 
Bombardier, Hayden and Beaton, 2001).  Often patients report continued disability despite varying 
pain intensities or the absence of pain (Rantanen, 2001). The ODI has been used in LBP studies, in 
South African populations (Kruger and Bilson, 2014). The ODI was widely used to measure CLBP 
disability in the two systematic reviews using physiotherapy or walking as a treatment (Hendrick et 
al., 2010; Lawford, Walters and Ferrar., 2015). A large cohort study of 837 Finnish outpatients with 
LBP aimed to investigate the psychometric properties of the ODI (Saltychev et al., 2017). Data from 
the study showed the ODI to be an internally consistent (α=0.85), unidimensional scale (measuring 
functional level and nothing else) with overall excellent construct validity and ability to discriminate 
between disability severities (Saltychev et al., 2017). Supporting its construct validity, it has been 
used to validate the Pain Disability Index, The Low Back Outcome Score, has moderate correlation 
with pain measures (NRS); and is a better predictor of return to work than mechanical methods of 
lumbar spine assessment (Roland and Fairbank, 2000).  
 
The ODI comprises of 10 sections each covering one of the following domains mentioned in Table 
25. Within each section there are six statements ranked zero to five. The anchors are domain specific 
although zero score indicates no disability associated with a domain statement (e.g.: lifting, walking). 
A score of five indicates pain prevents a participant from executing that domain. The participant 
chooses which of the six statements within each section that best applies to them. A score is generated 
as a percentage. The higher the score (%), meant a greater perceived disability. Table 25 describes 
the associated level of disability, by score for the total included domains of disability. The MCID for 
the ODI is 10% (Ostelo et al., 2008). Details of the items included, and the formula used to calculate 





Table 25: ODI levels of disability relative to contributing domains. 
Domains of the ODI Total ODI score (%) Level of disability 
1. Pain intensity 






8. Sex life (if applicable) 
9. Social life 
10. Travelling 
0-20 Minimal disability 
21-40 Moderate disability 
41-60 Severe disability 
61-80 Crippled 
81-100 Bed bound or magnifier 
(Roland and Fairbank, 2000) 
 
The Tampa Scale for Kinesiophobia (TSK)   
The Tampa Scale for Kinesiophobia (TSK) measures fear of movement/ (re)injury and is used in 
studies supporting the fear avoidance model (Vlaeyen et al., 1995). The fear avoidance model 
describes CLBP patients who acquire a fear of movement after an initial acute phase of LBP. After 
suffering an initial injury, one may become fearful of movements that hurt and hence avoid further 
activity. This in turn may result in CLBP from acute LBP (Crombez et al., 2012). The TSK is used 
to assess fear and avoidance beliefs in movement and re-injury studies, specifically in CLBP (Kori, 
Miller and Todd, 1990; Vlaeyen et al., 1995). The TSK scale has been well validated in chronic pain 
populations including musculoskeletal pain, neuropathic pain, headache, and abdominal pain 
(Vlaeyen et al., 2002; Tkachuk and Harris., 2012). In CLBP studies, construct validity of the TSK 
was supported by Roelofs et al., (2011). The reliability of the TSK was examined in a review of 12 
articles, with four English variations of the TSK (Lundberg et al., 2011). Various English language 
versions contain four, 11, 13, or 17 items. The reliability in four English articles ranged from 
acceptable (α=0.71) in the four-item version subscale TSK to high (α=0.86) in the 13-item version 
(Lundberg et al., 2011). The English 17 item version reliability was not reported in Lundberg et al., 
(2011). 
 
The TSK used in this RCT used 17 statement questions (Woby et al., 2005; Woby et al., 2008.) The 
questionnaire asks individuals to rate the extent to which they agree with the statements. Each of the 
17 questions have four points ranging from 1 = strongly disagree to 4 = strongly disagree. Four 
questions are reverse scored (4; 8; 12; 16). Total scores range from 17 – 68. A high value on the TSK 
indicates a high degree of kinesiophobia. A cut-off score of 37 or greater is considered as clinically 
relevant (Vlaeyen et al., 1995). Since the current RCT was underpinned by an exercise intervention 
involving movement (walking), evaluating changes in kinesiophobia using the TSK (Appendix 13) 




Pain catastrophizing scale (PCS)  
Pain catastrophizing is defined as an exaggerated, negative mental state that can occur in patients in 
response to an actual or anticipated painful experience (Sullivan et al., 2001a). The Pain 
Catastrophizing Scale (PCS) is made up of three factors: rumination, helplessness and magnification 
of painful events. The contribution of catastrophizing in physiotherapy studies to CLBP is well 
established (Peters, Vlaeyen and Weber, 2005; George, Valencia and Benecluk, 2010). Measuring 
pain catastrophizing in CLBP patients is important with self-management strategies, as proposed by 
a walking intervention (Nicholas et al., 2012). With various models implicating pain catastrophizing 
in CLBP, the PCS was chosen as a relevant outcome measure of catastrophic thinking in relation to 
chronic pain in this RCT (Appendix 14).   
 
Three studies conducted on pain outpatient samples found strong evidence of validity for the PCS 
(Osman et al., 1997). Demonstrating internal consistency, in a study of 425 undergraduate Canadian 
psychology volunteers, the Cronbach’s alpha values reported for the total PCS (α= 0.87) was very 
good (Sullivan, Bishop and Pivik, 1995). Aiming to evaluate the assumption that the PCS taps a 
single construct characterized by three dimensions, a study examined evidence for concurrent and 
discriminant validity of the PCS in an American community sample (n=215) (Osman et al., 2000). 
High and significant inter-correlations were found between factors of rumination, helplessness and 
magnification which make up pain catastrophizing. Regarding construct validity, this appeared to be 
the first finding in the literature confirming the assumption that the PCS taps a single construct 
(catastrophizing) characterized by three related dimensions (Osman et al., 2000). The PCS is 
recommended as a valid and reliable tool in South African pain studies (Morris et al., 2012). 
 
The 13-item questionnaire accurately evaluates pain related magnification, helplessness and 
rumination (Jensen, Turner and Romano, 2001; Sullivan et al., 2001b; Picavet, Vlaeyen and 
Schouten, 2002; Lamé et al., 2008; Sullivan et al., 2009; Suzuki et al., 2020). The PCS consists of a 
five-point scale of 13 items asking the participant to reflect on past painful experiences and indicate 
the degree to which they have experienced certain feelings or thoughts upon experiencing pain. The 
points range from a score of zero to four, where zero represents ‘no worry at all’ and four represents 
‘worrying all the time’ or increased levels of catastrophizing (Sullivan, Bishop and Pivik, 1995). A 
PCS total score ranges from 0 – 52. A total score of 30 or greater is a cut-off score and represents a 
clinically relevant level of catastrophizing (Sullivan, Bishop and Pivik, 1995).   
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3.5 Visual Analogue Scale Pain and Activity diaries  
 
Additional tools to assess pain, daily and step counts were used and are described below.  
 
Pain and activity diaries 
Daily pain and activity diaries were used by participants in this RCT (appendix 3 and 4 respectively). 
Diaries were designed by the principal researcher. These were used to keep record of average pain 
intensity on a Visual Analogue Scale (VAS), and daily steps taken/ kilometres (completed on a daily 
basis). Each diary had a page per day for pain intensity and steps/ kilometres (Table 26).  
 
Table 26: Visual Analogue Scale Pain and Activity Diaries 
 Screening tool description 









Measuring step count and distance 
Measuring time taken to walk in 
walking intervention (W and PW) 




by participant  
Measuring daily average pain 
intensity. Visual analogue scale 
(VAS) on a horizontal 100mm line. 
0mm=no pain and 100mm=worst 
pain imaginable 
Daily (at bedtime) Hägg, Fritzell and 
Nordwall, 2003; 
Ostelo and de Wet 
2005 






All participants were provided with and instructed in completing the daily pain and activity diary 
(baseline to 12-week follow-up). Participants randomised to the W or PW treatment groups were 
shown how to use pain and activity diary A (Appendix 3). Participants randomised to the P treatment 
group were shown how to use pain and activity diary B (Appendix 4). The difference between the 
diaries was that the Walking Intervention component was included in diary A. This design was used 
to maximise information gathered and to control for walking (as a physical activity) done outside of 
the walking intervention (exercise). Both diaries were designed for participants to record daily 
number of steps taken, distance covered, and time taken to complete a walking intervention if 
randomised to one.  
 
Both diaries included a VAS. Decreasing the need for interviews, patient diaries are an alternative to 
capturing patient perceptions of their pain (Miller, Pinnington and Stanley, 1999). Thus, in this RCT 
participants were asked to complete diaries at bedtime in the evening. The diary satisfies part of the 
biopsychosocial paradigm where the opportunity of the participants experiences to be recorded is on 




Visual Analogue Scale (VAS) 
To improve supervision, participants were requested to log their daily average pain using the VAS 
in a pain and activity diary (appendix 3 and 4). The daily VAS was used to record average daily pain 
from baseline to follow-up. Attending physiotherapists could examine this diary when discussing 
participant progress on subsequent physiotherapy visits during the RCT. This diary would inform the 
physiotherapist if pain had increased substantially, hindering the participant’s continuation in the 
RCT. The intention was to concurrently monitor daily average pain intensity in the diary in order to 
avoid further added walking in the intervention in case this was making the pain worse. This was 
supported by a review for LBP patients with leg pain, recommending exercising regularly providing 
this does not increase leg pain (Pedersen and Saltin, 2015). There is no consensus on when and how 
often to measure pain due to its unreliable duration (Mannion et al., 1999). Physiotherapists could 
monitor the participant’s pain diaries retrospectively since a daily record in the diary would log both 
pain intensity and frequency. These are often highly correlated (Chang et al., 2003). However, 
measuring symptom frequency within 24 hours is not supported (Deyo et al., 1992). This supported 
the decision to log the daily average pain intensity in the diary, and not hourly, as this would be a 
cumbersome measure. 
 
Using a three 100mm horizontal VAS scales per daily diary page, participant’s pain was measured 
for right leg, left leg and lower back pain. The VAS can be used vertically although the horizontal 
scale is preferred in CLBP (Ogon et al., 1996). Each VAS being identical, the VAS in this RCT was 
anchored with a statement of: your average pain being no pain (0mm) - very severe pain (100mm) 
on a 0-100mm horizontal line (Appendices 3 and 4). A MCID on a VAS in CLBP is around 20mm 
on a 100mm line, or 20% (Hägg, Fritzell and Nordwall, 2003; Ostelo and de Wet, 2005). Both paper 
diaries and electronic format VAS compare well (Jamison and Edwards, 2012). However, the 
purpose of this RCT was to make it generalizable and equitable and so paper diaries were used. The 
VAS is a validated outcome measure for a CLBP population in South Africa (Kruger and Bilson, 
2012) 
 
Objective measure of walking  
Pedometers were used to objectively measure walking in each of the intervention groups. These data 
of steps taken, distance covered, and time taken to complete walking interventions if randomised to 
one were recorded by participants in pain and activity diaries (Appendix 3 and 4). By using diaries, 
differences in steps and distance covered could be identified in the walking done by treatment groups 
involved in walking intervention (W and PW) and those not using a walking intervention (P).  
 
All participants were required to record total daily steps and distance walked, daily, in their activity 
diaries. Walking interventions (W and PW) used diary A (Appendix 3). Usual care with no walking 
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intervention used diary B (Appendix 4). The difference between diaries lay in that diary A could be 
used to log daily time involved in the walking intervention (Table 21). 
 
3.6 Pedometers  
 
In-line with previous studies Omron Walking Style One 2.1 HJ-321-E pedometers were used in this 
RCT (Tudor-Locke et al., 2011; Rodriguez-Sanchez et al., 2014). These battery-operated pedometers 
were used to measure daily step count and distance walked (Omron Healthcare INC., 2015).  
 
Fifty OMRON Walking Style One 2.1 HJ 321 E Pedometers were purchased and 30 were supplied 
as a sponsorship from Omron Europe. The sponsored pedometers were obtained six-weeks after the 
RCT began.  
 
To accurately measure step count and distance, at baseline each pedometer was programmed by the 
assigned physiotherapist with the participant’s relevant information (height and step length).  
Participants were instructed in how to change batteries and re-enter their anthropometric data and 
stride length. The participant was issued with and instructed in the use of the pedometer in 
conjunction with the Pain & Activity Diary (Appendix 3 and 4). Participants were requested to wear 
their pedometers from when they got up in the morning until when they went to bed. At baseline, 
participants were asked to trial the pedometer for the remainder of the day. If any problems with 
pedometer arose, they were to contact their assigned physiotherapist who would attend to related 
problems related to the pedometer or diary use. Data from the pedometer were to be entered into 
corresponding diaries the day after the baseline interviews.  
 
3.7 Training for delivery of interventions of RCT physiotherapists  
 
A month prior to the main RCT, training for the RCT physiotherapists regarding RCT protocols was 
run for one week. Training was based on the intervention planning by the principal researcher.  
Training of physiotherapists was to ensure that treatments in Table 20 were rehearsed in order to 
remain homogenous within treatment groups when delivered by the physiotherapists. RCT 
physiotherapists underwent one week of training to gain a better understanding of CLBP including 
treatments available and pain phenotyping. The training involved intervention delivery. This 
involved rehearsal with the protocol which would be followed from the first physiotherapy visit 
baseline interview including all questionnaires, pedometer use, and the ability to execute 





The training for RCT physiotherapists incorporated 2 phases: 
1. A teaching platform for the physiotherapists involved in delivering the intervention in order 
to educate them about explaining CLBP, education of potential evidence-based benefits for 
treatments used in this RCT, and pain phenotyping.  
2. A teaching platform to attempt standardizing obtaining baseline questionnaires, involvement 
in the randomization process through painDETECT completion, performing a standardized 
lumbar assessment, assisting in completion of outcome measures, delivery of components 
involved in each treatment group. 
 
Phase 1: 
The training was based on the literature review, including UK NICE guidelines on CLBP 
physiotherapist treatment (National Collaborating Centre for Primary Care [UK], 2009). 
Understanding pain phenotyping was included (Freynhagen et al., 2006).  
 
Phase 2: 
Training was provided on:  
1. Baseline screening of inclusion criteria, explanation of the RCT, signing of the consent form, 
completing health history questionnaires, and completing the painDETECT phenotyping 
questionnaire. 
2. Completing a lumbar spine assessment.  
3. Liaising with the practice secretary to obtain treatment randomization according to the 
painDETECT score. 
4.  Assisting participants complete outcome measures at baseline and follow-up outcome 
measures at six-weeks, and at 12-week follow-up. 
5. All three treatments and included practice of improvised CLBP education, massage, 
manipulation, isometric lumbar stabilization exercise and supervised pedometer-based 
walking as to be used in the RCT.  
6. Completing pain and activity diaries were rehearsed whilst trialling the pedometer in order 





3.8 Feasibility study of procedures involved in the main randomised controlled trial  
 
Once all training had been delivered, a feasibility study of the procedures to be used was conducted. 
This was run three weeks prior to the main RCT. Results from the feasibility study run would be 
used to streamline RCT processes used in the main RCT if necessary.  
 
The feasibility study consisted of running through procedures that would be used in the main RCT 
in the three treatment groups (P, PW and W). The principal researcher invited five physiotherapists 
and six healthy lay members of the public to participate in the one week-long feasibility study. The 
principal researcher would also participate in this feasibility study. All 11 participants were 
interviewed by the principal researcher to illuminate the purpose of the feasibility study and would 
gain their consent to participate. The exact RCT procedure including informed consent, 
questionnaires, pedometers and treatment groups all as described previously were included in the 
feasibility study.  
 
The physiotherapists would fill two roles; firstly as a treating physiotherapist role, followed by a role 
as a participant treated by a fellow physiotherapist. The role as a treating physiotherapist was done 
by each physiotherapist in order to experience treating the P, PW and W procedures over a one-week 
period. During this week each physiotherapist would treat either another physiotherapist or lay 
member of public designated by the principal researcher to one treatment group per individual 
participant until the treating physiotherapist had experienced treating one allocated participant three 
times in a week for each individual treatment group. 
 
In some instances, participating members of the lay public may have had to experience two or three 
different treatment types for every physiotherapist to have trialled the treatments and protocols to be 
used. Participants may have experienced several different treatments (P, W and or PW) during one 
day for all treating physiotherapists to complete the experience of treating according to RCT protocol.  
 
The role a physiotherapist played acting as a participant would be to experience the usefulness of the 
questionnaires, pain and activity diary and pedometer used as well as having received treatment 
intended to be homogenous for each treatment group (P, W and PW). Each physiotherapist would 
have to experience being treated by one other physiotherapist three times per treatment group. During 
the week, the treating physiotherapist would repeat treatment accordingly to W, P, and PW protocol 
to participants allocated to those treatment groups. The participants were not randomised to treatment 





Physiotherapist treats participant three times as per W treatment group. 
Physiotherapist treats participant three times as per P treatment group.  




Physiotherapist receives treatment as per W treatment group. 
Physiotherapist receives treatment as per P treatment group. 
Physiotherapist receives treatment as per PW treatment group. 
The process involved in the feasibility study and physiotherapist protocol training are described in 
Table 27.  
 
Table 27: Physiotherapist and participant roles in protocol training during feasibility study. 
A B C 
People involved 
in the feasibility 
study 
Steps taken by people involved in the 
feasibility study 
Aim of feasibility study 
Physiotherapist 
role as a treating 
physiotherapist 
1. Treating physiotherapist would explain the 
purpose of the RCT and answer any 
questions related to the RCT 
2. After the consent was signed, the 
physiotherapist to assist participant with 
filling in baseline questionnaire health 
history and painDETECT.  
3. Physiotherapist to complete a lumbar 
assessment of the participant.  
4. Physiotherapist to assist participant with 
completing baseline outcome measures and 
pain expectation questionnaire 
5. Physiotherapist to teach the participant how 
to use the daily pain and activity diary 
6. Physiotherapist to teach the participant how 
to use the pedometer 
7. Physiotherapist to treat the participant in the 
procedure of P, PW or W for all three 
treatments to be completed over a week by 
each physiotherapist. Three treatments per 
participant i.e.: resembling baseline, 
midway, follow-up. 
8. Assist participant in completing the 
outcome measures mid-week (which would 
be used at six-weeks in the main RCT) and 
follow-up at the end of the week (which 
would be used at 12-weeks in the main 
RCT). These outcome measures were both 
identical  
Each RCT physiotherapist would complete one 
week of each individual treatment for one 
participant per treatment. For example: 
 
• Treat one participant three times a week 
using procedure P. 
 
• Treat one participant three times a week 
using procedure PW 
 
• Treat one participant three times a week 
using procedure W 
 
Each RCT physiotherapist would treat two 
members of lay public, and one other 
physiotherapist involved in the RCT for P, PW 
or W procedure three times a week. In this way 
all three treatments would have been practiced 







A B C 
People involved 
in the feasibility 
study 
Steps taken by people involved in the 
feasibility study 
Aim of feasibility study 
Physiotherapist 
role acting as a 
participant. 
1. Ask the physiotherapist questions if they 
felt any important information had been 
excluded and sign consent. 
2. Complete the attending baseline health 
history questionnaires, painDETECT 
3. Undergo a lumbar assessment as a 
participant by a RCT physiotherapist.  
4. Complete baseline outcome measures 
questions and pain expectation questions 
5. Learn how to use a pedometer and the pain 
and activity diary 
6. Participate daily for 1 week in the P, PW or 
W treatment (i.e.: complete pain and activity 
diary and receive treatment on allocated 
days) 
7. Complete the outcome measures mid-week 
(which would be used at six-weeks in the 
main RCT) and follow-up at the end of the 
week (which would be used at 12-weeks in 
the main RCT). These outcome measures 
were both identical 
Each RCT physiotherapist would act as a 
participant in one of the other RCT 
physiotherapist’s treatments. The 
physiotherapist acting as a participant would 
experience either steps 1-5 (column B) as a 
participant receiving P, PW and W treatments 
from three individual physiotherapists. 
Participant’s (lay 
member of the 
public) role in the 
feasibility study  
1. After listening to the RCT explanation by an 
attending physiotherapist ask the 
physiotherapist questions if they felt any 
important information had been excluded. 
Sign a consent form. 
2. Complete the attending baseline health 
history questionnaires, painDETECT 
3. Undergo a lumbar assessment as a 
participant by a RCT physiotherapist. 
4. Complete baseline outcome measures 
questions and pain expectation questions 
5. Learn how to use a pedometer and the pain 
and activity diary 
6. Participate daily for 1 week in the P, PW or 
W treatment (i.e.: complete pain and activity 
diary and receive treatment on allocated 
days) 
7. Complete the outcome measures mid-week 
(which would be used at six-weeks six in the 
main RCT) and follow-up at the end of the 
week (which would be used at 12-weeks in 
the main RCT). These outcome measures 
were both identical  
Fulfil the role of the participant with 
physiotherapy visits per treatment group in one 
week. The three physiotherapy visits that the 
participant would complete was arranged by the 
treating physiotherapist. The number of times a 
participant could participate was determined in 
order for each physiotherapist to have assessed 
and treated one person (either physiotherapist 
acting as a participant or member of the lay 






After one week of treatment, the participants and physiotherapists were asked to return their 
completed pain and activity diaries. Baseline and follow-up outcome measures were collected at the 
first and last appointment respectively. The RCT outcomes were collected by the physiotherapist in 
the following order: 
• Baseline outcome measures: NRS, ODI, TSK, PCS (Appendix 9, 12, 13, 14 respectively) as 
well as pain expectation questionnaire (Appendix 7) (mimicking baseline in the main RCT)  
• Midway outcome measures: NRS, ODI, TSK, PCS (Appendix 9, 12, 13, 14 respectively) 
(mimicking six-week follow-up in the main RCT) 
• Follow-up outcomes measures: NRS, ODI, TSK, PCS (Appendix 9, 12, 13, 14 respectively) 
(mimicking 12-week follow-up in the main RCT) 
 
All the forms were inspected by the principal researcher in order to see if there was a need to change 
the procedure. Benefits of the feasibility study are shown in figure 7. 
 




















Feasibility study:  
 




• Tested patient screening 
procedure 
• Tested baseline and follow-up 
interviews 
• Familiarized use of pain and 
activity diary with pedometer 
use. 
• Rehearsed 3 treatment types 
On participants 
• Experienced treatment from a 
participant perspective 
Principal researchers’ benefit 
• Tested the practical application 
of questionnaires, outcome 
measures and treatments to be 
used in the procedures of the 
main RCT. 




No changes were made following this process. Key disadvantages of the feasibility study were three-
fold:   
1. Template for data entry: A template for data entry had not been created for results of the 
feasibility study 
2. Data Analysis: No data analysis had been planned for results gained from the feasibility 
study 
3. No dummy table of results was developed for the feasibility study 
 
3.9 The randomised controlled trial: Main study 
 
This RCT compared three treatments: P, W and PW. 
 
Primary outcome: A change in baseline global pain intensity using a numerical rating scale between 
baseline and 12-week follow-up. 
 
Secondary outcomes: A change in baseline disability, kinesiophobia and pain catastrophizing 
between baseline and 12-week follow-up. 
 




































Legend □: Shaded areas in figure 8 explain the first physiotherapy visit. A detailed account of the process from when the 
participant arrived at the first physiotherapy visit until the completion of the RCT at follow-up is noted in the following 
procedure chapter. 
  
Consent obtained from University of Bath Ethics committee 
CLBP participants make an appointment with practice secretary on a central telephone line. 
Practice secretary screens for inclusion and exclusion criteria on the phone. Appointment to see 
physiotherapist for the first visit was made by the practice secretary on the phone. 
Meet the physiotherapist: Information sheet provided for the patient. Nature and purpose of the 
RCT explained; inclusion/exclusion criteria verified, questions about the study answered. 
Consent form signed. 
Complete painDETECT questionnaire. The 
physiotherapist gives this to the practice secretary 
Diary use and treatment explained as per treatment group. Treatment initiated. 
Proposed 3 to 9 treatments executed over 12-week period. Repeated outcome measures of pain 
intensity, disability, kinesiophobia and pain catastrophizing are completed at physiotherapy 
visits at 6 and 12 weeks 
When the sample size was reached, new data collections stopped and data cleaning for data 
analysis began. 
PainDETECT score is given to the 
research assistant off-site. The score 
combined with practice site allows for 
random allocation using computer 
generated simple randomization. 
computer 
The random allocation number is 
given back to the secretary and this is 
communicated back to the 
physiotherapist. The number ensures 
anonymity throughout the RCT 
Patient has lumbar assessment and completes 
health history/ demographic, completes PCOQ, 
completes baseline outcome measures: pain 
intensity, disability, kinesiophobia and pain 
catastrophizing. Physiotherapist assesses patients 




 use explained. 
Patient informed about which treatment group 
they were allocated to. 
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Participant recruitment, setting, and procedures for the main randomised controlled trial 
The following section will detail participant recruitment, setting and recruitment procedures. 
 
Participants included in the RCT recruitment  
The inclusion and exclusion criteria are described in Table 28 were adapted from previous studies 
using walking to treat CLBP used in a systematic review at the inception of the RCT (Hendrick et 
al., 2010).   
 







• LBP lasting for longer than 3 months and/or recurring episodes greater than 3 per year. 
• Less than 150 minutes of intentional exercise per week. 
• LBP with or without radiation into leg/s. 
• Participants attending private practice physiotherapy. 
• Age: 18-65 years. 
• Participant able to walk a minimum of 20 minutes. 
• Participant willing to participate in a 12-week RCT, which required a minimum of three and a 
maximum of nine physiotherapy treatments. 
Exclusion 
criteria 
• Current pregnancy. 
• Knowledge of a malignancy. 
• Knowledge of rheumatic disease systemically causing lower back pain. 
• Currently diagnosed with fibromyalgia. 
• History of serious psychological or psychiatric illness (mild depression eligible for inclusion). 
• Involvement in a Workman’s compensation claim or on-going litigation due to CLBP. 
• Medically unfit to participate in exercise intervention. 
• Acute/ recent spinal fractures. 
• Any other current musculoskeletal injury or contraindication to increasing walking times, including 
cardiorespiratory or other medical condition limiting exercise tolerance. 




This was a multi-site RCT. Participants were recruited from the following private physiotherapy 
practices in Johannesburg South Africa:  
1. North-riding Private Practice Neurosurgical Rooms.  
2. Randburg Medicross Clinic.  
3. Doornfontein Towers West Medical and Dental centre. 




An advert was designed by the principal researcher and deemed acceptable by the University of Bath 
Ethics Committee. It was placed in the waiting areas of all three settings. The advert stated a 
telephone call should be made on the central booking line with the practice secretary for any enquires. 
If a potential participant contacted the practice secretary, she would explain the RCT in brief as well 
as clearly describe the inclusion and exclusion criteria. In line with standard private practice routine, 
the practice secretary would on an ad hoc basis arrange an appointment at a mutually convenient 
time for the participant and one of six physiotherapists. The setting that the participant would be seen 
at was also based on the participants’ convenience.  
 
Procedures  
Following the plan to design homogenous treatments within each treatment group to be used in this 
RCT, and having completed a feasibility study of procedures, the main study commenced. The use 
of measurements and treatments trialled in the feasibility study were deemed appropriate to be used 
in the main RCT. The procedures involved a team of people invited by the primary researcher, each 
had specific functions described in Table 29. 
 
Table 29: Research team involved in the main study and their function 
Team member Role 
Practice secretary 
To take telephone bookings for the RCT, screen the potential participants for eligibility on 
the phone, and arrange a baseline/ first physiotherapy visit. 
To communicate the painDETECT score from the baseline/ first visit to an off-site research 
assistant in order to obtain a random allocation number and treatment which was to be 
communicated to the physiotherapist. All done during the first visit. 
To take bookings for additional appointments over the telephone from RCT participants. 
Off-site research 
assistant 
To obtain a painDETECT score from the practice secretary and check the random allocation 
sequence. The off-site research assistant used the painDETECT score and which practice the 
participant was seen at to find the randomization number and treatment type. The off-site 
research assistant had access to the random allocation sequence list (Appendix 17) and was 
blinded to the three treatments. Eligible potential participants were randomised using simple 
randomization from a previously generated computer sequence. Participants were then 
assigned with equal probability to one of three treatment groups. This was communicated to 
the secretary and hence the physiotherapist and participant. 
Six qualified and 
registered 
physiotherapists 
including the primary 
researcher 
To conduct the screening interview on the baseline/ first physiotherapy visit including 
completion of consent form, health history and demographic questionnaire, painDETECT, 
lumbar assessment, pain expectation questionnaire, outcome measures, explain pain and 
activity diaries and pedometer use. 
Apply treatment throughout the RCT to participants 
Collect completed pain and activity diaries 
Help participants with problems encountered in the RCT 
Ensure completion and collection of outcome measures at six-weeks and 12-weeks follow-
up. 
Two blinded research 
assistants 
Used to help with capturing data into research database from baseline screening interview, 
all outcome measures and pain and activity diaries. 
RCT statistician 
Employed to assist in generating a randomization table, assist in development of data analysis 




The main study could commence following booking an appointment to participate in the RCT and 
arriving at the arranged first physiotherapy visit. All six physiotherapists involved in the RCT 
including the primary researcher were qualified, physiotherapists, registered with the South African 
Society of Physiotherapy. The baseline/ first physiotherapy visit of the RCT entailed an order of 
procedures in Table 30. This first visit included completion of baseline questionnaires, described in 
Table 23 and 24, undergoing the randomization process and receiving the first treatment. Depending 
on treatment group allocation, treatments received are briefly described in Table 20. Following the 
first physiotherapy visit participants were encouraged to book further appointments within the 12-
week period. The RCT criteria were designed that there would be a minimum of three physiotherapy 
visits, and a maximum of nine. The three minimum physiotherapy visits were designed to be arranged 
at baseline, at six-weeks and at 12-week follow-up in order to capture maximum information from 
outcome measures. Table 30 outlines which procedures would be conducted in each physiotherapy 
visit. All data recorded by each physiotherapist, including the outcome from participant examinations 
and treatment, were stored in a locked cupboard, with access only permitted by the principle 
researcher and treating physiotherapists. Participants were free to withdraw at any time during the 
RCT. Participant who requested to withdraw were requested to complete the 12-week follow-up 





Table 30: Procedures from baseline to 12-week follow-up. 
Physiotherapy visit Procedures described 
Baseline / First 
physiotherapy visit 
 
Information sheet given, inclusion/ exclusion criteria checked, RCT explained, questions 
answered 
Consent form signed 
Health history and demographic questionnaire completed 
painDETECT questionnaire completed, scored by physiotherapist  
and given to practice secretary 
Participant randomised to one of three treatment groups  
(through random allocation sequence) 
Complete form: expectation of pain intensity (PCOQ) 
Lumbar spine assessment done by physiotherapist 
Complete forms: outcome measures (NRS, ODI, TSK, PCS) 
Pedometer explained and provided to participant 
Pain and activity diary explained and provided to participant 
Participant receives the first treatment that they have been randomised to 
Participant books second physiotherapy visit (or later by telephone) 
2 
Physio visits 2 – 8 




Participant received treatment that they have been randomised to 
Returned any completed pain and activity diary to attending physiotherapist on successive 
physiotherapy visits (2-9) 
Participant booked following physiotherapy visit (minimum of three, maximum of nine 
visits) 
At the six-week time frame, the participant completed outcome measures (pain intensity, 
ODI, TSK, PCS) 
If less than nine visits are received in the 12-week time frame, the participants complete 
the 12-week/ follow-up outcome measures (pain intensity, ODI, TSK, PCS). 
If the participant completes the 12-week/ follow-up outcome measures, the participant 







Physio visit 9  
(12-week follow-up) 
At the 12-week time frame, the participants completed the 12-week/ follow-up outcome 
measures (pain intensity, ODI, TSK, PCS). 
Participant received final treatment that they have been randomised to 
Participant returned pedometer and any outstanding pain and activity diaries 
10 
This physiotherapy visit was designed in case participants arrived for the ninth treatment 
on follow-up and were not able to complete all outcome measures (for collection of fully 
complete outcome measures) 
 
First physiotherapy visit 
The first physiotherapy visit occurred at baseline. Prior to randomization, the physiotherapist 
assessed each potential participant’s eligibility against the inclusion/ exclusion criteria (Table 28), as 
part of the initial appointment at baseline.  This was followed by randomization, baseline data 
collection as described in tables 23 and 24, and initial treatment. At this appointment, participants 
were provided with an information sheet (Appendix 15) explaining the nature and purpose of the 
RCT. The outline of the RCT was then explained, and participants were encouraged to ask further 
questions, as necessary. After signing the informed consent (Appendix 16), a health history and 
demographic questionnaire (Appendix 5) would be completed, followed by participants completing 
a set of baseline outcomes and associated variables (Initial Outcome Measure Questionnaire). This 
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included the painDETECT questionnaire (Appendix 6). After the pain DETECT questionnaire was 
completed it was scored by the physiotherapist and given to the practice secretary during the first 
physiotherapy visit. At this point two processes would occur simultaneously: 
 
1. The practice secretary would call a research assistant off-site with the painDETECT score. 
This would allow for the simple randomization of the participant by the research assistant. 
The off-site research assistant used the painDETECT score and which practice the 
participant was seen at to find the randomization number and treatment type. The off-site 
research assistant had access to the random allocation sequence list (Appendix 17) and was 
blinded to the three treatments. Eligible potential participants were randomised using simple 
randomization from a previously generated computer sequence. Participants were then 
assigned with equal probability to one of three treatment groups (P, PW, or P). This was 
communicated back to physiotherapist via the practice secretary. 
2. Once treatment group allocation had been determined, an associated baseline variable, 
measuring expectation of pain by the end of the 12 weeks, was obtained using the Patient 
Centred Outcomes Questionnaire (Appendix 7). Following this the physiotherapist 
completed the lumbar assessment (Appendix 8) and proceeded with explaining the nature 
and purpose of the allocated treatment group. Following this, the participant would then 
complete the Numerical Rating of Pain Scale (Appendix 9), the Oswestry Disability Index 
(Appendix 12), the Tampa Scale for Kinesiophobia (Appendix 13), and the Pain 
Catastrophizing questionnaire (Appendix 14). 
 
Prior to starting the first treatment, participants were provided with instructions for using their 
pedometer. They were requested to record the outcome from their daily walking, from the pedometer, 
into their pain and activity diary (Appendix 3 and 4). Participants were encouraged to complete their 
diary entries daily to maximise accurate monitoring of the steps taken. Diaries were marked with the 
participants random allocation number. Diaries are described in Table 22. 
 
Depending on group allocation to one of P, PW, W groups, each participant completed the 12-week 
RCT, described in the intervention planning chapter (Table 20). Due to the subjective nature of pain, 
not all participants required equal number of treatments. The treatments are briefly compared in the 
Table 20. Treatments were intended to decrease sensitization and the perception of pain. All the 
modalities (education on CLBP, massage, manipulation, isometric transversus abdominus 
stabilization exercise, and pedometer-based walking) were applied by the therapist in order not to 
sensitize the participant and increase pain intensity. Physical application was based on hand pressures 
that felt beneficial to the participant and did not illicit pain or increase sensitization. Manipulation 
was based on Maitland mobilization (Maitland, 2001). It was used according to which type (e.g.: 
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rotation, postero-antero, unilateral) and grade (I, II, III or IV) of mobilization that relieved the 
participants pain symptoms. Type and grade of mobilization would be decided by the physiotherapist 
at each treatment. A systematic review supported sub-maximal isometric transversus abdominus 
stabilization exercise in CLBP treatment (Gordon and Bloxham, 2016). This evidence-based exercise 
was used as part of the usual care treatment. The walking intervention too was applied at baseline 
totalling in weekly minutes < 150 minutes. This minute total ensured the participants started the 
intervention with a level which was classified as insufficiently active in keeping with modalities 
justified not to increase sensitization. Furthermore, all participants would receive therapeutic time 
with a physiotherapist commonly discussing CLBP education and reassuring advice. Additionally, 
every treatment group had an exercise component. The PW treatment group had both exercises in 
one treatment group (isometric lumbar stabilization and a pedometer-based walking intervention). 
All questionnaires and outcome measures completed at baseline are listed in Table 23 and 24. 
 
Physiotherapy visits two-nine 
Following the first physiotherapy visit, visits for treatment would be booked prospectively after 
attending each treatment. This would be done by telephone, with the practice secretary to ensure 
consistency with the same treating physiotherapist, for the duration of the RCT. This treatment 
booking approach was consistent with that used in private physiotherapy practices in South Africa. 
Physiotherapy visit number two-nine would aim to replicate the initial treatment. Participants self-
selected further physiotherapy visits. Consequently, the number of physiotherapy visits per 
participant varied, with not all participants accessing the nine available physiotherapy appointments. 
These treatments were spread over the 12-week intervention period. 
 
Pain and activity diaries completed during the weeks prior to the appointment, were collected by the 
physiotherapist. These were and then stored in a locked cupboard, with only the principal researcher 
having access to the cupboard.  
 
Repeated outcome measures 
Follow-up visits to include repeated outcome measures were scheduled by the treating 
physiotherapist’ at six-week (Appendix 10, 12, 13, 14) and 12-week (Appendix 11, 12, 13and 14) 
follow-up visits. The repeated outcome measures, NRS, ODI, TSK and PCS were conducted as per 
baseline procedures. The treating physiotherapist would provide the outcome measure forms and 
assist the participant in their completion. If the participants were not able to complete the outcomes 
or forgot their diaries at the ninth treatment, a tenth physiotherapy visit would be arranged for 
maximum data collection. Nine and ten physiotherapy visits were categorized as the same category 




Methods to control bias 
The RCT was conducted in accordance with the CONSORT checklist (Moher et al., 2010). The RCT 
design includes the methodological feature of true randomisation which is recognised as minimising 
bias in clinical trials. Participants would be randomised to three treatment groups by a predetermined 
allocation schedule and not based on the researcher’s judgement. Specification of eligibility criteria 
and intention to treat are met through similar CLBP walking intervention studies to obtain maximum 
information for participants with CLBP. Physiotherapists involved in this RCT worked equally at all 
three sites and received standardized training on assessment and treatment protocols, reducing bias 
and ensuring consistency of treatment and assessment. Assessment and treatment notes were 
reviewed regularly by the principal investigator to address any deviation from the protocol. 
Participants and physiotherapists were instructed not to talk to other patients/ participants who may 
be potentially included in the RCT to maintain blinding. Participants were asked not to receive any 
other treatment or start any new form of exercise other than the one they had been randomised to 
during the RCT period. Participants were reminded of their physiotherapy appointments and their six 
and 12-week-follow-up outcome measure evaluations after each successive treatment, or by 
telephone if a participant missed a treatment. Participants were furthermore reminded not to reveal 
their treatment to people wishing to participate in the RCT. 
 
3.10 Incentive  
 
All participants were offered a pharmacy gift voucher upon trial participation.  
 
3.11 Data management and analysis  
 
A statistician was employed to generate a random allocation sequence and assist with data analysis. 
The statistician was not involved in collection of data or delivery of treatment. Two research 
assistants remained blinded to the RCT group allocation.  
 
Sample size 
G*Power was used to calculate sample size (Faul et al., 2007). Sample size estimation was based on 
a between-group repeated measures analysis of (a) weekly average pain measurements on a 100-mm 
VAS scale and (b) baseline, 6-week, and 12-week measurements of the ODI on a scale of 0-100%. 
The estimations are based on a 5% significance level, 80% power and a 0.5 correlation among the 
repeated measures. 
 
Sample size was calculated based on a minimum clinically relevant between-group difference in pain 
intensity measurement of 10mm/100mm on a VAS scale, using a standard deviation of 25mm 
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(Torstensen et al., 1998; Mirovsky et al., 2006).  Estimated Sample size calculated was 147 
participants. At the time of sample size calculation only one systematic review had been done on 
using walking as a treatment for CLBP (Hendrick et al., 2010).  
 
The minimum clinically relevant between-group difference used in ODI is 10% (Hägg and Fritzell, 
2003; Bombardier, Hayden and Beaton, 2001; Ostelo and de Wet., 2005). The within-group standard 
deviation was 15 (Torstensen et al., 1998; Mirovsky et al., 2006). The estimated sample size for using 
ODI as an outcome measure was 72. 
 
To include both NRS for pain and ODI, the larger sample size of 147 was required for this RCT (50 
for each treatment arm was used for convenience). This RCT was powered to detect between-group 
repeated measures of pain intensity and ODI but not differences between groups in nociceptive and 
neuropathic pain phenotypes. 
 
Randomisation 
The RCT statistician used a randomization table (random allocation sequence) which was generated 
using the RCT statistician’s random computer software. Simple randomization was used to maintain 
complete randomness of the assignment of participants to one of three treatment groups. The random 
allocation sequence was kept in a locked cupboard offsite.  
 
Data analysis 
The RCT was analysed on an intention-to-treat basis. All data were tabulated by treatment group (P, 
W and PW). For those participants whose treatment included a daily walking intervention (W and 
PW), daily number of steps, distance walked (km), and duration (minutes) was averaged for each 
week of the 12-weeks of the RCT. All data were coded and entered as continuous or categorical data. 
A data analysis plan was prepared and given to the independent RCT statistician. 
 
The coding of baseline assessments was done on Microsoft Excel by two independent research 
assistants. After the 12-weeks of treatment, information from the pain and activity diaries was coded 
on Microsoft Excel together with the remaining outcome measures (6-week and 12-week follow-up) 
by one research assistant and the principal researcher who remained blinded, having access only to 
the anonymous details of the participants. Data analysis was conducted using SAS version 9.4. The 
5% significance level was used throughout. 
 
Parametric and non-parametric statistical tests were selected after examination of the residual 




Descriptive analysis of the data was conducted as follows:  
• Categorical variables were summarised by frequency and percentage and illustrated by 
means using a bar chart.  
• Continuous parametric variables were summarised by mean and standard deviation. 
• Continuous non-parametric data as median and interquartile range. 
• Continuous variables were illustrated by means of box-and-whisker plots. 
 
Outcome data were presented in histograms and examined for distribution and outliers. 
 
The number of weeks each participant spent in the RCT was determined from the last week in which 
a total step count was recorded in the pain and activity diary. Missing outcome data were replaced 
by the corresponding baseline observation (week 1 observations in the case of walking 
measurements). 
 
Participant dropout was analysed. Association between number of weeks in the RCT and treatment 
group was analysed using a Chi-Squared test. The effect of pain phenotype on drop out was analysed 
using a Fishers exact test. The effect of treatment, pain phenotype, baseline outcome on dropout 
(categories included: less than 12-weeks in RCT vs. 12-weeks in RCT) for each of the Pain Intensity 
(NRS), ODI, TSK and PCS outcomes was determined using logistic regression with dropout as the 
dependent variable, and outcome at baseline, treatment group, and pain phenotype as independent 
variables. The effect of last measured outcome on dropout, treatment group, and pain phenotype was 
determined similarly. In the dropout analysis nociceptive pain phenotype and PW treatment group 
were chosen as the reference categories since these had the lowest dropout. Only main effects were 
assessed because sample size considerations for logistic regression estimated that at most b = 4 
parameters could be included in the model based on the smallest outcome class having 10*b cases 
(dropouts = 40, and hence b = 4 parameters (Peduzzi et al 1996).  
 
Categorical variables were compared using the Χ2 test.  Fisher’s exact test was used for 2 x 2 tables 
or where the requirements for the Χ2 test could not be met. Continuous variables were compared 
using the independent samples t-test (or the Wilcoxon rank sum test where the assumptions of the t-
test were not met). The strength of the associations was measured by the Cohen’s d for parametric 
tests and the r-value for the non-parametric tests. Hypothesis tests were used.  The strength of the 
associations was measured by Cramer’s V and the phi coefficient, respectively. The scale of 





Table 31: Interpretation of effect size measures 
Χ2 test/ Fisher’s exact test Independent samples t-test / Wilcoxon rank sum test 
Cramer’s V / phi 
coefficient 
Interpretation Cohen’s d / r-value Interpretation 
0.50 and above High/strong association 0.80 and above       Large effect 
0.30 to 0.49 Moderate association 0.50 to 0.79 Moderate effect 
0.10 to 0.29  Weak association 0.20 to 0.49 Small effect 
Below 0.10   Little if any association Below 0.20 Near zero effect 
 
Baseline variables were compared between treatment groups using standardised mean effect size 
(SMES) (Woodward 2013). Where some studies demonstrate the statistical significance, which is 
the probability that the observed difference between two groups is due to chance, the effect size is 
independent of sample size. Typically, participants in the groups in an RCT are ‘the same’ in the 
population at large, and hypothesis testing will only be as effective as the randomisation process 
used; the larger the sample size, and the more comparisons made, the more likely we were to obtain 
at least one significant result. In this RCT, differences in the cohort were examined using SMES. 
 
Normally a threshold of 10% for important imbalance between groups is used but given the small 
sample size (which increases the risk of imbalance), focus was on the differences > 30%. In summary 
tables, the magnitude of the SMES was categorized: 10-19%; 20-29%; and 30% or more.  
 
The number of physiotherapy visits was compared by treatment group using a Chi-Squared test. 
 
The outcome measure analyses used in this RCT are demonstrated in Table 32. Analysis was 
performed in an order of sequence. If an association with predictive variables occurred during 






Table 32: Sequence of outcome measure analysis presentation 
Outcome 
measure 




Preliminary data analysis. Summary measures for mean NRS, ODI, 
TSK, and PCS.  





Primary outcome measure analysis: Primary analysis using LMM 1 and 2 
Primary outcome measure analysis: Investigative analysis using 
LMM 
3 and 4 
ODI ANOVA  
Secondary outcome measure analysis using LMM 5 and 6 
TSK ANOVA  
Secondary outcome measure analysis using LMM 7 
PCS ANOVA  
Secondary outcome measure analysis using LMM 8 
ANOVA: Analysis of variance (baseline-week-12 follow-up: did not control for any independent variables) 
LMM: Linear mixed model (baseline, six and 12-week follow-up) 
 
As a preliminary analysis of the data, two summary measures were calculated. Firstly, the mean (95% 
confidence interval) for the NRS, PCS, TSK, and ODI for each treatment group (P, PW, W) at each 
time-period (weeks 0, 6 and 12) was calculated. Then, for each intervention, the mean (95% 
confidence interval) change in score from week 0 was calculated for week 6 and 12 for each outcome 
measure. Finally, to assess the effect size between the mean change score at each time interval, 
Cohen’s d values were calculated for P and PW versus W for each outcome measure. 
Cohen suggested that d = 0.2 be considered a small effect size, d = 0.5 be considered a 
'medium' effect size, and d = 0.8 be considered a large effect size (Cohen, 1988). 
 
The primary analysis was conducted on the primary outcome measure which was pain intensity using 
an analysis of variance (ANOVA) and an analysis using Linear mixed models (LMM) (Table 32). 
Pain intensity was used as the dependant variable. In the primary analysis, potential predictors of 
pain intensity at 12-week follow-up included the independent variables: pain intensity at baseline, 
treatment group allocation (P, W, or PW), number of physiotherapy visits and pain phenotype. These 
independent variables were selected a priori, based on the literature. The ANOVA was used to 
determine a statistically significant difference in pain intensity score from baseline to 12-week 
follow-up between groups. The independent variables’ effect on pain intensity (NRS) at 12-week 
follow-up was determined using a LMM. Prior to the analyses, the association between each pair of 
independent variables was assessed to identify any strong associations which could introduce 




Following the primary analysis, an investigative analysis of pain intensity was conducted using linear 
mixed models (Table 32). Standard modelling was used. Factors commonly associated with pain 
intensity were included in the investigative modelling (Meucci et al 2015, Dionne et al 2001, Watson 





• smoking status 
• BMI  
In the analysis, where time is used as an independent variable in the analysis, two time points were 
used: six-week follow-up and 12-week follow-up. The effect of treatment, time in intervention, pain 
phenotype, baseline NRS and selected covariates on the pain intensity outcome measure (NRS) was 
determined using a LMM, with the NRS as the dependent variable, and NRS at baseline, treatment 
group allocation, time (week in the RCT), treatment group allocation x time interaction, pain 
phenotype, pain phenotype x treatment group allocation interaction, pain phenotype x time 
interaction, and the other covariates as independent variables. The participant was the random effect 
in the linear mixed model.  
 
For all secondary outcome measures of disability, kinesiophobia and pain catastrophizing, a 
secondary outcome measure analysis was conducted using an ANOVA and linear mixed models 
(Table 32). The analyses were conducted on each outcome measure (ODI, TSK, and PCS) separately. 
In each secondary outcome measure analysis, the outcome measured, either ODI, TSK or PCS, was 
classified as the dependant variable. For each outcome measure, an ANOVA was used to determine 
a statistically significant difference in secondary outcome measure score from baseline to 12-week 
follow-up between groups at 12-week follow-up. In the LMM for each secondary outcome measure, 
as with the investigative analysis of pain intensity, standard modelling was used. The same factors 
commonly associated with pain intensity were included in the modelling and comprised: age, gender, 
employment, education, smoking status, and BMI (Meucci et al 2015, Dionne et al 2001, Watson et 
al 2004, Shiri et al 2010).  
 
The effect of treatment group allocation, time, pain phenotype, baseline outcome and selected 
covariates on ODI, TSK, and PCS outcome measures was determined using a LMM (Table 32) with 
the outcome as the dependent variable, and outcome measure at baseline, treatment group allocation, 
time (week in the RCT), treatment group allocation x time interaction, pain phenotype, pain 
phenotype x treatment group allocation interaction, pain phenotype x time interaction, and the other 
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covariates as independent variables. In the analysis, where time is used as an independent variable in 
the analysis, two time points were used: six-week follow-up and 12-week follow-up. The participant 
was the repeated measure.   
 
Prior to these analyses, the association between each pair of independent variables was assessed to 
identify any strong associations which could introduce confounding effects into the modelling.  The 
association between a continuous and a categorical variable was assessed by the independent samples 
t-test (or one-way ANOVA in the case of more than two categories).  Non-parametric equivalents 
(the Wilcoxon rank sum and the Kruskal-Wallis tests, respectively) were used where necessary.  The 
association between two categorical variables was assessed by the Χ2 test, or Fisher’s exact test was 
used for 2 x 2 tables or where the requirements for the Χ2 test could not be met.  Finally, the 
association between two continuous variables was assessed by Pearson’s correlation coefficient (or 
Spearman’s correlation coefficient where the assumptions of the former test could not be met).  
 
The strength of the associations was measured by the Cohen’s d for parametric tests and the r-value 
for the non-parametric tests.   
 
In additional analysis, the relationship between expectation of pain intensity (following the 12-week 
RCT) and the actual change in pain intensity was investigated. The correlation between expectation 
of pain intensity at baseline and the change in pain between baseline and 12-weeks was assessed 
using Spearman’s rank correlation coefficient (since some of the data were not normally distributed).   
 
An independent research assistant was instructed to process the walking data from the pain and 
activity diaries. To account for missing PA data, steps were averaged for each week. Weekly step 
count was averaged using total number of steps taken over a week, divided by the number of days 
that steps were recorded. The variation in the number of days recorded per week, were not 
considered. This method was used for walking done as PA of total daily steps and for the advised 
walking that was performed in the walking intervention. Diaries that had a minimum of one day per 
week through to seven days per week of steps recorded were included. The number of weekly steps 
taken, and weekly minutes spent performing the walking intervention were presented as means. The 
ideal walking program in weekly minutes was plotted against the two walking interventions. The 
descriptive statistics for all the walking variables are presented by treatment group as mean, standard 
deviation, and weekly mean steps divided by seven for interpretation as average steps per day. The 
effect of treatment group allocation, time (week in the RCT) and pain phenotype on total weekly 
steps was determined using a LMM with total weekly steps as the dependent variable, and treatment 




Chapter 4: Results 
 
4.1 Study recruitment and randomisation 
 
Recruitment commenced in August 2015 and continued until the achievement of recruitment targets, 
in March 2017. Random assignment ensured no bias toward group allocation. 
 
Five hundred and forty patients were assessed for eligibility, from which 153 were randomised to 
intervention or control conditions. Participants were randomised to one of three treatment groups:   
 
• Usual Care/ Physiotherapy (P. n = 48)  
• Pedometer-based walking intervention (W. n=54) 
•  Usual care/ Physiotherapy combined with a Pedometer-based walking intervention (PW. 
n=51).  
 
This was a 12-week intervention, with repeated measures at 6-weeks and a final follow-up at 12-





Figure 9: The flow of participants through the RCT, in-line with the CONSORT statement (Schulz 








































Not meeting inclusion criteria n=296 
 
Declined to participate n=74  
 
Other reasons n=17 
(Not wanting exercise) 
(Diary will be too much effort) 
(Unwilling to participate in a 12 week 
intervention) 





Usual Care only 
(P) 
 





Nociceptive n=23 Neuropathic n=23 
Allocated to intervention n=46 
 
Nociceptive n=24 Neuropathic n=25 
Allocated to intervention n=49 
 
Nociceptive n=30 Neuropathic n=22 









Allocated to group (n=54) 
Did not complete baseline 
interview (n=2) 
1 was pregnant 
1 did not wish to continue 




Allocated to group (n=48) 
Did not complete baseline 
interview (n=2) 
2 didn’t complete baseline 
interview and did not return 




Allocated to group (n=51) 
Did not complete baseline interview (n=2) 
1 with a fracture 
1 with immunocompromised health  
Allocated to intervention (n=49) 
 
 
Received allocated intervention n=33 
Did not receive allocated 
intervention n=13 
Lost to follow-up (n=7) 
Discontinued intervention (n=6) 
[n=1 too sore; n=2 Dr told them to 
stop trial; n=2 no transport; n=1 went 
on holiday] 
Received allocated intervention n=42 
Did not receive allocated intervention n=7 
Lost to follow-up (n=4) 
Discontinued intervention (n=3) 
[n=2 too sore; n=1 too much effort] 
Received allocated intervention n=32 
Did not receive allocated intervention 
n=20 
Lost to follow-up (n=7) 
Discontinued intervention (n=13) 
[n=1 Ankle fracture; n=5 wanted usual 




4.2 Participant dropout  
 
This section will present results relating to attrition during the RCT. Dropout associated with either 
treatment group or pain phenotype was assessed. Pain intensity associated with dropout was assessed 
as this was the primary outcome measure. 
 
Participant dropout characteristics 
Table 33 describes dropout by week of intervention. In total, 27% (n=40) of participants had dropped 
out by 12-week follow-up. 
 






1 17 11.6 
2 6 4.1 
3 5 3.4 
4 3 2.0 
5 1 0.7 
6 4 2.7 
7 3 2.0 
11 1 0.7 
12 0 0 
 
To demonstrate the number of participants who completed the RCT, participants were categorized 
into two groups, not completing the 12-week intervention, and having completed the 12-week 
intervention. Dropout was compared by treatment group (Table 34) and by pain phenotype (Table 
35 and 36).   
 
A chi-squared test demonstrated a statistically significant association between treatment group and 
drop out. The PW treatment group were more likely to stay in the RCT compared to the other two 


















weeks in the 
study 
<12 40(27.2) 13(28.3) 20(38.5) 7(14.3) 
0.02* 
12 107(72.8) 33(71.7) 32(61.5) 42(85.7) 
Groups compared with Chi² n (%) 
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
A fisher’s exact test demonstrated no association between pain phenotype and drop out (p=0.09).  
 
Dropout and the effect of pain intensity  
Binary logistic regression was used explore whether baseline pain intensity scores were a potential 
predicator of participant drop out. The dependant variable (drop out) was categorical with one of two 
responses predicting drop out; pain intensity at baseline in participants that did complete the 12-week 
RCT, and pain intensity at baseline in those who did not complete the 12-week RCT. Independent 
variables entered into the equation were baseline pain intensity, allocation to treatment group and 
pain phenotype (Table 35). After controlling for all other variables in the model, there was a 
significant effect for pain intensity score at baseline, on drop out, in the W treatment group compared 
to the PW treatment group (p=0.01, OR 4.18, 95% confidence intervals (CI) 1.54-11.37). Moreover, 
after controlling for the other variables in the model (pain intensity at baseline, and allocation to 
treatment groups), there was an effect of pain phenotype on drop out. The odds of dropout were 
higher for the neuropathic pain phenotype compared to the nociceptive pain phenotype (p=0.04, OR 
2.55 (95% CI 1.04 to 6.22)). 
 
Table 35: The association between participant dropout and pain intensity at baseline, treatment group 
allocation, and pain phenotype.  
Effect p value 
Odds 
ratio 
95% Confidence intervals for odds 
ratio 
Lower Upper 
Pain intensity at baseline: 0.59 0.99 0.97 1.02 
Treatment: P vs. PW 0.10 2.40 0.85 6.79 
Treatment: W vs. PW 0.01** 4.18 1.54 11.37 
Pain phenotype: Neuropathic vs. Nociceptive 0.04* 2.55 1.04 6.22 
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
Binary logistic regression was used explore whether last observed pain intensity scores were a 
potential predicator of participant drop out. Independent variables entered into the equation were last 
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observed pain intensity, allocation to treatment group and pain phenotype (Table 36). After 
controlling for all other variables in the model (allocation to treatment group and pain phenotype), 
there was a significant effect of last observed pain intensity score on drop out (p=0.01, OR 1.03 (95% 
CI 1.01to1.04)). 
 
Moreover, after controlling for the other variables in the model (last observed pain intensity, and 
allocation to treatment group (P vs. PW), pain phenotype), there was a significant effect of last 
observed pain intensity score on drop out, in the W treatment group compared to the PW treatment 
group (p=0.01, OR 3.81 (95% CI 1.33 to 10.91)). 
 
Table 36: The association between participant dropout and last observed pain intensity, treatment 
group allocation, and pain phenotype 
Effect p value 
Odds 
ratio 
95% Confidence Limits for odds 
ratio 
Lower Upper 
Pain intensity last observed: 0.01*** 1.03 1.01 1.04 
Treatment: P vs. PW 0.08 2.67 0.89 8.01 
Treatment: W vs. PW 0.01* 3.81 1.33 10.91 
Pain phenotype: Neuropathic vs. Nociceptive 0.33 1.51 0.66 3.48 
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
4.3 Baseline characteristics  
 
Baseline characteristics by treatment group are described below. There were no missing data in this 
section. 
 
Baseline characteristics of treatment groups  
The RCT’s primary outcome measure was pain intensity. In order to detect a 10-point difference on 
a 100-point pain scale, assuming a 25-point standard deviation, at 80% power required a sample size 
of 147 participants. A total of 153 participants consented to the RCT however six participants were 
withdrawn prior to completing the baseline interview due to exclusion criteria, see figure 9. Baseline 









P W PW 
Standardized mean 
effect sizes between 
treatment groups in 
the effect of the 
intervention versus 
usual care.  
     P/PW P/W 
Age (years)* 46.2 (10.9) 45.4 (9.6) 47.7 (11.3) 45.5 (11.6) 0.3% 12.1% 
Gender Female. n (%) 92 (62.6%) 27 (58.7%) 35 (67.3%) 30 (61.2%) 5.2% 17.9% 
Gender Male. n (%) 55 (37.4%) 19 (41.3%) 17 (32.7%) 19 (38.8%) 5.2% 17.9% 














school. n (%) 
60 (40.8%) 16 (10.9%) 18 (12.2%) 26 (17.7%) 4.1% 31.2% 
Diploma. n (%) 45 (30.6%) 16 (10.9%) 12 (8.1%) 17 (11.6%) 0.2% 26% 
Degree. n (%) 42 (28.6%) 14 (9.5%) 14 (9.5%) 14 (9.5%) 4.1% 7.8% 
Smoker. n (%) 58 (39.5%) 19 (41.3%) 18 (34.6%) 21 (42.9%) 3.1% 13.8% 
Employed. n (%) 135 (91.8%) 45 (97.8%) 47 (90.4%) 43 (87.8%) 39.7% 32% 
Pain duration (years)** 8 (4-13) 8 (5-10) 10 (5-14) 7 (3-14) 6.9% 6% 
Neuropathic. n (%) 70 (47.6%) 23 (32.9%) 22 (31.4%) 25 (35.7%) 2.4% 15.5% 
Nociceptive. n (%) 77 (52.4%) 23 (29.9%) 30 (39.0%) 24 (31.2%) 2.4% 15.5% 
Expectation of Pain Intensity after 
RCT at 12-weeks * 
16.9(18.4) 15.8(14.9) 19(19.9) 15.6(19.8) 9.8% 4.2% 
Pain Intensity * 53.9(21.8) 52.3(21.7) 53.0(20.7) 56.5(23.3) 18.9% 3.2% 
Oswestry Disability Index * 24.9(11.2) 26.7(12.2) 25.0(11.0) 23.3(10.4) 12.4% 5.2% 
Tampa Scale for Kinesiophobia * 38.4 (7.1) 39.7(6.1) 38.1(8.2) 37.6(6.6) 33.8% 21.9% 
Pain Catastrophizing Scale * 17.9(12.2) 16.6(11.9) 19.8(12.3) 17.0(12.2) 0.6% 12.7% 
P, usual care treatment; W, pedometer-based walking intervention; 
PW, usual care treatment and pedometer-based walking intervention 
*mean (SD) **median (IQR)  
Numerical Rating Scale (0-100): higher score indicates more pain intensity 
Oswestry Disability Index (0-100): higher score indicates more LBP-related functional disability 
Tampa Scale of Kinesiophobia (17-68): Scores ≥37 indicates more fear avoidance beliefs 
Pain Catastrophizing Scale (0-52): Scores ≥30 indicates more pain catastrophizing behaviour 
SD: Standard deviation 
IQR Interquartile range 
 
4.4 Physiotherapy visits  
 
The numbers of physiotherapy visits made by participants in each treatment group, over the 12-
week intervention, are described in Table 38. There were no missing data in this section.  
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1-2 28(19.1) 6(13.0) 19(36.5) 3(6.1) 
<0.01 
3-4 34(23.1) 7(15.2) 19(36.5) 8(16.3) 
5-6 31(21.1) 10(21.7) 8(15.4) 13(26.5) 
7-8 29(19.7) 13(28.3) 3(5.8) 13(26.5) 
9-10 25(17.0) 10(21.7) 3(5.8) 12(24.5) 
*Groups compared with Chi² n (%) 
 
To capture the follow-up information, all participants were asked to book a minimum of three 
physiotherapy appointments. These were included at: 
•  Baseline 
•  Six-week follow-up  
• 12-week follow-up 
 
Table 38 demonstrates the number of physiotherapy visits varied between participants with 28 
participants attending less than three physiotherapy visits.   
 
4.5 Outcome measures  
 
Outcome measures of Pain Intensity, Disability, Kinesiophobia and Catastrophizing were measured 
in all participants (n-147), at: 
• Baseline (0 weeks) 
• Six-week follow-up  
• 12-week follow-up 
 
Pain intensity (NRS), disability (ODI), kinesiophobia (TSK), and pain catastrophizing (PCS) data 
were described with mean and standard deviation. Outcome measure data observed at baseline was 
normally distributed. There were no missing data in this section. 
 
To track the four outcome measures from baseline to follow-up at 12 weeks, summary statistics were 





Table 39. Summary statistics for the four outcome measures at each time point for the three treatment 
groups 
Treatment group 
Mean change (95% confidence interval) 
 P PW W 
Week 0 52.3 (45.9 to 58.7) 56.5 (49.8 to 63.2) 53 (47.2 to 58.7) 
Week 6 37.1 (29.9 to 44.3) 36.6 (29.6 to 43.6) 42.1 (34.8 to 49.4) 
Week 12 33.5 (26 to 41) 29.6 (21 to 38.2) 40.2 (32.7 to 47.7) 
ODI (% scale, where 0% indicates no disability) 
Week 0 26.7 (23.1 to 30.3) 23.3 (20.3 to 26.3) 25 (21.9 to 28) 
Week 6 20.7 (17.1 to 24.4) 18 (14.7 to 21.2) 22.7 (19.2 to 26.1) 
Week 12 19 (15.1 to 23) 14.6 (11.2 to 18) 19.8 (16.6 to 23) 
TSK (17 to 69 scale, where 17 indicates no kinesiophobia) 
Week 0 39.7 (37.9 to 41.5) 37.6 (35.7 to 39.5) 38.1 (35.8 to 40.4) 
Week 6 36.2 (33.3 to 39.1) 33 (31 to 34.9) 35.6 (33.6 to 37.6) 
Week 12 36.7 (34.4 to 39) 31.5 (29 to 34) 34.8 (32.6 to 37) 
PCS (0 to 52 scale, where 0 indicates no catastrophizing) 
Week 0 16.6 (13.1 to 20.2) 17 (13.5 to 20.5) 19.8 (16.3 to 23.2) 
Week 6 12.1 (8.58 to 15.7) 9.65 (6.83 to 12.5) 15.2 (11.9 to 18.5) 
Week 12 11.3 (7.94 to 14.8) 9.04 (5.82 to 12.3) 14.7 (11.2 to 18.1) 
 
Mean changes from baseline at both follow-up points showing reductions in scores in all three 
interventions and improvements in all three interventions. With a minimally clinically important 
difference in pain intensity of >2/10, the PW intervention showed a MCID at 12-week follow-up. All 
three intervention groups showed high degrees of kinesiophobia and all three intervention groups 
showed levels of kinesiophobia lower than the cut-off score of 37 at both time points. The largest 





Table 40. Mean change from baseline scores for all outcome measures and between-group effect 
sizes* 
Treatment group 
Mean change (95% confidence interval) 
 P PW W 
NRS (0 to 100 scale, where 0 indicates no pain) 
Week 6 -15.2 (-22.5 to -7.87) -19.9 (-27.9 to -11.9) -10.9 (-16.3 to -5.47) 
Cohen's d -0.2 -0.38 REF 
Week 12 -18.8 (-26.3 to -11.2) -26.9 (-35.9 to -17.9) -12.8 (-19.8 to -5.74) 
Cohen's d -0.24 -0.5 REF 
ODI (% scale, where 0% indicates no disability) 
Week 6 -5.93 (-8.3 to -3.57) -5.31 (-8.07 to -2.54) -2.31 (-4.65 to 0.03) 
Cohen's d -0.44 -0.33 REF 
Week 12 -7.63 (-10.4 to -4.85) -8.67 (-11.8 to -5.51) -5.15 (-7.72 to -2.59) 
Cohen's d -0.27 -0.35 REF 
TSK (17 to 69 scale, where 17 indicates no kinesiophobia) 
Week 6 -3.5 (-5.31 to -1.69) -4.61 (-6.51 to -2.71) -2.5 (-4.38 to -0.62) 
Cohen's d -0.16 -0.32 REF 
Week 12 -2.98 (-4.44 to -1.51) -6.06 (-8.14 to -3.99) -3.27 (-5.37 to -1.17) 
Cohen's d 0.05 -0.38 REF 
PCS (0 to 52 scale, where 0 indicates no catastrophizing) 
Week 6 -4.48 (-6.87 to -2.09) -7.37 (-10.1 to -4.61) -4.56 (-7.16 to -1.96) 
Cohen's d 0.01 -0.3 REF 
Week 12 -5.26 (-7.71 to -2.81) -7.98 (-10.9 to -5.07) -5.1 (-8.08 to -2.12) 
Cohen's d -0.02 -0.28 REF 
* Between-group effect sizes: P vs W (reference group) and PW vs W (reference group) 
 
Outcome measures are presented as independent sections and will be reported in the following 
sequence (figure 10): 
• Primary outcome measure analysis (ANOVA and linear mixed model regressions analyses): 
NRS  
• Secondary outcome measure analysis (ANOVA and linear mixed model regressions 





























*ANOVA (baseline - 12-week follow-up: did not control for any independent variables) 
Linear mixed model (baseline, 6-week follow-up, 12-week follow-up) 
 
Association between independent variables  
Association was examined between predictive variables as described in the data analysis section of 
the methods. Where there was statistically significant association between predictive variables, only 
one of these variables was used in modelling associations with the primary outcome measure and 
secondary outcome measures.  
 
Exploration for the confounding variables for outcome measures at 12-week follow-up in the models 
used, included baseline data (Table 41). The association between each pair of covariates was assessed 
to identify any strong associations which could introduce a confounder into the modelling.  
 
Primary outcome 


















Analysis of ODI 
ANOVA* 
Linear mixed models 5&6  
Analysis of TSK 
ANOVA* 
Linear mixed model 7 
Analysis of PCS 
ANOVA* 
Linear mixed model 8 
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Table 41: A summary of the independent variables included in the models for each outcome measure 
(NRS, ODI, TSK, and PCS) 
Covariate NRS ODI PCS TSK 
Age √ √ √ √ 
Gender √ √ √ √ 
Employment level √ √ √ √ 
Education level √ √ √ √ 
Smoking √ √ √ √ 
BMI √ √ √ √ 
# of Physiotherapy visits √  √ √ 
Pain intensity at 12-week follow-up  √   
Pain duration (years) √ √ √ √ 
Pain intensity at baseline √    
ODI score at baseline  √   
PCS at baseline   √  
TKS at baseline    √ 
Pain phenotype √ √ √ √ 
NRS: Numerical Rating Scale for Pain Intensity 
ODI: Oswestry Disability Index 
TSK: Tampa Scale of Kinesiophobia 
PCS: Pain Catastrophizing Scale 
√: indicates an assumption that the predictors are independent of each other. If associations were found between above 
predictors, in which case the predictor was excluded from the model. 
 
The following confounded pairs of variables were identified (Table 41); the strength of association 
was measured using Cohen’s d, where values greater than 0.8 are considered as large: 
• Pain phenotype and pain intensity score at baseline (Cohen’s d=1.1) 
• Pain phenotype and ODI score at baseline (Cohen’s d=1.1) 
• Pain intensity at 12-weeks and number of physiotherapy visits (Cohen’s d=0.9) 
 
Therefore, the following independent variables (Table 41) could not be used together in the linear 
mixed model:  
• For primary outcome measure analysis (NRS): Pain intensity at baseline and pain phenotype.  
• For the secondary outcome measure analysis for ODI: ODI at baseline and pain phenotype; 
number of physiotherapy visits and pain intensity at 12-week follow-up. 
• For the secondary outcome measure analysis for TSK: The number of physiotherapy visits 
and pain intensity at 12-week follow-up.  
• For the secondary outcome measure analysis for PCS: The number of physiotherapy visits 




Due to pain phenotype having a strong association with both NRS at baseline and ODI at baseline, 
this led to the development of two models for NRS and again for ODI outcomes at 12-week follow-
up. Therefore, in the primary analyses and investigative analysis of the primary outcome measure 
analysis where the dependant variable was the NRS (Figure 10), two models were constructed. 
Models 1 and 2 for the primary analysis, and models 3 and 4 for the investigative analysis:  
Model 1: Over and above other predictive variables the model controlled for baseline pain intensity 
score but excluded pain phenotype, and  
Model 2: Included pain phenotype but excluded baseline pain intensity score.  
Model 3: Included all the predictive variables in Table 41. Over and above other predictive variables 
the model controlled for baseline pain intensity score but excluded pain phenotype, and  
Model 4: Included all the predictive variables in Table 41. Included pain phenotype and excluded 
baseline pain intensity score. 
 
In the secondary outcomes analyses where the dependant variable was the ODI, two models were 
constructed (Models 5&6): 
Model 5: Over and above other predictive variables the model controlled for baseline ODI score and 
excluded pain phenotype, and 
Model 6: Over and above other predictive variables the model controlled for pain phenotype and 
excluded baseline ODI score. 
For these models that used ODI as a dependant variable, number of physiotherapy visits was a 
confounding variable and was excluded from the model. 
 
In the two secondary outcome measures analyses where the dependant variables were the TSK and 
PCS respectively, only one model was required for each of the TSK (Model 7) and PCS (Model 8) 
outcomes. Pain phenotype did not act as a confounding variable with either of these secondary 
outcome measures. Independent variables which were confounding variables with the TSK and PCS 
had to be excluded from the models. For the models where TSK and PCS scores at 12-week follow-
up were the dependant variables, the independent variable of pain intensity at 12-week follow-up 
was excluded. 
 
Primary outcome measure analyses 
The primary analyses investigated whether there was a significant difference in pain intensity 
between treatment groups at 12-week follow-up using analysis of variance (ANOVA) and two linear 
mixed models. An investigative analysis of the primary outcome was also conducted to determine if 
any of the independent variables referred to in Table 41 included in the models predicted pain 
intensity at 12-week follow-up using two linear mixed models. 
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Primary analysis of pain intensity  
An ANOVA was used to determine any differences in pain intensity between baseline and 12-week 
follow-up between treatment groups. There was no statistically significant difference in the change 
in pain intensity scores between baseline and 12-week follow-up between treatment groups (F 
(2,103) = 1.33, p = 0.27; Figure 11) 
 
Figure 11: Change in pain intensity between treatment groups from baseline to 12-week follow-up.  
 
P, usual care treatment; W, pedometer-based walking intervention; 
PW, usual care treatment and pedometer-based walking intervention; 
Week 0, baseline; Week 12, 12-week follow-up 
 
Due to baseline pain intensity and pain phenotype being confounding variables, results were 
presented in Models 1 and 2. A linear mixed model regression analysis compared pain intensity 
between the three treatment groups at the 12-week follow-up. Depending on which model (Model 1 
or 2) was used, there were three to four fixed effects and the participants were taken as random 
effects. This was completed to determine the effect of treatment group allocation, pain phenotype, 
baseline pain intensity and the number of physiotherapy visits on pain intensity at 12-week follow-
up. 
 
Linear mixed model 1: Controlling for treatment group allocation, pain intensity at baseline and 
number of physiotherapy visits.  
In the linear mixed model 1, and in reference to treatment group allocation, pedometer-based walking 
(W) was the reference group. Treatment group allocation was not a statistically significant predictor 
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of pain intensity between treatment groups at 12-week follow-up (Table 42). After controlling for all 
other variables in the model (treatment by group and number of physiotherapy visits), pain intensity 
at baseline was a statistically significant predictor of pain intensity at 12-week follow-up (p<0.01). 
A one-unit increment in baseline pain intensity score being associated with a 0.5 unit increase in pain 
intensity at 12-week follow-up (Table 42). After controlling for the other variables in the model 
(treatment by group and pain at baseline), the number of physiotherapy visits was also a statistically 
significant predictor of pain intensity at 12-week follow-up (p=0.01) (Table 42). Those who attended 
the physiotherapist on one – two occasions were most likely to have no significant change in pain 
intensity at 12-week follow-up. Post-hoc tests completed only on physiotherapy visits showed that 
the pain intensity score at 12-week follow-up was statistically significantly greater for participants 
who had attended one to two physiotherapy visits than that for three to four, seven to eight and nine 
to ten physiotherapy visits (p=0.03, 0.02 and 0.01 respectively) (Figure 12). 
 
Table 42: Linear mixed model 1- fixed effects output exploring contributions of treatment group 





Df T p value 
Intercept -1.34 -16.82 to 
14.13 
145 -0.17 0.9 
Treatment PW -7.33 -17.66 to 3.00 2 -1.39 0.17 
Treatment P -0.53 -10.72 to 9.66 2 -0.01 0.92 
Treatment W. Reference group 0  2   
Pain intensity at baseline 0.53 0.35 to 0.71 1 5.85 <0.01*** 
Number of physio visits 1-2 24.89 11.13 to 38.66 4 3.54 0.01*** 
Number of physio visits 3-4 7.13 -5.74 to 20.01 4 1.09 0.28 
Number of physio visits 5-6 10.49 -2.11 to 23.09 4 1.63 0.10 
Number of physio visits 7-8 4.07 -8.62 to 16.77 4 0.63 0.53 
Number of physio visits 9-10. 
Reference group 
0  4   





Figure 12: Mean pain intensity scores against the number of physiotherapy visits throughout the 
intervention period.  
 
 
Linear mixed model 2: Controlling for treatment group allocation, pain phenotype, number of 
physiotherapy visits and interaction of treatment group allocation and pain phenotype. 
Model 2 was constructed to exclude pain intensity at baseline as it was a confounding variable when 
used with pain phenotype in the analysis. In reference to treatment group allocation, W treatment 
group was the reference group. Treatment group allocation was not a statistically significant predictor 





Table 43: Linear mixed model 2 - fixed effects output exploring contributions of treatment group 
allocation, pain phenotype, and number of physiotherapy visits, and interactions between treatment 




df t p value 
Intercept 23.04 8.96 to 37.12 145 3.21 0.00 
Treatment PW -10.88 -25.26 to 3.49 2 -1.48 0.14 
Treatment P -1.14 -15.40 to13.13 2 -0.16 0.88 
Treatment W. Reference group 0  2   
Neuropathic pain phenotype 14.91 1.05 to 28.76 1 2.11 0.04* 
Nociceptive pain phenotype. Reference 
group 
0  1   
Number of physio visits 1-2 20.71 6.08 to 35.33 4 2.78 0.01** 
Number of physio visits 3-4 6.32 -7.33 to 19.96 4 0.91 0.37 
Number of physio visits 5-6 6.07 -7.21 to 19.35 4 0.9 0.37 
Number of physio visits 7-8 0.65 -12.91 to 14.21 4 0.09 0.93 
Number of physio visits 9-10. Reference 
group 
0  4   
Treatment PW x Neuropathic Pain 
phenotype 
8.04 11.77 to 27.85 2 0.8 0.43 
Treatment PW x Nociceptive Pain 
phenotype. Reference group 
0  2   
Treatment P x Neuropathic Pain 
phenotype 
-1.99 -21.99 to 17.99 2 -0.2 0.84 
Treatment P x Nociceptive Pain 
phenotype.  Reference group 
0  2   
Treatment W x Neuropathic Pain 
phenotype. Reference group 
0  2   
Treatment W x Nociceptive Pain 
phenotype. Reference group  
0  2   
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
After controlling for all other variables in the model (treatment by group, number of physiotherapy 
visits, and the interaction of treatment by group and pain phenotype), pain phenotype was a 
statistically significant predictor of pain intensity at 12-week follow-up (p=0.04) (Table 43). 
Neuropathic pain phenotype predicted greater pain intensity at 12-week follow up. 
 
After controlling for the other variables in the model (pain phenotype, treatment by group, and the 
interaction of treatment by group and pain phenotype), the effect of the number of physiotherapy 
visits on pain intensity score at the 12-week follow-up demonstrated there was a statistically 
significant association with the number of physiotherapy visits. One - two physiotherapy visits 
associated with greater pain intensity at 12-week follow-up (p=0.01) (Table 43). This finding is the 




A linear mixed model regression analysis was conducted to determine, whether any of the 
independent variables (Table 41) were associated with pain intensity at 12-week follow-up, thereby 
investigating factors predicting pain intensity in all participants at 12-week follow-up. The models 
(3 and 4) included independent variables typically associated with CLBP (Table 41). Pain intensity 
at baseline, treatment group allocation, time point at six-week follow-up, time point at 12-week 
follow-up, number of physiotherapy visits, and pain duration were also included.  
 
Linear mixed model 3: Looking for changes in pain intensity controlling for all independent 
variables except pain phenotype. 
The model 3 showed both pain intensity at baseline (p<0.01) and number of physiotherapy visits 
(p=0.01) remained statistically significant predictors of the pain intensity outcome at 12-week 






Table 44: Linear mixed model 3- fixed effects output exploring contributions of variables to pain 




df t p value 
Intercept 11.5 -19.51 to 42.51 133 0.73 0.46 
Treatment PW. -9.95 -20.42 to 0.51 140 -1.86 0.06 
Treatment P. -2.85 -13.19 to 7.49 137 -0.54 0.59 
Treatment W. Reference group 0     
Pain intensity at baseline 0.55 0.38 to 0.71 130 6.66 <0.01*** 
Number of physio visits 1-2 16.78 3.99 to 29.58 130 2.57 0.01* 
Number of physio visits 3-4 1.24 -10.33 to 12.81 130 0.21 0.83 
Number of physio visits 5-6 6.84 -4.71 to 18.39 130 1.16 0.24 
Number of physio visits 7-8 -0.70 -12.18 to 10.77 130 -0.12 0.90 
Number of physio visits 9-10. 
Reference group 
0     
Six-week follow-up 1.12 -4.99 to 7.22 117 0.36 0.72 
12-week follow-up. Reference group 0     
Age 0.01 -0.34 to 0.35 130 0.03 0.97 
Gender female 2.30 0.54 to 9.59 3.7145 130 0.62 
Gender male. Reference group 0     
Employed 0.96 -11.83 to 13.74 130 0.15 0.88 
Unemployed. Reference group 0     
Education: university/post grad. -1.1734 -9.97 to 7.62 130 -0.26 0.79 
Education: Diploma 2.6899 -5.62 to 11.00 130 0.63 0.52 
Education: Completed school. 
Reference group 
0     
Smoker: no -2.27 -9.58 to 5.05 130 -0.61 0.54 
Smoker: yes. Reference group 0     
BMI -0.35 -1.03 to 0.33 130 -1.02 0.31 
Pain Duration 0.14 -0.30 to 0.59 130 0.63 0.53 
Treatment PW x Six-week follow-up.  4.17 -4.65 to 12.98 117 0.93 0.35 
Treatment PW x 12-week follow-up. 
Reference group 
0     
Treatment P x Six-week follow-up -3.75 -12.66 to 5.17 117 -0.82 0.41 
Treatment P x 12-week follow-up. 
Reference group 
0     
Treatment W x Six-week follow-up. 
Reference group 
0     
Treatment W x 12-week follow-up. 
Reference group 
0     




After controlling for all other variables in the model including treatment by group, number of 
physiotherapy visits, week (six-week follow-up, 12-week follow-up), age, gender, employment, 
education, smoking status, BMI, pain duration, interaction of treatment by group and six-week 
follow-up, and interaction of treatment by group and 12-week follow-up, pain intensity at base-line 
was a statistically significant predictor of pain intensity at 12-week follow-up (p<0.01). A one-unit 
increment in baseline pain intensity score being associated with a 0.5-unit increase in pain intensity 
at 12-week follow-up (Table 44).  
 
After controlling for the other variables in the model including treatment by group, pain intensity at 
baseline, week (six-week follow-up, 12-week follow-up), age, gender, employment, education, 
smoking status, BMI, pain duration, interaction of treatment by group and six-week follow-up, and 
interaction of treatment by group and 12-week follow-up, the effect of the number of physiotherapy 
visits on pain intensity score at 12-week follow-up also demonstrated a statistically significant 
association with the number of physiotherapy visits (p=0.01). Fewer physiotherapy visits were 
associated with greater pain intensity at 12-week follow-up (Table 44).  
 
All of the other predictors were not statistically significantly associated with pain intensity at 12-
week follow-up in this model (treatment by group, six-week follow-up, 12-week follow-up, age, 
gender, employment, education, smoking status, BMI, and pain duration). 
 
Linear mixed model 4: Looking for changes in pain intensity controlling for all independent 
variables except baseline pain intensity. 
Model 4 was constructed to exclude pain intensity at baseline as it was a confounding variable when 
used with pain phenotype in the analysis. Treatment group allocation was not a statistically 
significant predictor of pain intensity at 12-week follow-up (Table 45). After controlling for other 
variables in the model including treatment by group, number of physiotherapy visits, week (six-week 
follow-up, 12-week follow-up), age, gender, employment status, education status, smoking, BMI, 
pain duration, interaction of treatment by group and pain phenotype, interaction of treatment by 
group and six-week follow-up, interaction of treatment by group and 12-week follow-up, interaction 
of pain phenotype and six-week follow-up, interaction of pain phenotype and 12-week follow-up, 
neuropathic pain phenotype was shown to be a statistically significant predictor of greater pain 
intensity at 12-week follow-up (p=0.01) (Table 45). The effects of the other variables in the model 





Table 45: Linear mixed model 4- fixed effects output exploring contributions of variables to pain 




df t p value 
Intercept 35.93 3.06 to 68.80 133 2.14 0.03 
Treatment PW -5.49 -19.70 to 8.71 150 -0.76 0.45 
Treatment P -1.00 -15.50 to 13.49 150 -0.14 0.89 
Treatment W. Reference group 0     
Neuropathic pain phenotype 21.05 7.06 to 35.04 149 2.95 0.01** 
Nociceptive pain phenotype. Reference 
group 
0  . . . 
Number of physio visits 1-2 11.39 -2.76 to 25.56 128 1.58 0.12 
Number of physio visits 3-4 -1.18 -13.96 to 11.59 128 -0.18 0.86 
Number of physio visits 5-6 1.16 -11.54 to 13.87 128 0.18 0.86 
Number of physio visits 7-8 -2.87 -15.55 to 9.81 128 -0.44 0.66 
Number of physio visits 9-10. 
Reference group 
0  . . . 
Six-week follow-up 0.46 -6.51 to 7.44 115 0.13 0.89 
12-week follow-up. Reference group 0     
Age -0.12 -0.50 to 0.26 128 -0.62 0.54 
Gender female 6.00 -2.17 to 14.18 128 1.44 0.15 
Gender male. Reference group 0     
Employed -3.12 -17.27 to 11.02 128 -0.43 0.66 
Unemployed. Reference group 0     
Education: university/post grad. 0.67 -9.24 to 10.58 128 0.13 0.89 
Education: Diploma 0.74 -8.47 to 9.95 128 0.16 0.87 
Education: Completed school. 
Reference group 
0  . . . 
Smoker: no -1.99 -10.23 to 6.23 128 -0.48 0.63 
Smoker: yes. Reference group 0     
BMI -0.24 -0.99 to 0.51 128 -0.63 0.53 
Pain Duration 0.13 -0.37 to 0.64 128 0.52 0.60 
Treatment PW x Neuropathic Pain 
phenotype 
-6.25 -24.31 to 11.80 128 -0.68 0.49 
Treatment PW x Nociceptive Pain 
phenotype. Reference group 
0     
Treatment P x Neuropathic Pain 
phenotype 
-9.50 -28.52 to 9.51 128 -0.98 0.32 
Treatment P x Nociceptive Pain 
phenotype. Reference group 
0     
Treatment W x Neuropathic Pain 
phenotype. Reference group 
0     
Treatment W x Nociceptive Pain 
phenotype. Reference group 






df t p value 
Treatment PW x Six-week follow-up 3.11 -5.84 to 12.06 115 0.68 0.49 
Treatment PW x 12-week follow-up. 
Reference group 
0     
Treatment P x Six-week follow-up -3.86 -12.96 to 5.23 115 0.83 0.40 
Treatment P x 12-week follow-up. 
Reference group 
0     
Treatment W x Six-week follow-up. 
Reference group 
0     
Treatment W x 12-week follow-up. 
Reference group 
0     
Neuropathic pain phenotype x Six-week 
follow-up  
1.53 -5.89 to 8.97 115 0.41 0.68 
Neuropathic pain phenotype x 12-week 
follow-up. Reference group 
0     
Nociceptive pain phenotype x Six-week 
follow-up. Reference group 
0     
Nociceptive pain phenotype x Six-week 
follow-up. Reference group 
0     
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
To summarise the primary outcome of pain intensity, information for change in pain intensity from 
baseline to 12-week follow-up: the primary analysis (ANOVA and linear mixed model 1 and 2), 
together with further investigative analysis using linear mixed models (models 3 and 4) including all 
the predictors in Table 41, concluded treatment group allocation was not significant predictor of 
reduction in pain intensity at 12-week follow-up. However, both linear mixed models in the primary 
and investigative analyses showed the number of physiotherapy visits did predict a reduction in pain 
intensity at 12-week follow-up. Both primary and investigative analyses show that baseline pain 
intensity and pain phenotype were statistically significant predictors of a decrease in pain intensity 
at 12-week follow-up.  
 
Figure 13 shows changes in pain intensity between baseline and follow-up at six-weeks and 12-weeks 
within treatment groups. The linear mixed model regression analyses showed there was no 
statistically significant effect of time (follow-up at six-weeks and 12-weeks), treatment group 





Figure 13: Comparison of pain intensity within each treatment group over time.  
 
P, usual care treatment; W, pedometer-based walking intervention; 
PW, usual care treatment and pedometer-based walking intervention; 
Week 0, baseline; Week 6, six-week follow-up; Week 12, 12-week follow-up 
 
Secondary outcome measures analyses 
Secondary outcomes measured in this RCT included, disability, kinesiophobia and pain 
catastrophizing. 
 
A secondary outcome measure analysis was completed using an ANOVA, individually comparing 
the change in secondary outcomes (ODI, TSK and PCS) from baseline to 12-week follow-up, 
between treatment groups. In addition, for every individual secondary outcome measure, linear 
mixed models were constructed. Using the linear mixed models, analyses were conducted using 
covariates (Table 41) to examine if there were changes in any of the secondary outcome measures, 
and what the predictors were of these outcome measures at 12-week follow-up. 
 
Disability 
The Oswestry Disability Index (ODI) was used to measure disability related to CLBP. Participants 
baseline ODI mean score for the entire cohort was 24.9 (SD 11.2) (Table 37).  
 
An analysis for ODI investigated whether there was a significant difference in ODI score between 
treatment groups at 12-week follow-up. An ANOVA showed no statistically significant difference 
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in the change in ODI score from baseline to 12-week follow-up between groups at 12-week follow-
up (F (2,104) = 0.42, p = 0.66).  
 
Linear mixed models 5 and 6 were generated for a comparison of ODI score between the three 
treatment groups at 12-week follow-up. Due to baseline ODI score and pain phenotype being 
confounding variables when used together in a single model, results were presented in models 5 and 
6.  Model 5 controlled for baseline ODI score and excluded pain phenotype. Model 6 controlled for 
pain phenotype and excluded baseline ODI score. However, depending on which model was used 
(model 5 or 6), the analysis was used for determination of the effect of treatment group allocation, 
pain phenotype, baseline disability, and selected independent variables (Table 41) on the ODI score 
at 12-week follow-up. Associated variables that are commonly associated with pain intensity were 
likewise included in the analysis of ODI at 12-week follow-up. These included: week (six-week 
follow-up and 12-week follow-up), age, gender, employment, education, smoking status, BMI, pain 
duration, and pain intensity at 12-week follow-up. These variables were taken as the fixed effects 
and the participants were taken as random effects. 
 
Linear mixed model 5: Looking for changes in ODI score controlling for all independent variables 
except baseline pain phenotype and number of physiotherapy visits. 
Controlling for variables, including ODI score at baseline, week (six-week follow-up, 12-week 
follow-up), age, gender, employment, education, smoking status, BMI, pain duration, pain intensity 
at 12-week follow-up, and interaction of treatment group allocation and six-week follow-up and 
interaction of treatment group allocation and 12-week follow-up on ODI score at 12-week follow-
up, there was no statistically significant effect of treatment group allocation on ODI score at 12-week 
follow-up (p=0.23 for PW and p=0.86 for P) (Table 46). However, controlling for variables described 
in table 41, ODI score at baseline (p<0.01), and at six-week follow-up (p=0.02), along with age 
(p=0.05) and pain intensity at 12-week follow-up (p<0.01) predicted ODI score at 12-week follow-
up (Table 46).  One-unit increment in ODI scores at baseline being associated with a 0.5 unit increase 
in ODI score at 12-week follow-up. The ODI mean score was higher at six-week follow-up compared 
to 12-week follow-up. Additionally, the model indicted that there was a 0.1 unit increase in ODI 
score for every one-year increase in age. Furthermore, for every 1-unit increase in pain intensity 
score at 12-week follow-up the ODI score increased by 0.2 units at 12-week follow-up. No other 





Table 46: Linear mixed model 5- fixed effects output exploring contributions of variables to ODI 
score at 12-week follow-up. 
Effect Estimates Confidence intervals df t p value 
Intercept -8.47 -15.40 to -1.53 147 -2.39 0.02 
Treatment PW -1.63 -4.30 to 1.04 137 -1.2 0.23 
Treatment P 0.23 -2.49 to 2.96 138 0.17 0.86 
Treatment W.  Reference group 0  . . . 
ODI at baseline 0.51 0.42 to 0.60 147 11.25 <0.01*** 
Six-week follow-up 2.57 0.49 to 4.64 124 2.43 0.02* 
12-week follow-up. Reference 
group 
0     
Age 0.09 0.00 to 0.18 137 1.99 0.05* 
Gender female -0.82 -2.73 to 1.08 136 -0.85 0.39 
Gender male.  Reference group 0  . . . 
Employed 1.63 -1.80 to 5.07 136 0.93 0.35 
Unemployed.  Reference group 0  . . . 
Education: university/post grad. 0.27 -2.01 to 2.57 137 0.24 0.81 
Education: Diploma 0.67 -1.51 to 2.87 136 0.61 0.54 
Education: Completed school.  
Reference group 
0  . . . 
Smoker: no 0.76 -1.16 to 2.69 137 0.78 0.43 
Smoker: yes.  Reference group 0  . . . 
BMI 0.02 -0.15 to 0.20 136 0.24 0.81 
Pain Duration 0.03 -0.09 to 0.15 136 0.47 0.63 
Pain intensity at 12-week follow-up 0.24 0.20 to 0.27 240 13.89 <0.01*** 
Treatment PW x   Six-week follow-
up 
-0.27 -3.24 to 2.70 125 -0.18 0.85 
Treatment PW x 12-week follow-
up.  Reference group 
0  . . . 
Treatment P x Six-week follow-up -0.23 -3.26 to 2.79 125 -0.15 0.87 
Treatment P x 12-week follow-up.  
Reference group 
0     
Treatment W x Six-week follow-up.  
Reference group 
0     
Treatment W x 12-week follow-up.  
Reference group 
0     
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
Linear mixed model 6: Looking for changes in ODI score controlling for all independent variables 
except baseline ODI score and number of physiotherapy visits. 
Controlling for variables including, pain phenotype, week (six-week follow-up, 12-week follow-up), 
age, gender, employment, education, smoking status, BMI, pain duration, pain intensity at 12-week 
follow-up, interaction of treatment group allocation and pain phenotype, interaction of treatment 
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group allocation and six-week follow-up, interaction of treatment group allocation and 12-week 
follow-up, interaction of pain phenotype and 6-week follow-up, and interaction of pain phenotype 
and 12-week follow-up described in Table 47, there was no statistically significant effect of treatment 
group allocation on ODI score at 12-week follow-up (p=0.56 for PW and p=0.59 for P). However, 
controlling for variables described in Table 47, pain phenotype (p=0.01), along with employment 
status (p=0.03) and pain intensity at 12-week follow-up (p<0.01) predicted ODI score at 12-week 
follow-up. Having a neuropathic pain phenotype was predictive of a greater ODI score at 12-week 
follow-up. Being unemployed was a statistically significant predictor of higher ODI scores at 12-
week follow-up. Furthermore, for every 1-unit increase in pain intensity score at 12-week follow-up 
the ODI score increased by 0.3 units at 12-week follow-up. No other statistically significant 
predictors of ODI score at 12-week follow-up were found. 
 
Table 47: Linear mixed model 6 - fixed effects output exploring contributions of variables to ODI 




df t p value 
Intercept -3.50 -12.01 to 5.00 145 -0.81 0.42 
Treatment PW -1.14 -5.08 to 2.78 156 -0.57 0.56 
Treatment P 1.08 -2.96 to 5.14 155 0.53 0.59 
Treatment W. Reference group 0     
Neuropathic pain phenotype 6.30 2.15 to 10.45 156 2.98 0.01** 
Nociceptive pain phenotype. Reference group 0     
Six-week follow-up 1.98 -0.42 to 4.39 110 1.62 0.10 
12-week follow-up. Reference group 0     
Age 0.10 -0.01 to 0.21 134 1.81 0.07 
Gender female -0.57 -2.91 to 1.75 134 -0.49 0.62 
Gender male. Reference group 0  . . . 
Unemployed  4.41 0.34 to 8.48 134 2.13 0.03* 
Employed: yes. Reference group 0  . . . 
Education: university/post grad. 2.10 -0.68 to 4.90 134 1.48 0.14 
Education: Diploma 1.78 -0.84 to 4.40 134 1.33 0.18 
Education: Completed school. Reference group 0  . . . 
Smoker: no 0.48 -1.85 to 2.82 134 0.41 0.68 
Smoker: yes. Reference group 0  . . . 
BMI 0.06 -0.14 to 0.28 134 0.63 0.52 
Pain Duration 0.13 -0.01 to 0.27 134 1.8 0.07 
Pain intensity at 12-week follow-up 0.27 0.23 to 0.31 247 14.14 <0.01*** 
Treatment PW x Neuropathic Pain phenotype -3.21 -8.47 to 2.03 134 -1.2 0.23 
Treatment PW x Nociceptive Pain phenotype. 
Reference group 






df t p value 
Treatment P x Neuropathic Pain phenotype -1.63 -7.13 to 3.87 134 -0.58 0.56 
Treatment P x Nociceptive Pain phenotype. 
Reference group 
0  . . . 
Treatment W x Neuropathic Pain phenotype. 
Reference group 
0  . . . 
Treatment W x Nociceptive Pain phenotype. 
Reference group 
0  . . . 
Treatment PW x Six-week follow-up -0.49 -3.58 to 2.60 111 -0.31 0.75 
Treatment PW x 12-week follow-up. Reference 
group 
0     
Treatment P x Six-week follow-up -0.22 -3.38 to 2.93 111 -0.14 0.88 
Treatment P x 12-week follow-up. Reference 
group 
0  . . . 
Treatment W x Six-week follow-up. Reference 
group 
0  . . . 
Treatment W x12-week follow-up. Reference 
group 
0  . . . 
Neuropathic pain phenotype x Six-week follow-up  1.29 -1.27 to 3.87 110 0.99 0.32 
Neuropathic pain phenotype x 12-week follow-up. 
Reference group 
0  . . . 
Nociceptive pain phenotype x Six-week follow-
up. Reference group 
0  . . . 
Nociceptive pain phenotype x 12-week follow-up. 
Reference group 
0  . . . 
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
Figure 14 shows changes in ODI score within treatment groups between baseline and follow-up at 
six-weeks and 12-weeks. All groups followed a trend in decreasing disability score between baseline 





Figure 14: Comparison of ODI score within each treatment group over time.  
 
P, usual care treatment; W, pedometer-based walking intervention; 
PW, usual care treatment and pedometer-based walking intervention; 
Week 0, baseline; Week 6, six-week follow-up; Week 12, 12-week follow-up 
 
Kinesiophobia 
The Tampa Scale of Kinesiophobia (TSK) was used to measure fear of movement related to CLBP. 
The mean score for kinesiophobia on the TSK for the entire cohort at baseline was 38/68 indicative 
of a fear avoidance behaviour, since the cut off score was 37/68 with scores of 37 and above 
categorized as kinesiophobic (Table 37).  
 
An ANOVA was used to look for changes in kinesiophobia, between treatment groups between 
baseline and follow-up at 12-week follow-up. There was no statistically significant difference in TSK 
mean scores between baseline and 12-week follow-up between treatment groups at 12-week follow-
up (F (2,104) = 1.49, p = 0.23). 
 
There was no association with baseline score of TSK and pain phenotype, therefore only one model 
was generated. Linear mixed model 7 was generated for a comparison of TSK score between the 
three treatment groups at 12-week follow-up. The analysis was used to determine the effect of 
treatment group allocation, pain phenotype, baseline TSK score, number of physiotherapy visits, and 
selected independent variables (Table 41) on the TSK score at 12-week follow-up. Associated 
variables that are commonly associated with pain intensity were included in the analysis of TSK at 
12-week follow-up. These included: week (six-week follow-up and 12-week follow-up), age, gender, 
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employment, education, smoking status, BMI, and pain duration. Pain intensity at 12-week follow-
up was excluded from the analysis because it was associated with number of physiotherapy visits. 
These variables were taken as the fixed effects and the participants were taken as random effects. 
 
Linear mixed model 7: Looking for changes in TSK score controlling for all independent variables 
except pain intensity at 12-week follow-up.  
After controlling for variables including TSK score at baseline, pain phenotype, number of 
physiotherapy visits, week (six-week follow-up, 12-week follow-up), age, gender, employment, 
education, smoking status, BMI, pain duration, interaction of treatment by group and pain phenotype, 
interaction of treatment group allocation and six-week follow-up, interaction of treatment group 
allocation and 12-week follow-up,  interaction of pain phenotype and six-week follow-up, and 
interaction of pain phenotype and 12-week follow-up described in Table 48, there was no statistically 
significant effect of treatment group allocation on TSK score at 12-week follow-up (p=0.34 for PW 
and p=0.47 for P).   
 
However, after controlling for variables in the model described in Table 48, TSK score at baseline 
(p<0.01), and number of physiotherapy visits (p=0.01) predicted TSK score at 12-week follow-up. 
A one-unit increment in baseline TSK scores being associated with a 0.8 unit increase in TSK score 
at 12-week follow-up. The effect of the number of physiotherapy visits on TSK score at the 12-week 
follow-up demonstrated there was a statistically significant association with the number of 
physiotherapy visits. One - two physiotherapy visits were associated with greater TSK scores. No 
other statistically significant predictors of TSK score at 12-week follow-up were found.  
 
Table 48: Linear mixed model 7 - fixed effects output exploring contributions of variables to TSK 
score at 12-week follow-up. 
Effect Estimates Confidence intervals df t p value 
Intercept 1.85 -7.23 to 10.94 129 0.4 0.69 
Treatment PW -2.86 -6.06 to 0.34 145 -1.75 0.08 
Treatment P 1.18 -2.09 to 4.47 145 0.71 0.47 
Treatment W. Reference group 0     
TSK Baseline 0.75 0.61 to 0.87 126 11.06 <0.01*** 
Neuropathic pain phenotype 1.56 -1.63 to 4.77 145 0.96 0.33 
Nociceptive pain phenotype. Reference 
group 
     
Physiotherapy visits 1-2 3.84 0.65 to -7.03 126 2.36 0.01* 
Physiotherapy visits 3-4 -0.74 -3.66 to 2.16 126 -0.5 0.61 




Effect Estimates Confidence intervals df t p value 
Physiotherapy visits 7-8 -0.52 -3.36 to 2.31 126 -0.36 0.71 
Physiotherapy visits 9-10. Reference 
group 
0     
Six-week follow-up 0.87 -1.04 to 2.79 111 0.89 0.37 
12-week follow-up. Reference group 0     
Age -0.00 -0.08 to 0.08 126 -0.06 0.94 
Gender female 1.05 -0.79 to 2.90 126 1.11 0.26 
Gender male. Reference group 0     
Unemployed -0.99 -4.21 to 2.23 126 -0.6 0.54 
Employed. Reference group 0     
Education: university/post grad. 1.71 -0.50 to 3.93 126 1.51 0.13 
Education: Diploma 0.42 -1.65 to 2.51 126 0.40 0.68 
Education: Completed school. 
Reference group 
0     
Smoker: no 1.72 -0.12 to 3.57 126 1.83 0.06 
Smoker: yes. Reference group 0     
BMI 0.07 -0.09 to 0.25 126 0.89 0.37 
Pain Duration -0.09 -0.21 to 0.01 126 -1.7 0.09 
Treatment PW x Neuropathic Pain 
phenotype 
1.06 -2.98 to 5.11 126 0.52 0.60 
Treatment PW x Nociceptive Pain 
phenotype. Reference group 
0     
Treatment P x Neuropathic Pain 
phenotype 
-0.10 -4.39 to 4.17 126 -0.05 0.96 
Treatment P x Nociceptive Pain 
phenotype. Reference group 
0     
Treatment W x Neuropathic Pain 
phenotype. Reference group 
0     
Treatment W x Nociceptive Pain 
phenotype. Reference group 
0     
Treatment PW x Six-week follow-up  0.79 -1.64 to 3.24 111 0.64 0.52 
Treatment PW x 12-week follow-up. 
Reference group 
0     
Treatment P x six-week follow-up -0.63 -3.13 to 1.85 111 -0.5 0.61 
Treatment P x 12-week follow-up. 
Reference group 
0     
Treatment W x Six-week follow-up. 
Reference group 
0     
Treatment W x 12-week follow-up. 
Reference group 




Effect Estimates Confidence intervals df t p value 
Neuropathic pain phenotype x Six-week 
follow-up  
0.43 -2.47 to 1.59 111 -0.42 0.67 
Neuropathic pain phenotype x 12-week 
follow-up. Reference group 
0     
Nociceptive pain phenotype x Six-week 
follow-up. Reference group 
0     
Nociceptive pain phenotype x 12-week 
follow-up. Reference group 
0     
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
Figure 15 demonstrates the changes in TSK score within treatment groups between baseline and 
follow-up at six-weeks and 12-weeks. The linear mixed model regression analyses showed there was 
no statistically significant effect of time (six-weeks and 12-weeks follow-up), treatment group 
allocation, or interaction between treatment group allocation and time. 
 
Figure 15: Comparison of TSK score within each treatment group over time.  
 
P, usual care treatment; W, pedometer-based walking intervention; 
PW, usual care treatment and pedometer-based walking intervention; 
Week 0, baseline; Week 6, six-week follow-up; Week 12, 12-week follow-up 
 
Pain catastrophizing 
The Pain Catastrophizing Scale (PCS) was used to measure pain catastrophizing related to CLBP. 
The mean score for pain catastrophizing on the PCS for the entire cohort at baseline was 18/52  
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(Table 37). This indicates low levels of pain catastrophizing in this cohort, with scores greater than 
30/52 indicating high levels of catastrophizing. 
 
An ANOVA was used to determine any changes in PCS score between treatment groups, between 
baseline and follow-up at 12-week follow-up. There was no statistically significant difference in PCS 
scores between baseline and 12-week follow-up between treatment groups at 12-week follow-up 
(2,104) = 0.32, p = 0.73). 
 
There was no association with baseline score of PCS and pain phenotype, therefore only one model 
was generated. Linear mixed model 8 was generated for a comparison of PCS score between the 
three treatment groups at 12-week follow-up. The analysis was used for determination of the effect 
of treatment group allocation, pain phenotype, baseline PCS score, number of physiotherapy visits, 
and selected independent variables (Table 41) on the PCS score at 12-week follow-up. Associated 
variables that are commonly associated with pain intensity were likewise included in the analysis of 
PCS at 12-week follow-up. These included: week (six-week follow-up and 12-week follow-up), age, 
gender, employment, education, smoking status, BMI, and pain duration. Pain intensity at 12-week 
follow-up was excluded from the analysis because it was associated with number of physiotherapy 
visits. These variables were taken as the fixed effects and the participants were taken as random 
effects. 
 
Linear mixed model 8: Looking for changes in PCS score controlling for all independent variables 
except pain intensity at 12-week follow-up. 
After controlling for variables including treatment group allocation, pain phenotype, number of 
physiotherapy visits, week (six-week follow-up, 12-week follow-up), age, gender, employment, 
education, smoking status, BMI, pain duration,  interaction of treatment group allocation and pain 
phenotype, interaction of treatment group allocation and week, and interaction of pain phenotype and 
week, PCS score at baseline was found to be a statistically significant predictor of PCS at 12-week 
follow-up (p<0.01) (Table 49). For every 1-unit increase in the PCS baseline score, the PCS score at 
12-week follow-up increased by 0.6 units. After controlling for treatment group allocation, PCS score 
at baseline, pain phenotype, week (six-week follow-up, 12-week follow-up), age, gender, 
employment, education, smoking status, BMI, pain duration, interaction of treatment group 
allocation and pain phenotype, interaction of treatment group allocation and week, and interaction of 
pain phenotype and week, the number of physiotherapy visits was found to be a predictor of PCS 
score at 12-week follow-up. Attending 1-2 physiotherapy visits was shown to be a predictor of a 





Table 49: Linear mixed model 8 - fixed effects output exploring contributions of variables to PCS 




df t p value 
Intercept -2.93 -14.03 to 8.15 131 -0.52 0.60 
Treatment PW -2.77 -7.37 to 1.82 142 -1.18 0.23 
Treatment P 0.90 -3.80 to 5.61 142 0.38 0.70 
Treatment W. Reference group 0     
Pain catastrophizing at baseline 0.59 0.47 to 0.71 128 9.94 <0.01*** 
Neuropathic pain phenotype 1.57 -3.10 to 6.25 141 0.66 0.50 
Nociceptive pain phenotype. Reference 
group 
0     
Number of physio visits 1-2 7.89 3.21 to 12.56 128 3.31 0.01** 
Number of physio visits 3-4 -0.40 -4.64 to 3.82 128 -0.19 0.85 
Number of physio visits 5-6 -0.85 -5.05 to 3.34 128 -0.4 0.69 
Number of physio visits 7-8 -0.35 -4.54 to 8.84 128 -0.16 0.86 
Number of physio visits 9-10. Reference 
group 
0  . . . 
Six-week follow-up 0.66 -1.40 to 2.73 113 0.63 0.52 
12-week follow-up. Reference group 0     
Age -0.00 -0.13 to 0.12 128 -0.1 0.91 
Gender female 1.99 -0.71 to 4.69 128 1.44 0.15 
Gender male. Reference group 0  . . . 
Unemployed -0.19 -4.98 to 4.59 128 -0.08 0.93 
Employed. Reference group 0  . . . 
Education: university/post grad. 3.20 -0.06 to 6.48 128 1.92 0.06 
Education: Diploma 1.72 -1.33 to 4.78 128 1.1 0.27 
Education: Completed school. Reference 
group 
0  . . . 
Smoker: no -0.03 -2.77 to 2.71 128 -0.02 0.98 
Smoker: yes. Reference group 0  . . . 
BMI 0.03 -0.21 to 0.28 128 0.28 0.78 
Pain Duration -0.06 -0.23 to 0.10 128 -0.74 0.45 
Treatment PW x Neuropathic Pain 
phenotype 
1.81 -4.16 to 7.78 128 0.59 0.55 
Treatment PW x Nociceptive Pain 
phenotype. Reference group 
0  . . . 
Treatment P x Neuropathic Pain 
phenotype 
-1.41 -7.70 to 4.86 128 -0.44 0.65 
Treatment P x Nociceptive Pain 
phenotype. Reference group 







df t p value 
Treatment W x Neuropathic Pain 
phenotype. Reference group 
0  . . . 
Treatment W x Nociceptive Pain 
phenotype. Reference group 
0  . . . 
Treatment PW x Six-week follow-up. 0.10 -2.55 to 2.75 113 0.07 0.94 
Treatment PW x 12-week follow-up. 
Reference group 
0     
Treatment P x Six-week follow-up. 0.26 -2.43 to 2.96 113 0.19 0.84 
Treatment P x 12-week follow-up. 
Reference group 
0     
Treatment W x Six-week follow-up. 
Reference group 
0     
Treatment W x 12-weeks. Reference 
group 
0     
Neuropathic pain phenotype x Six-week 
follow-up. 
-0.30 -2.51 to 1.89 113 -0.27 0.78 
Neuropathic pain phenotype x 12-week 
follow-up.. Reference group 
0     
Nociceptive pain phenotype x Six-week 
follow-up. Reference group 
0     
Nociceptive pain phenotype x 12-week 
follow-up. Reference group 
0     
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
Figure 16 demonstrates the changes in PCS score within treatment groups between baseline and 
follow-up at six-weeks and 12-weeks. The linear mixed model regression analyses showed there was 
no statistically significant effect of time (six-weeks and 12-weeks follow-up), treatment group 





Figure 16: Comparison of PCS score within each treatment group over time.  
 
P, usual care treatment; W, pedometer-based walking intervention; 
PW, usual care treatment and pedometer-based walking intervention; 
Week 0, baseline; Week 6, six-week follow-up; Week 12, 12-week follow-up 
 
4.6 Additional measures  
 
Expectation of pain intensity following treatment at 12-week follow-up and walking data are 
presented below. 
 
Participant expectation for pain intensity 
Data was not normally distributed therefore median scores were described.  There was no missing 
data in this section. The statement was anchored with 0= no pain and 100= worst imaginable. 
Baseline scores were 10/100 (Table 37).  
 
Spearman’s rank correlation was used to explore the relationship between expected pain intensity at 
baseline and change in pain intensity between baseline and 12-week follow-up in the entire cohort. 
There was a strong correlation with expected pain intensity and actual change in pain intensity at 12-
week follow-up (p=0.01). This suggests that those who expected lower pain intensity had lower pain 
intensity at the 12-week follow-up, compared to those who expected less improvement who had low 






Daily steps walked and distance covered was recorded across all three treatment groups, using a 
pedometer. Data was recorded in the provided participant study diary. In addition, participants in the 
W and PW treatment groups recorded number of steps taken, distance covered, and time taken to 
perform the walking intervention. 
 
There was missing walking data for one participant for weeks 1-6; (diaries not received). In this case 
no baseline observation carried forward (BOCF) substitution was possible. Walking data were 
presented as mean weekly steps for all treatment groups over the 12-week intervention. Steps referred 
to in the data were separated into walking intervention steps and mean daily steps. Week 0 = baseline 
and week 1 = data at the end of the first week. Since walking as a physical activity could be measured 
by steps and minutes spent doing the walking intervention, the W and PW treatment groups walking 
intervention data were presented together to eliminate any differences in pacing. The effect of 
treatment group, week in the study, and pain phenotype on total number of weekly steps taken was 
analysed using a linear mixed model.  
 
Total weekly steps 





Figure 17: Mean number of weekly steps at the end of each week, by treatment group 
 
Data presented as mean (Error bars denote SD). 
PW: Usual care and walking intervention 
W: Walking intervention only 
P: Usual care only  
 
Both W and PW treatment groups received the same, paced, and progressive walking intervention. 
The total weekly steps were greater in these two treatment groups versus the P group, who self-paced. 
The P group achieved fewer steps than the W and PW groups throughout the 12-weeks. 
 
Total weekly steps: Walking intervention 
The walking intervention was designed to increase time spent walking by 10% per week. These data 
represent walking intervention steps separate from total weekly steps. The mean number of walking 
intervention steps per week by treatment group is illustrated in Figure 18.  The trend shows a 





Figure 18: Mean number of steps per week in usual care and walking intervention treatment group 
and the walking intervention treatment group only.  
 
Data presented as mean (Error bars denote the SD). 
PW: Usual care and walking intervention 
W: Walking intervention only 
 
Total weekly time spent doing the walking intervention 
The mean walking intervention time in minutes, for each treatment group with a walking 
intervention is illustrated below (Figure 19). Both intervention groups using walking as exercise 






Figure 19: Mean number of minutes walked, by group allocation, per week.  
 
 
Data presented as mean (Error bars denote the SD). 
PW: Usual care and walking intervention 
W: Walking intervention only 
 
Comparison of walking data between treatment groups 
 
Total weekly steps by treatment group were recorded for 12 weeks. To interpret average steps per 






Table 50: Summary table demonstrating total number of weekly steps taken by treatment group.   
TREATMENT 
GROUP 















1 46 27 796 16 413 2 149 78 253 3970 
3993 
2 46 28 203 15 715 580 81 177 4029 
3 46 28 601 15 185 1 787 77 741 4085 
4 46 28 816 17 746 1 887 102 486 4116 
5 46 26 833 13 827 2 556 56 933 3833 
6 46 28 908 16 372 3 896 84 594 4129 
7 46 28 035 18 503 3 696 81 338 4005 
8 46 26 010 15 383 1 866 73 639 3715 
9 46 28 039 15 368 2 149 71 589 4005 
10 46 28 476 15 004 1 195 72 669 4068 
11 46 27 726 15 970 1 934 69 889 3960 
12 46 27 982 17 619 2 149 69 703 3997 
PW 
1 48 41 132 16 892 7 280 82 708 5876 
6258 
2 48 42 401 19 204 5 061 96 506 6057 
3 48 42 159 18 575 7 280 84 485 6022 
4 48 44 792 16 951 7 280 94 485 6398 
5 48 45 380 19 223 7 280 94 300 6482 
6 48 43 594 19 955 7 280 88 443 6227 
7 49 41 005 21 140 0 105 678 5857 
8 49 43 879 19 549 7 280 81 870 6268 
9 49 43 556 19 757 7 280 79 567 6555 
10 49 44 467 20 862 7 280 86 659 6352 
11 49 47 267 23 756 7 280 98 228 6752 
12 49 46 043 25 388 2 933 111 672 6577 
W 
1 52 38 796 20 431 1 459 112 921 5542 
5565 
2 52 36 957 17 637 1 459 79 136 5279 
3 52 36 939 20 546 1 459 104 706 5277 
4 52 38 467 18 388 1 459 74 821 5495 
5 52 39 582 18 762 1 459 83 168 5654 
6 52 38 839 18 095 1 459 78 358 5548 
7 52 40 679 18 656 1 459 83 542 5811 
8 52 39 586 20 273 1 459 88 074 5655 
9 52 40 483 21 069 1 459 83 150 5783 
10 52 38 011 20 276 1 459 89 611 5430 
11 52 37 972 21 622 1 459 90 465 5424 




A linear mixed model was generated to determine the effect of treatment group allocation, pain 
phenotype and time on total number of weekly steps (Table 51). 
 
Table 51: Linear mixed model 9 - fixed effects output exploring contributions of treatment group 
allocation, number of weeks in the study (1-12), and pain phenotype on total weekly steps. 
Effect Estimate Confidence intervals df t p value 
Intercept 46048 39570.16 to 52525.84 189 13.93 <.01 
Treatment PW 2644.17 -6892.41 to 12180.75 176 0.54 0.58 
Treatment P -12831 -22480.5 to -3181.51 176 -2.61 0.01** 
Treatment W. Reference group 0  
   
Week 1 -3652.52 -7393.04 to 88.00 1027 -1.91 0.06 
Week 2 -5475.48 -9216 to -1734.96 1028 -2.87 0.01** 
Week 3  -4935.47 -8675.89 to -1195.05 1028 -2.59 0.01** 
Week 4 -3758.13 -7499.67 to -16.588 1030 -1.97 0.05* 
Week 5 -2701.51 -6442.64 to 1039.62 1034 -1.42 0.15 
Week 6  -3131.84 -6870.21 to 606.52 1044 -1.64 0.10 
Week 7  -1662.87 -5398.69 to 2072.94 1070 -0.87 0.38 
Week 8 -2607.75 -6328.26 to 1112.76 1135 -1.37 0.16 
Week 9 -1352.93 -5031.69 to 2325.83 1288 -0.72 0.47 
Week 10 -4065.27 -7604.76 to -525.78 1529 -2.25 0.02* 
Week 11 -2751.71 -5870.15 to 366.72 1245 -1.73 0.08 
Week 12. Reference week 0  . . 
 
Neuropathic pain phenotype  -11858 -21446 to -2270.01 163 -2.42 0.02* 
Nociceptive pain phenotype. 
Reference group 
0  
   
p-value < 0.05: *; p-value < 0.01: **; p-value < 0.001: ***. 
 
The total number of weekly steps for the P group were significantly lower than that for the PW 
treatment group (p=0.01) (Table 51). Weeks two, three, four and ten in the study had a statistically 
significant effect on total weekly steps taken compared to the reference group, week 12 (p=0.01, 
p=0.01, p=0.05 and p=0.02 respectively). Given the wide confidence intervals, at every time point it 
is unclear whether or not the significant findings are spurious. The trend for walking to increase over 
the 12-week intervention period is demonstrated in figure 17. 
 
There was a statistically significant effect of pain phenotype on total weekly steps (p=0.02), such 
that participants with a nociceptive pain phenotype, accumulated a greater total number of weekly 
steps than did participants with a neuropathic pain phenotype (Table 51, Figure 20). No other 
variables in the model predicted total weekly steps walked.  
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At the time of writing, this was the first RCT where the aim was to compare the effect of a pedometer-
based walking intervention; usual care physiotherapy and a combination of both treatment groups on 
pain intensity and associated biopsychosocial outcome measures in participants with nociceptive and 
neuropathic chronic lower back pain (CLBP). 
 
The three treatment groups used in this RCT are independently recognized in previous studies 
included in reviews to improve mean pain and disability outcome scores using walking and 
physiotherapy treatments (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; 
Sitthipornvorakul et al 2018).  
 
The primary outcome was change in global pain intensity from baseline to 12-week follow-up as 
measured by participants on a NRS. Secondary outcomes were changes in disability, kinesiophobia 
and catastrophic thinking over the same time period measured using the ODI, TSK and PCS.  
  
The main finding of this RCT concluded that there were no statistically significant differences in 
pain intensity, disability, kinesiophobia and pain catastrophizing between baseline and 12-week 
follow-up between the three treatment groups. The findings in the present RCT concurred with those 
in previous trials treating CLBP where no statistically significant difference in pain intensity between 
groups was observed when comparing walking to exercise groups or walking to usual care (Eadie et 
al., 2013; Hurley et al., 2015). The research question therefore could not be answered with no 
statistically significant differences between treatment groups. However, a minimum clinical 
important difference in reduced pain intensity is observed in the PW treatment group at 12-week 
follow up.  
 
The findings in the current RCT showed significant improvements in pain intensity, disability, 
kinesiophobia and pain catastrophizing over time in all three treatment groups. It has been said that 
participation in a trial with intensive assessment and monitoring received from researchers can 
improve the course of symptoms (Artus et al., 2010). This could be related to placebo or regression 
to the mean. With multiple levels of influence, general improvement in CLBP may be related to 




Attending more than two physiotherapy visits across groups over the intervention period, 
demonstrated significantly improved pain, kinesiophobia and pain catastrophizing outcome measure 
scores between baseline and 12-week follow-up, regardless of group allocation. This dosage of 
treatment affecting outcomes has yet to be explored in the literature exploring walking and 
physiotherapy treatments for CLBP thus far. 
 
The three treatment groups used in this RCT have to date not yet been compared by recording PA by 
measuring weekly steps in every treatment group over the intervention period. Participants 
randomised to walking interventions (W and PW) increased their weekly steps from baseline when 
compared to the usual care physiotherapy treatment group whose weekly steps remained consistent. 
Regardless of PA changes due to treatment group allocation, treatment group allocation did not 
predict changes in outcomes. According to the advised walking used in the current trial, additional 
walking exercise when combined with usual care physiotherapy did demonstrate the greatest 
improvement in mean pain intensity score even though there was no statistically significant 
difference in pain intensity. This potentially indicates minimal clinical change in pain intensity when 
walking is combined with physiotherapy. 
 
There is a growing body of evidence highlighting pain heterogeneity (Chetty et al., 2012; Baron et 
al., 2016). The current trial did not examine pain phenotype between treatments however due to the 
focus being on the primary outcome of pain intensity, it was deemed salient that the modelling 
process involved phenotyping pain in the CLBP cohort. To date, when studying pain intensity, pain 
phenotypes of CLBP patients in physiotherapy cohorts have not been widely explored. In this RCT, 
each patient’s predominant phenotype was identified using the painDETECT questionnaire, their 
symptom burden determined and the association between pain phenotype and the outcome measures 
were studied by including pain phenotype in the modelling process. Due to the confounding factors 
of pain intensity with pain phenotype, and disability with pain phenotype, it is unclear whether pain 
intensity or pain phenotype, and disability or pain phenotype were predictive of pain intensity and 
disability at 12-week follow-up. This may explain limited attempts to study outcomes associated to 
pain phenotypes when examining CLBP treatments. In the entire cohort, participants with 
neuropathic pain phenotype took fewer steps over the course of the RCT compared to those with 
nociceptive pain phenotype. The current trial in South Africa concurred with international studies 
looking at pain phenotype demonstrating that the clinical burden (increased pain and disability), was 
greater in patients with a neuropathic phenotype compared to those experiencing nociceptive pain 
(Smart et al., 2012b; Baron et al., 2106; Spahr et al., 2017).  
 
Seen in reviews on walking and physiotherapy as a CLBP treatment, the pain findings of this RCT 
are comparable to studies where walking as an exercise was shown not to be statistically significantly 
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different to treatment using physiotherapy, pain education, or exercise groups in previous reviews 
(Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al., 2018). However, 
a clinical significance was observed in reduced pain intensity scores when combining walking and 
physiotherapy. A salient finding  demonstrates that the number of physiotherapy visits is an important 
clinical variable to consider in CLBP outcome measurement change.  
 
5.2 Assessment of trial strengths and limitations 
 
Strengths 
The interventions have each individually been compared to other interventions, but never to each 
other (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al., 2018). The 
literature up until now demonstrates each individual treatment groups application. The current RCT 
demonstrates the largest mean score changes in all outcome measures in the PW treatment group 
although no statistically significant differences between groups in changes in outcomes were 
observed. Due to the usual care physiotherapy component typically used, it is highly relevant in 
physiotherapy in South Africa and the UK (Naidoo et al., 2012; National Institute for Health and 
Care Excellence, 2016). The strength of this RCT is within the context of physiotherapy treatment 
decision in a specific organizational infrastructure. Depending on the patient’s needs, and what the 
physiotherapist can deliver, these three treatments demonstrate small improvements in all outcomes 
although physiotherapy combined with walking exercise shows the largest mean score improvements 
in all outcome measures. Patients and clinicians have an informed choice as to which treatment to 
offer due to the results from this RCT. 
 
This RCT demonstrated that the number of visits to the physiotherapist requires consideration to 
achieve significant change when treating CLBP outcome measures used in this RCT. The results 
indicate that three or more (up to ten) physiotherapy visits will change these outcomes when using 
either of these treatment groups. Physiotherapists and patients may now be aware that a minimum 
exposure may be necessary to achieve significant changes when treating CLBP over 12-weeks. 
 
There is a paucity of evidence examining pain catastrophizing when comparing walking to 
physiotherapy treatments. The current RCT demonstrates that reductions in pain catastrophizing 
were observed when using the three treatments in this RCT. Placebo or regression to the mean 
however can also explain the improved PCS score. 
 
Additionally, it is the first time that each intervention used in this RCT measured step counts in the 
same trial. The results show that usual care physiotherapy did not increase step count PA over twelve 
weeks, however the two other walking intervention treatment groups did. This objective comparison 
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together with the results showing no significant difference between treatment groups outcomes may 
influence physiotherapist decisions not to increase patient step counts per se, but to concentrate on 
education of CLBP and patient interaction. Notwithstanding, a clinically meaningful reduction in 
pain intensity was seen in the PW treatment group at the 12-week follow-up. The limited increase 
shown in PA in the PW treatment group has merit for exploring combining a partly supervised 
pedometer-based walking program to usual care physiotherapy when treating pain intensity. 
 
Results demonstrated that delayed progress is to be expected with patients with a neuropathic pain 
phenotype in all outcomes used. There is a lack of certainty as to which treatments to offer patients 
with CLBP having a neuropathic pain phenotype (Chetty et al., 2012; Naidoo et al., 2012; Clenzos, 
Naidoo and Parker, 2013; Baron et al., 2016). Because this trial was not powered for pain phenotypes, 
uncertainty remains for specific physiotherapy treatments benefitting pain phenotype.  
 
There is a paucity of studies of CLBP treatment executed in Africa (Louw, Morris and Grimmer-
Somers, 2007; Morris et al., 2018). Conducting the study in Africa demonstrates improved 
knowledge related to CLBP in an African context. 
 
The intervention period of 12-weeks in this RCT is a strength, since trials should be ideally 12-weeks 
long (Moore and Wiffen, 2013). This length was observed in one RCT comparing three treatment 
groups; walking as self-exercise, an exercise group using strength and flexibility, and a physiotherapy 
group (Torstensen et al., 1998). RCTs using walking to treat CLBP had different lengths of 
interventions including eight weeks (Eadie et al., 2013; McDonough et al., 2013; Hurley et al., 2015), 
six weeks (Shnayderman and Katz-Leurer, 2013) and four weeks (Karadeniz et al., 2014). Duration 
bias possibly overestimating the effectiveness of the intervention, may be seen in the trials with these 
interventions shorter than 12-weeks (Moore and Wiffen, 2013). Interventions showing improved 
outcomes all were relatively short (Eadie et al., 2013; McDonough et al., 2013; Shnayderman and 
Katz-Leurer, 2013; Karadeniz et al., 2014; Hurley et al., 2015). Results in two similar RCTs 
concurred with that of the current RCT (Eadie et al., 2013; McDonough et al., 2013). Showing no 
significant difference between treatment groups in the current RCT may suggest shortening 
interventions from 12 weeks to eight weeks.  
 
Furthermore, none of these mentioned trials demonstrated a MCID of >2/10 for improvements in 
pain intensity (Eadie et al., 2013; McDonough et al., 2013; Shnayderman and Katz-Leurer, 2013; 
Karadeniz et al., 2014; Hurley et al., 2015). There was a mean difference of -26.9 in a 0-100 NRS in 
the current trial PW treatment group. The confidence intervals of -35.9 to -17.9 demonstrate this was 
a plausible minimal clinical change. Three other previous trials showed improvements in mean pain 
intensity score >2/10. Interventions of lumbar traction and walking (Mirovsky et al., 2006), home 
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exercise combined with walking, compared to both physiotherapy, and home exercise (Koldaş Doğan 
et al 2008), walking exercise, education on CLBP, and strength exercise compared to motion control 
exercise combined with strength and stretching exercises (Magalhães et al., 2015) all showed 
improved mean pain intensity MCIDs >2/10 at follow-up. Follow-ups however were all less than six 
weeks. The MCID shown in the PW group in the current trial according to Moore and Wiffen (2013), 
did not include the duration bias. If the PW treatment group showed statistical and clinically 
significant differences, the intervention could wholly be considered effective.  
 
Limitations 
The efficacy of the treatment groups may only be truly explored if a true control (no intervention) 
was added to this RCT. No treatment group was used with absent treatment. 
 
Unlike other studies using walking and physiotherapy interventions, which examined the longer-term 
effects on pain outcomes and the sustainability of the effects, only a 12-week follow-up was 
completed in the current RCT. In RCTs using walking to treat CLBP, a 6-month follow-up point was 
used (McDonough et al., 2013; Eadie et al., 2013; Krein et al., 2013; Hurley et al., 2015). 
Furthermore, three RCTs used year follow-up (Torstensen et al., 1998; Krein et al., 2013; Hurley et 
al., 2015). A follow-up of the participants may also have allowed for observation of long-term effects 
on outcomes and any behaviour change regarding weekly step counts. With pain intensity as the 
primary outcome, the outcomes disability and fear avoidance behaviour followed-up at one year is 
beyond the scope of this discussion. At six months, two feasibility studies measured average pain on 
an NRS in all treatment groups (McDonough et al., 2013; Eadie et al., 2013). Average pain improved 
in all other interventions but did not reduce in only the walking intervention in Eadie et al., (2013). 
At six months two RCTS demonstrated NRS average pain scores had improved significantly, with 
no difference between pain scores between treatment groups in each RCT (Krein et al., 2013; Hurley 
et al., 2015). At one year there were significant improvements in pain scores with no differences 
between groups (Hurley et al., 2015). At one year, although both groups pain intensity continued to 
be lower than baseline, these differences were no longer significant (Krein et al., 2013). The 
Norwegian study at one year indicates that although pain in the lower back was not significantly 
different between groups, pain in physiotherapy and medical exercise was significantly lower than 
in the self-exercise walking group (Torstensen et al., 1998). Although not expressing pain phenotypes 
in this RCT, behaviour of referred pain typical of neuropathy appears to present differently to 
localized pain after one year (Torstensen et al., 1998). There appears to be a time effect on the 
interventions beyond 12-weeks, although the sustainability of the intervention effects on pain 




The American study which compared pedometer readings of two groups, one with an internet 
supported walking program with goals and the other without a walking program showed significant 
differences between groups at six months, but not so at one year follow-up (Krein et al., 2013). The 
group randomised to the walking program showed statistically significant more average daily steps 
between baseline and six months only (Krein et al., 2013). Furthermore, at six months pedometer 
data substantiated increased PA in the walking and education group versus the education alone group 
in McDonough et al., (2013). Behaviour in increased walking appears to affect these CLBP treatment 
groups up to six months (Krein et al., 2013; McDonough et al., 2013). The behaviour in increased 
walking in walking interventions used in the current trial cannot be commented on at six months. 
 
There is a recent move internationally to offering Pain Neuroscience Education (PNE) to patients 
with CLBP (Puentedura and Flynn, 2016; Hush et al., 2018). The reviews on using walking to treat 
CLBP involve education on CLBP in four RCTs (Eadie et al., 2013; McDonough et al., 2013; Hurley 
et al., 2015; Magalhães et al., 2015). Although education and support were provided in the current 
RCT, it was not standardized as is documented in “the Back Book” (McDonough et al., 2013; Eadie 
et al., 2013; Hurley et al., 2015; Magalhães et al., 2015). It was also standardized in the 5A’s 
methodology (McDonough et al., 2013). This RCT would have been more repeatable if a 
standardized education and support protocol were used when education on CLBP was provided to 
all participants.  
 
Unlike the current RCT, self-efficacy was measured in other walking interventions (Krein et al., 
2013; McDonough et al., 2013, and Hurley et al., 2015). To predict PA and coping strategies, self-
efficacy can be measured with several scales and is documented in a meta-analysis and review 
(Brady, 2011; Jackson et al., 2014). It would be of use to include self-efficacy or the Patterns of 
Activity Measure-Pain (Huijnen et al., 2011). The use of these measures may have explained pacing 
differences in the W and PW groups as the weekly step count in the current RCT did not increase 
weekly as may have been anticipated by the methodology set out for the walking intervention. 
 
A limitation in the recording of data using step counts is noted. Recording step counts prior to 
baseline, using a minimum of three days per week rather than one day per week of step counts to 
calculate weekly averages, and presenting data as steps per day rather than weekly were limitations 
in the current trial. Recording weekly step counts in all three groups prior to receiving any 
interventions in the current RCT would have been preferable in order to objectively include those 
insufficiently active.  On the assumption that all three treatment groups began with a similar weekly 
step count due to the subjective inclusion criteria of being insufficiently active, after one week of 
advised pedometer walking, the W and PW group exceeded the step count of the P group. A solution 
to this would be to recruit and complete baseline measures, and only introduce a walking intervention 
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a week later. For the week prior to introducing the walking interventions, the weekly step count could 
have been recorded. One RCT was more specific and successful in recording activity and step data 
(McDonough et al., 2013). The same RCT was more specific in calculating pedometer data and 
change in steps per day from baseline as well as adherence to the walking program. The researchers 
cross checked their step count data to exclude long periods of time where steps were not recorded 
(McDonough et al., 2013). Furthermore, the RCT recorded baseline step data prior to beginning the 
walking program objectively to ensure insufficiently active behaviour of included participants 
(McDonough et al., 2013). Concurring with the Irish study, further thought needs to be given in 
measuring PA. In the current RCT, daily steps which were not entered were removed from the weekly 
calculation. For example, if seven days steps were completed the weekly amount would be divided 
by seven. If only two days steps were recorded, the amount would be divided by two. The current 
RCT design did not account for steps taken on days which were not recorded in participant diaries 
and therefore daily step variability may require further exploration. Accordingly, minimum valid 
step recorded should be three days per week (Tudor-Locke et al., 2011). The current trial minimum 
was one day per week. The aim of this trial however was not an association of outcomes to steps per 
week or day, but to intervention treatment groups. At the time of design, the current RCT priority 
was to compare objective steps per week and not use steps per day for analysis as the comparison 
between treatment groups in analysis was through weekly steps and not daily steps. 
 
This RCT did not record all adverse events related or unrelated to the walking program as was done 
in other RCTs (McDonough et al., 2013; Hurley et al., 2015; Krein et al., 2013). Only some 
participants who discontinued interventions reasons were recorded at baseline (P n=6, PW n=3, W 
n=13). Those lost to follow-up did not provide reasons (P n=7, PW n=4, W n=7). In total, 27% of 
participants had dropped out by 12-week follow-up and appears to be in the range of related trials 
using walking and physiotherapy to treat CLBP patients. Adverse effects were seen in 35% of 
participants in McDonough et al., (2013), 27% in Krein et al., (2013) and 19% in Hurley et al., 
(2015). Adverse events in these trials included colds and flu, road traffic collisions, ankle sprains, 
increased LBP, allergic reaction to the metal pedometer, callouses and chest pain. Despite 35% of 
participants having adverse events in one RCT, only one related adverse event led to the patient 
stopping the walking program (McDonough et al., 2013). Additionally, in the current RCT, 
participants were not encouraged to record as to why they were not able to maintain incremental time 
to walk in the W and PW groups. If this data had been captured and analysed in the current RCT, 
potential obstacles to using the interventions, improved goal setting and improved pacing for a 
walking intervention may have been demonstrated.  
 
Different content, context and organizational infrastructure of health care systems is salient when 
comparing implementation of treatments. This study was done in private practice in South Africa 
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using a UK NHS NICE model for treatment. However, a study not using walking as a treatment, 
comparing LBP physiotherapy treatment in public and private practice physiotherapy showed similar 
outcomes at follow-up (Casserley-Feeney et al., 2012). Furthermore, comparing data from different 
countries can be problematic with different social structures. Factors including country, and private 
versus public organisational infrastructure vary in the studies used in comparison in this RCT. This 
does not reflect the heterogeneity of populations suffering with CLBP within different countries and 
health systems. 
 
No full pilot study was conducted. The feasibility study in the current RCT lacked a template for data 
entry, therefore no analysis could be done at early stages. The necessary components for data entry 
and analysis were only executed with the main RCT. This led to a lengthy period of data collection 
and analysis. 
 
This was the first trial using walking and physiotherapy to treat CLBP using pain phenotyping in the 
modelling process. The cut-off points in the painDETECT for neuropathic pain used previously, have 
been scores of 19-38 (Spahr et al., 2017). In the current RCT scores 13-38 were used as cut-off points 
for neuropathic pain (values 13-17 were defined in the tool as ambiguous, “likely having a 
neuropathic component”). The current RCT therefore included the ambiguous range as part of the 
neuropathic pain phenotype. This would mean that some participants were included in the 
neuropathic pain phenotype that may have had a greater proportion of a nociceptive pain phenotype. 
As agreed in a review on neuropathic LBP in clinical practice, a more rigorous approach would be 
to combine the screening tool with a focused clinical examination (Baron et al., 2016).  One could 
include scores 19-38 on painDETECT to only categorize those likely having a neuropathic 
component. The trial was also not powered for differences between pain phenotypes within treatment 
groups. Clinical use could be made if analysis could indicate differences between treatment groups 
applied to specific pain phenotypes. 
 
5.3 Comparison of the findings to other studies 
 
Baseline findings described similarities and differences in this cohort to existing CLBP literature. 
This cohort presented with higher levels of education and greater employment levels, unlike previous 
epidemiological studies on CLBP (Rubin et al., 2007; Schwellnus et al., 2011). Most of the cohort 
were high school educated, with 31% having a diploma and 29% a university degree; and 92% were 
employed. This difference in demographics might have influenced participants in this study to choose 
private physiotherapy practices, which attracts patients with more disposable income and higher 
levels of education, as evidenced in an African study comparing private and public medical practice 
patient demographics (Matchaya and Muula, 2009). Little is known about these differences in South 
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African physiotherapy practices, although the South African Society of Physiotherapy is underway 
in developing data strategies to improve comprehensive service for all communities (Fourie, 2019). 
Observed in this RCT, more women experience CLBP, and participants have increased BMIs. This 
too was observed in epidemiological studies of CLBP (Rubin et al., 2007; Schwellnus et al., 2011). 
It was possible to distinguish pain phenotypes at baseline in the cohort. 
 
Primary outcome measure: pain intensity 
Unlike the current RCT, patients’ pain intensity had not been previously phenotyped in other trials 
used in reviews comparing walking to other physiotherapy interventions (Hendrick et al., 2010; 
Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al 2018). Before exploring the effects of 
independent variables included in the RCT, pain intensity at baseline was found to be a confounding 
variable with pain phenotype. In order to examine the contributing effect of both of these variables 
on pain intensity at 12-week follow-up, models were constructed either controlling for pain intensity 
at baseline and excluding pain phenotype or controlling for pain phenotype and excluding pain 
intensity at baseline.  In addition to this association at baseline, the models found neuropathic pain 
phenotype to be a predictor of greater pain intensity at 12-week follow-up too. Unlike patient 
assessments observed in the physiotherapy and walking literature over a decade ago, this more 
specific evaluation of the patient concurs with the move in 2016 NHS NICE guidelines to further 
stratify patients with CLBP and underlying neurophysiological phenotypes. Recognizing these 
phenotypes may elucidate neurophysiological differences within cohorts. 
 
The fundamental finding in the current RCT was that the NRS for pain intensity was not predicted 
due to treatment group, with no statistically significant between group differences. The findings in 
the present RCT concurred with those in previous trials treating CLBP where no statistically 
significant difference in pain intensity between groups was observed when comparing walking to 
exercise groups or walking to usual care (Eadie et al., 2013; Hurley et al., 2015). In this RCT, pain 
intensity improved significantly from baseline to 12-week follow-up, within all three treatment 
groups. Thus, pain intensity improved regardless of treatment group. The research question could 
not be answered with no statistically significant differences between treatment groups. A meta-
analysis of 70 RCTs (included 57% CLBP participants) and 19 cohort studies (included 11% CLBP 
participants), found that the clinical course of LBP symptoms including pain intensity improved 
regardless of the treatment (Artus et al., 2010). Similarly, the result of no statistically significant 
between group differences was seen in two RCTs comparing walking interventions to usual care 
physiotherapy and supervised exercise classes in CLBP patients, where all three treatment groups 




However, when treating patients with pain intensity as an outcome a minimally clinically important 
difference is considered salient in judging the clinical application of a therapeutic regimen (Page 
2014). Concurring views show that a 2.0 reduction on 0-10 NRS is recognized as a minimal clinically 
important difference (MCID) on the NRS (Farrar et al., 2000; Farrar et al., 2001; Haefeli and 
Elfering, 2006; Suzuki et al., 2020). In the current RCT when examining mean change from baseline 
to follow-up points in pain intensity scores, the greatest mean score change between three treatment 
groups is in the partly supervised pedometer walking program combined with usual care 
physiotherapy (-26.9/100) despite no statistical significance between groups. The confidence 
intervals of -35.9 to -17.9 indicate that there is a plausible minimal clinical change. When observing 
the mean change from baseline scores for pain intensity and between-group effect sizes, the effect 
size was moderate. The only other trial using the combination of usual care physiotherapy and 
walking exercise, comparing usual care physiotherapy and an over ground walking intervention, with 
physiotherapy and a treadmill walking intervention, demonstrated statistically significant 
improvements in pain intensity scores in both treatment groups (Karadeniz et al., 2014). Although 
these treatments were similar to the PW treatment group in the current RCT, no mean change in pain 
intensity scores were provided so understanding if a MCID was achieved is unknown.  
 
Three trials in Table 19 comparing walking to physiotherapy modalities used on patients with CLBP 
demonstrate a potential MCID in pain intensity (Mirovsky et al., 2006; Koldaş Doğan et al 2008; 
Magalhães et al., 2015). Follow-ups in these three studies were at six weeks or less. The remaining 
trials in Table 19 with follow-ups eight weeks or longer reported smaller improvements in pain 
intensity. The results in the current RCT and a follow-up at 12-weeks support further investigation 
into the clinical application of a partly supervised pedometer-based walking program added to usual 
care physiotherapy.  
 
Number of physiotherapy visits 
The number of physiotherapy visits predicted reduced pain intensity at 12-week follow-up in all 
treatment groups. There is limited evidence around the number of physiotherapy visits affecting 
outcomes. There is a wide range of number and types of physiotherapy interactions in other studies. 
In the reviews using walking to treat CLBP, the heterogeneity in number of visits or supervision was 
not measured as an independent variable (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; 
Sitthipornvorakul et al 2018). The current RCT demonstrated that three or more treatments show 
significant reductions in pain. Differences in the way physiotherapy visits or interactions are 
provided in previous studies have been observed. Physiotherapy visits include telephone, internet, 
and face to face consultation. The common factors which appear in visits are the provision through 




In this RCT the number of physiotherapy visits within each of the three treatment groups varied. This 
was due to combined patient and physiotherapist choice and was similar to that found in other studies 
(Eadie et al., 2013; Hurley et al., 2015). The ideal number of physiotherapy visits for CLBP has not 
been extensively studied and visit numbers vary considerably in the literature. The current RCT is 
the first which included the number of physiotherapy visits as an independent variable in the models 
used to determine pain intensity, when compared to the studies in systematic reviews on walking 
interventions for CLBP (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul 
et al 2018).  
 
There is however an array of information on the variety of numbers of physiotherapy visits for LBP 
studies which includes both acute and CLBP. Physiotherapy visit data is scarce and due to differences 
in parametric and non-parametric data, findings up to now are expressed with both mean and median 
values. A retrospective study of 64 CLBP patients with symptomatic grade I spondylolisthesis 
evaluated the optimal number of physiotherapy visits needed to improve pain outcomes (Ferrari et 
al., 2018). Patients were divided into two groups; those who had a mean number of five - eight 
physiotherapy visits, and those who had nine - 12 visits. Both groups received similar stabilising 
exercises, massage, and pain education in a six - 16-week intervention. Both groups had similar NRS 
outcomes, indicating superior efficiency when using five – eight physiotherapy visits when treating 
spondylolisthesis CLBP pain intensity. In a nationwide survey of LBP treatments conducted in 
outpatient practices in the USA, a mean number of 11 physiotherapy visits over five weeks was 
observed (Jette et al., 1994). A median number of five visits (range 0-20 visits) over a median number 
of four weeks (range 1-19 weeks) were observed in a Northern Ireland CLBP study (Gracey et al., 
2002). Two studies in the Netherlands showed varied mean number of treatments, with van Baar et 
al., (1998) demonstrating seven treatments (range 6-15 weeks), compared with mean (S.D) 9.9 (6.6) 
treatments in 1733 NSLBP patients (Swinkels et al., 2005). The treatment visits ranges varied 
extensively (minimum 1; maximum 67) (Swinkels et al., 2005). In a survey of 846 Canadian 
physiotherapists, the majority of patients with LBP, mostly in private practice, would visit the 
physiotherapist between two to three times per week for one to three months (Orozco et al., 2017). 
Despite use of mean and median data, the range of physiotherapy visits used clinically is large. 
Despite the large range, the current RCT suggests a minimum number of visits necessary though for 
a statistically significant change in pain intensity. 
 
Varied lengths of treatment in a chronic condition like CLBP may be the reason for the paucity of 
evidence on an optimal number of physiotherapy visits for CLBP. In studies where walking has been 
used as an intervention for CLBP, a variety of number of physiotherapy visits are demonstrated 
between studies with almost all interventions showing reductions in pain intensity. For example, 
comparing supervised exercise, usual care physiotherapy and a self-paced walking intervention, all 
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participants barring those in the walking intervention (who received phone calls every second week), 
received 36 face to face physiotherapy treatments (three per week for one hour over 12 weeks) 
(Torstensen et al., 1998). Traction with a walking program was compared to traction alone, where 
each patient received 20 face to face physiotherapy visits over 28 days (Mirovsky et al., 2006). Two 
RCT’s using walking interventions to treat pain compared to an eight-week supervised exercise and 
usual care physiotherapy found a reduction in pain between baseline and follow-up and included a 
mean of 3.5 face to face usual care physiotherapy visits (Eadie et al., 2013; Hurley et al., 2015). 
Exercise classes which had a face-to-face interaction, ranged from four (Hurley et al., 2015), and 4.7 
(Eadie et al., 2013) to 36 visits in Torstensen et al., (1998), to achieve reduced pain intensity. 
Telephone contacts used in walking interventions ranged from six (Torstensen et al., 1998; Eadie et 
al., 2013; Hurley et al., 2015) to eight (McDonough et al., 2013). Although, it appears that RCTs 
with fewer than 36 visits in less than 12 weeks demonstrated reduced pain intensity in those with 
CLBP (Eadie et al., 2013; McDonough et al., 2013; Hurley et al., 2015). None of these studies used 
number of visits as an independent variable. The current RCT allows for deeper understanding of the 
dosage per treatment group required for improved outcomes. 
 
Related to the number of physiotherapy visits is the teaching of exercise. Exercises are considered 
best practice for CLBP (Chou et al., 2007; Chou, 2010; Gordon and Bloxham, 2016). These exercises 
can vary in duration, frequency and intensity upon the patient’s interpretation once done outside of 
the clinical setting. The current RCT methodology used exercise as a taught modality in all three 
treatment groups. In a prospective, observational cohort study of 54 outpatient physiotherapy 
practices in Israel, a higher compliance to active home exercise was associated with better outcomes 
(Deutscher et al., 2009). Furthermore, concurring evidence states therapeutic alliance may improve 
patient compliance in home exercises (Deutscher et al., 2009; Hall et al., 2013). Both compliance 
rate of attending scheduled visits and doing home exercises is lower in lumbar spine problems than 
in shoulder and knee problems (Deutscher et al., 2009). The authors did not investigate the exercise 
improving with compliance but suggested that the relationship of the physiotherapist to the patient 
involved selling or convincing the patient of the importance of physiotherapy and home exercises 
(Deutscher et al., 2009). A similar finding was seen in a meta-analysis of forty RCT’s on CLBP 
exercises where reductions in CLBP pain intensity were observed with treatment when compared to 
minimal or no treatment (Ferreira et al., 2010). Of 40 RCT’s, only three included unsupervised 
exercise treatment. The number of exercise sessions was significantly associated with the effect of 
exercise on pain intensity (p=0.028). The study suggested that with each extra exercise session, the 
effect size would increase by 0.13 on a 100 - point continuous scale measuring pain intensity (95% 
CI=0.02 to 0.24). Although significantly associated with outcome, the number of sessions only has 
a small impact on exercise treatment effect since 8 additional exercise sessions would have to be 
added to provide an extra 1 - point difference on a 100 - point NRS difference between an exercise 
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intervention and control. The total number of exercise hours was not significantly associated (p=0.25) 
with exercise effect size (Ferreira et al., 2010). This supported the argument for the influence of 
supervisory relationship influencing pain intensity and not the length of time spent together. Despite 
the small effect on pain, there appears to be a link between the number of supervisory exercise 
sessions and reduced pain intensity in CLBP. With all three treatment groups in the current RCT 
receiving face to face supervision and a form of exercise to be done in treatment and at home, the 
association with supervision and exercise may explain reduced pain intensities in all three groups. 
 
A systematic review demonstrated that the alliance between therapist and patient appears to have a 
positive effect on outcomes associated with CLBP (Hall et al., 2013). Although, this alliance was not 
defined explicitly. The current RCT demonstrates a significant association between number of 
physiotherapy visits and treatment group (p<0.01). Those in the W treatment group had fewer 
physiotherapy visits than those in the P and PW treatment groups. Despite this, participants in the W 
treatment group showed small yet improved mean pain intensity score at 12-week follow-up. 
Therefore, although not receiving a hands-on approach of massage and manipulation combined with 
exercise, the presence of the physiotherapist to supervise a walking intervention may reduce pain 
intensity, although differences in pain intensity may not be clinically meaningful in the W treatment 
group. The physiotherapy visits supervision in all three treatment groups had common factors of 
supervising exercise (either walking or isometric lumbar stabilization), pain education and advice to 
stay active. These factors may contribute to the therapeutic alliance and the influence on pain 
intensity reduction.  
 
The number of physio visits within studies may be determined by factors including, financial 
resources, practice settings and responses to treatment (Gracey et al., 2002). As indicated by the 
NICE clinical guidelines, No.88, for Low Back Pain, the guidelines advocate eight sessions when 
offering a structured exercise program, nine treatments when applying manual therapy, or ten 
sessions of acupuncture over a 12-week period for non-specific CLBP (National Collaborating 
Centre for Primary care [UK], 2009). Methodology in the current RCT was in line with UK NICE 
guidelines recommending between 8-10 physiotherapy visits (National Collaborating Centre for 
Primary Care [UK], 2009). Patients with CLBP within LBP cohorts were treated more frequently 
than acute LBP (Swinkels et al., 2005; Groenendijk et al., 2007). Sub-acute and CLBP received 2.3 
more visits than acute LBP (Swinkels et al., 2005). Similarly, Groenendijk et al., (2007) found a 
significant increase in the number of CLBP treatments between 1989/91- 2002/3 when acute LBP 
treatment number had decreased. This is of interest since RCTs using walking interventions to treat 
CLBP demonstrate that reducing the number of hands-on treatments may be optional as a treatment 
(Torstensen et al., 1998; Mirovsky et al., 2006; Eadie et al., 2013; McDonough et al., 2013; Hurley 
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et al., 2015). Minimum clinically important differences and effect sizes should however be 
considered when offering walking exercise as a treatment alone. 
 
The number of physiotherapy visits is influenced by a number of organisational infrastructure factors 
too. A multilevel analysis involving 1733 patients at 41 practices treated by 97 physiotherapists in 
the Netherlands explained variation in visits was determined by patient, practice, or physiotherapist. 
The Netherlands study showed that the number of physiotherapy visits depends mainly on patient 
characteristics (p<0.001) (Swinkels et al., 2005). Patients having more physiotherapy visits were 
older, female, having chronic complaints, having had previous therapy, referred by a specialist 
(Swinkels et al., 2005). Similarly, participants seen in the current RCT, suffering with CLBP were 
mostly female, with the entire cohort with a mean age of 46 years. In the current RCT, the number 
of visits was not compared to these patient level characteristics. With these demographics represented 
in the RCT, it may have attracted the attention of these patients as the methodology supported three 
to nine treatments.  
 
Physiotherapist characteristics are known to influence number of physiotherapy visits (Swinkels et 
al., 2005). Although most of the variance was in patients, therapists with additional training in LBP 
treated their patients 1.5 sessions fewer times than patients treated by other physiotherapists 
(Swinkels et al., 2005). Physiotherapists that were female, or older (>45 years) or working less than 
20 hours a week, treated patients fewer times (Swinkels et al., 2005). Physiotherapists that were male, 
worked more than 40 hours a week, or younger than 45 years of age treated patients more frequently 
(Swinkels et al., 2005). In the current RCT participants were seen by a balance of male and female 
physiotherapists, although experience treating LBP was not quantified. The RCT methodology 
sufficiently prepared all the qualified physiotherapists to deliver similar evidence-based care. 
Physiotherapist level factors appear highlighted with the current evidence that the number of 
physiotherapy visits is associated with pain outcomes. Factors that influence the number of 
physiotherapy visits have not been explored in the reviews using walking to treat CLBP (Lawford, 
Walters and Ferrar, 2015; Sitthipornvorakul et al 2018).  
 
Physiotherapists in the UK and the Netherlands have noticed changes in the number of physiotherapy 
visits by patients. A cross-sectional voluntary electronic survey was conducted and 223 
musculoskeletal physiotherapists in the UK were asked to gauge the relevance and practicality of 
NICE guidelines for LBP (Parr and May 2014). NHS physiotherapists commented that the numbers 
of visits recommended in the guidelines were not realistic and that limitations were placed on them, 
limiting patient’s follow-up appointments due to financial constraints represented in current 
economic policies. Private practitioners in the same paper suggested that medical insurance 
companies were restricting the number of physiotherapy visits making therapeutic benefit impractical 
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(Parr and May, 2014). This decrease in visits is echoed in a study of 3148 patients treated for LBP 
by physiotherapists in the Netherlands aimed to see if there was a change in knowledge and health 
policy from the period 1989-1992 to 2002-2003 (Groenendijk et al., 2007). This decrease was in 
acute LBP and not CLBP treatment though. The results show quality management by professional 
bodies and volume policy by government and insurance companies have decreased the number of 
visits and increased use of evidence-based interventions for acute LBP. The former period had an 
average number of 11.3 (S.D. 1.4) visits. A significant decrease of 1.1 visits per treatment episode 
of each patient was measured in the later period (p<0.001). Subgroup analysis showed that this 
decrease was only in public health insured patients and not private health insurance. It appears that 
quality management and volume policy in improving treatment efficacy by the Netherlands 
government and the use of evidence-based interventions have been the driving forces for this change. 
With the absence of NICE guidelines for the management of CLBP in South Africa, the methodology 
used in this RCT was implemented to carry out a level of evidence-based care regarding number of 
visits. In typical South African physiotherapy private practice, patients can receive as many visits as 
they can afford in their own capacity, as well as the amount individual’s medical insurance may 
cover. This was not the focus of this RCT. 
 
Even though face to face physiotherapy visits were utilized for all three treatment groups in this RCT, 
it is notable to mention the varied types of visits or physiotherapist interactions physiotherapists had 
with patients in other studies. In other similar studies on CLBP, physiotherapy visits are typically 
conducted in person, and are referred to as visits, treatments, or sessions (Hendrick et al., 2010; 
Lawford, Walters and Ferrar, 2015). Four primary studies in these two systematic reviews used 
telephone calls for physiotherapists to engage with participants and were referred to as contacts 
(Torstensen, 1998; McDonough et al., 2013; Eadie et al., 2013; Hurley et al., 2015). Where walking 
as a sole intervention has been used to treat CLBP, methodology of physiotherapy visits or participant 
supervision was observed in varied guises; either as, face to face supervision (Shnayderman and 
Katz, 2013), telephone contacts (Torstensen et al., 1998; McDonough et al., 2013; Eadie et al., 2013; 
Hurley et al., 2015) or logging onto the internet in an internet-based treatment (Krein et al., 2013). 
The effect of different interactions with patients may be unknown and the advantage of the current 
RCT was that patient interaction was consistent using face to face supervision in all three treatment 
groups. This was not consistent in related literature (Torstensen, 1998; McDonough et al., 2013; 
Eadie et al., 2013; Hurley et al., 2015). 
 
Related to the number of visits may be a placebo response. Information indicates that increased visits 
to health care practitioners improves results (Ilnyckyj et al., 1997; Deutscher et al., 2009). Contrary 
to this, a meta-analysis of placebo response in irritable bowel syndrome trials showed lower placebo 
response with increased visits (Patel et al., 2005). The same meta-analysis did suggest that this lower 
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placebo response may have been due to three factors. Factors included; investigator interaction 
opposed to clinician interaction; increased clinician visits may introduce inadequate blinding and 
may lead patients to suspect they were receiving placebo causing drop out, and dissatisfaction when 
insufficient pain relief was obtained (hence the addition of extra visits) (Patel et al., 2005). Previously 
shown, a strong doctor-patient relationship improves clinical outcomes (Patel et al., 2005; Tavel, 
2014). Highlighted were warmth and empathy, both contributors to placebo (Patel et al., 2005; Tavel, 
2014). These were not measured in the current RCT, nor in studies using walking and physiotherapy 
to treat CLBP (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al 
2018). However, these factors, for example, may have contributed to participating physiotherapists 
being hired to work in private practice. 
 
Understanding concepts within pain neuroscience may be a salient point when examining pain 
intensity as an outcome. Two reviews focussed on the neurocognitive aspects of pain perception 
using placebo induced analgesia as an example, and mention that mechanisms of expectation, 
attention, and reappraisal in pain cognitive modulation (Wiech et al., 2008; Bystad et al., 2015). 
Neurocognitive pain modulation refers to modulation of pain through several brain areas, neural 
pathways, and brain cortical networks. It seems likely that neurocognitive pain modulation may be 
an important component in pain intensity reduction in this RCT as well as, however unmentioned, in 
reviews where walking and physiotherapy was used to treat CLBP pain intensity (Hendrick et al., 
2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al., 2018). Recent advances in 
neuroscience show neurocognitive pain modulation evidence using fMRI and describe it as the 
dynamic pain connectome (Kucyi and Davis et al., 2015). The evidence describes interactions of 
three key brain systems involved in spontaneous attentional fluctuations toward and away from pain: 
the salience network, the default mode network, and the antinociceptive system. The clinical 
interpretation may be that there are potentially people who are more prone to attention to pain, and 
those who are not (Wiech et al., 2010; Kucyi and Davis et al., 2015). The paper demonstrates the 
effect of attention modulation away from the pain. This RCT’s treatment groups may have shown 
improved outcomes due to attention to non-painful stimulation or distraction which is known 
experimentally to decrease pain intensity and attenuate nociceptive brain neuronal responses 
(Eccleston and Crombez, 1999; Hayes et al., 1999; Iwata et al., 2005; Morrison et al., 2013). 
Mindfulness meditation training, meditation, and cognitive-behavioural therapy are said to engage 
the mind in mind wandering away from the pain in a non-effortful manner (Kucyi and Davis et al., 
2015). Similarly, the treatments used in this study with individual components and/or the common 
components of pain education and exercise (walking, isometric lumbar stabilization, or a 




A review on placebo described supportive patient-practitioner components of the placebo effect and 
that the effect is enlarged by hands-on contact with close verbal communication between therapist 
and patient (Tavel, 2014). This was the design of two of the groups (P and PW) in this RCT. The W 
group in the current RCT also showed small mean reductions in pain, implicating the hypothesis that 
close verbal communication may be influential in pain reduction. However, the results of the current 
RCT showing a MCID in pain reduction at 12-weeks in only the PW group concurs with the evidence 
that the placebo effect is enlarged by hands-on contact with close verbal communication between 
therapist and patient. An earlier review expands on related objective measurement of fMRI studies 
in pain analgesia exploring the association of therapeutic relationships and reduced pain outcomes 
(Benedetti et al., 2005). This is furthermore corroborated in a RCT of 262 patients with irritable 
bowel syndrome (Kaptchuck et al., 2008). A waiting list, (observation), was compared to placebo 
acupuncture alone, and placebo acupuncture with patient practitioner relationship augmented by 
warmth, attention, and confidence. The key finding was that placebo plus empathy/warmth was more 
effective than placebo alone. Findings included global improvement, relief of symptoms, improved 
symptom severity and improved quality of life. Demonstrated components (assessment and 
observation, a therapeutic ritual, and a supportive patient-practitioner relationship) could be 
progressively combined resembling a graded dose escalation of component parts with the patient 
practitioner relationship having the greatest effect (Kaptchuck et al., 2008). The relationship was 
specified as comprising of individual factors of warmth, duration of interaction, empathy, and 
communication of a positive expectation (Kaptchuck et al., 2008). A systematic review listed 67 
communication factors correlating with the therapeutic alliance, and implicated patient centred 
communication to be the focus to strengthen this alliance (Pinto et al., 2012). The concepts of 
placebo, therapeutic alliance, warmth, and empathy appear to be associated with reducing pain 
symptoms and may be important considerations when treating pain. This was not discussed in the 
reviews using walking and physiotherapy to treat CLBP (Hendrick et al., 2010; Lawford, Walters 
and Ferrar, 2015; Sitthipornvorakul et al 2018). 
 
It is unknown if the significant association with pain intensity outcome at 12-week follow-up would 
continue with more physiotherapy visits. Unlike the current RCT, a study conducted in Israel found 
a high number of visits for LBP were associated with poorer outcomes including pain intensity 
(Deutscher et al., 2009). The current RCT was conducted in a private practice setting unlike the 
public health care system in Deutscher et al., (2009). In context of the Maccabi public health care 
system in Israel, therapist reimbursement is not dependant on the number of visits (Deutscher et al., 
2009). Their data suggests that when the patient improves, the treatment number is shortened and 
when patients do not show improvements, the therapists add visits hoping it will improve outcomes. 
The number of physiotherapy visits highlights the context, content, and organizational infrastructure 
of health.   
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Factors involved in treatment 
Treatment in this RCT were based on standardized modalities recommended as part of UK NICE 
guidelines for usual care physiotherapy (National Collaborating Centre for Primary Care [UK], 
2009). Guidelines proposed by the ACSM were used for the walking intervention. Results in this 
RCT corroborated findings in previous walking intervention RCTs with no statistically significant 
difference in pain outcome measures between treatment groups (Eadie et al., 2013; Hurley et al., 
2015). These previous studies using treatments sanctioned by NICE and ACSM, together with the 
current RCT showed reduced pain intensity in all three treatment groups. Aside from the placebo 
effect or regression to the mean, several factors are worth mentioning regarding treatments in 
physiotherapy and walking trials. 
 
Varied modalities can be applied by physiotherapists, and all may have an effect on pain. The 
combination of physiotherapy treatments and modalities for treating CLBP vary due to 
physiotherapist’s discretion as seen in previous trials (Torstensen et al., 1998; Eadie et al., 2013; 
Hurley et al., 2015). However, three core modalities of manipulation, massage and lumbar 
stabilization exercise utilized in unknown amounts are described in the literature as part of usual care 
physiotherapy (Torstensen et al., 1998; Eadie et al., 2013; Hurley et al., 2015). The current RCT 
delivered these modalities as physiotherapy usual care with no discretion on type, and amount of 
modality used but delivered in a standard manner. Regardless of which discretionary combination of 
modalities were used in usual care physiotherapy groups (ice, heat, massage, manipulation, 
electrotherapy, exercise), pain intensity was also reduced in previous usual care interventions 
(Torstensen et al., 1998; Eadie et al., 2013; Hurley et al., 2015).  
 
Used alone or in combination, objective PA monitoring, education on CLBP, and exercise, may 
improve pain and associated outcome measures. An American RCT compared a pedometer-based 
walking program with motivation, feedback and social support to the comparative arm which 
received no support but only a pedometer with which to measure steps taken (Krein et al., 2013). 
Both treatment arms utilized a pedometer and therefore were potentially motivational to increasing 
participant steps (Krein et al., 2013). Without the educational component, exercise, or walking 
intervention the comparator arm also achieved small reductions in pain. The pedometer may have 
affected the participants feeling of care. Walking interventions may show benefit if they are 
objectively monitored (using a pedometer), graded via an evidence base, and are combined with pain 
education. This was observed in the current RCT. However, albeit showing a reduction in pain 
intensity, PA was unrecorded using a pedometer in intervention arms of usual care physiotherapy, 
and supervised exercise (Torstensen et al., 1998; Eadie et al., 2013; Hurley et al., 2015). Additionally, 
explicit pain education on CLBP was absent in one of these RCTs (Torstensen et al., 1998). The 
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combinations of these modalities are suggestive of other factors involved in treatment effect on 
reducing pain intensity. 
 
More recently, standardized evidence-based forms of education on CLBP are frequently now referred 
to as PNE, are used to reduce pain intensity (Puentedura and Flynn, 2016; Hush et al., 2018). Three 
previous RCT’s compared a usual care physiotherapy intervention to an exercise intervention 
including strength and flexibility exercises and a walking intervention for CLBP (Torstensen et al., 
1998; Eadie et al., 2013; Hurley et al., 2015). Of these, only two RCTs delivered explicit advice and 
education using ‘the Back Book’ to participants (Eadie et al., 2013; Hurley et al., 2015). The Back 
Book is intended as a valid and current guide for patients and clinicians containing advice based on 
the evidence-based research for management of LBP and mitigating disability (Roland, 2002). In 
three RCTs using walking as a CLBP treatment however, physiotherapists gave individualized 
education/ advice and the patients received information from ‘The Back Book’ promoting self-
management (Eadie et al., 2013; McDonough et al., 2013; Hurley et al., 2015). All intervention 
groups using ‘The Back Book’ showed reduced pain intensity at follow-up. The intervention groups 
included usual care physiotherapy, strength, and flexibility exercise, walking programs or PNE. 
Unlike these studies using the Back Book, the current RCT did not use standardized information but 
did educate patients on CLBP. Each physiotherapist was tutored in the understanding of CLBP 
according to NICE guidelines (National Collaborating Centre for Primary Care [UK], 2009). Each 
of the modalities applied, alone or in combination were used internationally as part of evidence-based 
practice. Physiotherapists were instructed to encourage participants with the knowledge of PNE 
focussing on the neurobiology of pain (Moseley, 2003; Moseley and Arntz, 2007; Louw et al., 2011; 
Puentedura and Louw, 2012; Butler and Moseley, 2013). The method used was to educate patients 
about neurophysiological processes involved in pain experiences rather than focussing on tissue 
pathology. The common factor between the previous studies using education and the current RCT 
was that patients received a form of education proposing management of CLBP. This interaction may 
have been responsible for reduction in pain intensity. The explicit absence of PNE may explain why 
some study interventions demonstrate significant differences in pain intensity. In some CLBP 
intervention studies, patient education on the self-management of CLBP was not described as being 
included in any of the treatment groups (Torstensen et al., 1998; Mirovsky et al., 2006). During 
manual therapy or exercise interventions, physiotherapists are face to face with participants 
(Torstensen et al., 1998; Mirovsky et al., 2006). During face-to-face therapy there may be delivery 
of positive advice on CLBP, not explicitly PNE, which may positively assist the patient in behaviour 
change and self-management. Manual therapy was shown to be efficacious in treating pain when 
compared to walking and exercise interventions in a RCT comparing usual care physiotherapy to 
stretching and strengthening exercises or walking as self-exercise (Torstensen et al., 1998). This was 
controversial as heat, massage, TENS, and traction had been shown no better or no worse than a 
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placebo or control group in comparable physiotherapy studies (Van der Heijden et al., 1988; 
Manniche et al., 1988). The authors did not elaborate whether physiotherapists delivered pain 
education and if so, what kind of advice or education was included (Torstensen et al., 1998). Up to 
now, it appears that delivery of explicit reproducible education about CLBP may be an important 
factor in reducing pain intensity.  
 
Similarly, exercise in combination with education on CLBP may reduce pain. The comparative 
intervention arms using physiotherapy usual care and exercise therapy all used standardized 
education via ‘The Back Book’ (McDonough et al., 2013; Eadie et al., 2013; Hurley et al., 2015). A 
internet-based walking intervention had internet-based educational materials only for the walking 
intervention (Krein et al., 2013). All four trials using exercise combined with education showed small 
yet reduced mean pain scores (McDonough et al., 2013; Eadie et al., 2013; Krein et al., 2013; Hurley 
et al., 2015). Concurring with these results, exercise was combined with education on CLBP in the 
current RCT. In a trial that examined the impact of walking as self-exercise for CLBP treatment 
where no pain education was received, found that those who walked compared to stretching and 
strengthening exercise or usual care physiotherapy did not show significant pain reduction 
(Torstensen et al., 1998). Education on how to manage one’s CLBP pain symptoms may be a 
fundamental factor in reducing pain regardless of treatment modalities. 
 
For more than a decade a trend has been to move patients away from passive treatments such as 
massage and manipulation, towards prescribing exercise, education, and self-management for 
treatment of pain in those that have CLBP (Moseley, 2007; Groenendijk et al., 2007, Dean and 
Duncan, 2016). A concessionary view was conveyed, however, in a recent review of 13 papers 
showing LBP outcomes favoured a combination of manual therapy and/ or an exercise-based strategy 
in combination with PNE when compared to outcomes of education only approaches (Louw et al., 
2016). This elucidates the possible need for manual therapy in context, with appropriate education 
and advice delivered during physiotherapy visits. This evidence concurs with results seen in the 
current RCT and those using interventions of manual therapy, strength and stretching exercises or 
walking combined with PNE (McDonough et al., 2013; Eadie et al., 2013; Krein et al., 2013; Hurley 
et al., 2015). Furthermore, pain related outcomes were further improved when walking was combined 
with PNE when compared to PNE alone (McDonough et al., 2013). 
 
Aside from education on CLBP, varied forms of exercise, specifically when supervised are shown to 
improve CLBP pain outcomes, noted in a systematic review and meta-analysis (Hayden et al., 2005a; 
Ferreira et al., 2010). Both isometric lumbar stabilization and walking were used as exercise 
interventions in this RCT. The isometric lumbar stabilization taught may have had a carry-over effect 
when done at home as seen in Ferreira et al., (2010). Both P and PW interventions in the current RCT 
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used this modality. Concurring with this were interventions in previous walking intervention studies 
in the usual care physiotherapy intervention arm, which showed pain reduction outcomes (Torstensen 
et al., 1998; Eadie et al., 2013; Hurley et al., 2015).  
 
Exercise received by participants from a clinician differs in nomenclature, and is referred to as 
prescribed, dose or load, and pacing depends on the individual (Hayden et al., 2005a; American 
College of Sports Medicine, 2011). Graded frameworks of exercise graded by dose or pacing in 
walking may improve pain intensity outcomes. These varied factors may influence the mechanism 
of pain reduction. The mechanisms that may be responsible for pain intensity reduction through 
exercise are not clearly stated in previous reviews using walking and physiotherapy led lumbar 
stabilization exercises (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul 
et al 2018). The isometric lumbar stabilization exercise effect may decrease pain globally through 
the hypothesis that muscular hypertrophy and spinal stiffness are beneficial to the spine (Stanton and 
Kawchuk, 2008; Katsura et al., 2011). In the walking intervention, the assumption is made in Vogt 
et al., (2003) that altered hip extensor recruitment patterns alter muscle activation patterns impacting 
on the physiological loading and alter the direction and magnitude of joint reaction forces. Previous 
CLBP exercise studies emphasize biomechanical reasons why muscles involved in walking may 
reduce pain through muscular strength and neuromuscular control (Stanton and Kawchuk, 2008; 
Katsura et al., 2011; Vogt et al., 2003). Two physiotherapy reviews suggest aerobic exercise 
modulates CLBP by increasing blood flow and nutrients to lower back soft tissues, augmenting 
healing, and decreasing stiffness (Gosling, 2013; Gordon and Bloxham, 2016). The effect of exercise 
mechanisms on pain reduction remains multi-factorial. 
 
This RCT demonstrates that walking may have clinical application as an intervention for CLBP if 
combined with usual care physiotherapy. However, as there was no statistically significant difference 
between treatment groups in pain intensity, it remains unclear whether physiotherapist supervised 
exercise combination of walking and/or isometric lumbar stabilization exercise, or the beneficial 
effects of manual therapy, the placebo effect, or a combination of these factors lead to decreased pain 
intensities. None of the studies using walking as a CLBP treatment have been able to elaborate fully 
on the mechanisms involved in reducing pain intensity (Mirovsky et al., 2006; Koldaş Doğan et al 
2008; Eadie et al., 2013; McDonough et al., 2013; Karadeniz et al., 2014; Hurley et al., 2015 
Magalhães et al 2015; Cho et al., 2015; Lee and Kang 2016). 
 
The perception of any treatment as beneficial may play an important role in reducing pain related 
outcomes. The ‘Hawthorne effect’ is described as the alteration of behaviour by the participants of a 
study due to their awareness of being observed (Fry, 2018). Factors associated with the ‘Hawthorne 
effect’ including physiotherapy visits, completion of repeated outcome measures, using pain and 
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activity diaries, and wearing of pedometers may be of influence in pain reduction in all three groups. 
The Hawthorne effect is seen in improved outcomes across trials regardless of explicit treatments in 
the current RCT or discretionary use of modalities in previous studies. 
 
Expectation of pain following treatment 
From previous studies, patient expectation of the resolving of their pain has closely been studied 
alongside satisfaction, being similar but not the same (Bleich et al., 2009; Forero and Gómez, 2017). 
It is noted that satisfaction with treatment for reducing pain symptoms is associated with a ‘post 
purchase’ perception whereas expectation related to outcome is more related to a ‘pre-purchase’ 
perception (Forero and Gómez, 2017). The ontology of these two categories differs, where 
satisfaction is related to a retrospective view and expectation may be associated to a prospective 
view. In this RCT, expectation of pain outcomes was assessed in the entire cohort at baseline. A 
positive correlation was noticed between expectation of pain reduction and actual reduction in the 
whole cohort. Participants who expected less pain at 12-week follow-up demonstrated lower pain 
intensity at the 12-week follow-up. Expectation can influence outcome in terms of pain and has been 
corroborated and discussed elsewhere (Wiech et al., 2008; Atlas and Wager, 2012; Campbell et al., 
2013).  
 
Neurocognitive mechanisms of expectation may result in pain modulation (Wiech et al., 2008; 
Bystad et al., 2015). This may explain the result achieved in all three treatment groups. Expectation 
is a learned response involving previous positive experiences with a therapy, augmenting the placebo 
literature (Wiech et al., 2008; Colloca and Miller, 2011; Reicherts et al., 2016). Participants who had 
received previous physiotherapy were not excluded from this study, and so it is possible that they 
had had positive previous physiotherapy experiences. It is unclear if these associated factors were 
learned prior to entering the trial or developed after the trial began. 
 
It is not clear whether expectation or patient education in the initial appointment and assessment, the 
number of physiotherapy visits, exercises completed, or a combination of positive expectation, 
education and therapy received explained the decrease seen in pain intensity in the three treatment 
groups.  
 
Nociceptive pain and neuropathic pain  
Using the painDETECT questionnaire to determine pain phenotype, in this RCT, demonstrated that 
the clinical burden was greater for those patients with neuropathic CLBP compared to those with 
nociceptive CLBP across the entire cohort. This concurs with other studies (Chetty et al., 2012; Smart 
et al., 2012b; Baron et al., 2016; Spahr et al., 2017). It is not known what the clinical burden of pain 
phenotypes was in previous studies using walking to treat CLBP as pain was treated as a homogenous 
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entity (Torstensen et al., 1998; Mirovsky et al., 2006; Koldaş Doğan et al 2008; Eadie et al., 2013; 
Krein et al., 2013; McDonough et al., 2013; Hurley et al., 2015; Magalhães et al 2015; Cho et al., 
2015; Lee and Kang, 2016). 
 
The NeuPSIG guidelines on CLBP and PNP assessment in daily practice and clinical trials 
recommend measuring pain (Haanpää et al., 2010). Clinical practice research demonstrates the need 
for further neurophysiological understanding in in the treatment of CLBP (Moseley, 2007; Naidoo 
et al., 2012). Specifically, it is noted that South African physiotherapists have a poor understanding 
of the neurophysiology of pain (Naidoo et al., 2012). Hence, the current RCT may have clinical 
relevance for physiotherapists.  
 
The insight that pain related outcome measures in this RCT may present with greater patient burden 
for the neuropathic pain phenotype, may aid patient treatment through education and understanding 
of different outcome presentations when treating patients with CLBP. This RCT was not powered 
for six treatment groups (both pain phenotypes for each treatment group), but only for three treatment 
groups. Previously TENS and “specialised physiotherapy” had been mentioned as possible 
treatments for neuropathic pain (Chetty et al., 2012). This RCT does not demonstrate intervention 
effect on pain phenotype only greater post treatment burden with pain and disability outcomes 
remaining in the neuropathic pain phenotype. 
  
Further investigation into clinical management to improve neuropathic pain outcomes has been 
called for (Chetty et al., 2012). Patients can be informed of possible differences between pain 
phenotype presentations when discussing pain management.  
 
Effect of pain on dropout 
Walking interventions have been observed to reduce CLBP pain intensity and have had good 
adherence to walking protocols (McDonough et al., 2013; Krein et al., 2013; and Hurley et al., 2015). 
In this RCT, the largest drop out was found in the W treatment group. However, those in the W 
treatment group who were able to persist with the RCT were able to achieve a statistically significant 
reduction in pain intensity but not a clinically significant reduction in pain intensity. The patients that 
remained in the RCT, specifically in the W treatment group may have been a select group which did 
not avoid PA, indicating bias in the sample. Pain persistence or avoidance scenarios are previously 
documented. A study of 79 patients with CLBP were classified according to scores on the Patterns 
of Activity Measure-Pain into persisters, avoiders, mixed performers (high persistence and avoidance 
scores) or functional performers (low scores on both persistence and avoidance behaviour) (Huijnen 
et al., 2011). Measured using an accelerometer, the objectively measured PA over 14 days did not 
differ between groups (Huijnen et al., 2011). Since these differences in activity related behaviour 
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were not measured in the current RCT, further investigation may be warranted. To manage some of 
the potential bias, last observed pain intensity for the drop out analysis was analysed.  
 
There was a significant effect of pain intensity at baseline (p=0.01), and last observed pain intensity 
score (p=0.01) on drop out, in the W treatment group compared to the PW treatment group. Greater 
scores of pain intensity at baseline, and high last observed pain intensity scores predicted drop out. 
Since pain intensity and pain phenotype were confounding variables, either may be responsible for 
dropout. A fisher’s exact test demonstrated no association between pain phenotype and drop out 
(p=0.09). However, when examining the effect of baseline pain intensity on dropout, the odds of 
dropout were higher for the neuropathic pain phenotype compared to the nociceptive pain phenotype 
(OR 2.55 (95% CI 1.04 to 6.22)). Although when analysing the effect of last observed pain intensity, 
it appears that participants who had neuropathic pain phenotype would remain in the RCT since no 
significant effect on pain phenotype was shown in the data. If pain intensity was high as the RCT 
progressed, patients were likely to dropout.   
 
When treating CLBP patients using walking as an intervention for reducing pain intensity, careful 
clinical choice in deciding whether a walking program will be appropriate for patients may be 
necessary to avoid treatment termination. This opinion is supported early in the RCT where five 
participants who were randomised to the W treatment group discontinued the treatment because they 
were expecting manual therapy in usual care as offered in P and PW treatment groups. Other walking 
interventions have used the Self-efficacy scale measures to examine the extent to which participants 
could master their ability to persist with exercise and/ or walking in varied situations (McDonough 
et al., 2013; Hurley et al., 2015). Self-efficacy improved in the walking and education as well as the 
education only group, and participants in the walking group had 70% adherence to their weekly step 
targets (McDonough et al., 2013). Other trials however postulated that participants underestimate the 
difficulty of changing their exercise behaviour at baseline (Krein et al., 2013; Hurley et al., 2015). 
Both authors reported reduced self-efficacy post RCT and suggested future investigations, as their 
data appeared counter intuitive (Krein et al., 2013; Hurley et al., 2015). In order to analyse 
participants coping strategies with either persisting or avoiding further activity, the current RCT did 
not use a Self-Efficacy scale, Chronic Pain Coping Inventory or Patterns of Activity Measure-Pain 
scale (Jensen et al., 1995; Huijnen et al., 2011). In the current RCT, patients in the PW treatment 
group were more likely to remain in the RCT compared to W and P treatment groups. Related factors 
were not measured; however, the combination of therapies may have been more motivating and 
encouraging to participants. Clinically, the results may encourage the use of a pedometer-based 





A recent systematic review using walking as a treatment for CLBP concentrated on disability as the 
primary outcome (Lawford, Walters and Ferrar, 2015). It stated that walking was as effective as usual 
care, strength specific exercise, medical exercise therapy and supervised exercise classes to improve 
disability outcomes in adults with CLBP. Although the current trial did not concentrate on treatment 
effectiveness on disability, the results demonstrate no statistically significant between-groups 
differences in ODI scores between baseline and 12-week follow-up were seen. For the first time, P, 
PW, and W treatment groups were compared to one another including ODI as an outcome. However, 
even though all three treatment groups reported improved mean ODI score from baseline to 12-week 
follow-up, the greatest improvement in mean disability scores were observed in the PW treatment 
group. These results concur with latter systematic review furthermore recommending the use of 
walking and physiotherapy treatment for CLBP (Sitthipornvorakul et al., 2018). It is unclear at this 
point which factors involved in these treatments are more efficient to treat disability in CLBP. 
 
The Institute for Health Metrics and Evaluation (IHME) (2019) published their findings in the WHO 
publication ‘Global Burden of Disease’, headlining LBP, which included CLBP, as a leading cause 
of disability. Disability from LBP is greater than that caused by headache disorders, depressive 
disorders and diabetes (IHME, 2019). In the current RCT, disability measured with the ODI was 
significantly associated with pain intensity at 12-week follow-up, indicative of the relationship of 
disability and pain intensity in the clinical scenario. However, pain is not always an indicator of 
tissue damage (Eccleston and Crombez, 1999). The causes of disability can have numerous factors 
(O’Sullivan, 2005; Di Iorio et al., 2007; Chou, 2010; Schaller et al., 2015). Some of these are 
discussed below.  
 
The analysis demonstrated the effect of increased age, and unemployment on ODI score at 12-week 
follow-up. In the entire cohort at baseline, the mean participant age was 46.2 years, and 8.2% of 
participants were unemployed. The effect of age was significant, controlling for the other variables 
in the model. In the current RCT, age remained associated with ODI score, which concurs with 
studies on Japanese and Italian CLBP populations (Tonosu et al., 2012; Di Iorio et al., 2007). The 
current RCT ODI score was greater for those unemployed compared to those employed (p=0.03) at 
12-week follow-up. This narrative is reflected in a review stating that return to work be an essential 
outcome for chronic pain patients to reduce associated disability (Sullivan and Hyman, 2014). The 
association highlights that people who have greater disability from CLBP may be off work. At 
baseline, the current RCT cohort demonstrated moderate disability and included mostly employed 
patients (91.8%). This could be interpreted that moderate disability may not be sufficient to prevent 




Results from CLBP studies using education on CLBP, walking, strength and flexibility exercise 
classes, and usual care physiotherapy, demonstrate the possibility that one or many factors involved 
in these treatments may reduce disability (McDonough et al., 2013; Eadie et al., 2013; Hurley et al., 
2015). Varied education seen in pain management programs, typically focussing on cognitive and 
behavioural aspects, are constructive in reducing disability, normalising pain cognitions and promote 
self-efficacy (Moseley, 2002). Two reviews of physiotherapy pain management suggest exercise 
related factors globally reduce disability from CLBP (Gosling, 2013; Smith et al., 2014). Factors 
mentioned are muscle contractions mobilizing chemical irritants, non-opioid activation through 
descending inhibition via central nervous system effects together with positive psychophysiological 
adaptations (Gosling, 2013). Furthermore, improved musculature dampening forces may improve 
disability associated with CLBP (Smith et al., 2014). Pedometer-based walking and isometric lumbar 
stabilizations used are both considered as exercise. Usual care physiotherapy including massage and 
manipulation may reduce pain and furthermore encourage functional movement, reducing disability 
(Moseley, 2002). 
 
In studies of physiotherapy treatments including patients with CLBP, disability outcome measure 
scores appear to be reduced if exposed to increased number of treatments (Deutscher et al., 2009; 
Ferreira et al., 2010). In the current RCT, pain intensity at 12-weeks was associated with number of 
physiotherapy visits, so the number of physiotherapy visits was excluded from the analysis of ODI 
score. Although physiotherapy visits were excluded, the factor that was shared between all three 
treatment groups was exercise. Isometric lumbar stabilization, walking and the combination of both 
were exercise modalities in all three treatment groups in the current RCT which may have contributed 
to the effect of reduced ODI scores at 12-week follow-up. This concurs with the findings in two 
RCTs which showed no statistically significant difference between groups in disability scores, all 
interventions included exercise and showed reduced mean disability (Eadie et al., 2013; Hurley et 
al., 2015). As with pain intensity outcomes, a meta-analysis showed high doses of exercise were 
shown to reduce disability from CLBP (Hayden et al., 2005b). Previous CLBP epidemiological 
studies, and systematic reviews on CLBP treatment concur that CLBP is the leading cause of limiting 
activity (Chou, 2010; Schwellnus, 2011; Schaller et al., 2015). Hence, the importance of exercise 
associated interventions has been a focal point in CLBP research. 
 
Walking as exercise is evidenced to influence fitness, strength, and mobility of tissues of patients, 
possibly contributing to reduced disability from CLBP (Lawford, Walters and Ferrar, 2015).  
Disability may be influenced using a walking intervention if methodology of its application is 
evidence based and/or monitored objectively using graded doses of exercise. The current RCT and 
three others studied disability when comparing usual care physiotherapy to both exercise and walking 
interventions (Torstensen et al., 1998; Eadie et al., 2013; Hurley et al., 2015). A Norwegian study 
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found statistically significantly reduced ODI scores in the usual care physiotherapy and exercise 
interventions groups and not in a self-paced walking intervention (Torstensen et al., 1998). However, 
the current RCT, and two similar RCTs found that ODI score decreased in all groups whether it be 
usual care physiotherapy, group exercise or a graded dose walking intervention based on ACSM 
guidelines (Eadie et al., 2013; Hurley et al., 2015). Unlike the Norwegian study, disability scores 
were reduced in interventions describing graded doses of walking based on evidence-based structure 
(McDonough et al., 2013; Krein et al., 2013; Eadie et al., 2013; Hurley et al., 2015). Additionally, in 
one RCT, two groups of walking interventions both graded their dose of exercise over time (over 
ground compared to treadmill), both showing statistically significant reductions in ODI scores 
(Karadeniz et al., 2014). In this instance both groups were objectively measured (using heart rate) 
and combined with usual care physiotherapy (Karadeniz et al., 2014). Mean ODI score differences 
were not mentioned. In the current trial, the mean changes in ODI score from baseline to follow-up 
were largest in the group combining walking exercise and usual care physiotherapy. The current RCT 
is the first trial to compare this combination to its constituent parts and demonstrate the mean ODI 
score changes in in the PW treatment group.  
 
Furthermore, the current RCT and four other RCTs had participants wearing devices to measure 
activity in walking interventions (McDonough et al., 2013; Krein et al., 2013; Eadie et al., 2013; 
Hurley et al., 2015). The RCT conducted in Norway did not have any objective measure of activity 
grading (Torstensen et al., 1998). A pedometer-based walking program would allow the patient to 
recognize their levels of activity which may have influenced their activity and disability perception 
(Baker at al., 2008). It is unknown whether using an objective measure of walking alone reduces 
perception of disability when compared to other physiotherapy treatments.  
 
A meta-analysis showed high exercise doses (≥20 hours), individualized treatment, supervision of 
home exercise, and usual care physiotherapy which had an exercise component were associated with 
reductions in disability (Hayden et al., 2005b). This multiple-approach design applied to one RCT 
comparing usual care physiotherapy and a treadmill walking intervention, to a usual care 
physiotherapy and an over-ground walking intervention (Karadeniz et al., 2014). Both interventions 
used heart rate monitors to objectively measure exercise, had partial supervision, and both showed 
reduced disability (Karadeniz et al., 2014). Only the group which used over ground walking had 
statistically significant improvements in ODI scores after the Bonferroni correction. Using over 
ground walking in the current RCT (PW), the greatest ODI score reduction between three treatment 
groups was noted at 12-week follow-up. The benefit on disability may be linked to treatment setting 
(outdoors), a graded dose of evidence-based exercise, an objective measuring device regardless of 





In the current RCT, the usual care physiotherapy group also showed reduced disability however 
displayed unchanged step counts. The P treatment groups though still measured weekly steps, 
completed isometric lumbar stabilization exercise, and had a goal to reduce disability scores. 
Measuring activity, coupled with a set goal may add motivation to improve functional outcomes such 
as the ODI. However, this objective measure of steps was not seen in usual care physiotherapy which 
showed improvements in disability and no statistically significant difference between treatment 
groups in two former studies comparing walking, exercise and usual care interventions (Eadie et al., 
2013; Hurley et al., 2015). 
 
Isometric lumbar stabilization was used as an exercise in the P and PW treatment groups which could 
be the reason that reduced disability was seen in these two treatment groups. This modality of 
exercise was used in strength and flexibility exercises interventions which also showed reduced ODI 
scores in former studies (Eadie et al., 2013; Hurley et al., 2015). A systematic review on isometric 
lumbar stabilization which included 2,359 patients demonstrated statistically significant benefit on 
disability from CLBP (Smith et al., 2014). One mechanism that may explain why stabilization 
exercises may improve disability is its function to absorb stressful forces acting on the lumbar spine, 
increasing spinal stiffness and muscular hypertrophy, described in the motor control model 
(Richardson, Hodges and Hides, 2004; Behm et al., 2010; Byström et al., 2013). Additionally, if 
exercise is added to usual care physiotherapy, reductions in disability are expected (Hayden et al., 
2005b). In accordance with the evidence on exercise through isometric lumbar stabilization, future 
patients may use these modalities to minimize their disability. Exercises which were taught during 
physiotherapy sessions may have been done independently as per the current RCT methodology and 
are known to reduce disability (Ferreira et al., 2010).  
 
Systematic reviews demonstrate manual therapy used in usual care physiotherapy can also reduce 
disability from CLBP (Hayden et al., 2005a). The effects of pain-relieving modalities such as 
massage and manipulation may ease suffering which is known to predict reduced disability (Koes et 
al., 2010, Vigotsky and Bruhns, 2015; Pereira et al., 2017). This may emphasize the association of 
pain and disability in clinical practice (Moseley, 2002; Pereira et al., 2017). Therefore, usual care 
physiotherapy modalities that influence the periphery, mechanics, behaviour, and psychology of a 
patient might have disability reducing effects.  
 
Disability was examined in the current RCT in the combination treatment (PW) and in one RCT 
where walking interventions and usual care physiotherapy were combined (Karadeniz et al., 2014). 
Both RCTs found statistically significant improvements in ODI measures at follow-up. Both RCTs 
utilized massage in their physiotherapy in combination with walking. This concurs with evidence 
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that massage with remedial exercises is better than massage alone (Airaksinen et al., 2006). 
Furthermore, a Cochrane review suggested benefits of massage include improved functional status, 
especially if combined with exercise and education (Furlan et al., 2002). The current RCT and two 
other RCTs show no statistically significant difference between walking exercise and usual care 
physiotherapy including massage, mobilization, and exercises (Eadie et al., 2013; Hurley et al., 
2015). However, the current RCT demonstrates a greater mean change in ODI score in the PW 
treatment group. Despite no statistically significant difference, this is supported with evidence stating 
massage with remedial exercises is better than remedial exercise alone (Airaksinen et al, 2006). 
 
Due to the association of pain phenotype and disability seen in this RCT, it is unknown if the burden 
of disability is due to pain phenotype, disability, or pain intensity. This association has been 
demonstrated in previous detailed studies on pain phenotypes (Shaygan et al., 2013; Spahr et al., 
2017; Baron et al., 2016). Neuropathic pain phenotype is predictive of greater disability and is 
corroborated previously (Spahr et al., 2017; Baron et al., 2016). 
 
Kinesiophobia 
The TSK scores at baseline for all three treatment groups in this RCT suggested a kinesiophobic 
cohort. The TSK cut-off score of ≥37 indicates kinesiophobic behaviour (Vlaeyen et al., 1995; 
Nicholas et al., 2012). This fear avoidance behaviour was seen in all the intervention groups at 
baseline of three RCTs using walking interventions to treat CLBP (McDonough et al., 2013; Eadie 
et al., 2013; Hurley et al., 2015). This suggests the importance of fear avoidance and kinesiophobia 
as outcome measures with CLBP. A RCT (n=52) compared moderately intense treadmill walking to 
specific lower back exercises, mention a possible selection bias with participants only volunteering 
who had a low fear of activity (Shnayderman and Katz-Leurer, 2013). The strength of the current 
RCT was that the effects of the treatment groups used were observable since it was possible to recruit 
a cohort with high levels of kinesiophobia.  
 
Fear avoidance behaviour can impact on the perpetuation of CLBP related disability through 
hypervigilance and avoidance behaviours (Martinez-Calderon et al., 2020). The fear avoidance 
behaviour questionnaire was developed by Waddell et al., (1993). It was used in several studies using 
walking to treat CLBP (Shnayderman and Katz-Leurer, 2013; Eadie et al., 2013; Krein et al., 2013; 
McDonough et al., 2013; Hurley et al., 2015). However, in the current RCT the Tampa Scale of 
Kinesiophobia was used (Miller, Kori and Todd, 1991). Fear of pain in CLBP is broadly defined, 
however both scales are valid in underpinning the maladaptive psychology observed in CLBP 
(Martinez-Calderon et al., 2020). The fear avoidance model hypothesises that PA is avoided by some 
people with chronic pain believing that their pain will increase with increased PA (Leeuw et al., 
2007). Fear avoidance behaviour may contribute to increased disability since it contributes to 
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decreased PA levels (Verbunt et al., 2001; Ryan et al., 2009; Martinez-Calderon et al., 2020). Seeing 
as this cohort was classified as insufficiently active at baseline, the fear avoidance model may be 
reflected in this cohort.  
 
In the current RCT there was no statistically significant difference in TSK scores between baseline 
and 12-week follow-up between treatment groups. In RCTs where a walking intervention is 
compared to CLBP pain education (McDonough et al., 2013), pedometer wearing with no active or 
passive treatment exposure (Krein et al., 2013) or to usual care or exercise (Eadie et al., 2013; Hurley 
et al., 2015), the findings also found no statistically significant difference in fear avoidance between 
interventions following treatment.  
 
In the current RCT, all three treatment groups had reductions in mean TSK scores at the 12-week 
follow-up. This concurs with other RCTs using treadmill walking or exercise (Shnayderman and 
Katz-Leurer, 2013), walking and pain education or pain education (McDonough et al., 2013), and 
evidence based walking or usual care or exercise (Eadie et al., 2013; Hurley et al., 2015). These 
studies found no statistically significant differences in fear avoidance between groups at follow-up, 
although they did detect within-group fear avoidance score improvements between baseline and 
follow-up. The current RCT results demonstrate the PW treatment group presented with the greatest 
mean changes in TSK scores in the three treatment groups at 12-week follow-up. Only one trial in 
the three reviews in Table 19 analysed this combination of walking exercise and usual care 
physiotherapy (Karadeniz et al., 2014). No mean changes in TSK scores were analysed in that trial. 
The evidence from the current RCT highlight the requirement to examine CLBP biopsychosocially. 
Two recent systematic reviews on using walking as an intervention for CLBP included the studies 
using fear avoidance behaviour outcomes (Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et 
al., 2018). Fear-avoidance outcome measures were not used in studies in an earlier review using 
walking to treat CLBP and LBP (Hendrick et al., 2010). This may demonstrate the movement 
towards a biopsychosocial approach of CLBP over time. Kinesiophobia was developed as an 
outcome for chronic pain in 1991 (Miller, Kori and Todd, 1991). Therefore, this measure for CLBP 
treatment seems appropriate with walking interventions in the current RCT and in recent reviews 
using fear avoidance measures (Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al., 2018).  
 
Physiotherapy treatment involving many modalities (e.g.: exercise, mobilization) is now established 
as treatment for kinesiophobia (Martinez-Calderon et al., 2020). Isometric lumbar stabilization was 
one exercise used in the current RCT, and interventions in RCTs also using walking to treat CLBP 
(Eadie et al., 2013; Hurley et al., 2015). Due to improved scores in fear avoidance and kinesiophobia 
over time in all the treatment groups, the current RCT concurs with previous RCTs, that isometric 
lumbar stabilization may have a positive effect on reducing kinesiophobia (Eadie et al., 2013; Hurley 
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et al., 2015). It too has been shown to be effective in treating CLBP pain and disability outcomes 
(Smith et al., 2014). However, it has been criticized for increasing fear avoidance behaviour, 
promoting unhealthy beliefs and thoughts on pain and function in other studies (Unsgaard-Tøndel, 
2010; Marshall et al., 2013; Nijs et al., 2013). When comparing treatments, a trend towards fear 
avoidance in stabilization exercises compared to stationary bikes, slings, and general exercises is 
noted (Unsgaard-Tøndel, 2010; Marshall et al., 2013). Albeit having smaller mean TSK score 
improvement in the P treatment group, this was not observed in the current RCT or two similar RCTs 
(Eadie et al., 2013; Hurley et al., 2015). Lumbar stabilization may mechanically decrease pain and 
reduce fear of movement. However, in teaching the exercise, the positive cognitive effects cannot be 
ignored when clinicians educate and explain the benefits of these exercises. 
 
The fundamental use of exercise and advice/ pain education may have resulted in reductions in 
kinesiophobia. Exercise could have been either progressive walking exercise interventions and/or 
isometric lumbar stabilization. This was seen in this RCT and similar RCTs on cohorts with CLBP 
(McDonough et al., 2013; Eadie et al., 2013; Hurley et al., 2015). In a RCT with 135 acute patients 
with sciatica, patients with a higher baseline level of kinesiophobia had particular benefit with 
reducing leg pain intensity at 12-month follow-up in response to physiotherapy (consisting of non-
specific exercise and pain education) (Verwoed et al., 2015).   
 
Mechanisms supporting improvements in kinesiophobia largely rely on increased movement, not 
necessarily a reduction in insufficiently active behaviour (Parker et al., 2017). The South African 
study showed that people with chronic pain tended towards insufficiently active behaviour (Parker 
et al., 2017). Therefore, consideration should be applied during treatment by monitoring the amount 
of increased PA advised to patients with CLBP. With increasing levels of PA, pain persistence 
behaviour may increase central sensitization and associated pain (Parker et al., 2017). Pain education, 
manual therapy and isometric lumbar stabilization exercises are seen in the current RCT and in RCTs 
in Lawford, Walters and Ferrar (2015). The difference in the current RCT from studies in previous 
systematic reviews on walking is that the usual care physiotherapy treatment group measured step 
count over 12 weeks. The usual care physiotherapy and exercise groups in RCTs in a previous 
systematic review did not record PA through step counts (Lawford, Walters and Ferrar; 2015). These 
intervention modalities may reduce kinesiophobia and not change insufficiently active status 
according to the <150-minute criteria, as was observed in the current RCT. This evidence concurs 
with that seen in the up-to-date systematic review showing a variety of conservative therapies are 
successful at reducing kinesiophobia in CLBP participants, regardless of change in insufficiently 




Several factors involved in exercise, PNE, and usual care physiotherapy could reduce kinesiophobia. 
There may be common relationships with kinesiophobia as in pain intensity and disability. As 
observed in the current RCT results, the PW treatment group presented with the greatest mean 
changes in TSK scores as well as pain and disability scores. Repeated visits may allow for additional 
assessment allowing for appropriate changes in therapy to improve outcomes. Increased number of 
taught exercises are seen to reduce pain and disability (Ferreira et al., 2010). This may support 
increased exposure to safe movement reducing fear avoidance. The results in the current trial would 
suggest this. The use of a pedometer and diary supporting graded and progressive movement 
exposure may be fundamental instruments in mitigating kinesiophobia. Patient education on CLBP 
management appears to be an important mechanism used to reduce fear of movement, common to 
many interventions studied previously (Eadie et al., 2013; McDonough et al., 2013; Hurley et al., 
2015). PNE has shown in combination with manual therapy and/ or exercise to decrease pain 
(Puentedura and Flynn, 2016). This may in turn support return to normal activity thereby reducing 
fear of movement. An example of PNE is use of ‘the Back Book’. The Back Book was used in three 
RCTs using walking to treat CLBP (Eadie et al., 2013; McDonough et al., 2013; Hurley et al., 2015). 
Concurring with this evidence, a clinical trial on behavioural interventions using education and ‘the 
Back Book’ by participants with sub-acute LBP with graded exposure or graded activity when 
compared with treatment-based classification treatments showed reduction in fear avoidance beliefs 
in the graded exposure and treatment-based classification groups (George, et al., 2008). The 
treatment-based classification group received education on LBP and the graded exposure group 
utilized the Back Book. The graded activity group however also used the Back Book and did not 
show significant reductions in fear avoidance. This suggests that information on managing CLBP 
may amplify the effect on reducing kinesiophobia however not be limited to one source. 
 
The number of physiotherapy visits was previously not analysed in systematic reviews comparing 
walking interventions on CLBP (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; 
Sitthipornvorakul et al., 2018). In the current RCT the number of physiotherapy visits was a 
significant predictor of TSK score at 12-week follow-up. Participants attending one to two 
physiotherapy visits in the current RCT did not show statistically significant changes in TSK score 
at 12-week follow-up. In another study comparing physiotherapy to physiotherapy combined with a 
psychosocial intervention (PGAP), the number of physiotherapy visits ranged from two - four per 
week up to 10 weeks (Sullivan and Adams, 2010). Reductions of kinesiophobia occurred in both 
groups. Even though the number of physiotherapy visits were not analysed, both groups attended 
more than three physiotherapy visits. A recent systematic review of 61 RCTs analysed the 
effectiveness of conservative and surgical interventions in reducing fear, including kinesiophobia in 
people with CLBP (Martinez-Calderon et al., 2020). Mean time spent with participants was recorded 
in individual RCTs however the number of visits was never analysed as an independent variable. The 
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therapeutic relationship necessary to reduce kinesiophobia appears to require several visits to 
improve the outcome. Factors discussed previously such as exercise and/ or education on CLBP 
maybe fundamental requirements in the increased number of visits required for reduced 
kinesiophobia.  
 
Mitigating fear associated with CLBP may vary depending on the mode in which the therapy is 
delivered. Therapy can be delivered by internet, telephone, or face to face. An up-to-date systematic 
review of fear of movement in individuals with CLBP did include mostly face to face therapy 
(Martinez-Calderon et al., 2020). However, two studies in this systematic review used internet based 
cognitive based therapy, both showing clinically significant reductions in fear avoidance beliefs over 
time (Carpenter et al., 2012; Chiauzzi et al., 2010). A RCT compared two internet-based treatments, 
an internet mediated walking program with support to internet log-ins for daily steps taken without 
support (Krein et al., 2013). The RCT found no difference between and within groups in fear 
avoidance at any time point from baseline to 12 months (Krein et al., 2013). These results differed 
to interventions using telephonic or face to face interactions. Therapeutic interactions via telephonic 
support showed reduced fear avoidance over time in walking interventions (Eadie et al., 2013; Hurley 
et al., 2015). Face to face interactions used for the exercise and usual care physiotherapy interventions 
also showed reduced fear avoidance over time. There were no statistically significant differences 
between groups in fear of movement (Eadie et al., 2013; Hurley et al., 2015). All treatment groups 
in the current RCT showed reductions in kinesiophobia, with all three treatment groups receiving 
face to face interactions. Due to different results shown between trials using walking for the outcome 
of fear avoidance behaviour, it may be worth considering the mode of optimal delivery when 
choosing a treatment. 
 
Kinesiophobia may be worth clinical consideration when choosing an intervention for CLBP. It 
appears that there are a variety of treatment delivery options physiotherapists can choose from 
clinically, having varied value in the effect on TSK score. More than two physiotherapy visits appear 
to be beneficial for reducing kinesiophobia. Face to face or telephone supervision may be an avenue 
worth exploring with further research, as one RCT did not reduce fear of movement using internet 
mediated care (Krein et al., 2013).  
 
Pain Catastrophizing  
Patients who experience reductions in catastrophizing have demonstrated the potential for also 
minimising disability and pain outcome scores (Sullivan et al., 2006a; Adams et al., 2007). The pain 
catastrophizing cut - off score demonstrates pain catastrophizing behaviour with scores greater than 
30/52 (Sullivan, Bishop and Pivik, 1995). A PCS score of 30 corresponds to the 75th percentile of 
the distribution of PCS scores in clinic samples of chronic pain patients (Sullivan, Bishop and Pivik, 
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1995). According to a cross sectional study of related MCIDs in 161 CLBP patients, a mean change 
in PCS score of 6.71 indicates a clinically significant threshold (Suzuki et al., 2020). In the current 
RCT, all three groups at baseline exhibited low pain catastrophizing scores (18/52). In a trial using 
walking as a treatment for CLBP and measuring fear avoidance, the authors mention a possible 
selection bias with participants being below the cut-off score for fear avoidance suggesting 
participants only entered the study who had a low fear of activity (Shnayderman and Katz-Leurer, 
2013). The same may have occurred in the current RCT, where pain catastrophizers chose not to 
participate in this study.  
 
There was no statistically significant difference in PCS scores between baseline and 12-week follow-
up between treatment groups. All three treatment groups (P, PW, and W), however, showed 
statistically significant within group reduction in PCS scores from baseline to 12-week follow-up. 
The P and W treatment groups demonstrated similar mean reductions in PCS score from baseline to 
12-week follow-up. The PW treatment group however, demonstrated the largest mean change in 
mean PCS score (-7.98). The confidence intervals indicate a plausible clinically significant reduction 
in mean PCS scores over time. (-10.9 to -5.07). NeuPSIG guidelines recommend including 
measurements of PCS score in chronic pain cohorts (Sullivan et al., 2006a; Haanpää et al., 2011). 
However, this RCTs’ entire cohort at baseline presented with low levels of catastrophizing. There 
may be an over reliance on psychosocial factors, and some factors may not be the primary driver for 
the disorder (O’Sullivan, 2005). Future physiotherapy treatments may be informed that the results of 
this RCT were subject to a cohort with low PCS scores. Pain catastrophizing did not appear to be a 
psychosocial driver for CLBP in this cohort. 
 
No studies in the reviews using walking interventions to treat CLBP measured pain catastrophizing 
(Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al., 2018). Unlike 
studies in these three reviews comparing walking interventions to usual care, the PGAP intervention 
used for CLBP however does use progressive walking programs and education to modify the 
behavioural variable of catastrophic thinking (Sullivan and Adams, 2010). This is concurred that pain 
and disability can be psychologically driven by mal-adaptive coping strategies such as pain 
catastrophizing (Nachemson, 1999). The results of the current RCT suggest further clinical research 
into the effects of a partly supervised walking intervention combined with physiotherapy if pain 
catastrophizing is suspected as a driving mechanism for the CLBP.  
 
More than two physiotherapy visits had a significant effect on reducing PCS scores in the current 
RCT. Several factors may have influenced this variable. Repeated assessments may be an important 
mechanism in providing additional information to the therapists modifying additional treatment to 
improve the PCS outcome. Since pain catastrophizing is a maladaptive psychosocial variable, the 
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support and empathy during visits was not quantified but cannot be ignored in terms of the effects 
seen in placebo literature (Tavel, 2014). All three groups in this study were taught exercises which 
could be done independently and instructed not to aggravate pain intensity. As recognized in the 
PGAP intervention, increased exposure to movement has a positive effect on reducing pain 
catastrophizing (Sullivan and Adams, 2010). It is recognized that PNE can reduce pain and disability 
(Puentedura and Flynn, 2016). A trial on treating LBP using behavioural interventions and education, 
together with using ‘the Back Book’ by two treatment groups and education on LBP in the third 
group, showed similar reduction pain catastrophizing in all groups (George et. al, 2008). It is possible 
that pain education combined with treatments used in this RCT assisted the reduction in PCS scores.  
 
Pain catastrophizing in this RCT is a modifiable variable. Studies included in reviews using walking 
and physiotherapy to treat CLBP did not measure pain catastrophizing (Hendrick et al., 2010; 
Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al., 2018). This novel evidence shows 
clinical potential. 
 
5.4 Walking Intervention 
 
The three previous systematic reviews comparing walking interventions to physiotherapy and 
exercise interventions have not compared manual physiotherapy with isometric lumbar stabilization 
or a pedometer driven walking program added to manual physiotherapy with isometric lumbar 
stabilization to a pedometer driven walking program (Hendrick et al., 2010; Lawford, Walters and 
Ferrar, 2015; Sitthipornvorakul et al., 2018). Despite there being no statistically significant difference 
in pain intensity, disability, kinesiophobia and pain catastrophizing between treatment groups, 
weekly step count differences were observed between the three treatment groups. However, the 
largest reduction in mean pain intensity scores were observed in the pedometer driven walking 
program combined with usual care physiotherapy group. 
 
In three previous systematic reviews comparing walking interventions to physiotherapy and exercise 
interventions for CLBP, objectively measured PA was captured using pedometers, heart rate 
monitors and accelerometers in walking interventions (Hendrick et al., 2010; Lawford, Walters and 
Ferrar, 2015; Sitthipornvorakul et al., 2018). The current RCT demonstrated average weekly step 
counts in all three interventions whereby all participants used pedometers, regardless if a walking 
program was advised. This allowed for comparison of PA as a number of weekly steps taken between 
and within treatment groups. This was important in examining PA behaviour in CLBP participants 
which were exposed to three treatments. Previously, pedometers were used to measure the number 
of steps taken in the walking interventions, but not in the education or exercise or physiotherapy 
interventions (McDonough et al., 2013; Eadie et al., 2013; Hurley et al., 2015). Heart rate was used 
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in one RCT to grade PA intensity in both walking interventions (Karadeniz et al., 2014). 
Accelerometers were used for one week at baseline and follow-up to examine changes in PA 
(McDonough et al., 2013). Only one study used pedometers in the walking programme intervention 
and the control arm (Krein et al., 2013). It was novel to objectively compare weekly step counts 
between the current three treatment groups over time, while no statistically significant difference was 
seen in outcome measures between groups. Individual or multiple components of the three treatments 
may be responsible for the treatment effect.  
 
Observing step counts in all three treatment groups indicated the decreased level of PA in chronic 
pain sufferers, specifically CLBP. This finding was corroborated in a recent South African study 
showing South African chronic pain populations exhibited low levels of PA but not specifying CLBP 
(Parker et al., 2017). Contextually, studies show lower levels of PA in CLBP populations (Björck-
van Dijken et al., 2008; Vancampfort, Stubbs and Koyangi, 2017). However, it is inconclusive in 
studies of LBP (Heneweer et al., 2011).  A study of 34129 adults ≥50 years, in six low-middle income 
countries, showed significant associations between CLBP and insufficiently active behaviour 
(Vancampfort, Stubbs and Koyangi, 2017). A Swedish study of 5798 adults suggested CLBP was 
associated with lower PA during leisure time (Björck-van Dijken et al., 2008). In contrast, a study of 
5058 people demonstrated insufficient PA (<2.5 hours/week) was not associated with LBP (Hussain 
et al., 2016). Furthermore, and a systematic review between 1999-2009 noted inconsistent results for 
LBP with leisure time physical activities, sports, and physical exercise (Heneweer et al., 2011). It is 
possible that acute and sub-acute LBP may be precursors to insufficiently active behaviour associated 
with CLBP. 
 
Ten thousand steps per day have become a benchmark for generic benefit to health outcomes (Tudor 
Locke and Bassett, 2004; ACSM, 2011; ACSM, 2013). The American College of Sports Medicine 
(ACSM) recommends a daily goal of 10,000 steps (ACSM, 2011; ACSM, 2013). Exercise is 
Medicine LBP guidelines recommend between 7000-9000 steps per day (Exercise is Medicine, 
2019). It may be necessary to re-examine recommendations for people with CLBP during treatment. 
Participants in this trial increased their steps in the W and PW treatment groups. The P treatment 
group never increased their weekly step count over time. In the methodology of the current trial, 
steps were calculated as an average of steps taken per week. However, when observing the steps per 
week, the treatment groups randomised to the pedometer driven walking program never reached 10, 
000 steps per day. The walking program advised was time based and not step based in the current 
RCT. Despite this, neither treatment group using the pedometer driven walking program achieved 
the weekly time goal set at the beginning of the RCT. No statistically significant difference between 
groups outcome measures was seen. However, when mean scores of outcome measures were 
compared over time, salient differences were noted. The greatest mean score changes were seen in 
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the PW treatment group, with the primary outcome of pain intensity demonstrating a plausible MCID 
in this treatment group. Increasing step counts above an unknown threshold may cause pain in this 
CLBP cohort. Pain neurophysiology studies expand on the process of sensitization which may have 
been responsible for increased pain with excess PA (Gangadharan and Kuner, 2013; Courtney, 
Fernández-de-Las-Peñas and Bond et al., 2017). Historical data suggests insufficiently active 
individuals or people living with chronic disease are shown to take between 3500-5500 steps/day, 
making the 10000 steps/day goals unachievable, risking failure and attrition (Iwane et al., 2000; 
Tudor-Locke and Myers, 2001b; Tudor-Locke et al., 2002a). This RCT together with outcomes from 
a study that examined feasibility to use pedometer driven walking for CLBP, suggests that step 
counts can be increased, associated with improved pain and disability outcomes (McDonough et al., 
2013). However further investigation into optimal daily or weekly step counts, and strategies to 
increase them are required for CLBP treatment. 
 
In the current RCT, weekly steps (from week 1-12) were divided by seven to show average daily 
step counts. Daily average step counts would amount to 3993 steps (P), 5565 steps (W) and 6258 
steps (PW) over the trial period. Accelerometer data in a RCT in Ireland demonstrated baseline steps 
less than 8000 per day (McDonough et al., 2013). Average steps recorded in a South African Health 
study, which aimed to examine the relationship between average daily steps and health (determined 
by body composition), reflect similar numbers, where 312 adult participants took on average 
6571(±3541) pedometer steps/day (Pillay et al., 2015). Another South African study aimed to 
compare PA levels of people with chronic pain (n=12) to a control group matched for age, gender 
and residential area (n=12) (Parker et al., 2017). Although the chronic pain participants were not 
exclusively those with CLBP, mean average daily step counts for people with chronic pain (2985) 
were lower than healthy controls (6409) (Parker et al., 2017). Both studies concurred with the current 
RCT where South Africans typically take less than 10,000 steps per day and exhibit low levels of PA 
(Pillay et al., 2015; Parker et al., 2017). Chronic pain therefore is associated with low PA levels 
observed in step counts in the current RCT and Parker et al., (2017). According to categorical data 
that classifies activity levels with outdated nomenclature, in the current RCT, after 12-weeks the P 
group was categorized as sedentary and W and PW groups as ‘low-active’ (Tudor Locke and Bassett, 
2004). Despite objective differences, all three treatment groups remained insufficiently active taking 
less than 10,000 steps per day. This may indicate the walking intervention implementation was able 
to change activity levels in this cohort, but not able to reach 10,000 steps per day or more than 150 
minutes of walking exercise per week. Since there was no follow-up after the 12-week intervention 
in the current RCT, it is unknown whether changed PA levels were sustained. 
 
Furthermore, differences in PA were observed depending on pain phenotype in the entire cohort and 
not within treatment groups. Participants with neuropathic pain phenotype demonstrated lower step 
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counts compared to those with nociceptive pain phenotype over the trial (p=0.02). Albeit that both 
pain phenotypes in the entire cohort and not within treatment groups were insufficiently active, an 
activity level classification through steps taken categorized the nociceptive pain phenotype 
participants having greater activity levels (Tudor Locke and Bassett, 2004). Studies on CLBP have 
not yet measured pain phenotype differences in steps taken. However, in a study of 100 type-2 
diabetic patients with diabetic neuropathy, having neuropathy was strongly associated with a lower 
step count (van Slotten et al., 2011). When using walking to treat CLBP, this association may assist 
clinicians in understanding the delayed progress of step counts in patients with CLBP phenotyped 
with neuropathic pain.  
 
Methodologies in walking programs differ widely in studies included in systematic reviews using 
walking to treat CLBP (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul 
et al., 2018). Advising walking programs in the current RCT and two others were based on the ACSM 
guidelines (Eadie et al., 2013, Hurley et al., 2015). Specific evidence-based application of walking 
exercise may be critical for advised walking programs used in CLBP since the current RCT and two 
others demonstrate not finding a statistically significant difference to comparator arms (Eadie et al., 
2013; Hurley et al., 2015). However, the reporting of mean pain intensity score differences may 
indicate minimal clinical differences as observed in the current RCT. One RCT comparing a walking 
program and education to education only, utilized a graded pedometer-driven walking program 
around the 5A’s model of health behaviour advice (McDonough et al., 2013). This advice was used 
previously for smoking cessation (Whitlock et al., 2002). The RCT was not fully powered, and 
despite both treatment groups showing improved pain and disability scores, the group with the 
walking program showed greater improvement. Thus far there is a lack of evidence in methods used 
whether one walking program is superior to another to use for patients with CLBP. The results in 
systematic reviews so far show walking to have no statistically significant difference when compared 
to other physiotherapy treatments and exercise programs (Hendrick et al., 2010; Lawford, Walters 
and Ferrar, 2015; Sitthipornvorakul et al., 2018). In the current RCT, the same walking program was 
used in two interventions, one with physiotherapy added to it, and there was no statistically 
significant difference in outcome measures between the treatment groups. However, a MCID was 
indicated for pain intensity in the PW group. This may suggest a walking program that is added to 
usual care physiotherapy has clinical potential for treatment of pain intensity in CLBP, but further 
exploration is required. The pedometer demonstrated that the walking program was not strictly 
adhered to by the PW treatment group. However, this combination of increased walking monitored 
by a pedometer combined with physiotherapy showed clinically meaningful results. An ideal walking 
program that is superior to others by means of outcome measures that are significantly reduced when 




No trial used in the systematic reviews has compared the same walking program against itself and 
added an additional evidence-based treatment to it, such as physiotherapy while measuring step count 
in both (Hendrick et al., 2010; Lawford, Walters and Ferrar, 2015; Sitthipornvorakul et al., 2018). 
The pedometer-based walking intervention advised in the current RCT, for the W and PW groups 
was identical and increased in weekly increments based on ACSM guidelines. Both groups increased 
their step count over the 12-week intervention period indicating behavioural change in PA when 
exposed to a walking intervention. However, the PW group achieved higher weekly step counts 
compared to the W group. Weekly step count in both walking interventions did not increase to the 
extent proposed in the RCT methodology. Despite no statistically significant differences between 
treatment groups in pain intensity, disability, kinesiophobia and pain catastrophizing, the 
combination with usual care physiotherapy may have increased the supervisory capacity of the 
physiotherapists resulting in increased step counts. If secondary co-morbidities required increased 
step count, for example diabetes, cardiac conditions, or obesity, differences between groups step 
counts may require attention. The differences in step count/pacing between these two treatment 
groups may require further study to understand what factors motivated the increased step counts in 
the PW group despite being advised the same walking intervention. The W and PW groups increased 
their step number in week 1-12 however step number did not increase incrementally over the 12-
weeks as was advised. Step count increased from baseline but increased minimally from week two 
onwards despite an upward trend. Several factors may have limited participant adherence to the 
incremental exercise dose increase. One factor may have been pain sensitization. Participants’ pain 
may have increased, and the study methods were to instruct a reduction in walking until pain returned 
to ambient levels or lower. Furthermore, the PW group demonstrated a MCID in pain intensity at 12-
week follow-up. The relationship of a MCID in pain intensity and greatest weekly step count may 
require further exploration. Reasons for not walking exactly as set out by the program were not 
recorded. Therefore pacing, effects of supervision, and goal setting may require further study in order 
to examine what effects varied amounts of walking have on CLBP. Since there is no gold standard 
of frequency, duration and intensity of walking which will be beneficial for CLBP outcomes, 
variances in pacing may require additional RCTs to investigate if these contributing factors are of 
greater benefit for outcome measures and treatment groups in this RCT. Evidence for exact amounts 
of exercise benefitting CLBP outcomes remains elusive. A review of 16 studies showed for health 
outcomes such as adiposity, blood lipids and psychological wellness, there is a paucity of evidence 
showing whether several bouts of exercise is as effective as one continuous bout (Murphy et al., 
2009). A concurring view in cardiovascular benefits admits despite progress, understanding of how 
exercise dose across the spectrum affects cardiovascular health is needed (Wasfy and Baggish 2016). 
The same exists for CLBP. The current RCT proposed a methodology of a 10% weekly increase in 
time spent walking. This contrasts with steps counts set in participant consultation with 
physiotherapists in a RCT comparing a walking program with education on CLBP to education alone 
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(McDonough et al., 2013). It was noted in a few participants, that even with collaboration with their 
physiotherapists, step counts did not increase (McDonough et al., 2013). This behaviour was 
observed in the current RCT. The resistance to increase step counts in the current RCT requires 
further investigation as in McDonough et al., (2013). Perhaps setting of an activity goal is essential 
but how it is set is not important (McDonough et al., 2013). This was the case in the current RCT 
and three others setting goals for walking (McDonough et al., 2013; Eadie et al., 2013; Hurley et al., 
2015). It has been recommended that physiotherapists receive additional training in recognizing 
resistance to behavioural change and find strategies to better assist behaviour change (McDonough 
et al., 2013). Goal setting in clinical medicine is complex, involving several factors. However, unlike 
the current RCT, previous studies using walking for CLBP involved patient perspective on the 
amount of walking which should be completed (McDonough et al., 2013; Eadie et al., 2013; Hurley 
et al., 2015). Furthermore, methodological differences in how goals were set in the current RCT and 
walking interventions vary (McDonough et al., 2013; Eadie et al., 2013; Hurley et al., 2015). The 
current RCT allowed for less than the advised duration to be done with no minimum of walking set 
to avoid increases in peripheral and central sensitization, although exercise goals (minutes per day) 
were pre-set. The findings of improved outcomes in this RCT concur with the American College of 
Sports Medicine position stand on prescribing exercise (Garber et al., 2011). Short, supervised bouts 
of exercise can produce significant health benefits (Garber et al., 2011). Unlike the current RCT, 
consultations regarding increases in walking were planned in three previous RCTs (McDonough et 
al., 2013; Eadie et al., 2013; Hurley et al., 2015). Regardless of these differences, these three RCTs 
and the current trial achieved improved pain and disability scores in the walking interventions. A 
RCT conducted in Norway used a self-exercise walking intervention which had no explicit 
incremental goals (Torstensen et al., 1998). Unlike exercise and physiotherapy comparator arms the 
self-exercise walking group showed no significant improvement in pain and disability outcomes. 
This strengthens the view that further research may be necessary for implementing optimal goals for 
CLBP walking interventions.  
 
Individuals with CLBP may have varying levels of baseline PA, which may affect outcomes if 
exposed to walking or physiotherapy. To control for this variance individuals classified as 
insufficiently active (<150 minutes of exercise per week) were recruited for the current RCT. Some 
studies have also recruited participants classified as insufficiently active however using other 
methods to determine this. For example, one study used objective measures such as an ActivPAL 
ensuring less than 8500 steps per day at baseline (McDonough et al., 2013). Others have used a 
questionnaire to ensure “low” to “moderate” levels of PA measured using the International Physical 
Activity Questionnaire (IPAQ) (Hurley et al., 2015). Another study excluded participants doing PA 
more strenuous than slow paced walking more than twice a week (Shnayderman and Katz-Leurer, 
2013). All of these studies attempted to include insufficiently active individuals; however varied 
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identifiers of baseline PA and varied objective measures of PA during the RCTs were used 
(McDonough et al., 2013; Shnayderman and Katz-Leurer, 2013; Hurley et al., 2015). Using similar 
treatment groups to the current RCT, in other walking RCTs (Eadie et al., 2013; Torstensen et al., 
1998; Hurley et al., 2015), only Hurley et al., (2015) specified insufficiently active behaviour in the 
inclusion criteria. One fully powered RCT, however, did not recruit only insufficiently active 
individuals and used a self-paced walking intervention without objective measurement (Torstensen 
et al., 1998). Their results showed no significant improvements in pain or disability in the walking 
intervention. This may suggest supervised and graded dose walking as an exercise prescription for 
CLBP pain and disability outcomes may only be beneficial if the population is insufficiently active, 
but this requires further exploration. CLBP participants with stratified levels of insufficiently active 
behaviour may not respond equally to walking and physiotherapy interventions. Having a universal 
objective measure for study inclusion as well as objective measures throughout an intervention for 
insufficiently active and physically active CLBP populations may be worthwhile for matching 
treatment to prior levels of PA.  
 
The current RCT used the definition of <150 minutes of exercise per week to recruit an insufficiently 
active population. This definition was used in a RCT comparing a pedometer driven walking 
intervention to usual care, and a paper outlining strategies to increase PA (Krein et al., 2013; Tuso, 
2015). The methodological design for the current RCT was to increase PA to exceed the 150 minutes 
per week classification cut-off. When compared to other RCTs using pedometer-based walking 
interventions, the methodological design to supersede the threshold of 150 minutes was not used 
(Krein et al., 2013; McDonough et al., 2013). The results of the current RCT show that at no point 
in this 12-week RCT, did the mean value of the weekly time spent doing the walking intervention in 
the W or PW groups exceed 150 minutes per week. While PW and W treatment groups increased 
time spent walking, both remained insufficiently active according to this definition. It is not known 
if the results achieved in the W and PW groups would have remained the same had one or both groups 
increased step counts weekly in a linear manner and exceeded the 150 minute per week of advised 
walking threshold. This contrasted with the mean walking volume seen in the walking intervention 
of one RCT reporting 151.8 (±80.1) minutes per week (Hurley et al., 2015). A recent review on 
interventions to change PA classifies 150 minutes of PA per week or more as active, and 30-149 
minutes as fairly active (National Institute for Health Research, 2019). The recognition of less than 
150 minutes of PA per week may be necessary to encourage achievable exercise or PA goals for 
CLBP populations. This is particularly salient as the PW group demonstrated a MCID in pain 
intensity at the 12-week follow-up. Despite this, varied step counts between groups were seen over 
12 weeks, and in context that all three treatment groups, and were insufficiently active at inclusion 
and remained insufficiently active at follow-up according to the 150-minute cut-off. Further research 
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may highlight varied outcomes depending on participant’s levels of prior PA and appropriately 
advised PA or exercise. 
 
Despite increased weekly step counts in W and PW groups in this RCT, all three treatment groups 
demonstrated no statistically between group differences. These results echo those seen in two RCTs, 
where walking interventions were not superior to manual therapy or even exercise therapy, not 
achieving statistically significant between-group differences in pain, disability, and fear avoidance 
behaviour (Hurley et al., 2015; Eadie et al., 2013). Former RCTs did not examine the number of 
physiotherapy visits as an independent variable, which perhaps requires further exploration. 
Torstensen et al., (1998) however showed manual therapy, and exercise therapy, to be superior to a 
self-exercise walking program. There was an absence of objective measurement of goal orientated 
walking, and CLBP education in Torstensen et al., (1998). This may furthermore explain the reduced 
effect in improving pain and disability in their self-exercise walking intervention as this was present 
in the current RCT. Evidence promotes exercise over manual therapy (Hayden et al., 2005b; 
Hendrick et al., 2010). However, it is seen that increasing activity with graded participation improves 
outcomes (Sullivan et al., 2006a; Ogunlana et al., 2018). The perspective in a review highlights the 
importance of pain education added to either manual therapy or exercise on outcome measures 
(Puentedura and Flynn, 2016). Despite no statistical between groups results in pain intensity, the 
results in this RCT suggest that education added to manual therapy as well as two types of exercise 
notwithstanding an isometric lumbar stabilization exercise as well as a pedometer driven walking 
exercise program demonstrate a MCID in pain intensity. Despite a trend of moving away from 
manual therapy towards the use of exercise, it does appear the presence of manual therapy with PNE 
is of clinical value (Puentedura and Flynn, 2016). Care, advice and education by means of 
supervision, face to face contact, telephone contact, or internet log-ins may have a positive effect on 
CLBP pain and disability outcomes despite walking program methodology (Torstensen et al., 1998; 
McDonough et al., 2013; Eadie et al., 2013; Krein et al., 2013; Shnayderman and Katz, 2013; Hurley 
et al., 2015). 
 
5.5 Consideration of scientific and clinical implications  
 
The current trial is novel and has several scientific and clinical implications.  
 
Scientific recommendations 
A scientific implication that has not been explored in previous studies using walking as a CLBP 
treatment but was significant in this RCT was number of physiotherapy visits. With the absence of 
NICE guidelines for the management of CLBP in South Africa, the methodology used in this RCT 
was implemented to carry out a level of evidence-based care associated with the number of visits. At 
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the time of trial design, the standard number of visits in NICE guidelines was between 9-10 
physiotherapy visits. Due to the multiple factors involved in physiotherapy visits, this may be worth 
exploring at a practice, patient, or therapist level. Factors at a practice level including empathetic 
care, advice, and education by means of supervision, face to face contact, telephone contact, or 
internet logins may have a positive effect on CLBP pain and disability outcomes despite walking 
program or physiotherapy methodology. With the number of visits showing statistical significance 
in this RCT, it may be worth examining the relationship with number of visits and patient level 
characteristics further including patient gender, age, level of education, employment status and BMI 
associated to number of visits. Factors at therapist level associated with physiotherapy visits worth 
exploring may include additional LBP training, gender, age, and hours spent working per week. 
Additional examination into these variables may be of benefit with the knowledge that the number 
of visits has been associated with physiotherapist level variables. In typical South African 
physiotherapy private practice, patients can receive as many visits as they can afford in their own 
capacity. This includes the amount individual’s medical insurance may cover. This was not the focus 
of this RCT but may warrant further attention. Future analysis of the effect of number of 
physiotherapy visits in context of private and public health care systems may be necessary. 
 
According to the advised walking used in the current trial, increased walking used to treat CLBP 
independently, or in addition to usual care physiotherapy may require further exploration. The three 
treatment interventions used to improve the CLBP outcomes showed no statistically significant 
difference between groups. If walking exercise is to be studied as a treatment, with the hypothesis 
that it will be more effective than other CLBP treatments, perhaps a different method of walking 
intervention is to be used. Exploring a new methodology of walking intervention may require 
improvements on goal setting, and enhanced supervision understanding what factors affect pain 
intensity when walking. Although when the same walking program was added to usual care 
physiotherapy a MCID in pain intensity was observed at 12-week follow-up. Trialling this treatment 
against other forms of treatment for CLBP may prove to demonstrate statistically significant changes.  
In the current RCT, participants were not requested to record reasons why they were not able to 
maintain incremental time to walk in the W and PW treatment groups. If this data had been captured 
and analysed in the current RCT, potential obstacles to using the walking interventions, improved 
goal setting and improved pacing may have been demonstrated. Due to the chronic pain nature of the 
participants, pain sensitization may have been the main limiting factor in adhering to the walking 
programs. Solutions to this obstacle and others could be targeted. Future research into factors 
affecting participant adherence to walking interventions may prove useful in designing walking 




Deciding on which measurement or outcome to use has scientific implications. Previous reviews 
using walking and physiotherapy to treat CLBP did not make use of some measures that were 
highlighted in this trial. Measuring pain catastrophizing, and expectation of pain intensity taken at 
baseline, may provide useful information in future studies of CLBP using the current treatments. 
Measuring pain catastrophizing may be worthy of exploration in future studies whose cohorts are 
typified by pain catastrophizing behaviour as it was a modifiable variable in the current RCT. 
Clinician management of patient expectations is an avenue requiring further exploration. Studies up 
until now have measured satisfaction with treatment. Literature on expectation of pain which affects 
outcomes infers a relationship (Koyama et al, 2005; Keltner et al 2013). A strength in this trial is that 
expectation should be studied before treatment of CLBP, since participants who expected lower pain 
intensity at baseline were likely to have lower pain intensity at the 12-week follow-up. Previous 
studies using walking to treat CLBP did not record participant expectation of pain. Using the same 
study design would be of interest examining pain outcomes between groups of high, moderate, or 
low levels of expectation of reduced pain intensity. Assessment of coping strategies with difficult 
demands was used in previous RCTs using walking and physiotherapy to treat CLBP. A measure of 
patient behaviour that was not used in this RCT was differences in coping strategies involved in 
pacing and goal setting. Self-efficacy improved in the walking and education as well as the education 
group, and participants in the walking and education group had 70% adherence to their weekly step 
targets (McDonough et al., 2013). Other authors postulated that participants underestimate the 
difficulty of changing their exercise behaviour at baseline (Krein et al., 2013; Hurley et al., 2015). 
Both authors reported reduced self-efficacy post RCT and suggested future investigations (Krein et 
al., 2013; Hurley et al., 2015). Outcome measures worth considering are Self efficacy scale, Chronic 
Pain Coping Inventory, and Patterns of Activity Measure-Pain scales (Jensen et al., 1995; Huijnen et 
al., 2011). The current RCT did not use these measures to analyse participants coping strategies with 
either self-efficacy or persisting/avoiding further activity. In the current RCT, patients in the PW 
treatment group were more likely to remain in the RCT compared to W and P treatment groups. 
Using the above measurements may help with understanding these differences in future studies. 
 
Using the painDETECT to phenotype pain proved illuminating in observing distinct differences in 
pain phenotypes in this cohort. Potentially, future RCTs could use the painDETECT to phenotype 




There are several clinical implications to this novel research. Firstly, regardless of treatment 
intervention specifically applied in this RCT, the number of physiotherapy visits was statistically 
significant in changing the outcome measures used at follow-up. As expressed by a South African 
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study explaining that a poor understanding exists in treating CLBP, this trial should encourage 
physiotherapists to try a minimum of three treatments to see a positive change in outcomes. If the 
three treatment protocols are used clinically, patients and clinicians may expect to see positive 
changes following treatment exceeding three physiotherapy visits. 
 
The only treatment group that demonstrated a MCID in pain intensity was the PW treatment group. 
Given the choice, advising patients to follow a pedometer driven walking program whilst attending 
usual care physiotherapy has clinical application when treating CLBP pain intensity. 
 
No statistically significant difference between treatments was observed. Education about PNE 
together with walking or isometric lumbar stabilization appear to be common factors noticed in 
treatments associated with improved outcomes. These exercises and PNE may be encouraged in 
CLBP treatment.  
 
Measuring what the patient expects their change in pain intensity to be prior to treatment, may be 
warranted. Physiotherapists may gain confidence with the association of positive expectation 
associated with reduced pain intensity post treatment. Understanding this may assist physiotherapy 
management treating pain intensity depending on the level of patient expectation. 
 
Managing pain intensity remains a clinical priority. Although further study on coping mechanisms 
for managing pain intensity may be warranted in this cohort, caution may be necessary in selection 
of treatment and patient to prevent them discontinuing treatment. Patients with CLBP are more likely 
to continue with treatment using a pedometer-based walking program and usual care physiotherapy 
than a pedometer-based walking program alone. Physiotherapists using a NRS to measure pain 
intensity should be aware that patients with high levels of pain intensity may discontinue treatment 
at any point due to elevated pain levels. It may have been useful to use an outcome measure such as 
the Chronic Pain Coping Inventory or Patterns of Activity Measure-Pain understanding participants 
coping strategies with either persisting or avoiding further activity (Jensen et al., 1995; Huijnen et 
al., 2011).  
 
Furthermore, using pain phenotyping at baseline may help clinicians understand varied patient 
progress during CLBP treatment. Physiotherapists and patients should not become despondent with 
smaller improvements seen in neuropathic pain phenotypes. Recognizing this process will help guide 





Chapter 6: Conclusion  
 
Conservative treatments for CLBP are gaining traction since previously used treatments usual care 
physiotherapy and walking exercise. The two have not yet been combined and trialled against its 
constituent parts in a study. The primary objective of this RCT was to assess changes in pain intensity 
between baseline and 12-week follow-up between and within the following three treatment groups: 
usual care physiotherapy (P), a partly supervised pedometer-based walking intervention (W), and a 
combination of both (PW) in patients with nociceptive or neuropathic CLBP. Secondary objectives 
assessed changes in disability, kinesiophobia and pain catastrophizing between baseline and 12-week 
follow-up between and within the three groups. Uniquely, this RCT included pain phenotyping in 
the modelling processes. This RCT demonstrated that no statistically significant difference between 
groups was observed with respect to pain intensity, disability, kinesiophobia and pain 
catastrophizing. Respecting all four outcome measures, every treatment group showed improved 
within group scores at 12-week follow-up. The only treatment group showing a minimally clinically 
important difference in pain intensity at follow-up was the PW treatment group. Compared to the 
nociceptive pain phenotype, the neuropathic pain phenotype did predict a greater score in pain 
intensity and disability scores at 12-week follow-up. 
 
Aside from the placebo effect or regression to the mean, common factors exist in the three treatment 
groups. Key points of this research highlight common factors between the three intervention groups 
and novel information regarding treatment of CLBP. With no statistically significant difference 
between the treatment groups at 12-week follow-up in outcome measures, similarities between 
groups were examined and four common factors between the treatment groups were identified in this 
RCT: 
•  the number face to face physiotherapy visits.  
• The use of advice and education on CLBP. 
• objective pedometer measurement of step count. 
• implementation of an exercise intervention.  
 
These common factors may have independently or in combination contributed to the results showing 
no statistically significant difference between treatment groups. All three interventions were 
represented by the presence of a physiotherapist in all treatment groups who gave advice and pain 
education on CLBP. All three interventions used a pedometer, possibly acting as a motivational 
factor, and recorded their steps and distance daily promoted for patient feedback. Lastly, all three 
interventions were treated with exercise (isometric lumbar stabilization exercise, a pedometer-based 




Novel information in the treatment of CLBP from the current RCT proposes the effect of the number 
of physiotherapy visits on pain intensity, kinesiophobia and pain catastrophizing outcomes. 
Acknowledging that expectation of pain intensity following these interventions at 12 weeks had not 
been studied, expecting a lower pain intensity at baseline was associated with a lower pain intensity 
at 12-week follow-up. This influence of expectation may have influenced all three treatment groups 
reduction in pain intensity. Additionally, neuropathic pain phenotype predicts greater pain and 
disability scores at follow-up. 
 
The number of visits were shown to be a predictor of pain intensity, kinesiophobia and pain 
catastrophizing at 12-week follow-up. Up to now the number of physiotherapy visits has not been 
studied as an independent variable using the treatment groups in this RCT. There appears to be a 
threshold to how many treatments are necessary to obtain a significant improvement in outcome 
measures. The current trial showed three or more physiotherapy visits were statistically significant 
in improving pain intensity, kinesiophobia and pain catastrophizing scores at 12-week follow-up. 
Further exploration may provide insight into constituent factors in physiotherapy visits. Measurable 
factors can involve physiotherapist, patient, and practice levels. A more in-depth examination of 
these categories may facilitate insight into efficiency associated to number of physiotherapy visits 
for CLBP. The effect of physiotherapy visits may plateau and suggest the ideal number of visits 
necessary for improved outcomes. The physiotherapy visits were all done face to face in this RCT 
unlike the combination of face to face, telephone, or the internet in comparative RCTs. Depending 
on resources available, the number of physiotherapy visits may differ depending on the mode of 
interaction between physiotherapist and patient. 
 
Associated with the number of visits was the teaching of an exercise to every treatment group. The 
novelty in this RCT was that all three treatment groups measured their steps throughout the week. 
When comparing weekly step count, only the usual care physiotherapy treatment group maintained 
consistent steps whilst the two treatment groups using the same walking program showed increased 
step counts. Despite statistically significant differences between treatment group step counts, there 
were no statistically significant differences in outcome measures between the three treatment groups 
at 12-week follow-up. The addition of the walking program used in this RCT, its absence, or used 
alone demonstrated no statistically significant difference in outcomes. The MCID in pain intensity 
shown in the PW treatment group is salient. In this RCT, step number can be compared between 
treatment groups. This suggests two courses of thought. One whereby results show statistical 
significance and the other denoting the clinical relevance of treatment. Firstly, the increased number 
of steps is not a requirement for a statistically significant difference in outcomes in this RCT, but 
only teaching of an exercise. The usual care physiotherapy treatment group demonstrated this 
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possibility by only performing isometric lumbar stabilization exercises. However, the addition of a 
pedometer driven walking program to usual care physiotherapy has clinical applications in the 
reduction of pain intensity. Additionally, the clinical implication of the MCID in pain intensity shown 
after 12-weeks in the PW group suggests clinical relevance to the use of this treatment. When 
choosing a walking intervention to reduce pain and disability from CLBP, the current RCT concurs 
with past evidence suggesting not all walking programs are equivalent in reducing CLBP. Up to now 
it appeared that designing a supervised or partly supervised progressive graded walking program 
whilst using a pedometer for objective measurement may demonstrate greater pain intensity score 
improvements compared to an unsupervised walking program with no graded dosage of walking and 
no objective measurement of PA. Objective measurement, and a form of structured program appear 
to be important factors although exercise pacing was not analysed in the current RCT walking 
programs. Possible alterations in frequency, duration and intensity of walking may be associated with 
different results in outcomes used. The motivation to improve health outcomes has been noticed 
when using pedometers previously. The ambient use of pedometers throughout the trial, in all three 
treatment groups, cannot be excluded as having a motivational effect on improving outcomes. 
 
Another factor which was common to all three treatment groups was advice and education on CLBP. 
Although it was not standardized and based on manuscripts as seen in the Back Book, it may have 
contributed to all three treatment groups improved outcomes at 12-week follow-up. The effect of 
number of physiotherapy visits, inclusive of exercise, advice, and education on CLBP may include 
other factors that were not measured. The care effect or factors related to placebo have been studied 
previously, but never compared between the three interventions used in this trial. This RCT, as with 
others using walking and physiotherapy, may demonstrate that the care shown for CLBP patients has 
yet to be measured explicitly.  
 
Unlike patient satisfaction, patient expectation was analysed in the entire cohort. The cohort 
demonstrated that those who expected lower pain intensity showed lower pain intensity scores. The 
data indicates that clinicians should acknowledge the patient’s expectation of a treatment prior to 
administrating it. Treatments associated with patient’s positive expectation of a reduction in pain 
intensity should be encouraged. Analysis in the current RCT was not performed on expectation of 
treatment group so no comment can be made on specific treatment. The cohort was from three 
medical settings. It is therefore likely their expectation for a result in reduced pain would be likely 
as participants were actively seeking treatment which may affect expectation. Acknowledging the 
patient’s perspective on proposed treatment appears an important factor in future treatment. 
 
The current RCT calls for future studies to expand on novel points. Due to no statistically significant 
between group differences seen, a comparison to other interventions would be reasonable. Two 
207 
 
interventions worthy of comparison are either evidence-based pain neuroscience education only, or 
usual care physiotherapy including massage and manipulation and excluding exercise and pain 
neuroscience education. If future trials are considered, advice and education should be standardized 
and based on evidence such as that found in the Back Book to improve reliability. Removing the 
isometric lumbar stabilization exercise and CLBP advice and education from the usual care 
physiotherapy treatment group in a future trial comparing to treatment groups including these factors, 
may suggest their importance as contributing factors to CLBP treatment differences. Due to the 
largest mean pain intensity score improvement seen in the PW treatment group, this treatment could 
be investigated further and trialled against other treatments not used in this trial. 
 
Future studies should be constructed on examination of number of physiotherapy visits as an 
independent variable to treat outcomes of CLBP. Measuring how many visits are required before a 
treatment plateau is reached, including effect size of number of treatments is warranted for treatment 
groups used in this RCT. Further study can be done on patient, physiotherapist and practice level 
factors associated with number of treatments. Demographics factors influencing number of visits for 
example; age and gender could be influential factors in patient and physiotherapist characteristics. 
Physiotherapist experience may dictate the number of physiotherapist visits required to achieve a 
significant difference in outcome change. The same trial could be done in a public versus a private 
medical system to see if the number of physiotherapy visits required for a significant change in 
outcomes is the same between two system contexts. Furthermore, the mode in which physiotherapy 
visits would be worth further study due to differences seen in study methodologies. The number of 
physiotherapy visits could be compared using the same pedometer-based walking program to treat 
pain intensity, kinesiophobia and pain catastrophizing using face to face, telephone and internet 
logins as three different treatment groups. Treatment effect on outcomes and cost may differ 
depending on mode of interaction suggesting varied clinical application. Factors involved in patient 
care during physiotherapy visits that were not recorded in this RCT may be worth further examination 
such as empathy or warmth. 
 
Improved measures between groups may prove useful for efficacy of a walking intervention. 
Pedometer data for 24 hours, including periods of rest may describe frequency, duration, and 
intensity of PA between treatment groups better. Study of these variables associated with daily pain 
intensity may give further insight into how these factors may affect pain sensitization. A future 
walking intervention with examination of participant differences in pacing recorded by frequency, 
duration and intensity may demonstrate a more efficient walking program for the treatment of CLBP. 
Recording differences in pacing associated with pain sensitization would be worthwhile to overcome 
obstacles due to pain preventing walking implementation. Following this, possibly using a mixed 
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methods methodology may provide valuable additional qualitative data exploring the application of 
the walking programs used in this trial. 
 
South African physiotherapists have reported a lack of knowledge in understanding 
neurophysiological underpinnings of CLBP. Highlighting pain phenotyping, this trial is relevant for 
clinicians, patients and funders since neuropathic pain predicts greater pain intensity and disability 
scores at 12-week follow-up in this CLBP cohort. The relevance will allow patients to be tested using 
the painDETECT who receive CLBP treatment to understand that pain and disability outcomes may 
not be homogenous at baseline and following treatment between patients depending on pain 
phenotype. Acknowledging this allows for understanding of varied clinical outcomes between 
patients. Future trials may use the painDETECT together with more robust cut offs for neuropathic 
pain phenotype. Instead of using the 13-38 in this trial, using 19-38 would suggest a pain phenotype 
with an increased likelihood of neuropathic pain phenotype. An additional specialized clinical 
examination would add to making the clinical diagnosis of specific pain phenotypes. Future trials 
can test which treatment intervention is more efficient in reducing pain intensity, disability, 
kinesiophobia and pain catastrophizing in CLBP after phenotyping pain at baseline. This may prepare 
patients, physiotherapist’s, and funders for differences in pain phenotypes noticed in this RCT. This 
trial only introduced the effect of pain phenotypes in the modelling process but was not powered to 
detect changes between groups based on phenotypes. 
 
Recording what patients expect in pain intensity reduction from interventions in future trials is 
worthwhile. This trial showed that expecting a lower pain intensity was associated with achieving a 
reduced pain intensity at 12-week follow up in the entire cohort. Further study comparing 
intervention expectations may demonstrate cohort differences in expectation if treatment is revealed 
prior to baseline. It is known that expectation may be learned, so recording previous treatment 
experiences which were negative, ambiguous, or beneficial may be associated with varied changes 
in pain intensity at follow-up. This may add to understanding how treatment expectation can add 
value to proposed interventions. 
 
A trial with the same treatments with a one-year follow-up may be beneficial to re-examine between 
and within group outcome measures. Examining whether the groups who used the walking program 
continued to have step counts greater than the usual care physiotherapy treatment group may provide 
insight into PA modification. 
 
In future, studying the effects of the number physiotherapy visits on associated outcome measures 
would be a priority from findings of this study. A second point of departure would be to examine if 
other strategies could be employed to increase PA using walking and examine if these increases 
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promise improved outcome measure results. The clinical relevance of combining a partly supervised 
pedometer driven walking program with usual care physiotherapy is now better understood. 
Expectation appears intimately involved with pain intensity outcomes and is worthy of ethical 
appraisal in the clinical setting when treating patients. Lastly, physiotherapists may now have better 
understanding into varied responses in patients with CLBP based on pain phenotyping using 
questionnaires such as the painDETECT.  
 
This trial adds novel approaches to considering number of visits when treating CLBP. With previous 
attention to types of treatments, the current trial suggests a new focus on how many times 
physiotherapists treat patients may affect outcomes. The clinical relevance of a pedometer driven 
walking program added to usual care physiotherapy is noted when treating CLBP pain intensity. The 
current RCT acknowledges diagnosing CLBP with neurophysiological and psychosocial 
underpinnings. In addition, perhaps a deeper understanding of treatment content delivered in future 
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Dear Richard, 
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To:  
Subject: Trial registration on www.pactr.org - Approved 
Importance: High 
 
Dear Mr Feher 
 
Re: A comparison of a pedometer-based walking program versus physiotherapy for patients suffering 
from nociceptive or neuropathic chronic, recurrent low back pain in Johannesburg 
 
Please find attached confirmation of your registration with www.pactr.org; please ensure that you 
have read this letter and responded accordingly. Thank you for your application. We look forward to 
your registration of future trials. 
 





www.pactr.org Project Manager 
Senior Scientist: Cochrane Centre 
South African Medical Research Council 
Tel: +  | Cell:  
Francie van Zijl Drive, Parow Valley | Cape Town| Western Cape 
www.samrc.ac.za 
 
Disclaimer - The information contained in this communication from the sender is confidential. It is 
intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, 
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contents of this information is strictly prohibited and may be unlawful. This email has been 
automatically archived by Mimecast SA (Pty) Ltd This e-mail and its contents are subject to the 
South African Medical Research Council e-mail legal notice Available from. 
http://www.mrc.ac.za/about/EmailLegalNotice.htm   
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HEALTH HISTORY and DEMOGRAPHIC QUESTIONNAIRE 
Please answer the following health questions regarding your physical health: 
If you wish to add any details, please do so in the additional information column. Please ask the 
physiotherapist to explain anything below if you have any questions.  
 YES NO ADDITIONAL INFORMATION  
Age > 70 years    
Minor trauma if age > 50 years    
Significant trauma    
History of recent infection    
Penetrating wound near the spine    
Night pain     
Pain at rest    
Unexplained weight loss    
History of cancer    
Progressive or disabling neurological 
symptoms/ signs (numbness between 
your legs, bilateral sciatica or leg 
weakness, urinary retention, faecal 
incontinence 
   
History of osteoporosis    
Intravenous drug abuse    
Long term corticosteroid use    
Non responsive to conservative  
treatment after six weeks 
   
Immunocompromised    
Current Pregnancy    
Current Malignancy    
Rheumatic disease    
Diagnosed with Fibromyalgia    
Known Psychological disorders    
Current spinal fracture    
Medically unfit to participate in 
exercise program 
   
Are you a smoker?    
Are you able to walk a minimum of 20 
minutes 
   
Level of education  (no matric, matric, 
diploma, degree, post graduate) 
 
Age (years), Gender, Ethnicity  
Employed (yes/no)  
Smoker (yes/no)  
Height (cm)/ Weight(kg)  























Appendix 8: Lumbar assessment  
 
 
Professional Doctorate in Health 
Principal Researchers Name: RICHARD FEHER 
                                                      BSc (Physiotherapy) WITS 
                                                      MPhil (Sports Physiotherapy) UCT 
                                                      E-mail:  
                                                      Tel:  
                                                    
Title of the Project: A comparison of a pedometer-based walking program versus physiotherapy for 
patients suffering from primarily nociceptive or neuropathic chronic low back pain in Johannesburg. 
 
Complex evaluation involving a subjective and objective lower back pain examination. 
 
Lumbar Evaluation Form 
Patient Name  Eval Date  
Physician  DOB  




















   Flexion: Extension: 
R Lateral flexion:  





R Single leg extension :  
L Single leg extension: 
 
PASSIVE MOVEMENTS (ALL ACTIVE MOVEMENTS WITH OVER PRESSURE) 
 
   Flexion: Extension: 
R Lateral flexion:  





R Single leg extension :  



















Pt History of Pain/Symptoms  
1.    Onset of Sx’s →  ❑ Gradual    ❑ Sudden              If sudden, was there a specific event/injury?  
2.   Pain Level lower back  →                       Current pain    ____/10                    Worst pain   
_____/10                    Best pain     _____/10 
      Pain Level R Leg  →                       Current pain    ____/10                    Worst pain   _____/10                    
Best pain     _____/10 
      Pain Level L Leg →                       Current pain    ____/10                    Worst pain   _____/10                    
Best pain     _____/10 
3.     Pain Type lower back  →   ❑ Aching      ❑ Dull       ❑Tingling       ❑ Stabbing       ❑ 
Burning       ❑ Nauseating       ❑Other: 
        Pain Type R Leg  →   ❑ Aching      ❑ Dull       ❑Tingling       ❑ Stabbing       ❑ Burning       
❑ Nauseating       ❑Other: 
        Pain Type L Leg  →   ❑ Aching      ❑ Dull       ❑Tingling       ❑ Stabbing       ❑ Burning       
❑ Nauseating       ❑Other: 
4.    What relieves pain/Sxs?   
 
        Pain  lower back :  
        Pain R Leg  : 
        Pain  L Leg  : 
(positions, movements meds, modalities) 
5.   What makes pain/Sxs worse?  
         
       Pain  lower back :  
        Pain R Leg  : 
        Pain  L Leg  : 
(positions, movements, activities) 
6.   LBP Pain/Sx’s. Frequency:   
❑  Intermittent       ❑  
Constant         
Leg Pain/Sx’s. Frequency:   
❑  Intermittent       ❑  
Constant 
 
7.  LBP Duration of 
Pain/Sx’s: 
❑  < 16 days        ❑   > 16 
days 
 
8. Leg Duration of 
Pain/Sx’s: 
❑  < 16 days        ❑   > 16 
days 
9. LBP Pain/Sx’s worse: 
10. ❑  In Morning      ❑  At 
Night 
11.  Leg Pain/Sx’s worse: 
❑  In Morning      ❑  At Night 
 
12. Symptoms below the 
knee?    
YES      NO 
IF YES →  PERFORM LOWER QUARTER SCREEN 





LOWER QUARTER SCREEN 
 
SI/PELVIC ASSESSMENT     
Initial SI Test 
1. PSIS Levels in Sitting:                
+   - 
2. Standing Forward Flexion:
 +   -       
3. Supine to Sit:  
 +   -        
4. Prone Knee Flexion: 
 +   -  












Special Tests Right Left 
Right Left Right Left 
L1/L2 
(Hip flex) 
    Patellar DTR (L3-4) 
(Hypo 1+, Normal 2+, 




    Achilles DTR (S1-2) 
(Hypo 1+, Normal 2+, 




    
Babinski (+ or -) 
  
L5 (EHL)     Clonus (If +, # of beats)   
L5/S1 
(Evertors) 
    SLR (+ or -) 


















Flexion    
Extension    
R SB’ing    
L SB’ing    
R Rotation    
L Rotation    
 




















Does it recreate “their” pain?       
T12      
L1      
L2      
L3      
L4      
L5      
 












Does it recreate “their” pain?       
T12     
L1     
L2     
L3     
L4     

























    
 
SPECIAL TESTS: 
• STRAIGHT LEG RAISE TEST/ SLUMP: 
• PRONE KNEE BEND/FEMORAL SLUMP: 
• SACRO-ILLIAC JOINT TEST: 
• NEUROLOGICAL EXAMINATION: 
• X-RAY 
• BONE SCAN 
• CT SCAN 
• MRI SCAN 
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Appendix 9: Numerical Rating Scale for pain at baseline 









Appendix 10: Numerical Rating Scale for pain at six-weeks 










Appendix 11: Numerical Rating Scale for pain at 12-weeks 











FIRST, WE WOULD LIKE TO KNOW YOUR USUAL LEVEL OF PAIN 
On a scale of 0 (none) to 100 (worst imaginable), please indicate your usual level (during the 
past week) of: 
• Pain _________ 
 
FINALLY, WE WOULD LIKE TO KNOW YOUR USUAL LEVEL OF PAIN FOLLOWING 
TREATMENT. IN OTHER WORDS, WHAT ARE YOUR CURRENT LEVELS OF PAIN? 
On a scale of 0 (none) to 100 (worst imaginable), please indicate your usual level (during the 
past week) of: 
• Pain _________ 
 
FINALLY, WE WOULD LIKE TO KNOW YOUR USUAL LEVEL OF PAIN FOLLOWING 
TREATMENT. IN OTHER WORDS, WHAT ARE YOUR CURRENT LEVELS OF PAIN? 
On a scale of 0 (none) to 100 (worst imaginable), please indicate your usual level (during the 
past week) of: 






































Principal Researchers Name: RICHARD FEHER 
                                                      BSc (Physiotherapy) WITS 
                                                      MPhil (Sports Physiotherapy) UCT 
                                                      E-mail: r  
                                                      Tel:  
                                                    
Title of the Project: A comparison of a pedometer-based walking program versus physiotherapy for 
patients suffering from nociceptive or neuropathic chronic, recurrent low back pain in Johannesburg. 
 
Letter to study participant/ patient. 
Dear Participant 
 
We are investigating three different treatments for patients with chronic and recurrent lower back 
pain. The study is being run by Richard Feher (principal investigator) studying his Doctorate in 
Health at the University of Bath, Department of Health (United Kingdom). Patients who attend the 
Medicross Randburg, Dr Guy Teuwen Private Practice Neurosurgical Rooms or Towers West 
Medical Centre have been invited to participate.  
We would like to investigate which specific pain types respond best to preferred treatments for your 
pain. After you have given us your consent, using the painDETECT questionnaire, you will receive 
a specific diagnosis of your chronic recurrent lower back pain. You will then be randomly allocated 





We will then conduct a clinical examination which will involve the following: 
1. You will complete a form telling us about your general health. 
2. You will be asked a series of questions about your pain and function, and its effect on your 
life.  
3. The physiotherapist will examine your back using their hands as well as asking you to 
perform some activities using your lower back and your legs. 
Following the above steps, you will be treated by a qualified physiotherapist. The treatment program 
will last for 12-weeks. During this time you will visit the physiotherapist between 3 and 9 times 
depending on your individual needs. You will receive, and be shown how to use a pain and activity 
diary and pedometer. It is important that you wear the pedometer from the moment you put your 
clothes on in the begging of the day until you go to bed at night, in order for your correct step count 
to be measured. The pedometer will record step counts, distance and time. The diary must be 
completed every day before you go to sleep in the evening. Please record your average daily pain 
and the areas where you felt the pain in the spaces provided on each diary page. There will also be 
spaces to fill in your step counts and distance you walked in the day. Only fill in changes in 
medication taken if it differs from what you recorded on your very first entry. The diary should be 
filled out accurately and honestly over the next 12-weeks, with the completed diary handed in to your 
physiotherapist on your last physiotherapy appointment for the study to be successful. For the 
purposes of this study, only completed diaries will be accepted. If you do not hand in your pain diary 
on the last physiotherapy appointment, you will be contacted either telephonically or by e mail within 
2 weeks after the predicted date of your last appointment. If you still cannot be reached, then you 
will be excluded from the study. 
Direct benefits to you may include decreased pain during and after the study. Additional benefit may 
be shown in improved function with activities of daily living. Indirect benefits suggested by the study 
may be matching specific physiotherapy treatments to different types of pain. Since the study 
involves the participation of people who are suffering with chronic and/or recurrent lower back pain, 
the risk therefore involves increasing your levels of pain with participation in various physiotherapy 
treatments. The treatments aim to decrease your pain and improve your function over the 12-week 
period. If pain starts to increase, let your attending physiotherapist know. It is important that we try 
not to let your pain increase when participating in the study. Since this study involves participants 
suffering chronic pain, it is important to note that compensation and free medical treatment is not 
generally owed to research participants who suffer expected or foreseen adverse reactions to 
investigational therapeutic, diagnostic or preventative treatment when such reactions are not different 
in kind from those known to be associated with established interventions in standard medical 
practice. If however, impairment, disability or handicap as consequence of one’s participation in the 
study results, you will be entitled to free medical treatment and compensation. 
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You may withdraw from the study at any time without prejudice or penalty, but are kindly asked to 
contact the researcher if a decision is taken to do so. If you wish to withdraw from the study, please 
fill out section B in your pain diary. It will be more beneficial if more patients complete the study. 
Your data will only be accessed by the primary researcher as well as the treating physiotherapist 
allocated to you. Information regarding your treatments will be kept anonymous and safely stored in 
a safe on the premises of the practice where the research and treatments are to take place. The data 
will be kept in a secure location after the completion of the study by the principal researcher. If you 
have any queries before participation or during the study, do not hesitate to contact me on the 
numbers provided below. 
 
Researchers Contact information 
 
Investigator Name Contact Number Email address 

























This study has been reviewed and received ethics clearance through the Research Ethics Approval 
Committee for Health. 
Kind regards 






Appendix 16: Participant consent form 
 
 
Professional Doctorate in Health 
 
Principal Researchers Name: RICHARD FEHER 
                                                      BSc (Physiotherapy) WITS 
                                                      MPhil (Sports Physiotherapy) UCT 
                                                      E-mail: r  
                                                      Tel:  
                                                    
Title of the Project: A comparison of a pedometer-based walking program versus physiotherapy for 
patients suffering from nociceptive or neuropathic chronic, recurrent low back pain in Johannesburg. 
 
 




The University of Bath and doctoral student, Richard Feher, will be conducting a study to investigate 
the following: 
• To assess whether an allocated program will decrease lower back and/or leg pain in either or 
both of the different pain (pheno)type groups. 
• To assess if an allocated program will increase function in either or both of the different pain 
(pheno) type groups. 
• To assess which treatment group and/or pain phenotype best matches treatment expectation 
to outcome. 
 
The study will help us understand how much walking is necessary regardless of physiotherapy 





Researchers Contact information 
 
Investigator Name Contact Number Email address 






Nikki Coghill (Supervisor) 

















Please answer all the following questions by ticking the appropriate block. Once all the questions 
have been answered please print your name and sign the form in the space provided. 
Consent Form 
Have you read the study information sheet? Yes No 
Have you had an opportunity to ask questions and discuss the study? Yes No 
Have you received satisfactory answers to all of your questions? Yes No 
Have you received enough information about the study? Yes No 
Do you agree that your participation in this study is voluntary and that you are 
free to withdraw at any stage? 
Yes No 
Do you understand that the project has been reviewed by, and received ethics 
clearance through, the Research Ethics Approval Committee for Health of the 
University of Bath? 
Yes No 
Do you understand who will have access to personal data provided, how the data 
will be stored, and what will happen to the data at the end of the project? 
Yes No 
Do you agree to take part in the study? Yes No 
 
Participant (Please print name)   
Signature                                                                               Date                                        
Witnessed consent (please print name)                                                                             
Signature                                                                               Date                                        
Researcher (please print name)                                                                                         





Appendix 17: Random allocation schedule  
Neuropathic pain phenotype 
Study ID Treatment 
Patient 
file no. Physio 
Date 
recruited 
MCR-NP1 Standard Physiotherapy + Walking       
MCR-NP2 Standard Physiotherapy ONLY       
MCR-NP3 Walking ONLY       
MCR-NP4 Standard Physiotherapy + Walking       
MCR-NP5 Standard Physiotherapy + Walking       
MCR-NP6 Standard Physiotherapy + Walking       
MCR-NP7 Standard Physiotherapy + Walking       
MCR-NP8 Walking ONLY       
MCR-NP9 Standard Physiotherapy ONLY       
MCR-NP10 Standard Physiotherapy + Walking       
MCR-NP11 Standard Physiotherapy ONLY       
MCR-NP12 Standard Physiotherapy + Walking       
MCR-NP13 Walking ONLY       
MCR-NP14 Walking ONLY       
MCR-NP15 Walking ONLY       
MCR-NP16 Standard Physiotherapy ONLY       
MCR-NP17 Standard Physiotherapy ONLY       
MCR-NP18 Standard Physiotherapy + Walking       
MCR-NP19 Standard Physiotherapy + Walking       
MCR-NP20 Standard Physiotherapy + Walking       
MCR-NP21 Standard Physiotherapy ONLY       
MCR-NP22 Walking ONLY       
MCR-NP23 Walking ONLY       
MCR-NP24 Standard Physiotherapy ONLY       
MCR-NP25 Walking ONLY       
MCR-NP26 Standard Physiotherapy ONLY       
MCR-NP27 Standard Physiotherapy + Walking       




Neuropathic pain phenotype 
Study ID Treatment 
Patient 
file no. Physio 
Date 
recruited 
MCR-NP29 Standard Physiotherapy ONLY       
MCR-NP30 Walking ONLY       
MCR-NP31 Walking ONLY       
MCR-NP32 Standard Physiotherapy ONLY       
MCR-NP33 Standard Physiotherapy + Walking       
MCR-NP34 Standard Physiotherapy + Walking       
MCR-NP35 Standard Physiotherapy ONLY       
MCR-NP36 Walking ONLY       
MCR-NP37 Walking ONLY       
MCR-NP38 Walking ONLY       
MCR-NP39 Standard Physiotherapy + Walking       
MCR-NP40 Standard Physiotherapy ONLY       
MCR-NP41 Standard Physiotherapy ONLY       
MCR-NP42 Standard Physiotherapy + Walking       
MCR-NP43 Standard Physiotherapy + Walking       
MCR-NP44 Standard Physiotherapy + Walking       
MCR-NP45 Walking ONLY       
MCR-NP46 Standard Physiotherapy ONLY       
MCR-NP47 Standard Physiotherapy + Walking       
MCR-NP48 Walking ONLY       
MCR-NP49 Walking ONLY       
MCR-NP50 Walking ONLY       
MCR-NP51 Standard Physiotherapy ONLY       
MCR-NP52 Standard Physiotherapy ONLY       
MCR-NP53 Standard Physiotherapy ONLY       
MCR-NP54 Walking ONLY       
MCR-NP55 Walking ONLY       






Nociceptive pain phenotype 
Study ID Treatment 
Patient 
file no. Physio 
Date 
recruited 
MCR-NC1 Walking ONLY       
MCR-NC2 Standard Physiotherapy ONLY       
MCR-NC3 Standard Physiotherapy + Walking       
MCR-NC4 Standard Physiotherapy + Walking       
MCR-NC5 Walking ONLY       
MCR-NC6 Standard Physiotherapy + Walking       
MCR-NC7 Standard Physiotherapy ONLY       
MCR-NC8 Standard Physiotherapy + Walking       
MCR-NC9 Walking ONLY       
MCR-NC10 Standard Physiotherapy ONLY       
MCR-NC11 Standard Physiotherapy ONLY       
MCR-NC12 Walking ONLY       
MCR-NC13 Walking ONLY       
MCR-NC14 Standard Physiotherapy + Walking       
MCR-NC15 Standard Physiotherapy + Walking       
MCR-NC16 Standard Physiotherapy + Walking       
MCR-NC17 Standard Physiotherapy ONLY       
MCR-NC18 Standard Physiotherapy + Walking       
MCR-NC19 Walking ONLY       
MCR-NC20 Standard Physiotherapy ONLY       
MCR-NC21 Standard Physiotherapy + Walking       
MCR-NC22 Standard Physiotherapy ONLY       
MCR-NC23 Standard Physiotherapy + Walking       
MCR-NC24 Standard Physiotherapy ONLY       
MCR-NC25 Walking ONLY       
MCR-NC26 Walking ONLY       
MCR-NC27 Standard Physiotherapy + Walking       
MCR-NC28 Standard Physiotherapy + Walking       
MCR-NC29 Standard Physiotherapy ONLY       
MCR-NC30 Walking ONLY       
MCR-NC31 Walking ONLY    
MCR-NC32 Walking ONLY    





Nociceptive pain phenotype 
Study ID Treatment 
Patient 
file no. Physio 
Date 
recruited 
MCR-NC34 Standard Physiotherapy ONLY       
MCR-NC35 Standard Physiotherapy ONLY       
MCR-NC36 Standard Physiotherapy ONLY       
MCR-NC37 Standard Physiotherapy + Walking       
MCR-NC38 Standard Physiotherapy + Walking       
MCR-NC39 Standard Physiotherapy + Walking       
MCR-NC40 Standard Physiotherapy + Walking       
MCR-NC41 Standard Physiotherapy + Walking       
MCR-NC42 Standard Physiotherapy ONLY       
MCR-NC43 Standard Physiotherapy ONLY       
MCR-NC44 Walking ONLY       
MCR-NC45 Standard Physiotherapy ONLY       
MCR-NC46 Standard Physiotherapy ONLY       
MCR-NC47 Standard Physiotherapy + Walking       
MCR-NC48 Standard Physiotherapy ONLY       
MCR-NC49 Walking ONLY       
MCR-NC50 Walking ONLY       
MCR-NC51 Standard Physiotherapy ONLY       
MCR-NC52 Standard Physiotherapy + Walking       
MCR-NC53 Walking ONLY       
MCR-NC54 Walking ONLY       
MCR-NC55 Walking ONLY       
MCR-NC56 Walking ONLY       
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Neuropathic pain phenotype 
Study ID Treatment 
Patient 
file no. Physio 
Date 
recruited 
ABS-NP1 Standard Physiotherapy ONLY       
ABS-NP2 Standard Physiotherapy + Walking       
ABS-NP3 Standard Physiotherapy ONLY       
ABS-NP4 Walking ONLY       
ABS-NP5 Standard Physiotherapy + Walking       
ABS-NP6 Standard Physiotherapy + Walking       
ABS-NP7 Walking ONLY       
ABS-NP8 Standard Physiotherapy + Walking       
ABS-NP9 Walking ONLY       
ABS-NP10 Walking ONLY       
ABS-NP11 Standard Physiotherapy ONLY       
ABS-NP12 Standard Physiotherapy ONLY       
ABS-NP13 Standard Physiotherapy + Walking       
ABS-NP14 Standard Physiotherapy ONLY       
 
Nociceptive pain phenotype 
Study ID Treatment 
Patient 
file no. Physio 
Date 
recruited 
ABS-NC1 Standard Physiotherapy ONLY       
ABS-NC2 Walking ONLY       
ABS-NC3 Standard Physiotherapy + Walking       
ABS-NC4 Standard Physiotherapy ONLY       
ABS-NC5 Walking ONLY       
ABS-NC6 Standard Physiotherapy ONLY       
ABS-NC7 Standard Physiotherapy + Walking       
ABS-NC8 Standard Physiotherapy + Walking       
ABS-NC9 Walking ONLY       
ABS-NC10 Standard Physiotherapy + Walking       
ABS-NC11 Walking ONLY       
ABS-NC12 Walking ONLY       
ABS-NC13 Standard Physiotherapy ONLY       




Nociceptive pain phenotype 
Study ID Treatment 
Patient 
file no. Physio 
Date 
recruited 
DRT-NC1 Standard Physiotherapy + Walking       
DRT-NC2 Standard Physiotherapy + Walking       
DRT-NC3 Standard Physiotherapy + Walking       
DRT-NC4 Standard Physiotherapy ONLY       
DRT-NC5 Walking ONLY       
DRT-NC6 Walking ONLY       
DRT-NC7 Standard Physiotherapy ONLY       
DRT-NC8 Standard Physiotherapy ONLY       
DRT-NC9 Walking ONLY       
DRT-NC10 Walking ONLY       
DRT-NC11 Standard Physiotherapy ONLY       
DRT-NC12 Walking ONLY       
DRT-NC13 Standard Physiotherapy + Walking       
DRT-NC14 Standard Physiotherapy + Walking       
 
Neuropathic pain phenotype 
Study ID Treatment 
Patient 
file no. Physio 
Date 
recruited 
DRT-NP1 Walking ONLY       
DRT-NP2 Standard Physiotherapy ONLY       
DRT-NP3 Walking ONLY       
DRT-NP4 Standard Physiotherapy + Walking       
DRT-NP5 Standard Physiotherapy + Walking       
DRT-NP6 Standard Physiotherapy ONLY       
DRT-NP7 Walking ONLY       
DRT-NP8 Walking ONLY       
DRT-NP9 Standard Physiotherapy ONLY       
DRT-NP10 Standard Physiotherapy + Walking       
DRT-NP11 Standard Physiotherapy ONLY       
DRT-NP12 Standard Physiotherapy ONLY       
DRT-NP13 Walking ONLY       
DRT-NP14 Standard Physiotherapy + Walking       
DRT - North-riding Private Practice Neurosurgical Rooms.  
MRC - Randburg Medicross Clinic.  
ABS - Doornfontein Towers West Medical and Dental centre. 
